<!--#if expr="$title" --> <!--#echo var="title" --> <!--#else --> HIV Drug Resistance Database <!--#endif -->
Stanford University HIV Drug Resistance Database - A curated public database designed to represent, store, and analyze the divergent forms of data underlying HIV drug resistance.

Genbank References

BLAST search against GenBank file v. V 185.0 released on 2011-08-15
(search results include 129505 sequences from 1677 references)

This page contains a list of all GenBank entries on HIV-1 protease, RT and integrase grouped by reference. The reference may include a published paper or the title provided with the GenBank submission. The purpose of this page is to show which GenBank entries are in the HIV Drug Resistance Database and which aren't. The last column (Annotation) of the table shows whether or not there are plans to add the entry to the database. Each entry in the Annotation column is linked to a page explaining the annotation.

The entries were created by performing a BLAST search of the GenBank using the consensus B protease, RT and integrase amino acid sequence (give link to the sequences). The E-value column contains the lowest e-value (best match) for all the GenBank entries associated with a specific reference. The columns, # in GB, # in HIVDB, and % in HIVDB indicate the number of entries in GenBank associated with the reference, the number of these entries that are also in the HIV Drug Resistance Database, and the % of GenBank entries from a particular reference that are in the HIV Drug Resistance Database.

For a treatment summary for every isolate in our database and in the GenBank, click here. This file indicates whether or not the person from whom the sequenced virus was obtained had received one or more nucleoside RT inhibitor, nonnucleoside RT inhibitor, or protease inhibitor.


 

AuthorsTitleCitationE-value# in HIVDB# in Gb% in HIVDBAnnotation
Abecasis (2007) RECOMBINATION confounds the early evolutionary history of human immunodeficiency virus type 1: subtype g is a circulating recombinant form J. Virol. 81 (16), 8543-8551 (2007) 0 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Abecasis (2011) Molecular epidemiological analysis of paired pol/env sequences from portuguese HIV-1 patients AIDS Res. Hum. Retroviruses (2011) In press 0  
154
18PR
154RT
0 Pending
Acharya (2009) Human immunodeficiency virus type 1 drug resistance mutations in patients from India Unpublished 1e-178  
1
1RT
0 Unpublished
Achkar (2004) INFECTION with group M non-B HIV-1 subtypes in individuals living in New York City Unpublished 1e-159  
34
34PR
3RT
0 ARV Rx and/or other data are N/A
Adachi (1986) PRODUCTION of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone J. Virol. 59 (2), 284-291 (1986) 1e-165 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Adojaan (2004) PREDOMINANCE of a Rare Type of HIV-1 in Estonia J. Acquir. Immune Defic. Syndr. 39 (5), 598-605 (2005) 0 4
4PR
4RT
4IN
143
142PR
4RT
4IN
2 Gene fragment(s)
Aghokeng (2007) FULL-LENGTH sequence analysis of SIVmus in wild populations of mustached monkeys (Cercopithecus cephus) from Cameroon provides evidence for two co-circulating SIVmus lineages Virology 360 (2), 407-418 (2007) 0 5
3PR
5RT
5IN
5
5RT
5IN
100 HIVDB
Aghokeng (2009) Evaluation of transmitted HIV drug resistance among recently-infected antenatal clinic attendees in four Central African countries Antivir. Ther. (Lond.) 14 (3), 401-411 (2009) 0 135
135PR
135RT
135
3PR
135RT
100 HIVDB
Aghokeng (2010) Extensive survey on the prevalence and genetic diversity of SIVs in primate bushmeat provides insights into risks for potential new cross-species transmissions Infect. Genet. Evol. (2009) In press 0  
20
2RT
20IN
0 Pending
Aghokeng (2010) Genetic diversity of simian lentivirus in wild De Brazza's monkeys (Cercopithecus neglectus) in Equatorial Africa J. Gen. Virol. 91 (PT 7), 1810-1816 (2010) 2e-70  
1
1IN
0 Pending
Aghokeng (2011) High Failure Rate of the ViroSeq HIV-1 Genotyping System for Drug Resistance Testing in Cameroon, a Country with Broad HIV-1 Genetic Diversity J. Clin. Microbiol. 49 (4), 1635-1641 (2011) 1e-176  
145
22PR
145RT
0 Pending
Agneskog (2008) CHANGES in mutation patterns of a mosaic genome HIV-1 strain after treatment with nucleoside analogs and the integrase inhibitor raltegravir Unpublished 1e-173  
4
2RT
2IN
0 Pending
Agwale (2003) GENOTYPIC and phenotypic analyses of human immunodeficiency virus type 1 in antiretroviral drug-naive nigerian patients AIDS Res. Hum. Retroviruses 22 (1), 22-26 (2006) 5e-81 18
18PR
18RT
18
18PR
18RT
100 HIVDB
Agwu (2008) Analyses of HIV-1 Drug-Resistance Profiles Among Infected Adolescents Experiencing Delayed Antiretroviral Treatment Switch Following Initial Nonsuppressive Highly Active Antiretroviral Therapy Unpublished 1e-155  
155
146PR
31RT
0 Pending
Ahuka-Mundeke (2010) Full-length genome sequence a of Simian Immunodeficiency Viruses infecting a captive Agile Mangabey (Cercocebus agilis) is closely related to SIVrcm infecting red-capped mangabeys in Cameroon Unpublished 0 2
2PR
2RT
2IN
2
2RT
2IN
100 HIVDB
Ahumada-Ruiz (2009) Analysis of HIV-1 pol sequences from Panama: identification of phylogenetic clusters within subtype B and detection of antiretroviral drug resistance mutations Infect. Genet. Evol. 9 (5), 933-940 (2009) 0  
136
80PR
135RT
0 Pending
Ait-Khaled (2002) MUTATIONS in HIV-1 reverse transcriptase during therapy with abacavir, lamivudine and zidovudine in HIV-1-infected adults with no prior antiretroviral therapy Antivir. Ther. (Lond.) 7 (1), 43-51 (2002) 1e-98 156
156RT
156
156RT
100 HIVDB
Albert (1992) PERSISTENCE of azidothymidine-resistant human immunodeficiency virus type 1 RNA genotypes in posttreatment sera J. Virol. 66 (9), 5627-5630 (1992) 5e-55 20
20RT
20
20RT
100 HIVDB
Albert (1994) ANALYSIS of a rape case by direct sequencing of the human immunodeficiency virus type 1 pol and gag genes J. Virol. 68 (9), 5918-5924 (1994) 4e-77 23
23RT
26
26RT
88 HIVDB
Alcalde (2011) Clinical, epidemiological and molecular features of the HIV-1 subtype C and recombinants forms which is circulating in Sao Paulo city, Brazil Unpublished 1e-149  
14
12PR
8RT
0 Unpublished
Alexander (2002) INHIBITION of Human Immunodeficiency Virus Type 1 (HIV-1) Replication by a Two-Amino-Acid Insertion in HIV-1 Vif from a Nonprogressing Mother and Child J. Virol. 76 (20), 10533-10539 (2002) 0.027  
1
1IN
0 Gene fragment(s)
Ali (2010) Structure-based design, synthesis, and structure-activity relationship studies of HIV-1 protease inhibitors incorporating phenyloxazolidinones J. Med. Chem. 53 (21), 7699-7708 (2010) 1e-166  
6
3PR
4RT
0 Laboratory/experimental isolate
Alizon (1986) GENETIC variability of the AIDS virus: nucleotide sequence analysis of two isolates from African patients Cell 46 (1), 63-74 (1986) 1e-165 2
1PR
1RT
2IN
2
2PR
2RT
2IN
100 HIVDB
Allan (1993) SPECIES-SPECIFIC diversity among simian immunodeficiency viruses from African green monkeys J. Virol. 65 (6), 2816-2828 (1991) 2e-33  
8
8IN
0 Laboratory/experimental isolate
Allen (2005) SELECTIVE Escape from CD8+ T-Cell Responses Represents a Major Driving Force of Human Immunodeficiency Virus Type 1 (HIV-1) Sequence Diversity and Reveals Constraints on HIV-1 Evolution J. Virol. 79 (21), 13239-13249 (2005) 0  
14
14PR
14RT
14IN
0 Evolution/quasispecies study
Altfeld (2003) HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus Nature 420 (6914), 434-439 (2002) 0  
2
2PR
2RT
0 Case report(s) / study subset
Anderson (2000) TESTING the hypothesis of a recombinant origin of human immunodeficiency virus type 1 subtype E J. Virol. 74 (22), 10752-10765 (2000) 1e-164 4
4PR
4RT
4IN
4
4PR
4RT
4IN
100 HIVDB
Anderson (1993) ANALYSIS of envelope changes acquired by SIVmac239 during neuroadaption in rhesus macaques Virology 195 (2), 616-626 (1993) 5e-99  
1
1PR
1RT
1IN
0 Laboratory/experimental isolate
Andersson (1999) MOLECULAR characterization of HIV-1 and HIV-2 in individuals from Guinea-Bissau with single or dual infections: predominance of a distinct HIV-1 subtype A/G recombinant in West Africa Virology 261 (1999) In press 2e-66 7
7RT
7
7RT
100 HIVDB
Andreani (2008) CLINICAL evolution and antiretroviral resistance patterns in HIV-1 dual infected patients in Argentina Unpublished 1e-151  
71
62PR
40RT
0 Pending
Andresen (2007) CHARACTERIZATION of Near Full-Length Genomes of HIV Type 1 Strains in Denmark: Basis for a Universal Therapeutic Vaccine AIDS Res. Hum. Retroviruses 23 (11), 1442-1448 (2007) 0 17
17PR
17RT
17IN
17
13PR
17RT
17IN
100 HIVDB
Anta (2010) Identification of a new HIV-1 circulating recombinant form in Spain Unpublished 0  
4
4RT
0 Unpublished
Anton (2004) GENOTYPIC Resistance to Efavirenz/Protease Inhibitor Regimens Unpublished 0  
219
219PR
219RT
0 ARV Rx and/or other data are N/A
Apetrei (1998) HUMAN immunodeficiency virus type 1 subtype F reverse transcriptase sequence and drug susceptibility J. Virol. 72 (5), 3534-3538 (1998) 1e-77 14
14RT
14
14RT
100 HIVDB
Apetrei (2003) HIV type 1 diversity in Northeastern Romania in 2000-2001 based on phylogenetic analysis of pol sequences from patients failing antiretroviral therapy AIDS Res. Hum. Retroviruses 19 (12), 1155-1161 (2003) 1e-117 163
77PR
86RT
163
77PR
86RT
100 HIVDB
Apetrei (2004) DIRECT Inoculation of Simian Immunodeficiency Virus from Sooty Mangabeys in Black Mangabeys (Lophocebus aterrimus): First Evidence of AIDS in a Heterologous African Species and Different Pathologic Outcomes of Experimental Infection J. Virol. 78 (21), 11506-11518 (2004) 4e-71  
18
18IN
0 Laboratory/experimental isolate
Apetrei (2005) MOLECULAR Epidemiology of Simian Immunodeficiency Virus SIVsm in U.S. Primate Centers Unravels the Origin of SIVmac and SIVstm J. Virol. 79 (14), 8991-9005 (2005) 4e-90 47
47IN
47
47IN
100 HIVDB
Apetrei (2006) POTENTIAL for HIV transmission through unsafe injections AIDS 20 (7), 1074-1076 (2006) 1e-148  
21
17PR
13RT
0 Pending
Apetrei (2007) SIVSMM Subtypes Induce Specific Immunologic and Virologic Changes in Naturally-Infected Sooty Mangabeys Unpublished 3e-70  
96
96IN
0 Pending
Arien (2005) REPLICATIVE fitness of historical and recent HIV-1 isolates suggests HIV-1 attenuation over time AIDS 19 (15), 1555-1564 (2005) 0 23
23PR
23RT
23
23RT
100 Case report(s) / study subset
Arnold (1995) AT least five HIV-1 sequence subtypes (A, B, C, D, A/E) occur in England AIDS Res. Hum. Retroviruses 11 (3), 427-429 (1995) 1e-126  
4
4PR
0 Case report(s) / study subset
Arroyo (2004) HIV Type 1 Subtypes among Blood Donors in the Mbeya Region of Southwest Tanzania AIDS Res. Hum. Retroviruses 20 (8), 895-901 (2004) 0 20
20PR
20RT
20IN
20
20PR
20RT
20IN
100 HIVDB
Arroyo (2006) HIV-1 diversity and prevalence differ between urban and rural areas in the Mbeya region of Tanzania AIDS 19 (14), 1517-1524 (2005) 0 14
14PR
14RT
14IN
14
8PR
14RT
14IN
100 HIVDB
Arruda (2009) Genetic diversity on the integrase region of the pol gene among HIV-1-infected patients naive for integrase inhibitors in Sao Paulo city, Brazil AIDS Res. Hum. Retroviruses 26, 1 (2010) 1e-168 76
76IN
76
76IN
100 HIVDB
Arruda (2010) Differences in frequencies of pi-resistance mutations from HIV-1 of different subtypes (B, C and F) in a cohort of patients failing arv therapy Unpublished 0  
869
245PR
787RT
0 Pending
Atkinson (2000) CORRELATION between human immunodeficiency virus genotypic resistance and virologic response in patients receiving nelfinavir monotherapy or nelfinavir with lamivudine and zidovudine J. Infect. Dis. 182 (2), 420-427 (2000) 1e-123 49
49PR
78
50PR
28RT
62 HIVDB
Aulicino (2004) CIRCULATION of novel HIV type 1 A, B/C, and F subtypes in Argentina AIDS Res. Hum. Retroviruses 21 (2), 158-164 (2005) 0 1
1PR
1RT
1IN
3
2PR
3RT
1IN
33 Case report(s) / study subset
Aulicino (2005) SEQUENCE Analysis of a South American HIV Type 1 BC Recombinant AIDS Res. Hum. Retroviruses 21 (10), 894-896 (2005) 0 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Aulicino (2009) HIV-1 non-nucleoside resistance mutations K103N + L100I are strongly associated with nucleoside resistance mutation L74V in BF recombinants from Argentine children under treatment failure, and reduce susceptibility to Etravirine Antivir Ther. 2010;15(4):641-50 3e-52  
8
8PR
0 Pending
Auswinporn (2001) GENOTYPIC subtyping of the HIV-1 polymerase gene in 30 naave patients from Thailand Southeast Asian J. Trop. Med. Public Health 32 (2), 346-350 1e-121 6
6PR
6RT
27
27PR
27RT
22 HIVDB
Auwanit (2001) FULL-LENGTH sequences of two CRF01_ae (subtype e) HIV type 1 isolates from 1995 samples of patients with sexually transmitted diseases in Thailand AIDS Res. Hum. Retroviruses 17 (9), 867-871 (2001) 1e-165  
2
2PR
2RT
2IN
0 Case report(s) / study subset
Auwanit (2009) Detection of drug resistance-associated and background mutations in human immunodeficiency virus type 1 CRF01_AE protease and reverse transcriptase derived from drug treatment-naive patients residing in central Thailand AIDS Res. Hum. Retroviruses 25 (6), 625-631 (2009) 1e-149 62
43PR
19RT
106
87PR
19RT
58 HIVDB
Avi (2009) Prevalence of Drug Resistance Mutations of Human Immunodeficiency Virus - 1 CRF06_cpx in Treatment-Naive Patients in Estonia in 2008 Unpublished 1e-144 55
55PR
55RT
55
55RT
100 HIVDB
Avi (2009) Polymorphisms of HIV-1 CRF06_cpx integrases in Estonia Unpublished 1e-164 112
112IN
114
114IN
98 HIVDB
AYEHUMIE (1991)   Unpublished (1991) 4e-41  
8
8PR
0 Gene fragment(s)
Ayouba (2009) Low prevalence of HIV type 1 drug resistance mutations in untreated, recently infected patients from Burkina Faso, Cote d'Ivoire, Senegal, Thailand, and Vietnam: the ANRS 12134 study AIDS Res. Hum. Retroviruses 25 (11), 1193-1196 (20 4e-51 105
105PR
105
105PR
100 HIVDB
Azevedo-Pereira (1998) COMPLETE nucleotide sequence of HIV-2ALI, a low infectious isolate with restricted tropism to primary CD4+ cells Unpublished 2e-97 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Babic (2005) PREVALENCE of antiretroviral drug resistance mutations and HIV-1 non-B subtypes in newly diagnosed drug-naive patients in Slovenia, 2000-2004 Virus Res. 118 (1-2), 156-163 (2006) 0 76
76PR
76RT
76
63PR
76RT
100 HIVDB
Babic (2005) MOLECULAR epidemiology of HIV-1 subtypes based on analysis of pol sequences in Slovenia, 1996-2005 J. Med. Virol. 78 (8), 997-1002 (2006) 0  
6
3PR
6RT
0 Case report(s) / study subset
Bacheler (2000) HUMAN immunodeficiency virus type 1 mutations selected in patients failing efavirenz combination therapy Antimicrob. Agents Chemother. 44 (9), 2475-2484 (2000) 1e-130 3669
3646PR
3662RT
3708
3708PR
3708RT
98 HIVDB
Bacheler (2001) GENOTYPIC correlates of phenotypic resistance to efavirenz in virus isolates from patients failing nonnucleoside reverse transcriptase inhibitor therapy J. Virol. 75 (11), 4999-5008 (2001) 1e-126 87
84PR
87RT
87
84PR
87RT
100 HIVDB
Badreddine (2007) IDENTIFICATION and Characterization of HIV Type 1 Subtypes Present in the Kingdom of Saudi Arabia: High Level of Genetic Diversity Found AIDS Res. Hum. Retroviruses 23 (5), 667-674 (2007) 0 60
6PR
6RT
60IN
60
6RT
60IN
100 HIVDB
Baier (1990) COMPLETE nucleotide sequence of a simian immunodeficiency virus from African green monkeys: a novel type of intragroup divergence Virology 176 (1), 216-221 (1990) 1e-109 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Bailey (2007) EVOLUTION of HIV-1 in an HLA-B*57-Positive Patient during Virologic Escape J. Infect. Dis. 196 (1), 50-55 (2007) 0  
38
35RT
6IN
0 Evolution/quasispecies study
Bailey (2008) TRANSMISSION of Human Immunodeficiency Virus Type 1 from a Patient Who Developed AIDS to an Elite Suppressor J. Virol. 82 (15), 7395-7410 (2008) 0  
14
7PR
7RT
14IN
0 Case report(s) / study subset
Balakrishnan (2005) HIV Type 1 Genotypic Variation in an Antiretroviral Treatment-Naive Population in Southern India AIDS Res. Hum. Retroviruses 21 (4), 301-305 (2005) 1e-139 49
49PR
49RT
49
3PR
49RT
100 HIVDB
Baldanti (2010) Early emergence of raltegravir resistance mutations in patients receiving HAART salvage regimens J. Med. Virol. 82 (1), 116-122 (2010) 1e-156 11
11IN
11
11IN
100 HIVDB
Baldrich-Rubio (2001) A complex human immunodeficiency virus type 1 A/G/J recombinant virus isolated from a seronegative patient with AIDS from Benin, West Africa J. Gen. Virol. 82 (PT 5), 1095-1106 (2001) 1e-161 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Balode (2010) Direct Submission Submitted (26-JAN-2010) Department of Virology, Sw 7e-50  
1
1PR
0 Unpublished
Balode (2010) Low prevalence of transmitted drug resistance among newly diagnosed HIV-1 patients in Latvia J. Med. Virol. 82 (12), 2013-2018 (2010) 1e-148 107
107PR
107RT
107
79PR
67RT
100 HIVDB
Balode (2010) Direct Submission Submitted (26-JAN-2010) Department of Virology, Sw 1e-143  
6
5PR
4RT
0 Unpublished
Balode (2010) Low prevalence of transmitted drug resistance among newly diagnosed HIV-1 patients in Latvia J. Med. Virol. 82 (12), 2013-2018 (2010) 7e-49 2
2PR
2RT
2
2PR
100 HIVDB
Balode (2010) Low prevalence of transmitted drug resistance among newly diagnosed HIV-1 patients in Latvia J. Med. Virol. 82 (12), 2013-2018 (2010) 2e-48 3
3PR
3RT
3
3PR
100 HIVDB
Balotta (2000) PREVALENCE of transmitted nucleoside analogue-resistant HIV-1 strains and pre-existing mutations in pol reverse transcriptase and protease region: outcome after treatment in recently infected individuals Antivir. Ther. (Lond.) 5 (1), 7-14 (2000) 1e-128 71
33PR
38RT
71
33PR
38RT
100 HIVDB
Balotta (2000) PREVALENCE of multiple dideoxynucleoside analogue resistance (MddNR) in a multicentric cohort of HIV-1 Italian patients with virologic failure Unpublished 1e-133 149
132PR
149RT
157
137PR
157RT
94 HIVDB
Balotta (2001) INCREASING prevalence of non-clade B HIV-1 strains in heterosexual men and women, as monitored by analysis of reverse transcriptase and protease sequences J. Acquir. Immune Defic. Syndr. 27 (5), 499-505 (2001) 1e-100 19
19PR
19RT
19
19PR
19RT
100 HIVDB
Bang (2007) PREVALENCE of primary antiretroviral resistance: trends in Korea AIDS Res. Hum. Retroviruses 24 (1), 83-85 (2008) 0 81
81PR
81RT
81
77PR
81RT
100 HIVDB
Banke (2009) Positive selection pressure introduces secondary mutations at Gag cleavage sites in human immunodeficiency virus type 1 harboring major protease resistance mutations J. Virol. 83 (17), 8916-8924 (2009) 7e-52  
268
268PR
0 Pending
Bao (2008) MOLECULAR tracing of sexual HIV Type 1 transmission in the southwest border of China AIDS Res. Hum. Retroviruses 24 (5), 733-742 (2008) 0  
2
1PR
2RT
0 Case report(s) / study subset
Bar (2010) Wide variation in the multiplicity of HIV-1 infection among injection drug users J. Virol. 84 (12), 6241-6247 (2010) 3e-16  
390
390IN
0 Evolution/quasispecies study
Bar-Magen (2009) Comparative Biochemical Analysis of HIV-1 Subtype B and C Integrase Enzymes AIDS. 2010 Sep 10;24(14):2171-9. 1e-165  
2
2IN
0 Laboratory/experimental isolate
Barditch-Crovo (2001) PHASE i/ii trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adults Antimicrob. Agents Chemother. 45 (10), 2733-2739 (2001) 4e-96 14
14RT
14
14RT
100 HIVDB
Barlow (2001) RECOMBINANT strains of HIV type 1 in the United Kingdom AIDS Res. Hum. Retroviruses 17 (5), 467-474 (2001) 1e-109  
12
12PR
9RT
0 ARV Rx and/or other data are N/A
Barlow (2003) CHARACTERIZATION of a novel simian immunodeficiency virus (SIVmonNG1) genome sequence from a mona monkey (Cercopithecus mona) J. Virol. 77 (12), 6879-6888 (2003) 3e-92 2
1PR
1RT
2IN
2
1RT
2IN
100 HIVDB
Barnett (1993) DISTINGUISHING features of an infectious molecular clone of the highly divergent and noncytopathic human immunodeficiency virus type 2 UC1 strain J. Virol. 67 (2), 1006-1014 (1993) 0 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Barnett (1996) DIRECT Submission Submitted (11-OCT-1995) Barton Bryant, HIV Database, Los Ala 2e-98 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Barreto (2006) TRENDS in Antiretroviral Drug Resistance among HIV-1-Infected Blood Donors in Sao Paulo City, Brazil Unpublished 1e-142 6
6PR
6RT
6
4PR
3RT
100 HIVDB
Barrie (1996) NATURAL variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1 Virology 219 (2), 407-416 (1996) 1e-126  
37
37PR
0 Case report(s) / study subset
Bartolo (2007) ANALYSIS of HIV-1 protease and retrotranscriptase in drug-naive patients from Mozambique Unpublished 0 112
36PR
76RT
112
36PR
76RT
100 HIVDB
Bartolo (2007) MOLECULAR epidemiology of HIV-1 in Angola Unpublished 1e-170 140
19PR
121RT
140
19PR
121RT
100 HIVDB
Bartolo (2008) MOLECULAR epidemiology of HIV-1 infection in Maputo, Mozambique, and susceptibility to antiretroviral therapy Unpublished 1e-165 1
1PR
1RT
1
1RT
100 HIVDB
Bartolo (2009) Highly divergent subtypes and new recombinant forms prevail in the HIV/AIDS epidemic in Angola: new insights into the origins of the AIDS pandemic Infect. Genet. Evol. 9 (4), 672-682 (2009) 3e-49 9
9PR
9
9PR
100 HIVDB
Bartolo (2010) Origin and epidemiological history of CRF14_BG Unpublished 0 3
3PR
3RT
3IN
3
3RT
3IN
100 HIVDB
Baxter (2006) GENOTYPIC changes in human immunodeficiency virus type 1 protease associated with reduced susceptibility and virologic response to the protease inhibitor tipranavir J. Virol. 80 (21), 10794-10801 (2006) 0 1531
1531PR
1394RT
1534
394PR
1397RT
99 HIVDB
Beck (2007) OPTIMIZATION of the Oligonucleotide Ligation Assay (OLA), a Rapid and Inexpensive Test for Detection of HIV-1 Drug-Resistance Mutations, for Non-B Subtypes Unpublished 8e-53  
16
16PR
0 Case report(s) / study subset
Becker (1995) MOLECULAR and phylogenetic characterisation of a Guinea-Bissau-derived human immunodeficiency virus type 2 isolate Unpublished 1e-100 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Becker-Pergola (2000) ANALYSIS of HIV type 1 protease and reverse transcriptase in antiretroviral drug-naive Ugandan adults AIDS Res. Hum. Retroviruses 16 (8), 807-813 (2000) 1e-115 54
27PR
27RT
54
27PR
27RT
100 HIVDB
Beer (1999) SIMIAN immunodeficiency virus (SIV) from sun-tailed monkeys (Cercopithecus solatus): evidence for host-dependent evolution of SIV within the C. lhoesti superspecies J. Virol. 73 (9), 7734-7744 (1999) 4e-97 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Beer (2000) PATTERNS of genomic sequence diversity among their simian immunodeficiency viruses suggest that L'Hoest monkeys (Cercopithecus lhoesti) are a natural lentivirus reservoir J. Virol. 74 (8), 3892-3898 (2000) 3e-99 3
3PR
3RT
3IN
3
2PR
3RT
3IN
100 HIVDB
Beer (2001) CHARACTERIZATION of novel simian immunodeficiency viruses from red-capped mangabeys from Nigeria (SIVrcmNG409 and -NG411) J. Virol. 75 (24), 12014-12027 (2001) 1e-133 2
2PR
2RT
2IN
2
2PR
2RT
2IN
100 HIVDB
Beerenwinkel (2002) DIVERSITY and complexity of HIV-1 drug resistance: a bioinformatics approach to predicting phenotype from genotype Proc. Natl. Acad. Sci. U.S.A. 99 (12), 8271-8276 (2002) 1e-126  
489
466PR
467RT
0 Sequence Quality
Bellocchi (2009) Subtype Analysis and Mutations to Antiviral Drugs in HIV-1-Infected Patients From Mozambique Before Initiation of Antiretroviral Therapy: Results From the DREAM Programme J Med Virol (2005) 1e-177 59
59PR
59RT
59
59RT
100 HIVDB
BENVENISTE (1988)   Unpublished (1990) 6e-99 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Bermudez-Aza (2011) Antiretroviral resistance in MSM in Brazil Unpublished 1e-153  
142
100PR
90RT
0 Unpublished
Bernardin (2003) PRIMARY Infection of a Male Plasma Donor with Divergent HIV Variants from the Same Source Followed by Rapid Fluctuations in Their Relative Frequency and Viral Recombination AIDS Res. Hum. Retroviruses 19 (11), 1009-1015 (2003) 0  
3
3PR
3RT
3IN
0 Case report(s) / study subset
Bernardin (2004) HUMAN immunodeficiency virus mutations during the first month of infection are preferentially found in known cytotoxic T-lymphocyte epitopes J. Virol. 79 (17), 11523-11528 (2005) 0 18
18PR
18RT
18IN
18
18PR
18RT
18IN
100 HIVDB
Bernardin (2006) DIRECT Submission Submitted (12-DEC-2005) Molecular Virology, Blood Systems Re 0 13
13PR
13RT
13IN
13
13PR
13RT
13IN
100 HIVDB
Bessong (2004) CHARACTERIZATION of Human Immunodeficiency Virus Type 1 from a Previously Unexplored Region of South Africa with a High HIV Prevalence AIDS Res. Hum. Retroviruses 21 (1), 103-109 (2005) 1e-168 26
13PR
13RT
26
13PR
13RT
100 HIVDB
Bessong (2005) RESISTANCE mutational analysis of HIV type 1 subtype C among rural South African drug-naive patients prior to large-scale availability of antiretrovirals AIDS Res. Hum. Retroviruses 22 (12), 1306-1312 (2006) 1e-177 70
35PR
35RT
70
35PR
35RT
100 HIVDB
Bessong (2010) Analysis of pol integrase gene sequences of HIV-1 infected treatment naive individuals in the Limpopo province of South Africa Unpublished 1e-164  
89
89IN
0 Pending
Bibollet-Ruche (1996) GENETIC diversity of simian immunodeficiency viruses from West African green monkeys: evidence of multiple genotypes within populations from the same geographical locale J. Virol. 71 (1), 307-313 (1997) 1e-30  
10
10IN
0 Gene fragment(s)
Bibollet-Ruche (2004) NEW simian immunodeficiency virus infecting De Brazza's monkeys (Cercopithecus neglectus): evidence for a cercopithecus monkey virus clade J. Virol. 78 (14), 7748-7762 (2004) 0 4
4PR
4RT
4IN
11
4PR
6RT
11IN
36 HIVDB
Bibollet-Ruche (2005) COMPLETE genome analysis of one of the earliest SIVcpzPtt strains from Gabon (SIVcpzGAB2) AIDS Res. Hum. Retroviruses 20 (12), 1377-1381 (2004) 0 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Bibollet-Ruche (2005) GENETIC characterization of accessory genes from human immunodeficiency viruses type 1 group O Unpublished 3e-08  
14
14IN
0 Gene fragment(s)
Biesinger (2007) CHANGES in simian immunodeficiency virus reverse transcriptase alleles that appear during infection of macaques enhance infectivity and replication in CD4(+) T cells Virology 370 (1), 184-193 (2008) 0  
8
8RT
0 Case report(s) / study subset
Binverted question markelec (2000) HIGH levels of drug-resistant human immunodeficiency virus variants in patients exhibiting increasing CD4+ T cell counts despite virologic failure of protease inhibitor-containing antiretroviral combination therapy J. Infect. Dis. 181 (5), 1808-1812 (2000) 1e-128 100
100PR
100
100PR
100 HIVDB
Blankson (2007) ISOLATION and Characterization of Replication-Competent HIV-1 from a Subset of Elite Suppressors J. Virol. 81 (5), 2508-2518 (2007) 0  
6
4PR
6RT
6IN
0 Case report(s) / study subset
Blankson (2009) HIV-1 Evolution Following Transmission to an HLA-B*5801 Positive Subject J Infect Dis. 2009 Dec 15;200(12):1820-4. 0  
2
2PR
2RT
2IN
0 Case report(s) / study subset
Bleiber (2001) INDIVIDUAL contributions of mutant protease and reverse transcriptase to viral infectivity, replication, and protein maturation of antiretroviral drug-resistant human immunodeficiency virus type 1 J. Virol. 75 (7), 3291-3300 (2001) 1e-112  
21
15PR
15RT
0 Case report(s) / study subset
Blick (2006) THE Probable Source of Both the Primary Multidrug-Resistant (MDR) HIV-1 Strain Found in a Patient with Rapid Progression to AIDS and a Second Recombinant MDR Strain Found in a Chronically HIV-1-Infected Patient J. Infect. Dis. 195 (9), 1250-1259 (2007) 1e-163  
13
1PR
13RT
0 Case report(s) / study subset
Bobkov (2004) DIVERSITY of HIV-1 Subtype A and CRF03_AB Protease in Eastern Europe: Selection of the V77I Variant Followed by Its Rapid Spread in IDU Populations Unpublished 5e-40 27
27PR
30
30PR
90 HIVDB
Bodelle (2004) IDENTIFICATION and Genomic Sequence of an HIV Type 1 Group N Isolate from Cameroon AIDS Res. Hum. Retroviruses 20 (8), 902-908 (2004) 0 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Boeri (2003) EVOLUTIONARY characteristics of HIV-1 variants resistant to protease inhibitors in the absence of drug-selective pressure AIDS Res. Hum. Retroviruses (2003) In press 0  
18
18PR
18RT
0 Case report(s) / study subset
Bogh (2001) INVESTIGATING association between baseline HIV-1 genotypic resistance and virological response among protease in-hibitor-naive patients treated with HAART Unpublished 1e-133  
180
112PR
68RT
0 Unpublished
Bolivar (2009) The Challenge of HIV-1 Genetic Diversity: Discordant CD4+ T-Cell Count and Viral Load in an Untreated Patient Infected With a Subtype F Strain J. Acquir. Immune Defic. Syndr. 52 (5), 659-661 (2 1e-161  
1
1IN
0 Case report(s) / study subset
Bonhoeffer (2008) Evidence for positive epistasis in HIV-1 Science 306 (5701), 1547-1550 (2004) 1e-175 8676
8676PR
8676RT
8676
5624PR
7806RT
100 HIVDB
Bonhoeffer (2010) Evidence for positive epistasis in HIV-1 Science 306 (5701), 1547-1550 (2004) 9e-49 8
8PR
8RT
8
8PR
100 HIVDB
Bontell (2011) Transmitted drug resistance and phylogenetic analysis of HIV CRF01_AE in Northern Vietnam Infect. Genet. Evol. (2011) In press 2e-50 32
32PR
32RT
32
32PR
100 HIVDB
Bontell (2011) Transmitted drug resistance and phylogenetic analysis of HIV CRF01_AE in Northern Vietnam Infect. Genet. Evol. (2011) In press 2e-48 1
1PR
1RT
1
1PR
100 HIVDB
Bonura (2010) Transmission of drug-resistant HIV-1 strains in HAART-naive patients: a five-year retrospective study in Sicily, Italy Unpublished 0 109
109PR
109RT
109
41PR
109RT
100 HIVDB
Bouchard (2004) HIV Type 1 Drug Resistance among Naive Patients from Venezuela AIDS Res. Hum. Retroviruses 23 (3), 482-485 (2007) 1e-140 37
17PR
20RT
37
17PR
20RT
100 HIVDB
Bourara (2007) TARGET cell APOBEC3C can induce limited G-to-A mutation in HIV-1 PLoS Pathog. 3 (10), 1477-1485 (2007) 4e-52  
2
2PR
0 Case report(s) / study subset
Bouzeghoub (2005) HIGH Diversity of HIV Type 1 in Algeria AIDS Res. Hum. Retroviruses 22 (4), 367-372 (2006) 1e-149 248
133PR
116RT
248
132PR
116RT
100 HIVDB
Bouzeghoub (2008) FIRST Observation of HIV Type 1 Drug Resistance Mutations in Algeria AIDS Res. Hum. Retroviruses 24 (11), 1467-1473 (2008) 1e-148  
37
16PR
21RT
0 Pending
Brachtel (2002) DEMONSTRATION of de Novo HIV Type 1 Production by Detection of Multiply Spliced and Unspliced HIV Type 1 RNA in Paraffin-Embedded Tonsils AIDS Res. Hum. Retroviruses 18 (11), 785-790 (2002) 1e-62  
43
43PR
0 Evolution/quasispecies study
Bradshaw (2007) NOVEL Drug Resistance Pattern Associated with the Mutations K70G and M184V in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Antimicrob. Agents Chemother. 51 (12), 4489-4491 (2007) 0 9
4PR
9RT
9
9RT
100 HIVDB
Brandin (2003) POL Gene Sequence Variation in Swedish HIV-2 Patients Failing Antiretroviral Therapy AIDS Res. Hum. Retroviruses 19 (7), 543-550 (2003) 3e-97 30
30PR
30RT
30
30PR
30RT
100 HIVDB
Brann (2006) FUNCTIONAL Correlation between a Novel Amino Acid Insertion at Codon 19 in the Protease of Human Immunodeficiency Virus Type 1 and Polymorphism in the p1/p6 Gag Cleavage Site in Drug Resistance and Replication Fitness J. Virol. 80 (12), 6136-6145 (2006) 2e-49  
1
1PR
0 Case report(s) / study subset
Brehm (2011) Failure of initial therapy with two nucleosides and efavirenz is not associated with early emergence of mutations in the C-terminus of HIV-1 reverse transcriptase J. Acquir. Immune Defic. Syndr. 56 (4), 344-348 (2 0  
106
106RT
0 Pending
Brennan (1997) GENETIC variation in human immunodeficiency virus type 2: identification of a unique variant from human plasma AIDS Res. Hum. Retroviruses 13 (5), 401-404 (1997) 0.27 1
1PR
1RT
1IN
1
1RT
100 HIVDB
Brennan (2007) HIV-1 Strains Identified in Brazilian Blood Donors: Significant Prevalence of B/F1 Recombinants AIDS Res. Hum. Retroviruses 23 (11), 1434-1441 (2007) 1e-167 82
82IN
85
85IN
96 HIVDB
Brennan (2009) The prevalence of diverse HIV-1 strains was stable in Cameroonian blood donors from 1996 to 2004 J. Acquir. Immune Defic. Syndr. 49 (4), 432-439 (2 1e-166 572
572IN
573
573IN
99 HIVDB
Brennan (2009) Identification of HIV-1 Non-B Subtypes and Antiretroviral Drug Resistant Strains in United States Blood Donors Unpublished 0 65
62PR
62RT
3IN
65
43PR
62RT
3IN
100 HIVDB
Brennan (2011) Expanded Evaluation of Blood Donors in the United States for HIV-1 Non-B Subtypes and Antiretroviral Drug Resistant Strains: 2005-2007 Unpublished 0  
25
8PR
25RT
0 Pending
Brenner (2006) HIV-1 subtype C viruses rapidly develop K65R resistance to tenofovir in cell culture AIDS 20 (9), F9-F13 (2006) 0  
5
3PR
5RT
0 Pending
Brenner (2006) HIGH Rates of Forward Transmission Events after Acute/Early HIV-1 Infection J. Infect. Dis. 195 (7), 951-959 (2007) 0  
24
22PR
12RT
0 Case report(s) / study subset
Brenner (2010) HIV-1 Integrase Genotypic Analysis: Implications in the Study of HIV-1 Drug Resistance and Subtype Diversification Antimicrob. Agents Chemother. (2010) In press 0  
8
7RT
8IN
0 Unpublished
Brenner (2011) Subtype diversity associated with the development of HIV-1 resistance to integrase inhibitors J. Med. Virol. 83 (5), 751-759 (2011) 1e-167  
149
149IN
0 Pending
Brenner (2011) Spread of HIV-1 Drug-Resistant Sub-epidemics Unpublished 0  
1
1RT
0 Unpublished
Brigido (2005) SHORT Communication: Molecular Characteristics of HIV Type 1 Circulating in Sao Paulo, Brazil AIDS Res. Hum. Retroviruses 21 (7), 673-682 (2005) 0  
174
68PR
106RT
0 Pending
Brigido (2008) HIV type 1 subtype C and CB Pol recombinants prevail at the cities with the highest AIDS prevalence rate in Brazil AIDS Res. Hum. Retroviruses 23 (12), 1579-1586 (2007) 0 149
103PR
99RT
149
65PR
97RT
100 HIVDB
Brigido (2010) Southern Brazil HIV Type 1 C Expansion into the State of Sao Paulo, Brazil AIDS Res. Hum. Retroviruses 27 (3), 339-344 (2011) 0  
247
192PR
69RT
15IN
0 Pending
Brindeiro (1999) SEQUENCE diversity of the reverse transcriptase of human immunodeficiency virus type-1 from Brazilian untreated individuals Antimicrob. Agents Chemother. (1999) In press 2e-91 18
18RT
18
18RT
100 HIVDB
Brindeiro (2003) BRAZILIAN Network for HIV Drug Resistance Surveillance (HIV-BResNet): a survey of chronically infected individuals AIDS 17 (7), 1063-1069 (2003) 1e-145 350
199PR
191RT
357
199PR
199RT
98 HIVDB
Briones (2000) DYNAMICS of dominance of a dipeptide insertion in reverse transcriptase of HIV-1 from patients subjected to prolonged therapy Virus Res. 66 (1), 13-26 (2000) 1e-128  
186
180PR
186RT
0 Evolution/quasispecies study
Briones (2003) MEMORY in retroviral quasispecies: experimental evidence and theoretical model for human immunodeficiency virus J. Mol. Biol. 331 (1), 213-229 (2003) 1e-126  
15
15PR
15RT
0 Evolution/quasispecies study
Brown (2009) Phylogenetic reconstruction of transmission events from individuals with acute HIV infection: toward more-rigorous epidemiological definitions J. Infect. Dis. 199 (3), 427-431 (2009) 1e-172  
160
133PR
77RT
0 Evolution/quasispecies study
Brown (1999) SEQUENCE clusters in human immunodeficiency virus type 1 reverse transcriptase are associated with subsequent virological response to antiretroviral therapy J. Infect. Dis. 180 (4), 1043-1049 (1999) 1e-130  
55
55PR
55RT
0 DNAChip
Brown (2005) BIOLOGIC and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines J. Virol. 79 (10), 6089-6101 (2005) 0 21
21PR
21RT
21IN
21
21PR
21RT
21IN
100 HIVDB
Brumme (2007) EVIDENCE of Differential HLA Class I-Mediated Viral Evolution in Functional and Accessory/Regulatory Genes of HIV-1 PLoS Pathog. 3 (7), E94 (2007) 0 811
811PR
594RT
811
773PR
594RT
100 HIVDB
Brumme (2009) HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins PLoS ONE 4 (8), E6687 (2009) 0 1139
543PR
537RT
975IN
1285
415PR
691RT
1129IN
88 HIVDB
Bruselles (2009) Use of massive parallel pyrosequencing for near full-length characterization of a unique HIV BF recombinant associated with a fatal primary infection AIDS Res Hum Retroviruses. 2009 Sep;25(9):937-42. 0  
1
1PR
1RT
1IN
0 Pending
Buckton (2008) DEVELOPMENT and optimization of an internally controlled dried blood spot assay for surveillance of human immunodeficiency virus type-1 drug resistance J. Antimicrob. Chemother. 62 (6), 1191-1198 (2008) 0  
17
17RT
0 Case report(s) / study subset
Bulgheroni (2001) UNUSUAL codon 69 insertions: influence on human immunodeficiency virus type 1 reverse transcriptase drug susceptibility J. Clin. Virol. 29 (1), 27-32 (2004) 4e-77  
3
3RT
0 Pending
Buonaguro (2006) SCREENING of HIV-1 isolates by reverse heteroduplex mobility assay and identification of non-B subtypes in Italy J. Acquir. Immune Defic. Syndr. 37 (2), 1295-1306 (2004) 0  
3
3RT
3IN
0 Case report(s) / study subset
Burda (2005) HIV-1 CRF09_cpx circulates in the North West Province of Cameroon where CRF02_AG infections predominate and recombinant strains are common AIDS Res. Hum. Retroviruses 20 (12), 1358-1363 (2004) 2e-50  
17
17PR
0 Sequence quality
Burda (2010) HIV-1 reverse transcriptase drug-resistance mutations in chronically infected individuals receiving or naive to HAART in Cameroon J. Med. Virol. 82 (2), 187-196 (2010) 1e-156 1
1RT
1
1RT
100 HIVDB
Burkala (2005) COMPARTMENTALIZATION of HIV-1 in the central nervous system: role of the choroid plexus AIDS 19 (7), 675-684 (2005) 1e-152  
140
123PR
140RT
0 Evolution/quasispecies study
Burns (2005) SEQUENCE variability of the integrase protein from a diverse collection of HIV type 1 isolates representing several subtypes AIDS Res. Hum. Retroviruses 18 (14), 1031-1041 (2002) 1e-159 21
21IN
21
21IN
100 HIVDB
Bussmann (2005) HIV-1 subtype C drug-resistance background among ARV-naive adults in Botswana Unpublished 0 71
71PR
71RT
71
64PR
71RT
100 HIVDB
Buzon (2011) Combined antiretroviral therapy and immune pressure lead to in vivo HIV-1 recombination with ancestral viral genomes J. Acquir. Immune Defic. Syndr. (2011) In press 4e-50  
8
8PR
0 Evolution/quasispecies study
Bychenko (2009) Isolation and characterization of new HIV-1 subtype A1 strain from Russia, envelope proteins variability analysis Unpublished 0  
1
1PR
1RT
1IN
0 Case report(s) / study subset
Byrn (2006) HIV-1 in semen: an isolated virus reservoir Lancet 350 (9085), 1141 (1997) 4e-52  
35
35PR
0 Evolution/quasispecies study
Cabana (1999) EMERGENCE and genetic evolution of HIV-1 variants with mutations conferring resistance to multiple reverse transcriptase and protease inhibitors J. Med. Virol. 59 (4), 480-490 (1999) 1e-125 92
54PR
38RT
92
54PR
38RT
100 HIVDB
Cabrera (2008) RALTEGRAVIR Susceptibility and Fitness Progression of HIV-1 Integrase in Patients on Long-Term Antiretroviral Therapy Unpublished 1e-167 135
135IN
135
135IN
100 HIVDB
Calazans (2003) LOW Accumulation of L90M in Protease from Subtype F HIV-1 with Resistance to Protease Inhibitors Is Caused by the L89M Polymorphism J. Infect. Dis. 191 (11), 1961-1970 (2005) 1e-126 51
51PR
51RT
52
52PR
51RT
98 HIVDB
Cali (2004) EVIDENCE for host-driven selection of the HIV type 1 vpr gene in vivo during HIV disease progression in a transfusion-acquired cohort AIDS Res. Hum. Retroviruses 21 (8), 728-733 (2005) 0  
15
15PR
15RT
15IN
0 Case report(s) / study subset
Calugi (2006) ENTIRE Genome of a Strain of Human Immunodeficiency Virus Type 1 with a Deletion of nef That Was Recovered 20 Years after Primary Infection: Large Pool of Proviruses with Deletions of env J. Virol. 80 (23), 11892-11896 (2006) 0  
1
1RT
1IN
0 Sequence quality
Calvez (2002) IMPACT of stavudine phenotype and thymidine analogues mutations on viral response to stavudine plus lamivudine in ALTIS 2 ANRS trial Antivir. Ther. (Lond.) 7 (3), 211-218 (2002) 2e-94  
26
26RT
0 ARV Rx and/or other data are N/A
Candotti (1999) AIDS in an HIV-seronegative Ghanaian woman with intersubtype A/G recombinant HIV-1 infection J. Med. Virol. 62 (1), 1-8 (2000) 1e-165  
1
1PR
1RT
1IN
0 Case report(s) / study subset
Canducci (2008) DYNAMIC patterns of Human immunodeficiency virus type 1 (HIV-1) integrase gene evolution in patients failing Raltegravir based salvage therapies Unpublished 1e-154 37
37IN
37
37IN
100 HIVDB
Cao (2007) HIV subtype distribution in a cohort of HIV infected Ugandans: clinical implications Unpublished 0 46
45PR
46RT
46
26PR
46RT
100 HIVDB
Cardoso (2009) HIV-1 pol phylogenetic diversity and antiretroviral resistance mutations in treatment naive patients from Central West Brazil J. Clin. Virol. 46 (2), 134-139 (2009) 1e-145 76
76PR
76RT
76
76PR
8RT
100 HIVDB
Cardoso (2009) High level of multidrug resistance mutations in HIV type 1 pol gene and resistance-associated mutations to enfuvirtide (T-20) among antiretroviral-experienced patients from central Brazil AIDS Res. Hum. Retroviruses 25 (10), 943-950 (2009 1e-145 25
25PR
25RT
25
25PR
1RT
100 HIVDB
Cardoso (2010) HIV-1 primary and secondary antiretroviral drug resistance and genetic diversity among pregnant women from central Brazil J. Med. Virol. 82 (3), 351-357 (2010) 1e-144  
62
62PR
4RT
0 Pending
Cardoso (2011) Molecular Characteristics of HIV Type 1 Infection Among Prisoners from Central Western Brazil AIDS Res. Hum. Retroviruses (2011) In press 2e-52  
18
18PR
0 Pending
Caride (2000) DRUG-RESISTANT reverse transcriptase genotyping and phenotyping of B and non-B subtypes (F and A) of human immunodeficiency virus type I found in Brazilian patients failing HAART Virology 275 (1), 107-115 (2000) 5e-89  
14
14RT
0 ARV Rx and/or other data are N/A
Caride (2001) GENOTYPIC and phenotypic evidence of different drug-resistance mutation patterns between B and non-B subtype isolates of human immunodeficiency virus type 1 found in Brazilian patients failing HAART Virus Genes 23 (2), 193-202 (2001) 1e-123 14
14PR
28
28PR
50 HIVDB
Carneiro-Proietti (1997) DIRECT Submission Submitted (14-NOV-1996) Lab. Virus, Dept. Microbiologia, Uni 1e-128  
1
1PR
0 Case report(s) / study subset
Caron (2008) HUMAN immunodeficiency virus type 1 seroprevalence and antiretroviral drug resistance-associated mutations in miners in Gabon, central Africa AIDS Res. Hum. Retroviruses 24 (9), 1225-1228 (2008) 2e-50 4
4PR
4
4PR
100 HIVDB
Carr (1996) FULL-LENGTH sequence and mosaic structure of a human immunodeficiency virus type 1 isolate from Thailand J. Virol. 70 (9), 5935-5943 (1996) 1e-165 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Carr (1998) FULL genome sequences of human immunodeficiency virus type 1 subtypes G and A/G intersubtype recombinants Virology 247 (1), 22-31 (1998) 1e-164 3
3PR
3RT
3IN
3
3PR
3RT
3IN
100 HIVDB
Carr (1999) CHARACTERIZATION of subtype A HIV-1 from Africa by full genome sequencing AIDS 13 (14), 1819-1826 (1999) 1e-166 7
7PR
7RT
7IN
7
7PR
7RT
7IN
100 HIVDB
Carr (1999) DIRECT Submission Submitted (07-JUL-1998) Molecular Epidemiology, Henry M. Jac 1e-164 4
4PR
4RT
4IN
4
4PR
4RT
4IN
100 HIVDB
Carr (2001) THE AG Recombinant IbNG and Novel Strains of Group M HIV-1 are Common in Cameroon Virology (2001) In press 1e-166 7
7PR
7RT
7IN
7
7PR
7RT
7IN
100 HIVDB
Carr (2001) DIVERSE BF recombinants have spread widely since the introduction of HIV-1 into South America AIDS 15 (15), F41-F47 (2001) 1e-165 21
21PR
21RT
21IN
21
21PR
21RT
21IN
100 HIVDB
Carr (2004) OUTBREAK of a West African recombinant of HIV-1 in Tashkent, Uzbekistan J. Acquir. Immune Defic. Syndr. 39 (5), 570-575 (2005) 0 245
233PR
232RT
12IN
246
242PR
241RT
12IN
99 HIVDB
Carr (2005) HIV Subtype and Drug Resistance Patterns among Drug Naive Persons in Jos, Nigeria Unpublished 0 23
23PR
23RT
7IN
23
9PR
23RT
7IN
100 HIVDB
Carr (2006) FIRST report of an HIV-1 triple recombinant of subtypes B, C and F in Buenos Aires, Argentina Unpublished 0 10
10PR
10RT
10IN
10
9PR
10RT
10IN
100 HIVDB
Carr (2006) HIGH Genetic Complexity of HIV-1 in low-prevalence, rural regions of Cameroon Unpublished 0 2
2PR
2RT
2IN
2
1PR
2RT
2IN
100 HIVDB
Carr (2008) HIV-1 in the Caribbean is Dominated by Subtype B PLoS One. 2009;4(3):e4814. Epub 2009 Mar 12. 1e-139  
62
59PR
27RT
0 Pending
Carr (2008) IDENTIFICATION of CRF17_BF in Four South American Countries Unpublished 0  
6
1PR
6RT
6IN
0 Pending
Carr (2008) HIV-1 Epidemic in the Caribbean is Dominated by Subtype B Unpublished 0  
15
10PR
15RT
15IN
0 Pending
Carr (2010) HIV-1 Recombinants with Multiple Parental Strains in Low-Prevalence, Remote Regions of Cameroon Retrovirology. 2010 Apr 28;7:39. 0 24
24PR
23RT
24IN
24
24RT
24IN
100 HIVDB
Carrera (2010) Identification of unusual and novel HIV type 1 spliced transcripts generated in vivo AIDS Res. Hum. Retroviruses 26 (7), 815-820 (2010) 0.002  
1
1IN
0 Gene fragment(s)
Carrion (2002) CIRCULATING Recombinant Form CRF02_AG in South America AIDS Res. Hum. Retroviruses 19 (4), 329-332 (2003) 1e-163 2
2PR
2RT
2IN
2
2PR
2RT
2IN
100 HIVDB
Carrion (2004) DOCUMENTATION of subtype C HIV Type 1 strains in Argentina, Paraguay, and Uruguay AIDS Res. Hum. Retroviruses 20 (9), 1022-1025 (2004) 0 2
2PR
2RT
2IN
7
7PR
7RT
2IN
28 HIVDB
Carrion (2009) Molecular characterization of the human immunodeficiency virus type 1 among children in Lima, Peru AIDS Res. Hum. Retroviruses (2009) In press 1e-173  
2
2RT
0 Pending
Carvalho (2010) Primary Drug Resistance And HIV-1 Phylogenetic Diversity In North Brazil, Tocantins State Unpublished 1e-144 30
30PR
30RT
31
31PR
1RT
96 HIVDB
Carvalho (2010) Secondary Drug Resistance And HIV-1 Phylogenetic Diversity In North Brazil, Tocantins State Unpublished 4e-51  
5
5PR
0 Unpublished
Carvalho (2011) Moderate prevalence of primary drug resistance and interiorization of HIV-1 subtype C in the inland north state of Tocantins, Brazil AIDS Res. Hum. Retroviruses (2011) In press 3e-52 9
9PR
9RT
9
9PR
100 HIVDB
Casado (2003) NEAR Full-Length Genome Characterization of an HIV Type 1 CRF05_DF Virus from Spain AIDS Res. Hum. Retroviruses 19 (8), 719-725 (2003) 0 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Casado (2005) DIRECT Submission Submitted (18-JAN-2005) Patogenia Viral, Instituto de Salud 1e-126  
1
1PR
1RT
1IN
0 Case report(s) / study subset
Casado (2007) IDENTIFICATION of a novel HIV-1 circulating ADG intersubtype recombinant form (CRF19_cpx) in Cuba J. Acquir. Immune Defic. Syndr. 40 (5), 532-537 (2005) 0 2
2PR
2RT
2IN
2
1PR
2RT
2IN
100 HIVDB
Castelbranco (2010) Frequency of Primary Resistance to Antiretroviral Drugs and Genetic Variability of HIV-1 Among Infected Pregnant Women Recently Diagnosed in Luanda-Angola AIDS Res. Hum. Retroviruses 26 (12), 1313-1316 (20 2e-49 2
2PR
2RT
2
2PR
100 HIVDB
Castillo (2009) Surveillance of HIV Type 1 Drug Resistance among Naive Patients from Venezuela AIDS Res. Hum. Retroviruses (2009) In press 1e-150 89
54PR
35RT
89
54PR
35RT
100 HIVDB
Castro (2002) MOLECULAR epidemiology of HIV-1 in Venezuela: high prevalence of HIV-1 subtype B and identification of a B/F recombinant infection J. Acquir. Immune Defic. Syndr. 32 (3), 338-344 (2003) 7e-77  
2
1PR
1RT
0 Case report(s) / study subset
Castro (2004) BODY Compartments Follow-up & HIV-1 Mosaic Genome Definition. E7109254 (in) EXTENDED ABSTRACT BOOK, XV INTERNATIONAL AIDS CONFERENC 1e-135  
4
4RT
0 Case report(s) / study subset
Castro (2004) RESISTANCE mutations and molecular characterization of HIV-1 isolates from Venezuelan patients with virological failure Unpublished 1e-136  
41
20PR
21RT
0 Pending
Castro (2009) HIV-1 transmission network of 103N resistance mutation in Southwest Switzerland AIDS Res Hum Retroviruses. 2010 Sep 23. [Epub ahead of print 0  
19
14PR
10RT
0 Evolution/quasispecies study
Caumont (2001) SEQUENCE analysis of Env C2/V3, Gag p17/p24, and Prot regions of 25 HIV-1 isolates from Ho Chi Minh City, Viet Nam Unpublished 9e-98 26
24PR
2RT
27
25PR
2RT
96 HIVDB
Ceballos (2009) HIV dual infection with subtype B and BF recombinants in Argentina Unpublished 1e-146  
45
38PR
11RT
0 Pending
Ceccherini-Silberstein (2005) IDENTIFICATION of the minimal conserved structure of HIV-1 protease in the presence and absence of drug pressure AIDS 18 (12), F11-F19 (2004) 0  
477
242PR
477RT
0 Pending
Ceccherini-Silberstein (2006) HIGH sequence conservation of human immunodeficiency virus type 1 reverse transcriptase under drug pressure despite the continuous appearance of mutations J. Virol. 79 (16), 10718-10729 (2005) 0  
178
123PR
178RT
0 Pending
Ceccherini-Silberstein (2007) IMPACT of HIV-1 Reverse Transcriptase Polymorphism F214L on Virological Response to Thymidine Analogue-Based Regimens in Antiretroviral Therapy (ART)-Naive and ART-Experienced Patients J. Infect. Dis. 196 (8), 1180-1190 (2007) 0  
275
255PR
88RT
0 Pending
Ceccherini-Silberstein (2007) CHARACTERIZATION and structural analysis of novel mutations in human immunodeficiency virus type 1 reverse transcriptase involved in the regulation of resistance to nonnucleoside inhibitors J. Virol. 81 (20), 11507-11519 (2007) 0  
75
44PR
75RT
0 ARV Rx and/or other data are N/A
Ceccherini-Silberstein (2007) Impact of HIV-1 reverse transcriptase polymorphism F214L on virological response to thymidine analogue-based regimens in antiretroviral therapy (ART)-naive and ART-experienced patients J. Infect. Dis. 196 (8), 1180-1190 (2007) 2e-48  
7
7PR
0 Pending
Ceccherini-Silberstein (2010) Secondary Integrase Resistance Mutations Found in HIV-1 Minority Quasispecies in Integrase Therapy-Naive Patients Have Little or No Effect on Susceptibility to Integrase Inhibitors Antimicrob. Agents Chemother. 54 (9), 3938-3948 (2 0  
457
429RT
457IN
0 Evolution/quasispecies study
Cenci (1997) SELECTED nucleotide sequence of the pol gene of the monocytotropic strain HIV type 1 BaL AIDS Res. Hum. Retroviruses 13 (7), 629-632 (1997) 5e-49  
1
1RT
0 Case report(s) / study subset
Cenci (2003) LOW Intra-Host Diversity in HIV-1 Protease Gene in Untreated Primary Infection: a Crucial Role for Purifying Selection Unpublished 1e-126  
67
67PR
0 Unpublished
Cenci (2004) HIV-1 pol genotype divergence in the plasma and cerebrospinal fluid (CSF) of untreated patients in acute and chronic infection Unpublished 1e-108  
58
44PR
14RT
0 Unpublished
Chaix (2003) STABLE prevalence of genotypic drug resistance mutations but increase in non-B virus among patients with HIV-1 primary infection in France Unpublished 1e-116 244
244RT
244
244RT
100 HIVDB
Chakrabarti (1999) SEQUENCE of simian immunodeficiency virus from macaque and its relationship to other human and simian retroviruses Nature 328 (6130), 543-547 (1987) 1e-98 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Chakrabarti (2011) HIV-1 recombinants among Maipur IDUs Unpublished 0  
1
1RT
1IN
0 Unpublished
Chakraborty (2003) FAILURE to detect human immunodeficiency virus type 1 superinfection in 28 HIV-seroconcordant individuals with high risk of reexposure to the virus AIDS Res. Hum. Retroviruses 20 (9), 1026-1031 (2004) 0  
162
81PR
81RT
0 Evolution/quasispecies study
Chakraborty (2003) CAN HIV-1 superinfection compromise antiretroviral therapy? AIDS 18 (1), 132-134 (2004) 2e-87  
8
8RT
0 Case report(s) / study subset
Chaloin (2004) ANTIVIRAL activity of reverse trancriptase inhibitors with different HIV strains and isolates Unpublished 0  
14
14RT
8IN
0 ARV Rx and/or other data are N/A
Chamberland (2007) CHARACTERIZATION of drug resistance in a cohort of subjects on antiretroviral therapy infected with HIV-1 CRF02_AG and AGK subtypes in Mali and Burkina Faso Unpublished 0 88
88PR
88RT
88
11PR
88RT
100 HIVDB
Chamberland (2011) HIV-1 primary drug resistance prevalence in Cotonou, Benin Unpublished 0 127
127PR
127RT
127
6PR
127RT
100 HIVDB
Chang (2006) MOLECULAR Epidemiology of HIV Type 1 Subtypes in Taiwan: Outbreak of HIV Type 1 CRF07)BC Infection in Intravenous Drug Users AIDS Res. Hum. Retroviruses 22 (11), 1055-1066 (2006) 1e-145 152
152PR
152RT
152
128PR
146RT
100 HIVDB
Chang (2008) Molecular Epidemiology of HIV Type 1 Subtypes in Taiwan: Outbreak of HIV Type 1 CRF07_BC Infection in Intravenous Drug Users Unpublished 5e-49 3
3PR
3RT
3
3PR
100 HIVDB
Chang (2000) DIFFERENTIAL stability of the mRNA secondary structures in the frameshift site of various HIV type 1 viruses AIDS Res. Hum. Retroviruses 15 (17), 1591-1596 (1999) 1e-163  
5
5PR
5RT
5IN
0 Case report(s) / study subset
Chang (2000) SEQUENCE features downstream of the primer-binding site of HIV type 1 subtype E shared by subtype G and a subset of subtype A AIDS Res. Hum. Retroviruses 15 (18), 1703-1706 (1999) 1e-163  
1
1PR
1RT
1IN
0 Case report(s) / study subset
Chantratita (1999) HIV-1 resistant to antiretroviral drugs in Thailand Unpublished 1e-128  
722
342PR
469RT
0 ARV Rx and/or other data are N/A
Chaplin (2011) Impact of HIV Type 1 Subtype on Drug Resistance Mutations in Nigerian Patients Failing First-Line Therapy AIDS Res. Hum. Retroviruses 27 (1), 71-80 (2011) 1e-168 2
2PR
2RT
2
2RT
100 HIVDB
Charpentier (2009) Prevalence of HIV-1 drug resistance in HIV-1 infected patients treated in Douala, Cameroon Unpublished 0  
56
1PR
56RT
0 Pending
Charpentier (2011) High prevalence of antiretroviral drug resistance among HIV-1-untreated patients in Guinea-Conakry and in Niger Unpublished 1e-154 29
29RT
29
29RT
100 HIVDB
Charpentier (2011) Hot spots of integrase genotypic changes leading to HIV-2 resistance to raltegravir Unpublished 1e-100  
12
12IN
0 Pending
Charpentier (2011) Resistance analyses in highly experienced patients failing raltegravir, etravirine and darunavir/ritonavir regimen Unpublished 1e-166  
9
9IN
0 Pending
Chaturbhuj (2010) Human Immunodeficiency Virus Type 1 Transmitted Drug Resistance Threshold Surveillance among Newly HIV Type-1 diagnosed Drug Naive Clients attending Voluntary Counseling and Testing (VCT) sites in Mumbai, India Unpublished 0 34
34PR
34RT
34
34RT
100 HIVDB
Chen (2010) Near full-length genomic characterization of a novel HIV-1 CRF07_ BC/CRF08_ BC recombinant strain from Yunnan, China AIDS Res. Hum. Retroviruses (2010) In press 0  
1
1RT
1IN
0 Pending
Chen (1996) GENETIC characterization of new West African simian immunodeficiency virus SIVsm: geographic clustering of household-derived SIV strains with human immunodeficiency virus type 2 subtypes and genetically diverse viruses from a single feral sooty mangabey troop J. Virol. 70 (6), 3617-3627 (1996) 0 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Cheng (1992) MOLECULAR characterization of HIV-2 (ROD) protease following PCR cloning from virus infected H9 cells Adv. Exp. Med. Biol. 312, 83-88 (1992) 2e-24  
1
1PR
0 Laboratory/experimental isolate
Chin (2006) INVERSE Relationship between Viral Load and Genotypic Resistance Mutations in Korean Patients with Primary HIV Type 1 Infections AIDS Res. Hum. Retroviruses 22 (11), 1142-1147 (2006) 1e-147 52
52PR
52RT
52
49PR
52RT
100 HIVDB
Chin (2007) EARLY identification of seronegative human immunodeficiency virus type 1 infection with severe presentation J. Clin. Microbiol. 45 (5), 1659-1662 (2007) 1e-143  
3
3PR
3RT
0 Case report(s) / study subset
Chin (2007) FACTORS Associated with Short-term Clinical Parameters after Genotypic Resistance Assay in Korean Patients with HIV-1 Subtype B Virologic Failure J Korean Med Sci. 2009 Dec;24(6):1031-7. Epub 2009 Nov 7. 1e-146  
40
23PR
40RT
0 Pending
Chin (2010) Comparison of genotypic resistance mutations in treatment-naive HIV type 1-infected patients in Korea and China AIDS Res. Hum. Retroviruses 26 (2), 217-221 (2010) 1e-164 9
9PR
9RT
9
6PR
6RT
100 HIVDB
Chin (2010) Direct Submission Submitted (09-APR-2010) Aaron Diamond AIDS Researc 0  
1
1RT
1IN
0 Unpublished
Cho (2005) DIRECT Submission Submitted (26-APR-2005) Microbiology, University of Ulsan Co 0  
1
1PR
1RT
1IN
0 HIVDB
Cho (2005) FULL-LENGTH sequences of long-term slow progressor Unpublished 0  
6
5PR
6RT
6IN
0 HIVDB
Cho (2006) VARIATION of vif gene according to progression rate in Korean patients: association with KRG treatment Unpublished 0.02  
105
105IN
0 Gene fragment(s)
Cho (2006) HIV-1 Vif gene Unpublished 0.02  
75
75IN
0 Gene fragment(s)
Cho (2008) HIGH Frequency of Gross Deletions in the 5' LTR and gag Regions in HIV Type 1-Infected Long-Term Survivors Treated with Korean Red Ginseng AIDS Res. Hum. Retroviruses 24 (2), 181-193 (2008) 1e-52  
18
17PR
1IN
0 Case report(s) / study subset
Cho (2001) LONG-TERM intake of Korean red ginseng in HIV-1-infected patients: development of resistance mutation to zidovudine is delayed Int. Immunopharmacol. 1 (7), 1295-1305 (2001) 4e-96 16
16RT
37
37RT
43 HIVDB
Cho (2002) FREQUENCY of mutations conferring resistance to nucleoside reverse transcriptase inhibitors in human immunodeficiency virus type 1-infected patients in Korea J. Clin. Microbiol. 40 (4), 1319-1325 (2002) 1e-118 22
22RT
23
6PR
22RT
95 HIVDB
Cho (2003) MOLECULAR epidemiologic study of a human immunodeficiency virus 1 outbreak in haemophiliacs B infected through clotting factor 9 after 1990 Vox Sang. 92 (2), 113-120 (2007) 0 1
1PR
186
149PR
161RT
0 Evolution/quasispecies study
Cho (2005) FULL sequence of HIV type 1 Korean subtype B in an AIDS case with atypical seroconversion: TAAAA at TATA box AIDS Res. Hum. Retroviruses 21 (11), 961-964 (2005) 0  
1
1RT
1IN
0 Case report(s) / study subset
Cho (2006) HIGH frequency of grossly deleted nef genes in HIV-1 infected long-term slow progressors treated with Korean red ginseng Curr. HIV Res. 4 (4), 447-457 (2006) 0.02  
3
3IN
0 Case report(s) / study subset
Cho (2010) Molecular epidemiologic study of a human immunodeficiency virus 1 outbreak in haemophiliacs B infected through clotting factor 9 after 1990 Vox Sang. 92 (2), 113-120 (2007) 0  
6
5PR
6RT
6IN
0 Case report(s) / study subset
Cho (2010) Phylogenetic analysis of full-length pol gene from Korean hemophiliacs and plasma donors infected with Korean subclade B of HIV-1 AIDS Res. Hum. Retroviruses (2010) In press 0  
138
104PR
137RT
138IN
0 Evolution/quasispecies study
Choi (1997) HIV type 1 isolate Z321, the strain used to make a therapeutic HIV type 1 immunogen, is intersubtype recombinant AIDS Res. Hum. Retroviruses 13 (4), 357-361 (1997) 1e-164 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Choi (2010) Drug susceptibility of human immunodeficiency virus type 1-derived pseudoviruses from treatment-experienced patients to protease inhibitors and reverse transcriptase inhibitors, using a modified single-round assay J. Clin. Virol. (2010) In press 1e-174  
5
5PR
3RT
0 Case report(s) / study subset
Church (2007) HIV type 1 variants with nevirapine resistance mutations are rarely detected in antiretroviral drug-naive African women with subtypes A, C, and D AIDS Res. Hum. Retroviruses 23 (6), 764-768 (2007) 0 47
47PR
47RT
47
7PR
47RT
100 HIVDB
Church (2009) Analysis of NVP resistance in Ugandan infants who were HIV-infected despite receiving single dose (SD) nevirapine (NVP) vs. SD NVP plus up to 6-weeks of daily NVP to prevent HIV vertical transmission Unpublished 0 49
49PR
49RT
49
15PR
49RT
100 HIVDB
Ciccozzi (2005) MOLECULAR Diversity of HIV in Albania J. Infect. Dis. 192 (3), 475-479 (2005) 0 66
66PR
66RT
66
63PR
66RT
100 HIVDB
Ciccozzi (2007) THE HIV type 1 epidemic in Bulgaria involves multiple subtypes and is sustained by continuous viral inflow from West and East European countries AIDS Res. Hum. Retroviruses 24 (6), 771-779 (2008) 1e-143 33
33PR
33RT
33
33RT
100 HIVDB
Ciccozzi (2010) Genetic Diversity of HIV-1 in Montenegro AIDS Res. Hum. Retroviruses (2010) In press 0  
32
13PR
32RT
0 Pending
Cilla (2001) MOLECULAR evidence of homosexual transmission of HIV type 2 in Spain AIDS Res. Hum. Retroviruses 17 (5), 417-422 (2001) 7e-05  
4
4RT
0 Case report(s) / study subset
Cinque (2001) EFFECT of genotypic resistance on the virological response to highly active antiretroviral therapy in cerebrospinal fluid AIDS Res. Hum. Retroviruses 17 (5), 377-383 (2001) 1e-129 33
15PR
18RT
57
24PR
33RT
57 HIVDB
Claassen (2009) Direct Submission Submitted (16-NOV-2007) NHLS/University of Stellen 1e-150  
119
119RT
0 Unpublished
Clarke (2005) REVERSE transcriptase and protease sequences from HIV-1 non-subtype B infected persons in the United Kingdom Unpublished 0 274
118PR
156RT
497
334PR
379RT
55 HIVDB
Clavel (1996) MOLECULAR cloning and polymorphism of the human immune deficiency virus type 2 Nature 324 (6098), 691-695 (1986) 1e-98 2
1PR
1RT
2IN
2
2RT
2IN
100 HIVDB
Cleland (1996) EVOLUTION of zidovudine resistance-associated genotypes in human immunodeficiency virus type 1-infected patients J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 12 (1), 6-1 1e-123  
370
370RT
0 Gene fragment(s)
Clevenbergh (2002) LONG-TERM virologic outcome in patients infected with multi-nucleoside analogue resistant HIV-1 Antivir. Ther. (Lond.) (2002) In press 1e-121 24
12PR
12RT
24
12PR
12RT
100 HIVDB
Clewley (1998) A novel simian immunodeficiency virus (SIVdrl) pol sequence from the drill monkey, Mandrillus leucophaeus J. Virol. 72 (12), 10305-10309 (1998) 1.1 1
1PR
1RT
1
1RT
100 HIVDB
Clewley (2001) DIRECT Submission Unpublished 0 1
1IN
1
1PR
1RT
1IN
100 HIVDB
Cloyd (1990) SPECTRUM of biological properties of human immunodeficiency virus (HIV-1) isolates Virology 174 (1), 103-116 (1990) 1e-164  
2
2PR
2RT
2IN
0 Case report(s) / study subset
Collaco Veras (2011) Molecular Epidemiology of HIV-1 CRF02_AG in Cameroon and African Patients Living in Italy Unpublished 0  
52
3PR
52RT
0 Unpublished
Collman (2000) V3-INDEPENDENT determinants of macrophage tropism in a primary human immunodeficiency virus type 1 isolate Unpublished 1e-163 1
1IN
1
1PR
1RT
1IN
100 Laboratory/experimental isolate
Colonno (2004) IDENTIFICATION of I50L as the Signature Atazanavir (ATV)Resistance Mutation in Treatment-Naive HIV-1Infected Patients Receiving ATV-Containing Regimens J. Infect. Dis. 189 (10), 1802-1810 (2004) 3e-51 12
12PR
12
12PR
100 HIVDB
Condra (1996) GENETIC correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor J. Virol. 70 (12), 8270-8276 (1996) 1e-130 421
421PR
421
421PR
100 HIVDB
Cong (2006) THE Fitness Cost of Mutations Associated with Human Immunodeficiency Virus Type 1 Drug Resistance Is Modulated by Mutational Interactions J. Virol. 81 (6), 3037-3041 (2007) 1e-172  
4
4RT
0 Laboratory/experimental isolate
Coovadia (2008) PERSISTENT Minority K103N Mutations among Women Exposed to Single-Dose Nevirapine and Virologic Response to Nonnucleoside Reverse-Transcriptase Inhibitor-Based Therapy Clin. Infect. Dis. (2009) In press 1e-168  
99
99RT
0 Pending
Corbet (1999) ENV sequences of simian immunodeficiency viruses from chimpanzees in Cameroon are strongly related to those of human immunodeficiency virus group N from the same geographic area J. Virol. 74 (1), 529-534 (2000) 1e-147 1
1PR
1RT
1IN
2
1PR
1RT
2IN
50 HIVDB
Cornelissen (1997) POL gene diversity of five human immunodeficiency virus type 1 subtypes: evidence for naturally occurring mutations that contribute to drug resistance, limited recombination patterns, and common ancestry for subtypes B and D J. Virol. 71 (9), 6348-6358 (1997) 1e-126 42
42PR
42RT
42
42PR
42RT
100 HIVDB
Cornelissen (2000) SPREAD of distinct human immunodeficiency virus type 1 AG recombinant lineages in Africa J. Gen. Virol. 81 (Pt 2), 515-523 (2000) 2e-86 20
20PR
20RT
21
21PR
21RT
95 HIVDB
Courgnaud (1992) GENETIC differences accounting for evolution and pathogenicity of simian immunodeficiency virus from a sooty mangabey monkey after cross-species transmission to a pig-tailed macaque J. Virol. 66 (1), 414-419 (1992) 4.2 2
2PR
2RT
2IN
2
2RT
100 HIVDB
Courgnaud (2001) CHARACTERIZATION of a novel simian immunodeficiency virus from guereza colobus monkeys (Colobus guereza) in Cameroon: a new lineage in the nonhuman primate lentivirus family J. Virol. 75 (2), 857-866 (2001) 1e-76 3
1PR
1RT
3IN
3
1PR
3RT
3IN
100 HIVDB
Courgnaud (2002) CHARACTERIZATION of a Novel Simian Immunodeficiency Virus with a vpu Gene from Greater Spot-Nosed Monkeys (Cercopithecus nictitans) Provides New Insights into Simian/Human Immunodeficiency Virus Phylogeny J. Virol. 76 (16), 8298-8309 (2002) 4e-97 2
2PR
2RT
2IN
2
2RT
2IN
100 HIVDB
Courgnaud (2003) PARTIAL Molecular Characterization of Two Simian Immunodeficiency Viruses (SIV) from African Colobids: SIVwrc from Western Red Colobus (Piliocolobus badius) and SIVolc from Olive Colobus (Procolobus verus) J. Virol. 77 (1), 744-748 (2003) 1e-149 5
1PR
2RT
5IN
5
5RT
5IN
100 HIVDB
Courgnaud (2003) IDENTIFICATION of a New Simian Immunodeficiency Virus Lineage with a vpu Gene Present among Different Cercopithecus Monkeys (C. mona, C. cephus, and C. nictitans) from Cameroon J. Virol. 77 (23), 12523-12534 (2003) 0 2
2PR
2RT
2IN
2
2RT
2IN
100 HIVDB
Couto-Fernandez (2006) PHYLOGENETIC Analysis of Brazilian HIV Type 1 Subtype D Strains: Tracing the Origin of This Subtype in Brazil AIDS Res. Hum. Retroviruses 22 (2), 207-211 (2006) 0 5
5IN
10
3PR
5RT
5IN
50 HIVDB
Crandall (1999) PARALLEL evolution of drug resistance in HIV: failure of nonsynonymous/synonymous substitution rate ratio to detect selection Mol. Biol. Evol. 16 (3), 372-382 (1999) 1e-121  
41
41PR
0 Evolution/quasispecies study
Crandall (1999) ADVANCES in understanding the evolution of HIV AIDS 13, S39-S47 (1999) 1e-102  
49
49PR
0 Evolution/quasispecies study
Crowell (2003) OPTIMIZATION of Oligonucleotide Ligation Assay for Detection of Drug Resistance Mutations in Non-Subtype B HIV-1 Unpublished 1e-133  
18
17PR
18RT
0 ARV Rx and/or other data are N/A
Cuevas (2010) Incidence of non-B subtypes of HIV-1 in Galicia, Spain: high frequency and diversity of HIV-1 among men who have sex with men Euro Surveill. 14 (47) (2009) 0 92
92PR
92RT
92
41PR
88RT
100 HIVDB
Cuevas (2009) HIV-1 transmission cluster with T215D revertant mutation among newly diagnosed patients from the Basque Country, Spain J. Acquir. Immune Defic. Syndr. 51 (1), 99-103 (20 1e-52 233
233PR
233RT
233
233PR
100 HIVDB
Cuevas (2010) Biological and genetic characterization of HIV-1 subtype B and non subtype-B transmitted viruses: usefulness for vaccine candidate assessment AIDS Res Hum Retroviruses. 2010 Sep;26(9):1019-25 0  
28
7PR
28RT
28IN
0 Pending
Cunningham (2002) DEVELOPMENT of resistance mutations in women receiving standard antiretroviral therapy who received intrapartum nevirapine to prevent perinatal human immunodeficiency virus type 1 transmission: A substudy of pediatric AIDS clinical trials group protocol 316 J. Infect. Dis. 186 (2), 181-188 (2002) 5e-92  
79
79RT
0 ARV Rx and/or other data are N/A
D'Arrigo (2007) GP41 Sequence Variability in HIV Type 1 Non-B Subtypes Infected Patients Undergoing Enfuvirtide Pressure AIDS Res. Hum. Retroviruses 23 (10), 1296-1302 (2007) 0  
3
3RT
0 Case report(s) / study subset
Damond (2004) POLYMORPHISM of HIV-2 protease gene and selection of drug resistance mutations in HIV-2 infected patients treated with protease inhibitors J. Clin. Microbiol. (2004) In press 5e-25  
94
94PR
0 Pending
Damond (2006) IDENTIFICATION of a highly divergent HIV type 2 and proposal for a change in HIV type 2 classification AIDS Res. Hum. Retroviruses 20 (6), 666-672 (2004) 0 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Daniel (1993) SIMIAN immunodeficiency virus from African green monkeys J. Virol. 62 (11), 4123-4128 (1988) 1e-33  
1
1RT
0 Gene fragment(s)
Dash (2007) EXCEPTIONAL molecular and coreceptor-requirement properties of molecular clones isolated from an Human Immunodeficiency Virus Type-1 subtype-C infection Retrovirology 5 (1), 25 (2008) 0  
1
1RT
1IN
0 Case report(s) / study subset
Dau (2010) Connection domain mutations in treatment-experienced patients in the OPTIMA trial J. Acquir. Immune Defic. Syndr. 54 (2), 160-166 (2 0  
420
106PR
415RT
0 Pending
Daumer (2010) Short communication: selection of thymidine analogue resistance mutational patterns in children infected from a common HIV type 1 subtype G source AIDS Res. Hum. Retroviruses 26 (3), 275-278 (2010) 1e-166  
3
3RT
0 Evolution/quasispecies study
Dazza (2003) CHARACTERIZATION of a novel vpu-harboring simian immunodeficiency virus from a Dent's Mona monkey (Cercopithecus mona denti) J. Virol. 79 (13), 8560-8571 (2005) 0 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
De Arellano (2007) IMPACT of Ethnicity and HIV Type 1 Subtype on Response to First-Line Antiretroviral Therapy AIDS Res. Hum. Retroviruses 23 (7), 891-894 (2007) 1e-134  
10
10PR
1RT
0 Pending
de Baar (2001) NATURAL residues versus antiretroviral drug-selected mutations in HIV type 1 group O reverse transcriptase and protease related to virological drug failure in vivo AIDS Res. Hum. Retroviruses 16 (14), 1385-1394 (2000) 2e-17 5
5PR
5RT
5
5PR
5RT
100 HIVDB
de Felipe (2011) Prevalence and resistance mutations of HIV-1 non-B subtypes among immigrants in Southern Spain Unpublished 2e-51  
48
48PR
0 Unpublished
De Maio (2008) MOLECULAR characterization of the vif accessory gene of HIV-1 from perinatally infected children with different rates of disease progression Unpublished 0.032  
6
6IN
0 Gene fragment(s)
de Medeiros (2011) Co-circulation scenario of HIV1 subtypes B, C and CRF31BC in a drug naive population from southernmost Brazil: analysis of primary resistance mutation Unpublished 8e-52 41
41PR
41RT
41
41PR
100 HIVDB
de Mendoza (2005) RESISTANCE to non-nucleoside reverse transcriptase inhibitors and non-B subtypes are on the rise among recent HIV-1 infections in Spain Unpublished 0  
20
19PR
20RT
0 Case report(s) / study subset
de Mendoza (2009) Changes in drug resistance patterns following the introduction of HIV-1 non-B subtypes in Spain AIDS Res Hum Retroviruses. 2009 Oct;25(10):967-72 0  
135
9PR
134RT
0 Pending
de Mulder (2011) Drug resistance prevalence and HIV-1 variant characterization in naive and pretreated HIV-1 infected pedriatric population in Madrid, Spain Unpublished 0  
127
114PR
35RT
0 Pending
de Oliveira (2008) HIGH frequency of BF mosaic genomes among HIV-1-infected children from Sao Paulo, Brazil Arch. Virol. 153 (10), 1799-1806 (2008) 0  
129
64PR
68RT
0 Pending
De Pasquale (2004) DIFFERENCES in HIV-1 pol sequences from female genital tract and blood during antiretroviral therapy Unpublished 0  
39
39PR
39RT
0 ARV Rx and/or other data are N/A
de Ronde (2001) ESTABLISHMENT of new transmissible and drug-sensitive human immunodeficiency virus type 1 wild types due to transmission of nucleoside analogue-resistant virus J. Virol. 75 (2), 595-602 (2001) 2e-91  
8
8RT
0 Case report(s) / study subset
De Sa-Filho (2008) HIV Type 1 pol Gene Diversity and Antiretroviral Drug Resistance Mutations in Santos, Brazil AIDS Res. Hum. Retroviruses (2008) In press 1e-154 83
83PR
83RT
83
31PR
83RT
100 HIVDB
de Silva (2010) HIV-1 subtype distribution in the Gambia and the significant presence of CRF49_cpx, a novel circulating recombinant form Retrovirology 7 (1), 82 (2010) 0 3
3PR
3RT
3IN
3
2RT
3IN
100 HIVDB
Deacon (1995) GENOMIC structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients Science 270 (5238), 988-991 (1995) 1e-161  
1
1PR
1RT
1IN
0 Case report(s) / study subset
Deeks (1999) NOVEL four-drug salvage treatment regimens after failure of a human immunodeficiency virus type 1 protease inhibitor-containing regimen: antiviral activity and correlation of baseline phenotypic drug susceptibility with virologic outcome J. Infect. Dis. 179 (6), 1375-1381 (1999) 1e-127 15
15PR
15RT
16
16PR
16RT
93 HIVDB
Dehghani (2003) UNIQUE Pattern of Convergent Envelope Evolution in Simian Immunodeficiency Virus-Infected Rapid Progressor Macaques: Association with CD4-Independent Usage of CCR5 J. Virol. 77 (11), 6405-6418 (2003) 1e-101  
2
2RT
2IN
0 Laboratory/experimental isolate
Deho (2008) Subtype assignment and phylogenetic analysis of HIV type 1 strains in patients from Swaziland AIDS Res. Hum. Retroviruses 24 (2), 323-325 (2008) 5e-50 12
12PR
12RT
12
12PR
100 HIVDB
Delaugerre (2003) SELECTION of a rare resistance profile in an HIV-1-infected patient exhibiting a failure to an antiretroviral regimen including tenofovir DF J. Clin. Virol. 32 (3), 241-244 (2005) 1e-142 1
1RT
1
1RT
100 HIVDB
Delgado (2001) ANALYSIS of HIV type 1 protease and reverse transcriptase sequences from Venezuela for drug resistance-associated mutations and subtype classification: a UNAIDS study AIDS Res. Hum. Retroviruses 17 (8), 753-758 (2001) 1e-130 199
100PR
100RT
1IN
199
100PR
100RT
100 HIVDB
Delgado (2002) IDENTIFICATION of a newly characterized HIV-1 BG intersubtype circulating recombinant form in Galicia, Spain, which exhibits a pseudotype-like virion structure J. Acquir. Immune Defic. Syndr. 29 (5), 536-543 (2002) 2e-71 9
9PR
9RT
9IN
9
9PR
9RT
100 HIVDB
Delgado (2008) HIGH prevalence of unique recombinant forms of HIV-1 in Ghana: Molecular epidemiology from an antiretroviral resistance study Unpublished 0 199
199PR
199RT
199
2PR
199RT
100 HIVDB
Delgado (2008) High prevalence of unique recombinant forms of HIV-1 in Ghana: Molecular epidemiology from an antiretroviral resistance study Unpublished 1e-47 1
1PR
1RT
1
1PR
100 HIVDB
Delgado (2010) Identification of a new HIV-1 BF intersubtype circulating recombinant form (CRF44_BF) in Chile AIDS Res Hum Retroviruses. 2010 Jul;26(7):821-6. 0 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Delobel (2004) EVIDENCE for compartmentalization of human immunodeficiency virus type 1 in different blood cell types during prolonged suppressive antiretroviral therapy Unpublished 1e-129  
212
212RT
0 Evolution/quasispecies study
Demarest (2009) Virologic failure in first-line human immunodeficiency virus therapy with a CCR5 entry inhibitor, aplaviroc, plus a fixed-dose combination of lamivudine-zidovudine: nucleoside reverse transcriptase inhibitor resistance regardless of envelope tropism Antimicrob. Agents Chemother. 53 (3), 1116-1123 (2 1e-171  
16
10PR
15RT
0 Pending
Demeter (2000) DELAVIRDINE susceptibilities and associated reverse transcriptase mutations in human immunodeficiency virus type 1 isolates from patients in a phase I/II trial of delavirdine monotherapy (ACTG 260) Antimicrob. Agents Chemother. 44 (3), 794-797 (2000) 4e-96 67
67RT
67
67RT
100 HIVDB
Demeter (2001) IMPACT of Clinical Reverse Transcriptase Sequences on the Replication Capacity of HIV-1 Drug-Resistant Mutants Unpublished 4e-96 15
15RT
15
15RT
100 HIVDB
Deng (2010) Molecular tracing of HIV type 1 transmission in Hainan province of China AIDS. 2009 May 15;23(8):977-85 0  
1
1RT
0 Unpublished
Derache (2006) GENETIC Diversity and Drug Resistance Mutations in Human Immunodeficiency Virus Type 1 from Untreated Patients in Bamako, Mali Antivir. Ther. (Lond.) (2007) In press 1e-140 94
93PR
94RT
94
18PR
93RT
100 HIVDB
Derache (2008) EVOLUTION of genetic diversity and drug resistance mutations in HIV-1 among untreated patients from Mali between 2005 and 2006 J. Antimicrob. Chemother. 62 (3), 456-463 (2008) 1e-145 110
110PR
110RT
110
7PR
105RT
100 HIVDB
Deroo (2002) HIV-1 subtypes in Luxembourg, 1983-2000 AIDS 16 (18), 2461-2467 (2002) 1e-133  
568
284PR
284RT
0 ARV Rx and/or other data are N/A
Desai (2008) DIRECT Submission Submitted (05-AUG-2008) Department of Neurovirology, Nationa 0  
1
1RT
1IN
0 Case report(s) / study subset
Desai (2009) HIV-2 isolate NNVB-HIV-2 from India, partial genome Unpublished 1e-24  
1
1IN
0 Pending
Desai (2000) MOLECULAR cloning and primary nucleotide sequence analysis of a distinct human immunodeficiency virus isolate reveal significant divergence in its genomic sequences Proc. Natl. Acad. Sci. U.S.A. 83 (21), 8380-8384 (1986) 6e-74  
1
1PR
0 Gene fragment(s)
Descamps (1997) SUSCEPTIBILITY of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: in vitro phenotypic and genotypic analyses J. Virol. 71 (11), 8893-8898 (1997) 3e-19 10
10PR
10RT
10
10PR
10RT
100 HIVDB
Descamps (2011) Direct Submission Submitted (16-DEC-2010) Laboratoire de Virologie, 0  
136
136RT
0 Unpublished
Deshpande (2004) MOLECULAR characterization of HIV type 1 isolates from untreated patients of Mumbai (Bombay), India, and detection of rare resistance mutations AIDS Res. Hum. Retroviruses 20 (9), 1032-1035 (2004) 1e-146 248
122PR
126RT
248
122PR
126RT
100 HIVDB
Deshpande (2009) Phylogenetic analysis of HIV-1 reverse transcriptase sequences from 382 patients recruited in JJ Hospital of Mumbai, India, between 2002 and 2008 AIDS Res. Hum. Retroviruses 25 (6), 633-635 (2009) 1e-150 86
86RT
86
86RT
100 HIVDB
Desire (2001) QUANTIFICATION of human immunodeficiency virus type 1 proviral load by a TaqMan real-time PCR assay J. Clin. Microbiol. 39 (4), 1303-1310 (2001) 3e-15  
16
16IN
0 Gene fragment(s)
Devereux (1999) RAPID decline in detectability of HIV-1 drug resistance mutations after stopping therapy AIDS 13 (18), 123-127 (1999) 1e-128  
48
47PR
43RT
0 Evolution/quasispecies study
Devereux (1999) SUBSTANTIAL correlation between HIV-1 drug-associated resistance mutations detected in plasma and peripheral blood mononuclear cells in heavily treated patients Unpublished 1e-127  
76
38PR
38RT
0 Pending
Devereux (2000) REDUCTION in human immunodeficiency virus type 1 mutations associated with drug resistance after initiating new therapeutic regimens in pretreated patients J. Infect. Dis. 181 (5), 1804-1807 (2000) 1e-127  
80
40PR
40RT
0 Evolution/quasispecies study
Devereux (2000) IN vivo HIV-1 compartmentalisation: drug resistance-associated mutation distribution J. Med. Virol. 66 (1), 8-12 (2002) 1e-122  
213
122PR
91RT
0 Evolution/quasispecies study
Devereux (2001) REPLICATIVE fitness in vivo of HIV-1 variants with multiple drug resistance-associated mutations J. Med. Virol. 65 (2), 218-224 (2001) 1e-124  
27
27PR
27RT
0 Evolution/quasispecies study
Dewhurst (1993) SEQUENCE analysis and acute pathogenicity of molecularly cloned SIVSMM-PBj14 Nature 345 (6276), 636-640 (1990) 1e-101 1
1PR
1RT
1IN
5
2RT
5IN
20 Laboratory/experimental isolate
Diallo (2003) THE M184V Substitution in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Delays the Development of Resistance to Amprenavir and Efavirenz in Subtype B and C Clinical Isolates Antimicrob. Agents Chemother. 47 (7), 2376-2379 (2003) 1e-135  
6
3PR
3RT
0 Laboratory/experimental isolate
Diamond (2001) IDENTIFICATION of a simian immunodeficiency virus reverse transcriptase variant with enhanced replicational fidelity in the late stage of viral infection J. Biol. Chem. 276 (26), 23624-23631 (2001) 1.1  
1
1RT
0 Laboratory/experimental isolate
Diamond (2002) MONITORING Fidelity Change of Simian Immunodeficiency Virus Reverse Transcriptase (RT) During the Course of Viral Infection: A New RT Mutation Responsible for In Vivo RT Fidelity Change Unpublished 0.017  
2
2RT
0 Laboratory/experimental isolate
Diaz (2008) SELECTIVE regimes and evolutionary rates of HIV-1 subtype B V3 variants in the Brazilian epidemic Virology 381 (2), 184-193 (2008) 0  
6
4PR
6RT
6IN
0 Case report(s) / study subset
Dietrich (1997) A highly divergent HIV-2-related isolate Nature 342 (6252), 948-950 (1989) 0 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Dieudonne (2005) HIGH prevalence of secondary resistance mutations in Venezuelan HIV-1 isolates Invest. Clin. 47 (1), 27-34 (2006) 1e-145  
30
22PR
30RT
0 Pending
Dilernia (2007) HIV Type 1 Genetic Diversity Surveillance among Newly Diagnosed Individuals from 2003 to 2005 in Buenos Aires, Argentina AIDS Res. Hum. Retroviruses 23 (10), 1201-1207 (2007) 0 283
283PR
283RT
283
222PR
282RT
100 HIVDB
Diop-Ndiaye (2010) Antiretroviral Drug Resistance Mutations in antiretroviral-naive patients from 1998 to 2007 in Senegal AIDS Res Hum Retroviruses. 2010 Sep 19. [Epub ahead of print 0 122
122PR
122RT
122
5PR
122RT
100 HIVDB
Doualla-Bell (2007) HIGH prevalence of the K65R mutation in human immunodeficiency virus type 1 subtype C isolates from infected patients in Botswana treated with didanosine-based regimens Antimicrob. Agents Chemother. 50 (12), 4182-4185 (2006) 1e-176 23
23RT
23
23RT
100 HIVDB
Dourado (2005) HIV in the general population of an urban center in northeast Brazil Unpublished 2e-51  
4
4PR
0 Case report(s) / study subset
Dowling (2002) FORTY-ONE near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants AIDS 16 (13), 1809-1820 (2002) 1e-166 41
41PR
41RT
41IN
41
41PR
41RT
41IN
100 HIVDB
Drexler (2006) RATES of and Reasons for Failure of Commercial Human Immunodeficiency Virus Type 1 Viral Load Assays in Brazil J. Clin. Microbiol. 45 (6), 2061-2063 (2007) 1e-143  
16
6PR
16RT
0 Case report(s) / study subset
Duan (2001) INHIBITION of purified recombinant reverse transcriptase from wild-type and zidovudine-resistant clinical isolates of human immunodeficiency virus type 1 by zidovudine, stavudine, and lamivudine triphosphates J. Infect. Dis. 184 (10), 1336-1340 (2001) 5e-89  
2
2RT
0 Laboratory/experimental isolate
Dumans (2002) PREVALENCE of protease and reverse transcriptase drug resistance mutations over time in drug-naive human immunodeficiency virus type 1-positive individuals in Rio de Janeiro, Brazil Antimicrob. Agents Chemother. 46 (9), 3075-3079 (2002) 1e-129 101
54PR
47RT
102
55PR
47RT
99 HIVDB
Dumans (2004) SYNONYMOUS Genetic Polymorphisms within Brazilian Human Immunodeficiency Virus Type 1 Subtypes May Influence Mutational Routes to Drug Resistance J. Infect. Dis. 189 (7), 1232-1238 (2004) 0 186
83PR
130RT
188
84PR
131RT
1IN
98 HIVDB
Dumans (2008) DISTINCT resistance mutation and polymorphism acquisition in HIV-1 protease of subtypes B and F1 from children and adult patients under virological failure Infect. Genet. Evol. 9 (1), 62-70 (2009) 0 118
118PR
88RT
118
67PR
65RT
100 HIVDB
Dunne (2001) COMPARISON of genotyping and phenotyping methods for determining susceptibility of HIV-1 to antiretroviral drugs AIDS 15 (12), 1471-1475 (2001) 1e-124 17
17PR
17RT
17
17PR
17RT
100 HIVDB
Duque (2002) THERAPEUTICS failure: Portuguese Cohort Unpublished 1e-128 104
104RT
316
212PR
104RT
32 HIVDB
Duque (2002) HUMAN immunodeficiency virus type 1 M36TV insertion in protease sequence Unpublished 1e-78  
2
2PR
0 Pending
Dvali (2010) Characterization of HIV-1 Subtypes and Drug Resistance Mutations among Infected Individuals in Georgia Unpublished 1e-49  
7
7PR
0 Unpublished
Dykes (2004) DETECTION of Minority Drug-Resistant Variants of HIV-1 During Virologic Failure of Zidovudine (ZDV), Lamivudine (3TC), and Indinavir (IDV) Unpublished 0  
270
270PR
212RT
0 Evolution/quasispecies study
Dzissyuk (2011) Direct Submission Submitted (16-DEC-2010) Science, Republican Center 8e-50  
2
2PR
0 Unpublished
Eberle (2008) SEQUENCE of a HIV-1 Subtype F that is underquantified by Roche COBAS TaqMan and COBAS Amplicor Virus Load Tests Unpublished 0  
1
1RT
1IN
0 Case report(s) / study subset
Edmonson (1998) EVOLUTION of a simian immunodeficiency virus pathogen J. Virol. 72 (1), 405-414 (1998) 4e-22  
1
1IN
0 Laboratory/experimental isolate
El Annaz (2010) Presence of drug resistance mutations among drug-naive patients in Morocco AIDS Res. Hum. Retroviruses (2010) In press 1e-148 59
48PR
11RT
59
48PR
11RT
100 HIVDB
El-Khatib (2011) Viremia and drug resistance among HIV-1 patients on antiretroviral treatment: a cross-sectional study in Soweto, South Africa AIDS 24 (11), 1679-1687 (2010) 1e-167 54
47PR
54RT
54
10PR
54RT
100 HIVDB
Ellenberger (1997) GENETIC diversity of HIV-1 in Abidjan, Cote d'Ivoire Unpublished 7e-86 20
20PR
23
23PR
86 HIVDB
Ellis (2009) Increased detection of HIV-1 drug-resistance at primary diagnosis in peripheral blood cells compared to plasma Unpublished 0  
58
55PR
6RT
0 Unpublished
English (2011) Transmission of highly distinct HIV-1 variants from a single donor Unpublished 1e-152  
66
66RT
0 Unpublished
Eremin (2010) CRF02_A/G isolated from patient on HAART with NRTIs and NNRTIs high level resistance Unpublished 1e-178  
1
1RT
0 Unpublished
Eremin (2010) Genotyping HIV-1 isolated from HIV-infected children born to HIV-infected mothers Unpublished 0  
1
1RT
0 Unpublished
Eron (1998) RESISTANCE of HIV-1 to antiretroviral agents in blood and seminal plasma: implications for transmission AIDS 12 (15), F181-F189 (1998) 1e-130  
59
59PR
59RT
0 Pending
Escoto-Delgadillo (2007) DRUG-RESISTANCE mutations in antiretroviral-naive patients with established HIV-1 infection in Mexico HIV Med. 6 (6), 403-409 (2005) 7e-51  
30
30PR
0 Case report(s) / study subset
Eshleman (2001) IMPACT of human immunodeficiency virus type 1 (hiv-1) subtype on women receiving single-dose nevirapine prophylaxis to prevent hiv-1 vertical transmission (hiv network for prevention trials 012 study) J. Infect. Dis. 184 (7), 914-917 (2001) 1e-110 102
102PR
102RT
102
102PR
102RT
100 HIVDB
Eshleman (2001) ANALYSIS of human immunodeficiency virus type 1 drug resistance in children receiving nucleoside analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir (Pediatric AIDS Clinical Trials Group 377) J. Infect. Dis. 183 (12), 1732-1738 (2001) 1e-129 229
229PR
229RT
229
229PR
229RT
100 HIVDB
Eshleman (2002) SURVIVAL of Ugandan infants with subtype A and D HIV-1 infection (HIVNET 012) J. Acquir. Immune Defic. Syndr. 31 (3), 327-330 (2002) 1e-112 54
54PR
54RT
54
54PR
54RT
100 HIVDB
Eshleman (2003) USE of uracil N-glycosylase (UNG) negative Escherichia coli to clone dUTP-containing HIV-1 DNA generated using a commercial HIV-1 genotyping system Unpublished 0  
20
20PR
20RT
0 ARV Rx and/or other data are N/A
Eshleman (2004) CHARACTERIZATION of nevirapine resistance mutations in women with subtype A vs. D HIV-1 6-8 weeks after single-dose nevirapine (HIVNET 012) J. Acquir. Immune Defic. Syndr. 35 (2), 126-130 (2004) 0 178
178PR
178RT
178
178PR
178RT
100 HIVDB
Eshleman (2004) PERFORMANCE of the Celera Diagnostics ViroSeq HIV-1 Genotyping System for Sequence-Based Analysis of Diverse Human Immunodeficiency Virus Type 1 Strains J. Clin. Microbiol. 42 (6), 2711-2717 (2004) 0 124
124PR
124RT
124
124PR
124RT
100 HIVDB
Eshleman (2004) COMPARISON of nevirapine (NVP) resistance in Ugandan women 7 days vs. 6-8 weeks after single-dose NVP prophylaxis: HIVNET 012 AIDS Res. Hum. Retroviruses 20 (6), 595-599 (2004) 0 76
76PR
76RT
78
78PR
78RT
97 HIVDB
Eshleman (2005) LIMITED Evolution in the HIV Type 1 pol Region among Acute Seroconverters in Pune, India AIDS Res. Hum. Retroviruses 21 (1), 93-97 (2005) 0 29
29PR
29RT
33
33PR
33RT
87 HIVDB
Eshleman (2005) NEVIRAPINE (NVP) Resistance in Women with HIV-1 Subtype C, Compared with Subtypes A and D, after the Administration of Single-Dose NVP J. Infect. Dis. 192 (1), 30-36 (2005) 0 65
65PR
65RT
67
58PR
67RT
97 HIVDB
Eshleman (2005) DISTINCT patterns of emergence and fading of K103N and Y181C in women with subtype A vs. D after single-dose nevirapine: HIVNET 012 J. Acquir. Immune Defic. Syndr. 40 (1), 24-29 (2005) 0  
81
80PR
81RT
0 Evolution/quasispecies study
Eshleman (2006) PHENOTYPIC drug resistance patterns in subtype A HIV-1 clones with non-nucleoside reverse transcriptase (NNRTI) resistance mutations AIDS Res. Hum. Retroviruses (2005) In press 0 35
35PR
35RT
35
31PR
35RT
100 HIVDB
Eshleman (2006) NEVIRIPINE Resistance in Malawian Infants AIDS. 2005 Dec 2;19(18):2167-9. 0  
78
54PR
78RT
0 Pending
Eshleman (2007) ANTIRETROVIRAL drug resistance, HIV-1 tropism, and HIV-1 subtype among men who have sex with men with recent HIV-1 infection AIDS 21 (9), 1165-1174 (2007) 0 195
195PR
195RT
195
186PR
195RT
100 HIVDB
Eshleman (2008) HIV-1 variants with nevirapine resistance mutations are rarely detected in antiretroviral drug naive African women with subtypes A, C, and D AIDS Res. Hum. Retroviruses (2007) In press 0 198
198PR
198RT
198
82PR
198RT
100 HIVDB
Eshleman (2009) Analysis of pol integrase sequences in diverse HIV type 1 strains using a prototype genotyping assay AIDS Res. Hum. Retroviruses 25 (3), 343-345 (2009) 1e-167 110
110IN
120
120IN
91 HIVDB
Eshleman (2009) Antiretroviral drug susceptibility among drug-naive adults with recent HIV infection in Rakai, Uganda AIDS 27 (7), 845-852 (2009) 1e-169 104
104PR
104RT
104
82PR
54RT
100 HIVDB
Espinosa (2002) INTERSUBTYPE BF recombinants of HIV-1 in a population of injecting drug users in Argentina J. Acquir. Immune Defic. Syndr. 36 (1), 630-636 (2004) 1e-102 21
21PR
21RT
21
21PR
21RT
100 HIVDB
Esteves (2004) NATURAL variation of HIV-1 subtype G protease Unpublished 5e-52 51
51PR
55
55PR
53RT
92 HIVDB
Esteves (2007) FULL-LENGTH HIV-1 subtype G molecular clone Unpublished 0  
1
1PR
1RT
1IN
0 Case report(s) / study subset
Etiebet (2011) Tenofovir Disoproxil Fumarate based regimens associated with less nucleoside reverse transcriptase inhibitors drug resistance mutations in Nigerian patients failing first-line anti-retroviral therapy Unpublished 1e-52  
15
15PR
0 Unpublished
Eyer-Silva (2002) REMISSION of HIV-associated myelopathy after initiation of lopinavir in a patient with extensive previous exposure to highly active antiretroviral therapy AIDS 16 (17), 2367-2369 (2002) 4e-47  
1
1PR
0 Case report(s) / study subset
Eyer-Silva (2006) MOLECULAR epidemiology of HIV-1 infection in a small Brazilian county: usefulness of envelope and polymerase sequences to epidemiologic studies J. Acquir. Immune Defic. Syndr. 41 (5), 664-670 (2006) 1e-136  
54
15PR
54RT
0 Pending
Eyer-Silva (2007) MOLECULAR Epidemiology of HIV Type 1 in Inner Rio De Janeiro State, Brazil AIDS Res. Hum. Retroviruses 23 (2), 303-308 (2007) 0 24
24PR
24RT
79
31PR
78RT
30 HIVDB
Eyer-Silva (2008) AUTOCHTHONOUS horizontal transmission of a CRF02_AG strain revealed by a human immunodeficiency virus type 1 diversity survey in a small city in inner state of Rio de Janeiro, Southeast Brazil Mem. Inst. Oswaldo Cruz 102 (7), 809-815 (2007) 0 9
9PR
9RT
9
8PR
1RT
100 HIVDB
Eyre (2006) MULTIPLE drug resistance mutations in human immunodeficiency virus in semen but not blood of a man on antiretroviral therapy Urology 55 (4), 591 (2000) 2e-52  
33
33PR
0 Evolution/quasispecies study
Eyzaguirre (2006) FIRST Molecular Surveillance Report of HIV Type 1 in Injecting Drug Users And Female Sex Workers along The U.S.-Mexico Border AIDS Res. Hum. Retroviruses 23 (2), 331-334 (2007) 1e-149  
11
10PR
11RT
0 Case report(s) / study subset
Eyzaguirre (2007) GENETIC Characterization of HIV-1 Strains Circulating in Kazakhstan J. Acquir. Immune Defic. Syndr. (2007) In press 0 75
75PR
75RT
6IN
75
73PR
6RT
6IN
100 HIVDB
Eyzaguirre (2011) Low HIV-1 viral load associated with increased prevalence of defective proviruses in Natural Viral Suppressors Unpublished 0  
46
36PR
46RT
46IN
0 Unpublished
Eyzaguirre (2011) Molecular Epidemiology of Human Immunodeficiency Virus-Infected Individuals in Paraguay Unpublished 0  
25
14PR
25RT
25IN
0 Unpublished
Eyzaguirre (2011) Characterization of Acute HIV-1 Infection in High-Risk Nigerian Populations and the comparison with Acute HIV-1 Subtype B Infection Unpublished 0  
14
2PR
14RT
14IN
0 Unpublished
Falloon (2000) COMBINATION therapy with amprenavir, abacavir, and efavirenz in human immunodeficiency virus (HIV)-infected patients failing a protease-inhibitor regimen: pharmacokinetic drug interactions and antiviral activity Clin. Infect. Dis. 30 (2), 313-318 (2000) 1e-118 40
20PR
20RT
40
20PR
20RT
100 HIVDB
Fang (2000) GENETIC Variability of the HIV-1 Sequences from Plasma and Cervical Compartments Unpublished 1e-164  
42
42PR
42RT
18IN
0 Evolution/quasispecies study
Fang (2001) ANALYSIS of transition from long-term nonprogressive to progressive infection identifies sequences that may attenuate HIV type 1 AIDS Res. Hum. Retroviruses 17 (15), 1395-1404 (2001) 1e-163  
10
10PR
10RT
10IN
0 Case report(s) / study subset
Fang (2004) LONG-TERM Survivors in Nairobi: Complete HIV-1 RNA Sequences and Immunogenetic Associations J. Infect. Dis. 190 (4), 697-701 (2004) 0 7
7PR
7RT
7IN
7
7PR
7RT
7IN
100 HIVDB
Fang (2002) PCR-MEDIATED recombination: a general method applied to construct chimeric infectious molecular clones of plasma-derived HIV-1 RNA Nat. Med. 5 (2), 239-242 (1999) 1e-163  
2
2PR
2RT
2IN
0 Laboratory/experimental isolate
Fang (2003) RECOMBINATION following superinfection by HIV-1 AIDS 18 (2), 153-159 (2004) 0  
3
3PR
3RT
3IN
0 Case report(s) / study subset
Fang (1995) UNIQUE insertion sequence and pattern of CD4 expression in variants selected with immunotoxins from human immunodeficiency virus type 1-infected T cells J. Virol. 69 (1), 75-81 (1995) 1e-164  
1
1PR
1RT
1IN
0 Laboratory/experimental isolate
Farrar (1991) CHARACTERISATION of a series of human immunodeficiency virus isolates derived sequentially from a single patient J. Med. Virol. 34 (2), 104-113 (1991) 1e-163  
1
1PR
1RT
1IN
0 Evolution/quasispecies study
Federico (1989) BIOLOGIC and molecular characterization of producer and nonproducer clones from HUT-78 cells infected with a patient HIV isolate AIDS Res. Hum. Retroviruses 5 (4), 385-396 (1989) 1e-165  
1
1PR
1RT
1IN
0 Laboratory/experimental isolate
Fernandez (2006) FITNESS Landscape of Human Immunodeficiency Virus Type 1 Protease Quasispecies J. Virol. 81 (5), 2485-2496 (2007) 1e-52  
295
295PR
0 Evolution/quasispecies study
Fernandez-Garcia (2008) DEVELOPMENT of a Panel of Well-Characterized Human Immunodeficiency Virus Type 1 Isolates from Newly Diagnosed Patients Including Acute and Recent Infections AIDS Res. Hum. Retroviruses 25 (1), 93-102 (2009) 0  
14
3PR
14RT
14IN
0 Case report(s) / study subset
Fernandez-Garcia (2009) Near full-length genome characterization of a newly identified HIV type 1 subtype F variant circulating in St. Petersburg, Russia AIDS Res. Hum. Retroviruses 25 (11), 1187-1191 (20 0 2
2PR
2RT
2IN
2
2RT
2IN
100 HIVDB
Fernandez-Garcia (2010) Identification of a new HIV-1 circulating BF intersubtype recombinant form (CRF47_BF) in Spain AIDS Res. Hum. Retroviruses (2010) In press 0 4
4PR
4RT
2IN
7
4PR
7RT
2IN
57 HIVDB
Ferrari (2004) HLA-A and -B allele expression and ability to develop anti-Gag cross-clade responses in subtype C HIV-1 infected Ethiopians Hum. Immunol. 65 (6), 648-659 (2004) 8e-08  
11
11PR
0 Gene fragment(s)
Ferreira (2010) Prevalence of primary drug resistance-associated mutations among HIV type 1 vertically Infected children in Belo Horizonte, Brazil AIDS Res. Hum. Retroviruses 26 (2), 229-232 (2010) 0 40
40PR
40RT
40
12PR
40RT
100 HIVDB
Finzi (1997) IDENTIFICATION of a reservoir for HIV-1 in patients on highly active antiretroviral therapy Science 278 (5341), 1295-1300 (1997) 1e-124  
12
12PR
12RT
0 Evolution/quasispecies study
Fischetti (2003) MOLECULAR epidemiology of HIV in Ghana: dominance of CRF02_AG J. Med. Virol. 73 (2), 158-166 (2004) 4e-85  
235
235RT
0 Gene fragment(s)
Fish (2010) Natural polymorphisms of integrase among HIV type 1-infected South African patients AIDS Res. Hum. Retroviruses 26 (4), 489-493 (2010) 1e-163 73
73IN
73
73IN
100 HIVDB
Fitzgibbon (1991) IN vivo prevalence of azidothymidine (AZT) resistance mutations in an AIDS patient before and after AZT therapy AIDS Res. Hum. Retroviruses 7 (3), 265-269 (1991) 3e-56  
18
18RT
0 Case report(s) / study subset
Fitzgibbon (1993) HUMAN immunodeficiency virus type 1 pol gene mutations in an AIDS patient treated with multiple antiretroviral drugs J. Virol. 67 (12), 7271-7275 (1993) 9e-94 23
23RT
23
23RT
100 HIVDB
Fitzgibbon (1993) A new type of G-->A hypermutation affecting human immunodeficiency virus AIDS Res. Hum. Retroviruses 9 (9), 833-838 (1993) 6e-67 2
2RT
2
2RT
100 HIVDB
Fitzgibbon (1993) HUMAN immunodeficiency virus type 1 pol gene mutations which cause decreased susceptibility to 2',3'-dideoxycytidine Antimicrob. Agents Chemother. 36 (1), 153-157 (1992) 8e-54 17
17RT
17
17RT
100 HIVDB
Fitzgibbon (2001) EMERGENCE of drug resistance mutations in a group of HIV-infected children taking nelfinavir-containing regimens AIDS Res. Hum. Retroviruses 17 (14), 1321-1328 (2001) 1e-126 51
28PR
23RT
51
28PR
23RT
100 HIVDB
Flaherty (1997) MOLECULAR and biological characterization of a neurovirulent molecular clone of simian immunodeficiency virus J. Virol. 71 (8), 5790-5798 (1997) 5e-99  
1
1PR
1RT
1IN
0 Laboratory/experimental isolate
Fleury (2011) Drug resistance mutations in HIV-1 isolates from naive patients eligible for first line ART in JJ Hospital, Mumbai, India AIDS Res. Hum. Retroviruses (2011) In press 5e-50 5
5PR
5
5PR
100 HIVDB
Flores (1999) HIV-1 subtype F in single and dual infections in Puerto Rico: A potential sentinel site for monitoring novel genetic HIV variants in North America Emerging Infect. Dis. 5 (3), 481-483 (1999) 1e-130 19
19PR
19
19PR
100 HIVDB
Fomsgaard (1991) A highly divergent proviral DNA clone of SIV from a distinct species of African green monkey Virology 182 (1), 397-402 (1991) 1e-113 2
2PR
2RT
2IN
2
2PR
2RT
2IN
100 HIVDB
Fomsgaard (2008) FULL-LENGTH Characterization of A1/D Intersubtype Recombinant Genomes from a Therapy-Induced HIV Type 1 Controller during Acute Infection and His Noncontrolling Partner AIDS Res. Hum. Retroviruses 24 (3), 463-472 (2008) 0  
2
2PR
2RT
2IN
0 Case report(s) / study subset
Fonjungo (2000) HUMAN immunodeficiency virus type 1 group m protease in cameroon: genetic diversity and protease inhibitor mutational features J. Clin. Microbiol. 40 (3), 837-845 (2002) 1e-121 110
110PR
111
111PR
99 HIVDB
Frahm (2006) INCREASED Sequence Diversity Coverage Improves Detection of HIV-Specific T Cell Responses J. Immunol. 179 (10), 6638-6650 (2007) 0  
8
6PR
8RT
8IN
0 Case report(s) / study subset
Franchini (1996) MOLECULAR and biological characterization of a replication competent human immunodeficiency type 2 (HIV-2) proviral clone Proc. Natl. Acad. Sci. U.S.A. 86 (7), 2433-2437 (1989) 0.017 1
1PR
1RT
1IN
1
1RT
100 HIVDB
Franchini (2004) SEQUENCE of simian immunodeficiency virus and its relationship to the human immunodeficiency viruses Nature 328 (6130), 539-543 (1987) 0  
1
1RT
1IN
0 HIVDB
Frange (2008) NEW and Old Complex Recombinant HIV-1 Strains Among Patients with Primary Infection in 1996-2006 in France: the French ANRS CO06 Primo Cohort Study Unpublished 0  
2
2RT
2IN
0 Case report(s) / study subset
Frenkel (2002) MULTIPLE Viral Genetic Analyses Detect Low-Level Human Immunodeficiency Virus Type 1 Replication during Effective Highly Active Antiretroviral Therapy J. Virol. 77 (10), 5721-5730 (2003) 1e-135  
979
777PR
801RT
0 Evolution/quasispecies study
Frenkel (2003) DRUG-RESISTANT mutants of human immunodeficiency virus type 1 persist at higher concentrations in peripheral blood mononuclear cells compared to plasma and are detected at a higher rate by OLA compared to consensus sequencing Unpublished 1e-136  
107
57PR
99RT
0 ARV Rx and/or other data are N/A
Fujisaki (2009) An 11-Year Surveillance of HIV Type 1 Subtypes in Nagoya, Japan AIDS Res. Hum. Retroviruses 25 (1), 15-21 (2009) 2e-52 107
107PR
107RT
107
107PR
100 HIVDB
Fukasawa (1999) SEQUENCE of simian immunodeficiency virus from African green monkey, a new member of the HIV/SIV group Nature 333 (6172), 457-461 (1988) 1e-109 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Fumin (2002) CLONING and Characterization of a Virtually Full-Length HIV-1 Genome of a Prevalent Subtype B-Thai Strain in Central China Unpublished 1e-162  
1
1PR
1RT
1IN
0 Case report(s) / study subset
Gafarova (2008) Direct Submission Submitted (19-NOV-2008) Biotechnology, The D.I. Iv 1e-166  
44
1PR
43IN
0 Unpublished
Gafarova (2009) The sequence of fragment of HIV-1 subtype G pol gene from Russia patient 0110 Unpublished 1e-177  
2
1RT
1IN
0 Case report(s) / study subset
Gafarova (2009) Full sequence of HIV-1 subtype G protease gene, isolated from Russia patient 104 Unpublished 5e-49  
1
1PR
0 Unpublished
Galkin (2004) FULL-LENGTH Genomic Sequencing and Analysis of Four HIV Type 1 Subtype B Isolates Circulating in the Territory of Russia AIDS Res. Hum. Retroviruses 22 (11), 1192-1197 (2006) 0 4
4PR
4RT
4IN
4
3PR
4RT
4IN
100 HIVDB
Galkin (2006) SEQUENCING and analysis of full-length HIV-1 CRF06_cpx isolate from Russia Unpublished 0 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Galkin (2009) The study of long-term HAART treatment effect for resistance-connected alterations in HIV-1 subtype B genes of 4 Austrian IDU patients Unpublished 0  
3
2PR
3RT
3IN
0 Case report(s) / study subset
Gallant (2005) EARLY Virologic Non-Response to Tenofovir, Abacavir, and Lamivudine in HIV-Infected Antiretroviral Naive Subjects J. Infect. Dis. (2005) In press 1e-173 41
41PR
41RT
41
41PR
41RT
100 HIVDB
Galli (2007) RECOMBINATION analysis and structure prediction show correlation between breakpoint clusters and RNA hairpins in the pol gene of human immunodeficiency virus type 1 unique recombinant forms J. Gen. Virol. 89 (PT 12), 3119-3125 (2008) 1e-133  
28
27PR
4RT
0 Pending
Gandhi (2008) ROLE of APOBEC3G/F-mediated hypermutation in the control of human immunodeficiency virus type 1 in elite suppressors J. Virol. 82 (6), 3125-3130 (2008) 0.027  
1
1IN
0 Gene fragment(s)
Gao (2001) RECOMBINATION in human immunodefeciency virus type 2 Unpublished 1e-100 1
1PR
1RT
1IN
1
1RT
1IN
100 Laboratory/experimental isolate
Gao (2003) COMPLETE genomes of HIV-1 subtype C viruses in South Africa Unpublished 0 2
2PR
2RT
2IN
2
2PR
2RT
2IN
100 HIVDB
Gao (1999) ORIGIN of HIV-1 in the chimpanzee Pan troglodytes troglodytes Nature 397 (6718), 436-441 (1999) 1e-155 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Gao (1996) MOLECULAR cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization J. Virol. 70 (3), 1651-1667 (1996) 1e-162 2
2PR
2RT
2IN
2
2PR
2RT
2IN
100 HIVDB
Gao (1996) THE heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin J. Virology 70 (10), 7013-7029 (1996) 1e-164 2
2PR
2RT
2IN
2
2PR
2RT
2IN
100 HIVDB
Gao (1998) AN isolate of human immunodeficiency virus type 1 originally classified as subtype I represents a complex mosaic comprising three different group M subtypes (A, G, and I) J. Virol. 72 (12), 10234-10241 (1998) 1e-161 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Gao (1998) A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1 J. Virol. 72 (7), 5680-5698 (1998) 1e-166 8
8PR
8RT
8IN
8
8PR
8RT
8IN
100 HIVDB
Gao (2001) MOLECULAR characterization of a highly divergent HIV type 1 isolate obtained early in the AIDS epidemic from the Democratic Republic of Congo AIDS Res. Hum. Retroviruses 17 (12), 1217-1222 (2001) 1e-166 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Gao (2001) EVIDENCE of two distinct subsubtypes within the HIV-1 subtype A radiation AIDS Res. Hum. Retroviruses 17 (8), 675-688 (2001) 1e-164 6
5PR
5RT
6IN
10
9PR
6RT
6IN
60 HIVDB
Gao (1992) HUMAN infection by genetically diverse SIVSM-related HIV-2 in west Africa Nature 358 (6386), 495-499 (1992) 5e-66 3
3RT
16
16RT
16IN
18 HIVDB
Gao (1993) GENETIC typing of HIV-2 from a Senegalese/German heterosexual transmission AIDS Res. Hum. Retroviruses 9 (7), 703-704 (1993) 2e-64  
2
2RT
2IN
0 Case report(s) / study subset
Gao (1994) GENETIC diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology J. Virol. 68 (11), 7433-7447 (1994) 1e-111 2
2RT
6
6RT
4IN
33 HIVDB
Garaev (2006) 5' region of HIV-1 G subtype pol gene Unpublished 1e-163  
79
3PR
79RT
0 Pending
Garaev (2007) DIRECT Submission Submitted (08-NOV-2006) Biotechnology, The D.I. Ivanovsky In 1e-161  
13
2PR
12RT
0 Pending
Garcia-Arriaza (2007) CHARACTERIZATION of minority subpopulations in the mutant spectrum of HIV-1 quasispecies by successive specific amplifications Virus Res. 129 (2), 123-134 (2007) 2e-50  
3
3PR
0 Case report(s) / study subset
Garcia-Bujalance (2005) COMPARISON between Sequence Analysis and a Line Probe Assay for Testing Genotypic Resistance of Human Immunodeficiency Virus Type 1 to Antiretroviral Drugs J. Clin. Microbiol. 43 (8), 4186-4188 (2005) 1e-123 94
40PR
54RT
94
40PR
54RT
100 HIVDB
Garcia-Lerma (2001) INCREASED ability for selection of zidovudine resistance in a distinct class of wild-type HIV-1 from drug-naive persons Proc. Natl. Acad. Sci. U.S.A. 98 (24), 13907-13912 (2001) 5e-89  
7
7RT
0 Case report(s) / study subset
Garcia-Lerma (2004) TRANSMITTED Human Immunodeficiency Virus Type 1 Carrying the D67N or K219Q/E Mutation Evolves Rapidly to Zidovudine Resistance In Vitro and Shows a High Replicative Fitness in the Presence of Zidovudine J. Virol. 78 (14), 7545-7552 (2004) 1e-142  
6
6RT
0 Case report(s) / study subset
Garcia-Vallejo (2009) Molecular epidemiology of Human immunodeficiency virus (HIV-1) antiviral resistance in isolates from patient of Colombian Caribbean Region Unpublished 0  
107
48PR
59RT
0 Unpublished
Garcia-Vallejo (2009) First Report of Human Immunodeficiency Virus type 2 (HIV-2) Infection in the Colombian Caribbean Region Unpublished 0  
3
3RT
0 Unpublished
Garrido (2009) Integrase variability and susceptibility to HIV integrase inhibitors: impact of subtypes, antiretroviral experience and duration of HIV infection J. Antimicrob. Chemother. 65 (2), 320-326 (2010) 1e-166 418
418IN
418
418IN
100 HIVDB
Garrido (2010) Dynamics in the selection of resistance mutations in HIV patients failing Raltegravir and following its discontinuation Unpublished 1e-166  
53
53IN
0 Unpublished
Garriga (2010) HIV-1 reverse transcriptase thumb subdomain polymorphisms associated with virological failure to nucleoside drug combinations J. Antimicrob. Chemother. 64 (2), 251-258 (2009) 0  
153
76PR
147RT
0 Pending
Gashnikova (2011) Biological and Genetic Characterization of HIV-1 Strains Circulating in Siberia, Russia Unpublished 1e-176  
30
10PR
29RT
0 Unpublished
Gatanaga (1999) ACTIVE HIV-1 redistribution and replication in the brain with HIV encephalitis Arch. Virol. 144 (1), 29-43 (1999) 1e-52  
261
261RT
0 Evolution/quasispecies study
Gatanaga (1999) ANTI-HIV effect of saquinavir combined with ritonavir is limited by previous long-term therapy with protease inhibitors AIDS Res. Hum. Retroviruses 15 (17), 1493-1498 (1999) 1e-126 15
15PR
15
15PR
100 HIVDB
Gatanaga (2000) DISCORDANCE between plasma- and PBMC-derived HIV-1 genotypes on protease inhibitor resistance Unpublished 1e-130  
70
70PR
0 ARV Rx and/or other data are N/A
Gatanaga (2011) Drug-resistant HIV-1 prevalence in patients newly diagnosed with HIV/AIDS in Japan Antiviral Res. 75 (1), 75-82 (2007) 1e-165  
452
407PR
193RT
0 Pending
Geels (2003) IDENTIFICATION of Sequential Viral Escape Mutants Associated with Altered T-Cell Responses in a Human Immunodeficiency Virus Type 1-Infected Individual J. Virol. 77 (23), 12430-12440 (2003) 0  
7
7PR
7RT
7IN
0 Case report(s) / study subset
Geels (2005) DIFFERENTIAL loss of human immunodeficiency virus type I (HIV-1)-specific T-helper responses in two HIV-1 infected individuals following CTL escape Unpublished 0  
5
5PR
5RT
5IN
0 Case report(s) / study subset
Gendelman (1987) MOLECULAR characterization of a polymerase mutant human immunodeficiency virus Virology 191 (1), 529 (1992) 1e-98  
3
3RT
0 Laboratory/experimental isolate
Geng (2010) Indinavir resistance pathway in one human immunodeficiency virus type 1 infected patient revealed by single-genome amplification Unpublished 0  
169
10PR
169RT
0 Unpublished
Georges-Courbot (1998) NATURAL infection of a household pet red-capped mangabey (Cercocebus torquatus torquatus) with a new simian immunodeficiency virus J. Virol. 72 (1), 600-608 (1998) 5e-71  
1
1IN
0 Pending
Ghosh (1998) HUMAN Immunodeficiency Virus type 1 complete genomic sequence Unpublished 1e-164  
1
1PR
1RT
1IN
0 HIVDB
Ghosh (1993) A molecular clone of HIV-1 tropic and cytopathic for human and chimpanzee lymphocytes Virology 194 (2), 858-864 (1993) 1e-164  
1
1PR
1RT
1IN
0 Case report(s) / study subset
Giri (2000) CASE report of a novel amino acid deletion in codon 67 and T69G substitution in the RT of HIV-1 Unpublished 2e-76  
2
2RT
0 Case report(s) / study subset
Gittens (2002) THE Molecular Epidemiology and Drug Resistance Determination of HIV Type 1 Subtype B Infection in Barbados AIDS Res. Hum. Retroviruses 19 (4), 313-319 (2003) 1e-126 27
27PR
71
27PR
44RT
38 HIVDB
Giuliani (2008) NON-B HIV Type 1 Subtypes among Men Who Have Sex with Men in Rome, Italy AIDS Res. Hum. Retroviruses 25 (2), 157-164 (2009) 0  
116
64PR
116RT
0 Pending
Glenn (2006) A single amino acid change in gp41 is linked to the macrophage-only replication phenotype of a molecular clone of simian immunodeficiency virus derived from the brain of a macaque with neuropathogenic infection Virology 325 (2), 297-307 (2004) 8e-19  
1
1IN
0 Laboratory/experimental isolate
Goldberg (2009) Coinfection of Ugandan red colobus (Procolobus [Piliocolobus] rufomitratus tephrosceles) with novel, divergent delta-, lenti-, and spumaretroviruses J. Virol. 83 (21), 11318-11329 (2009) 2e-45  
3
3IN
0 Gene fragment(s)
Gomez-Carrillo (2004) DRUG Resistance Testing Provides Evidence of the Globalization of HIV Type 1: A New Circulating Recombinant Form AIDS Res. Hum. Retroviruses 20 (8), 885-888 (2004) 0 589
589PR
589RT
589
589PR
589RT
100 HIVDB
Gomez-Carrillo (2006) ANALYSIS of HIV Type 1 Diversity in Pregnant Women from Four Latin American and Caribbean Countries AIDS Res. Hum. Retroviruses 22 (11), 1186-1191 (2006) 0  
121
94PR
121RT
0 Pending
Gonzales (2002) EXTENDED spectrum of HIV-1 reverse transcriptase mutations in patients receiving multiple nucleoside analog inhibitors AIDS 17 (6), 791-799 (2003) 2e-97 287
287RT
287
287RT
100 HIVDB
Gonzales (2003) PROTEASE and Reverse Transcriptase Mutation Patterns in HIV Type 1 Isolates from Heavily Treated Persons: Comparison of Isolates from Northern California with Isolates from Other Regions AIDS Res. Hum. Retroviruses 19 (10), 909-915 (2003) 1e-173 100
38PR
62RT
100
38PR
62RT
100 HIVDB
Gonzales (2003) COLINEARITY of reverse transcriptase inhibitor resistance mutations detected by population-based sequencing J. Acquir. Immune Defic. Syndr. 34 (4), 398-402 (2003) 0 82
7PR
75RT
82
8PR
75RT
100 HIVDB
Gonzalez Perez (2003) EPIDEMIOLOGICAL and molecular characteristics of HIV and HTLV infection in Equatorial Guinea Unpublished 1e-169 41
41RT
41
14PR
41RT
100 HIVDB
Gonzalez (2004) DETECTION of Human Immunodeficiency Virus Type 1 Antiretroviral Resistance Mutations by High-Density DNA Probe Arrays J. Clin. Microbiol. 42 (7), 2907-2912 (2004) 0  
178
89PR
91RT
0 ARV Rx and/or other data are N/A
Gonzalez (2009) Anti-Retroviral Therapy Resistance Mutations Present in the HIV Type 1 Subtype C pol and env Regions from Therapy Naive Patients in Zambia Unpublished 1e-175 50
50PR
50RT
67
1PR
66RT
74 HIVDB
Gonzalez (2010) Short communication: antiretroviral therapy resistance mutations present in the HIV type 1 subtype C pol and env regions from therapy-naive patients in Zambia AIDS Res. Hum. Retroviruses 26 (7), 795-803 (2010) 1e-171  
55
13PR
55RT
0 Pending
Gordon (2002) MOLECULAR characteristics of human immunodeficiency virus type 1 subtype C viruses from KwaZulu-Natal, South Africa: implications for vaccine and antiretroviral control strategies J. Virol. 77 (4), 2587-2599 (2003) 2e-99 72
72PR
72RT
75
75PR
75RT
96 HIVDB
Gottlieb (2009) Emergence of multiclass drug-resistance in HIV-2 in antiretroviral-treated individuals in Senegal: implications for HIV-2 treatment in resource-limited west Africa Clin. Infect. Dis. 48, 476-483 (2009) 0  
169
169RT
0 Pending
Gottlieb (2011) HIV-2 Integrase Variation in Integrase Inhibitor-Naive Adults in Senegal, West Africa PLoS ONE 6 (7), E22204 (2011) 1e-101  
122
122IN
0 Pending
Goujon (2000) PHYLOGENETIC analyses indicate an atypical nurse-to-patient transmission of human immunodeficiency virus type 1 J. Virol. 74 (6), 2525-2532 (2000) 1e-137  
124
124RT
0 Evolution/quasispecies study
Graf (1998) CLONING and characterization of a virtually full-length HIV type 1 genome from a subtype B'-Thai strain representing the most prevalent B-clade isolate in China AIDS Res. Hum. Retroviruses 14 (3), 285-288 (1998) 1e-161 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Grant (2002) ACCURACY of the TRUGENE HIV-1 Genotyping Kit J. Clin. Microbiol. 41 (4), 1586-1593 (2003) 1e-128  
18
9PR
9RT
0 ARV Rx and/or other data are N/A
Grisson (2004) INFECTIOUS molecular clone of a recently transmitted pediatric human immunodeficiency virus clade C isolate from Africa: evidence of intraclade recombination J. Virol. 78 (24), 14066-14069 (2004) 0  
1
1PR
1RT
1IN
0 Case report(s) / study subset
Grossman (2004) MUTATION D30N Is Not Preferentially Selected by Human Immunodeficiency Virus Type 1 Subtype C in the Development of Resistance to Nelfinavir Antimicrob. Agents Chemother. 48 (6), 2159-2165 (2004) 4e-50 100
100PR
100
100PR
100 HIVDB
Guillon (1996) COMPLETION of nucleotide sequences of non-syncytium-inducing and syncytium-inducing HIV type 1 variants isolated from the same patient AIDS Res. Hum. Retroviruses 11 (12), 1537-1541 (1995) 1e-165  
2
2PR
2RT
2IN
0 Case report(s) / study subset
Guimaraes (2008) IDENTIFICATION of two new CRF_BF in Rio de Janeiro State, Brazil AIDS 22 (3), 433-435 (2008) 0  
7
7RT
7IN
0 Case report(s) / study subset
Guimaraes (2009) Close phylogenetic relationship between Angolan and Romanian HIV-1 subtype F1 isolates Retrovirology 6, 39 (2009) 0 9
4PR
9RT
4IN
9
9RT
4IN
100 HIVDB
Guimaraes (2010) Analysis of HIV-1 BF pr/rt recombinant strains from Rio de Janeiro/Brazil reveals multiple unrelated mosaic structures Infect. Genet. Evol. (2010) In press 1e-167  
24
24IN
0 Pending
Gunthard (1998) HUMAN immunodeficiency virus replication and genotypic resistance in blood and lymph nodes after a year of potent antiretroviral therapy J. Virol. 72 (3), 2422-2428 (1998) 1e-128  
50
34PR
50RT
0 Evolution/quasispecies study
Gunthard (1999) HIGHER selection pressure from antiretroviral drugs in vivo results in increased evolutionary distance in HIV-1 pol Virology 259 (1), 154-165 (1999) 1e-130  
72
72PR
72RT
0 DNAChip
Guo (2008) Near Full-Length Genome Characterization of an HIV Type 1 CRF01_AE Strain from China Unpublished 0  
1
1RT
1IN
0 Case report(s) / study subset
Guo (2009) First detection of a novel HIV Type 1 CRF01_AE/07_BC recombinant among an epidemiologically linked cohort of IDUs in Jiangsu, China AIDS Res. Hum. Retroviruses 25 (4), 463-467 (2009) 0 3
3PR
3RT
1IN
3
1PR
3RT
1IN
100 HIVDB
Guo (2008) EMERGENCE of first HIV-1 CRF01_AE/07_BC recombinant among an epidemiologically linked cohort of IDUs in Jiangsu, China Unpublished 1e-168 11
11PR
11RT
12
11PR
8RT
91 Case report(s) / study subset
Gupta (2008) GENETIC Variations in the Vif Gene from HIV-1 Infected Individuals from North India Unpublished 0.028  
4
4IN
0 Gene fragment(s)
Gupta (2008) EVIDENCE for HIV-1 gag as a determinant of susceptibility to protease inhibitors using a full length subtype A and C gag-protease AIDS. 2010 Jul 17;24(11):1651-5. 0  
1
1RT
1IN
0 Pending
Gupta (2000) CLONING and Sequencing of HIV-1 Gag (B-subtype) from Indian Strain Unpublished 1e-16  
1
1PR
0 Gene fragment(s)
Gurgo (1988) ENVELOPE sequences of two new United States HIV-1 isolates Virology 164 (2), 531-536 (1988) 1e-161 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Gurtler (1994) A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon J. Virol. 68 (3), 1581-1585 (1994) 1e-144 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Gurusinghe (1995) REVERSE transcriptase mutations in sequential HIV-1 isolates in a patient with AIDS J. Med. Virol. 46 (3), 238-243 (1995) 1e-89  
7
7RT
0 Case report(s) / study subset
Gutierrez (2003) PREVALENCE of HIV-1 non-B subtypes, syphilis, HTLV, and hepatitis B and C viruses among immigrant sex workers in Madrid, Spain J. Med. Virol. 74 (4), 521-527 (2004) 2e-49  
1
1PR
0 Case report(s) / study subset
Hachiya (2001) RAPID and simple phenotypic assay for drug susceptibility of human immunodeficiency virus type 1 using CCR5-expressing HeLa/CD4(+) cell clone 1-10 (MAGIC-5) Antimicrob. Agents Chemother. 45 (2), 495-501 (2001) 1e-123  
45
25PR
20RT
0 ARV Rx and/or other data are N/A
Hachiya (2007) A novel mutation, N348I, in HIV-1 Reverse transcriptase confers 2-class cross resistance for RTIs Unpublished 0  
16
16RT
0 Pending
Hachiya (2010) A novel mutation, K70Q, in HIV-1 reverse transcriptase with Q151M enhances resistance to nucleoside RT inhibitors that remain active to Q151M complex Unpublished 0  
2
2RT
0 Unpublished
Haddad (2000) EVIDENCE for late stage compartmentalization of HIV-1 resistance mutations between lymph node and peripheral blood mononuclear cells AIDS 14 (15), 2273-2281 (2000) 4e-96  
55
55RT
0 Evolution/quasispecies study
Hahn (1990) MOLECULAR characterization of an attenuated human immunodeficiency virus type 2 isolate Unpublished (1990) 6e-99 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Hamers (2010) HIV-1 Drug Resistance Mutations Are Present in Six Percent of Persons Initiating Antiretroviral Therapy in Lusaka, Zambia J. Acquir. Immune Defic. Syndr. (2010) In press 0 536
536PR
535RT
536
43PR
530RT
100 HIVDB
Hamers (2010) HIV-1 Drug Resistance Mutations Are Present in Six Percent of Persons Initiating Antiretroviral Therapy in Lusaka, Zambia J. Acquir. Immune Defic. Syndr. 55 (1), 95-101 (20 2e-47 1
1PR
1RT
1
1PR
100 HIVDB
Hamilton (2010) Partial pol sequence of HIV-1 in Jamaica Unpublished 1e-149  
37
30PR
22RT
0 Unpublished
Hamilton (2010) Analysis of protease and reverse transcriptase genes of HIV for antiretroviral drug resistance in Jamaican adults Unpublished 7e-52  
54
54PR
0 Unpublished
Hamilton (2010) Analysis of protease and reverse transcriptase genes of HIV for antiretroviral drug resistance in Jamaican adults Unpublished 1e-48  
1
1PR
0 Unpublished
Hamkar (2010) Assessing subtype and drug-resistance-associated mutations among antiretroviral-treated HIV-infected patients AIDS 24 SUPPL 2, S85-S91 (2010) 0 28
28PR
28RT
28
1PR
27RT
100 HIVDB
Han (2009) Epidemiologic and Genetic Characterization of Human Immunodeficiency Virus Type I Infection In Liaoning Province, China J Acquir Immune Defic Syndr. 2010 Feb;53 Suppl 1:S27-33. 1e-163  
79
49PR
64RT
0 Pending
Han (2006) MOLECULAR Epidemiology of HIV in Liaoning Province, Northeastern China: Complex Findings in a Low Prevalence Area Unpublished 1e-170 88
88PR
72RT
88
74PR
72RT
100 HIVDB
Han (2009) Molecular analyses confirmed a HIV-1 heterosexual transmission chain in Guangzhou, China Unpublished 0  
4
2PR
4RT
0 Case report(s) / study subset
Handema (2002) PREVALENCE of drug-resistance-associated mutations in antiretroviral drug-naive Zambians infected with subtype C HIV-1 AIDS Res. Hum. Retroviruses 19 (2), 151-160 (2003) 3e-88 53
25PR
28RT
53
25PR
28RT
100 HIVDB
Hanna (2000) PATTERNS of resistance mutations selected by treatment of human immunodeficiency virus type 1 infection with zidovudine, didanosine, and nevirapine J. Infect. Dis. 181 (3), 904-911 (2000) 1e-130  
14
14PR
14RT
0 ARV Rx and/or other data are N/A
Hanna (2002) DRUG-SELECTED resistance mutations and non-B subtypes in antiretroviral-naive adults with established human immunodeficiency virus infection J. Infect. Dis. 188 (7), 986-991 (2003) 1e-126 176
88PR
88RT
176
88PR
88RT
100 HIVDB
Harrigan (2007) A 21-Base Pair Insertion/Duplication at Codon 69 of the HIV Type 1 Reverse Transcriptase in a Patient Undergoing Multiple Nucleoside Therapy AIDS Res. Hum. Retroviruses 23 (7), 895-899 (2007) 0  
10
10RT
0 Pending
Harris (2005) GENOMIC Characterization of a Novel HIV Type 1 B/G Intersubtype Recombinant Strain from an Injecting Drug User in Germany AIDS Res. Hum. Retroviruses 21 (7), 654-660 (2005) 0 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Harris (2002) AMONG 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate AIDS Res. Hum. Retroviruses 18 (17), 1281-1290 (2002) 1e-166 45
45PR
44RT
45IN
45
45PR
45RT
45IN
100 HIVDB
Harris (2003) A cluster of HIV type 1 subtype C sequences from Ethiopia, observed in full genome analysis, is not sustained in subgenomic regions AIDS Res. Hum. Retroviruses 19 (12), 1125-1133 (2003) 0 6
6PR
6RT
6IN
6
6PR
6RT
6IN
100 HIVDB
Hase (2010) The different trend in epidemiology of HIV-1 in a local cohort within Japan Unpublished 0  
94
62PR
69RT
0 Unpublished
Hasegawa (1989) GENOMIC divergence of HIV-2 from Ghana AIDS Res. Hum. Retroviruses 5 (6), 593-604 (1989) 1e-100 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Hassaine (2000) CHARACTERIZATION of human immunodeficiency virus type 1 vif gene in long-term asymptomatic individuals Virology 276 (1), 169-180 (2000) 0.02  
42
42IN
0 Gene fragment(s)
Hatano (2009) Evolution of integrase resistance during failure of integrase inhibitor-based antiretroviral therapy J. Acquir. Immune Defic. Syndr. (2010) 1e-167 134
134IN
142
142IN
94 HIVDB
Hawkins (2009) Clinical and genotypic findings in HIV-infected patients with the K65R mutation failing first line antiretroviral therapy in Nigeria J. Acquir. Immune Defic. Syndr. 52, 2 (2010) 0 336
336PR
336RT
336
4PR
336RT
100 HIVDB
Held (2007) CROSS-CLADE inhibition of recombinant human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus SIVcpz reverse transcriptases by RNA pseudoknot aptamers J. Virol. 81 (10), 5375-5384 (2007) 0  
1
1RT
0 Laboratory/experimental isolate
Henry (2005) FACTORS Associated with Time to CD4 Count < 350 cells/mm3 After Treatment Interruption Following Effective Antiretroviral Therapy (ART) +/- Interleukin-2 (IL-2): Results of a Pilot Study (ACTG A5102) Unpublished 0  
55
47PR
55RT
0 Pending
Heredia (1997) EVIDENCE of HIV-2 infection in Equatorial Guinea (Central Africa): Partial genetic analysis of a B subtype virus AIDS Res. Hum. Retroviruses 13, 437-439 (1997) 4.2 1
1RT
1
1RT
100 HIVDB
Heredia (2001) GENETIC analysis of an HIV type 2 subtype B virus from a Spanish individual with AIDS AIDS Res. Hum. Retroviruses 13 (10), 899-900 (1997) 2e-86 1
1RT
1
1RT
100 HIVDB
Hermankova (2001) HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/ml receiving combination therapy JAMA 286 (2), 196-207 (2001) 1e-126  
47
47PR
47RT
0 Evolution/quasispecies study
Herring (2001) NATURAL Variation in HIV-1 Integrase Unpublished 1e-165 81
81IN
81
81IN
100 HIVDB
Herring (2005) POTENTIAL drug resistance polymorphisms in the integrase gene of HIV type 1 subtype A AIDS Res. Hum. Retroviruses 20 (9), 1010-1014 (2004) 1e-162 8
8IN
8
8IN
100 HIVDB
Heuverswyn (2007) GENETIC diversity and phylogeographic clustering of SIVcpzPtt in wild chimpanzees in Cameroon Virology 368 (1), 155-171 (2007) 1e-100  
8
8IN
0 Pending
Hierholzer (2002) HIV type 1 strains from East and West Africa are intermixed in Sudan AIDS Res. Hum. Retroviruses 18 (15), 1163-1166 (2002) 1e-130 30
30PR
30RT
30
30PR
30RT
100 HIVDB
Hierholzer (2003) MOLECULAR Epidemiology of HIV Type 1 in Ecuador, Peru, Bolivia, Uruguay, and Argentina AIDS Res. Hum. Retroviruses 18 (18), 1339-1350 (2002) 1e-164 10
10PR
10RT
10IN
10
10PR
10RT
10IN
100 HIVDB
Hirano (2010) Characterization of drug-resistance mutation profile kinetics in HIV-1 with infectious molecular clones Unpublished 0  
6
6RT
6IN
0 Laboratory/experimental isolate
Hirigoyen (2005) USE of Sequence Data Generated in the Bayer TruGene Genotyping Assay To Recognize and Characterize Non-Subtype-B Human Immunodeficiency Virus Type 1 Strains J. Clin. Microbiol. 43 (10), 5263-5271 (2005) 1e-144  
29
6PR
29RT
0 ARV Rx and/or other data are N/A
Hirsch (1997) A molecularly cloned, pathogenic, neutralization-resistant simian immunodeficiency virus, SIVsmE543-3 J. Virol. 71 (2), 1608-1620 (1997) 1e-100 1
1PR
1RT
1
1RT
1IN
100 HIVDB
Hirsch (1993) A distinct African lentivirus from Sykes' monkeys J. Virol. 67 (3), 1517-1528 (1993) 3e-91 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Hirsch (1993) DIRECT Submission Unpublished 1e-100 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Hirsch (1995) INDUCTION of AIDS by simian immunodeficiency virus from an African green monkey: species-specific variation in pathogenicity correlates with the extent of in vivo replication J. Virol. 69 (2), 955-967 (1995) 1e-06 1
1PR
1RT
1IN
1
1PR
1RT
100 HIVDB
Hirsch (1999) CHARACTERIZATION of a novel simian immunodeficiency virus (SIV) from L'Hoest monkeys (Cercopithecus l'hoesti): implications for the origins of SIVmnd and other primate lentiviruses J. Virol. 73 (2), 1036-1045 (1999) 0.017 1
1PR
1RT
1IN
1
1RT
100 HIVDB
Hirsch (2000) HUMAN retrovirses, cancer and AIDS: approach to prevention and therapy Unpublished 4.2 1
1PR
1RT
1IN
1
1PR
1RT
100 HIVDB
Ho (2009) Drug-Associated Changes in Amino Acid Residues in Gag p2, p7NC, and p6Gag/p6Pol in Human Immunodeficiency Virus Type 1 (HIV-1) Display a Dominant Effect on Replicative Fitness and Drug Response Unpublished 3e-50  
9
9PR
0 Case report(s) / study subset
Ho (2010) Genetic determinants in HIV-1 Gag and Env V3 are related to viral response to combination antiretroviral therapy with a protease inhibitor AIDS 23 (13), 1631-1640 (2009) 1e-52  
402
402PR
0 Pending
Hoelscher (2001) HIGH proportion of unrelated HIV-1 intersubtype recombinants in the Mbeya region of southwest Tanzania AIDS 15 (12), 1461-1470 (2001) 1e-166 9
9PR
9RT
9IN
9
9PR
9RT
9IN
100 HIVDB
Holguin Fernandez (2008) RAPID Increase of HIV-1 Non-B Subtypes and Recombinants Among Newly Diagnosed Native Spaniards Curr HIV Res. 2008 Jun;6(4):327-34. 0  
5
1PR
4RT
0 Pending
Holguin (1999) HUMAN immunodeficiency virus type 1 subtypes circulating in Portugal Unpublished 1e-126 29
29PR
31
31PR
93 HIVDB
Holguin (2000) HIV-1 subtype J recombinant viruses in Spain AIDS Res. Hum. Retroviruses 18 (7), 523-529 (2002) 1e-90 18
5PR
13RT
19
6PR
13RT
94 HIVDB
Holguin (2000) PROTEASE gene analysis of HIV type 1 non-B subtypes in Spain AIDS Res. Hum. Retroviruses 16 (14), 1395-1403 (2000) 2e-92 15
15PR
15
15PR
100 HIVDB
Holguin (2001) PREVALENCE of human immunodeficiency virus type 1 (HIV-1) non-B subtypes in foreigners living in Madrid, Spain, and comparison of the performances of the AMPLICOR HIV-1 MONITOR version 1.0 and the new automated version 1.5 J. Clin. Microbiol. 39 (5), 1850-1854 (2001) 1e-126 32
32PR
32
32PR
100 HIVDB
Holguin (2001) HIV-1 subtype J recombinant viruses in Spain AIDS Res. Hum. Retroviruses 18 (7), 523-529 (2002) 3e-69 1
1RT
1
1RT
100 HIVDB
Holguin (2002) HIGH prevalence of HIV-1 subtype G and natural polymorphisms at the protease gene among HIV-infected immigrants in Madrid AIDS 16 (8), 1163-1170 (2002) 1e-102 43
43PR
44
44PR
97 HIVDB
Holguin (2002) INCREASING prevalence and heterogeneous nature of HIV-1 subtype G recombinants spreading in Spain Unpublished 1e-123 70
38PR
32RT
70
38PR
32RT
100 HIVDB
Holguin (2002) THE Canary Islands (Spain) as a key entrance of HIV-1 non-B subtypes in Southern Europe Unpublished 2e-98 18
1PR
17RT
18
1PR
17RT
100 HIVDB
Holguin (2003) HETEROGENEOUS nature of HIV-1 recombinants spreading in Spain J. Med. Virol. 75 (3), 374-380 (2005) 5e-83 5
3PR
2RT
5
3PR
2RT
100 HIVDB
Holguin (2003) DIFFERENCES in the Length of Gag Proteins among Different HIV Type 1 Subtypes AIDS Res. Hum. Retroviruses 21 (10), 886-893 (2005) 1e-50 46
46PR
46
46PR
100 HIVDB
Holguin (2004) IMPACT of frequent natural polymorphisms at the protease gene on the in vitro susceptibility to protease inhibitors in HIV-1 non-B subtypes J. Clin. Virol. 31 (3), 215-220 (2004) 3e-50 21
21PR
21
21PR
100 HIVDB
Holguin (2004) HIV-1 subtypes in Spain HIV Med. 2005 Sep;6(5):313-20. 8e-51  
14
14PR
0 Pending
Holguin (2004) DIFFERENCES in the Length of Gag Proteins among Different HIV Type 1 Subtypes AIDS Res. Hum. Retroviruses 21 (10), 886-893 (2005) 4e-53 56
56PR
56
56PR
100 HIVDB
Holguin (2006) INTRODUCTION of Non-B Subtypes among Spaniards Newly Diagnosed with HIV Type 1 in the Canary Islands AIDS Res. Hum. Retroviruses 23 (4), 498-502 (2007) 0 18
17PR
18RT
25
11PR
22RT
72 HIVDB
Holguin (2007) NEGATIVE line immunoassay in a HIV-1 subtype D- infected patient with positive serological tests for HIV Unpublished 1e-50  
1
1PR
0 Case report(s) / study subset
Holguin (2007) INCREASE of prevalence of HIV-1 non-B subtypes and recombinants among Spanish native population from 2000 to 2007 Curr HIV Res. 2008 Jun;6(4):327-34. 0  
208
148PR
191RT
0 Pending
Holguin (2008) GENETIC characterization of complex inter-recombinant HIV-1 strains circulating in Spain and reliability of distinct rapid subtyping tools J. Med. Virol. 80 (3), 383-391 (2008) 0 5
5PR
4RT
1IN
5
4RT
3IN
100 HIVDB
Holguin (2008) RAPID Increase of HIV-1 Non-B Subtypes and Recombinants Among Newly Diagnosed Native Spaniards Unpublished 0  
48
17PR
37RT
0 Pending
Holguin (2008) HIV-1 subtypes in newly diagnosed patients in Gran Canaria, Spain (2004-2006) Unpublished 0  
120
67PR
120RT
0 Pending
Holguin (2008) Increase of prevalence of HIV-1 non-B subtypes and recombinants among Spanish native population from 2000 to 2007 Unpublished 5e-49  
8
8PR
0 Pending
Holguin (2011) Drug resistance prevalence in human immunodeficiency virus type 1 infected pediatric populations in Honduras and El Salvador during 1989-2009 Pediatr. Infect. Dis. J. 30 (5), E82-E87 (2011) 5e-52  
51
51PR
0 Pending
Holler (1994) HIV1 integrase expressed in Escherichia coli from a synthetic gene Gene 136 (1-2), 323-328 (1993) 1e-165  
1
1IN
0 Laboratory/experimental isolate
Holzmayer (2005) NEAR-FULL-LENGTH genomic sequence of a human immunodeficiency type 1 subtype g strain from cameroon AIDS Res. Hum. Retroviruses 21 (5), 414-419 (2005) 0 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Holzmayer (2009) Characterization of genetically diverse HIV type 1 from a London cohort: near full-length genomic analysis of a subtype H strain AIDS Res. Hum. Retroviruses 25 (7), 721-726 (2009) 0 15
1PR
1RT
15IN
15
1RT
15IN
100 HIVDB
Hong (2007) CHARACTERISTICS of a novel resistant HIV-1 strain against Tenofovir Unpublished 1e-144  
1
1RT
0 Laboratory/experimental isolate
Hoof (2010) Interdisciplinary analysis of HIV-specific CD8(+) T cell responses against variant epitopes reveals restricted TCR promiscuity J. Immunol. 184 (9), 5383-5391 (2010) 1e-152  
24
14PR
17RT
0 Pending
Hooker (1996) AN in vivo mutation from leucine to tryptophan at position 210 in human immunodeficiency virus type 1 reverse transcriptase contributes to high-level resistance to 3'-azido-3'-deoxythymidine J. Virol. 70 (11), 8010-8018 (1996) 2e-91  
2
2RT
0 HIVDB
Howard (1997) SEQUENCE analysis of the glycoprotein 120 coding region of a new HIV type 1 subtype A strain (HIV-1IbNg) from Nigeria AIDS Res. Hum. Retroviruses 10 (12), 1755-1757 (1994) 1e-164 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Hu (2003) CHARACTERIZATION and Comparison of Recombinant Simian Immunodeficiency Virus from Drill (Mandrillus leucophaeus) and Mandrill (Mandrillus sphinx) Isolates J. Virol. 77 (8), 4867-4880 (2003) 1e-122 2
2PR
2RT
2IN
2
1PR
2RT
2IN
100 HIVDB
Hu (2007) VIROLOGIC characterization of human immunodeficiency virus type 1 with a codon 70 deletion in reverse transcriptase Unpublished 0  
1
1RT
0 Case report(s) / study subset
Huang (2003) SEQUENCE characterization of the protease and partial reverse transcriptase proteins of the NED panel, an international HIV type 1 subtype reference and standards panel AIDS Res. Hum. Retroviruses 19 (4), 321-328 (2003) 1e-130 44
44PR
44RT
44
44PR
44RT
100 HIVDB
Huang (2009) Complex mosaic composition of near full-length genomes of two NED (NIH-ENVA-DOD) subtype panel HIV type 1 strains, BCF-Dioum and BCF-Kita, originating from the Democratic Republic of Congo (DRC) AIDS Res. Hum. Retroviruses 25 (10), 1039-1043 (20 0 2
2PR
2RT
2IN
2
2RT
2IN
100 HIVDB
Huang (2006) GENETIC characterization of three CRF01_AE full-length HIV type 1 sequences from Fujian Province, China Chin. Med. J. 119 (19), 1622-1628 (2006) 0 3
3PR
3RT
3IN
3
3PR
3RT
3IN
100 HIVDB
Huang (2006) GENETIC Characterization of CRF01_AE Full-Length Human Immunodeficiency Virus Type 1 Sequences from Fujian, China AIDS Res. Hum. Retroviruses 23 (4), 569-574 (2007) 0 10
10PR
10RT
10IN
10
7PR
10RT
10IN
100 HIVDB
Huang (1998) COMPLETE sequence of type B HIV-1 Taiwan strain Unpublished 1e-162  
1
1PR
1RT
1IN
0 Case report(s) / study subset
Hudelson (2010) Emergence and persistence of nevirapine resistance in breast milk after single-dose nevirapine administration AIDS 24 (4), 557-561 (2010) 0  
60
13PR
60RT
0 Pending
Hue (2003) HIV-1 pol gene variation is sufficient for reconstruction of transmissions in the era of antiretroviral therapy AIDS 18 (5), 719-728 (2004) 1e-130  
138
138PR
138RT
0 ARV Rx and/or other data are N/A
Hue (2009) Demonstration of sustained drug-resistant human immunodeficiency virus type 1 lineages circulating among treatment-naive individuals J. Virol. 83 (6), 2645-2654 (2009) 0  
41
24PR
32RT
0 Evolution/quasispecies study
Hue (2011) HIV-1 in a rural coastal town in Kenya shows multiple introductions with many subtypes and much recombination AIDS Res. Hum. Retroviruses (2011) In press 1e-177 32
32PR
32RT
159
1PR
159RT
20 HIVDB
Hue (2004) GENETIC analysis reveals the complex structure of HIV-1 transmission within defined risk groups Proc. Natl. Acad. Sci. U.S.A. 102 (12), 4425-4429 (2005) 1e-126  
223
223PR
223RT
0 ARV Rx and/or other data are N/A
Huet (1995) GENETIC organization of a chimpanzee lentivirus related to HIV-1 Nature 345 (6273), 356-359 (1990) 1e-157 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Huet (1989) A highly defective HIV-1 strain isolated from a healthy Gabonese individual presenting an atypical western blot AIDS 3 (11), 707-715 (1989) 1e-164 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Hughes (2009) Molecular phylodynamics of the heterosexual HIV epidemic in the United Kingdom PLoS Pathog. 5 (9), E1000590 (2009) 0  
301
43PR
266RT
0 Evolution/quasispecies study
Hunt (2002) CHARACTERISATION of near-full length genome sequences of three South African human immunodeficiency virus type 1 subtype C isolates Virus Genes 26 (1), 49-56 (2003) 1e-164 3
3PR
3RT
3IN
3
3PR
3RT
3IN
100 HIVDB
Ibanez (2000) HUMAN immunodeficiency virus type 1 population bottleneck during indinavir therapy causes a genetic drift in the env quasispecies J. Gen. Virol. 81 (Pt 1), 85-95 (2000) 1e-121  
86
86PR
0 Evolution/quasispecies study
Ibe (2008) TREND of drug-resistant HIV type 1 emergence among therapy-naive patients in Nagoya, Japan: an 8-year surveillance from 1999 to 2006 AIDS Res. Hum. Retroviruses 24 (1), 7-14 (2008) 1e-139 363
363PR
363RT
363
354PR
56RT
100 HIVDB
Ibe (2008) ANALYSIS of near full-length genomic sequences of drug-resistant HIV-1 spreading among therapy-naive individuals in Nagoya, Japan: amino acid mutations associated with viral replication activity AIDS Res. Hum. Retroviruses 24 (8), 1121-1125 (2008) 0 12
12PR
12RT
12IN
12
9PR
12RT
12IN
100 HIVDB
Ibe (2010) HIV-2 CRF01_AB: first circulating recombinant form of HIV-2 J. Acquir. Immune Defic. Syndr. 54 (3), 241-247 (2 0  
3
3RT
3IN
0 Pending
Ida (2000) HORIZONTAL Transmission of HIV-1 from Hemophiliac Son to Father Unpublished 1e-133  
34
34RT
0 Evolution/quasispecies study
Ignacio (2008) NOVEL Protease Insertion in HIV Type-1 AIDS Res. Hum. Retroviruses (2008) In press 1e-178  
1
1RT
0 Case report(s) / study subset
Imamichi (2001) HUMAN immunodeficiency virus type 1 quasi species that rebound after discontinuation of highly active antiretroviral therapy are similar to the viral quasi species present before initiation of therapy J. Infect. Dis. 183 (1), 36-50 (2001) 1e-126  
644
644PR
0 Evolution/quasispecies study
Imamichi (2011) Rerunning the Tape of Evolution: An Empirical Example with HIV Unpublished 3e-52  
50
50PR
0 Evolution/quasispecies study
Iqbal (2010) Primary HIV-1 Drug Resistance and Polymorphic Patterns Among Injecting Drug Users (IDUs) in Chennai, Southern India J Int Assoc Physicians AIDS Care 8, 323-327 (2009) 4e-49 4
4PR
4
4PR
100 HIVDB
Isarangkura-na-ayuthaya (2010) Appearance of Drug Resistance-Associated Mutations in Human Immunodeficiency Virus Type 1 CRF01_AE Integrase Derived from Drug-Naive Thai Patients AIDS Res. Hum. Retroviruses (2010) In press 1e-165 78
78IN
78
78IN
100 HIVDB
Ishizaki (2009) Profile of HIV Type 1 Infection and Genotypic Resistance Mutations to Antiretroviral Drugs in Treatment-Naive HIV Type 1-Infected Individuals in Hai Phong, Viet Nam AIDS Res. Hum. Retroviruses 25 (2), 175-182 (2009) 1e-152 410
408PR
389RT
410
333PR
218RT
100 HIVDB
Iweriebor (2010) Molecular epidemiology of HIV in two highly endemic areas of north-eastern South Africa Unpublished 1e-168 53
13PR
40RT
59
15PR
44RT
89 HIVDB
Iweriebor (2010) Near full-length genomic analysis of an HIV type 1 subtype A1/C recombinant isolate from Limpopo province in South Africa Unpublished 0  
1
1RT
1IN
0 Unpublished
Iweriebor (2010) Genetic Characterization of HIV-1 Unique C/CRF11_cpx Recombinant Form from Limpopo Province, South Africa Unpublished 0  
2
1RT
1IN
0 Unpublished
Izopet (1998) EVOLUTION of total and integrated HIV-1 DNA and change in DNA sequences in patients with sustained plasma virus suppression Virology 302 (2), 393-404 (2002) 1e-129  
278
18PR
260RT
0 Evolution/quasispecies study
Izopet (2000) SHIFT in HIV resistance genotype after treatment interruption and short-term antiviral effect following a new salvage regimen AIDS 14 (15), 2247-2255 (2000) 1e-133  
152
76PR
76RT
0 Evolution/quasispecies study
Izopet (2002) EVOLUTION of human immunodeficiency virus type 1 populations after resumption of therapy following treatment interruption and shift in resistance genotype J. Infect. Dis. 185 (10), 1506-1510 (2002) 1e-133  
306
149PR
157RT
0 Evolution/quasispecies study
Jackson (2002) IDENTIFICATION of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission AIDS 14 (11), F111-F115 (2000) 3e-22 15
15RT
15
15RT
100 HIVDB
Jacobs (2007) COMPLETE Genome Sequencing of a Non-syncytium-Inducing HIV Type 1 Subtype D Strain from Cape Town, South Africa AIDS Res. Hum. Retroviruses 23 (12), 1575-1578 (2007) 0 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Jacobs (2008) MOLECULAR Analysis of HIV Type 1 vif Sequences from Cape Town, South Africa AIDS Res. Hum. Retroviruses 24 (7), 991-994 (2008) 0.027  
1
1IN
0 Gene fragment(s)
Jacobs (2008) PHYLOGENETIC Diversity and Low Level Antiretroviral Resistance Mutations in HIV Type 1 Treatment-Naive Patients from Cape Town, South Africa AIDS Res. Hum. Retroviruses 24 (7), 1009-1012 (2008) 1e-149 103
94PR
88RT
103
45PR
79RT
100 HIVDB
Jacobson (2006) EVIDENCE That Intermittent Structured Treatment Interruption, but Not Immunization with ALVAC-HIV vCP1452, Promotes Host Control of HIV Replication: The Results of AIDS Clinical Trials Group 5068 J. Infect. Dis. 194 (5), 623-632 (2006) 6e-51  
2
2PR
0 Case report(s) / study subset
Jain (2010) Differential Persistence of Transmitted HIV-1 Drug Resistance Mutation Classes J. Infect. Dis. 203 (8), 1174-1181 (2011) 8e-52  
78
78PR
0 Pending
Jallow (2006) VIROLOGICAL and immunological response to Combivir and emergence of drug resistance mutations in a cohort of HIV-2 patients in The Gambia AIDS 20 (10), 1455-1458 (2006) 1e-160  
28
28RT
0 Pending
Jallow (2007) DEVELOPMENT and Evaluation of an Oligonucleotide Ligation Assay for Detection of Drug Resistance-Associated Mutations in the Human Immunodeficiency Virus Type 2 pol Gene J. Clin. Microbiol. 45 (5), 1565-1571 (2007) 1e-160  
26
26RT
0 Pending
Jallow (2009) Presence of a multidrug-resistance mutation in an HIV-2 variant infecting a treatment-naive individual in Caio, Guinea Bissau Clin. Infect. Dis. 48 (12), 1790-1793 (2009) 1e-157  
1
1RT
0 Pending
Jallow (2009) Virological response to highly active antiretroviral therapy in patients infected with human immunodeficiency virus type 2 (HIV-2) and in patients dually infected with HIV-1 and HIV-2 in the Gambia and emergence of drug-resistant variants J. Clin. Microbiol. 47 (7), 2200-2208 (2009) 1e-159  
11
11RT
0 Pending
Janin (2009) Low Prevalence of Drug Resistance Transmitted Virus in HIV Type 1-Infected ARV-Naive Patients in Cambodia AIDS Res. Hum. Retroviruses 25 (5), 543-545 (2009) 8e-51 48
48PR
48
48PR
100 HIVDB
Janini (1996) HORIZONTAL and vertical transmission of human immunodeficiency virus type 1 dual infections caused by viruses of subtypes B and C J. Infect. Dis. 177 (1), 227-231 (1998) 1e-130 39
39PR
42
42PR
92 HIVDB
Janini (2001) HUMAN immunodeficiency virus type 1 DNA sequences genetically damaged by hypermutation are often abundant in patient peripheral blood mononuclear cells and may be generated during near-simultaneous infection and activation of CD4(+) T cells J. Virol. 75 (17), 7973-7986 (2001) 1e-133  
350
350PR
0 ARV Rx and/or other data are N/A
Janssens (1995) DIRECT Submission Unpublished 3e-42  
1
1IN
0 Gene fragment(s)
Janssens (1995) FURTHER evidence of the presence of genetically aberrant HIV-1 strains in Cameroon and Gabon AIDS 8 (7), 1012-1013 (1994) 8e-41  
2
2IN
0 Gene fragment(s)
Janssens (2000) HIV-1 subtype H near-full length genome reference strains and analysis of subtype-H-containing inter-subtype recombinants AIDS 14 (11), 1533-1543 (2000) 1e-162 2
2PR
2RT
2IN
2
2PR
2RT
2IN
100 HIVDB
Janssens (2000) NEAR full-length genome analysis of HIV type 1 CRF02.AG subtype C and CRF02.AG subtype G recombinants AIDS Res. Hum. Retroviruses 16 (12), 1183-1189 (2000) 1e-162 2
2PR
2RT
2IN
2
2PR
2RT
2IN
100 HIVDB
Jenwitheesuk (2002) PREVALENCE of genotypic HIV-1 drug resistance in Thailand, 2002 Ann Clin Microbiol Antimicrob 2 (1), 4 (2003) 1e-126  
170
82PR
88RT
0 ARV Rx and/or other data are N/A
Jin (1994) MOSAIC genome structure of simian immunodeficiency virus from west African green monkeys EMBO J. 13 (12), 2935-2947 (1994) 1e-124 1
1PR
1RT
1IN
2
1PR
2RT
1IN
50 HIVDB
Jinnopat (2009) Impact of Amino Acid Variations in Gag and Protease of Human Immunodeficiency Virus Type 1 CRF01_AE strains on Drug Susceptibility of Virus to Protease Inhibitors J. Acquir. Immune Defic. Syndr. (2009) In press 3e-50 5
5PR
5
5PR
100 Case report(s) / study subset
Johnson (1990) SIMIAN immunodeficiency viruses from African green monkeys display unusual genetic diversity J. Virol. 64 (3), 1086-1092 (1990) 1e-111 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Johnson (2001) VERTICAL transmission of multidrug-resistant human immunodeficiency virus type 1 (HIV-1) and continued evolution of drug resistance in an HIV-1-infected infant J. Infect. Dis. 183 (11), 1688-1693 (2001) 1e-112  
6
6PR
6RT
0 Evolution/quasispecies study
Johnson (2007) DETECTION of HIV Drug Resistance at Regimen Failure during Sequential 3-Drug versus Initial 4-Drug HAART Strategies in AIDS Clinical Trials Group Protocol 384 J. Acquir. Immune Defic. Syndr. (2007) In press 0 731
731PR
731RT
731
711PR
151RT
100 HIVDB
Johnson (2007) Detection of HIV Drug Resistance at Regimen Failure during Sequential 3-Drug versus Initial 4-Drug HAART Strategies in AIDS Clinical Trials Group Protocol 384 J. Acquir. Immune Defic. Syndr. (2007) In press 3e-47 3
3PR
3RT
3
3PR
100 HIVDB
Johnston (2004) PANEL of prototypical infectious molecular HIV-1 clones containing multiple nucleoside reverse transcriptase inhibitor resistance mutations AIDS 19 (7), 731-733 (2005) 1e-158 2
2RT
2
2RT
100 HIVDB
Jonassen (1997) SEQUENCE analysis of HIV-1 group O from Norwegian patients infected in the 1960s Virology 231 (1), 43-47 (1997) 1e-102 3
1PR
1RT
1IN
4
2PR
1RT
2IN
75 HIVDB
Jonassen (2000) INTERSUBTYPE recombinant HIV type 1 involving HIV-MAL-like and subtype H-like sequence in four Norwegian cases AIDS Res. Hum. Retroviruses 16 (1), 49-58 (2000) 1e-162 1
1PR
1RT
1IN
7
5PR
2RT
3IN
14 HIVDB
Jones (2005) GENETIC Linkage of Nevirapine Resistance Mutations in HIV Type 1 Seven Days after Single-Dose Nevirapine AIDS Res. Hum. Retroviruses 21 (4), 319-324 (2005) 0 2
2PR
2RT
2
1PR
2RT
100 HIVDB
Jones (2009) In-depth analysis of the origins of HIV type 1 subtype C in South America AIDS Res. Hum. Retroviruses 25 (10), 951-959 (2009 0 4
4PR
4RT
4
4RT
100 HIVDB
Jorgensen (2000) GENOTYPIC and phenotypic nevirapine resistance correlates with virological failure during salvage therapy including abacavir and nevirapine Antivir. Ther. (Lond.) 5 (3), 187-194 (2000) 1e-127 73
37PR
36RT
76
39PR
37RT
96 HIVDB
Jorgensen (2002) GENOTYPIC and phenotypic resistance in cultured HIV reflect the genotype and phenotype of viral RNA in plasma Unpublished 1e-108  
34
17PR
17RT
0 Case report(s) / study subset
Jorgensen (2002) PREVALENCE of drug resistance mutations and non-B subtypes in newly diagnosed HIV-1 patients in Denmark Unpublished 1e-128 97
96PR
97RT
97
96PR
97RT
100 HIVDB
Jost (2002) A patient with HIV-1 superinfection N. Engl. J. Med. 347 (10), 731-736 (2002) 1e-107  
4
2PR
2RT
0 Case report(s) / study subset
Jullaksorn (2010) Sustained appearance of drug resistance-associated mutations in HIV-1 CRF01_AE protease and reverse transcriptase derived from protease inhibitor-naive Thai patients Southeast Asian J. Trop. Med. Public Health 41 (2) 0 271
118PR
153RT
271
118PR
153RT
100 HIVDB
K'Aluoch (2004) HIGH Frequency of Recombinant A and D HIV-1 subtypes in a Population from Uganda (in) 12TH CONFERENCE ON RETROVIRUSES AND OPPORTUNISTIC INFEC 0 29
29PR
29RT
29
29PR
29RT
100 HIVDB
K'Aluoch (2005) CHARACTERIZATION of HIV-1 Subtypes and Recombinants in a Uganda Cohort by use of the gag, nef and pol Genes Unpublished 0 37
34PR
37RT
37
34PR
37RT
100 HIVDB
Kalmar (2009) Evaluation of HIV-1 resistance to antiretroviral drugs among 150 patients after 6 months of therapeutic interruption Unpublished 1e-172  
74
56PR
35RT
0 Unpublished
Kandathil (2007) A Comparison of Interpretation by Three Different HIV Type 1 Genotypic Drug Resistance Algorithms Using Sequences from Non-Clade B HIV Type 1 Strains AIDS Res. Hum. Retroviruses 25 (3), 315-318 (2009) 1e-169 115
112PR
115RT
124
17PR
120RT
92 HIVDB
Kandathil (2008) Does India need a transmitted drug resistance surveillance network for HIV? Unpublished 1e-166 2
2PR
2RT
2
2RT
100 HIVDB
Kantor (2002) EVOLUTION of Primary Protease Inhibitor Resistance Mutations during Protease Inhibitor Salvage Therapy Antimicrob. Agents Chemother. 46 (4), 1086-1092 (2002) 1e-126 76
75PR
1RT
114
114PR
66 HIVDB
Kantor (2003) HIV-1 subtype C reverse transcriptase and protease genotypes in Zimbabwean patients failing antiretroviral therapy AIDS Res. Hum. Retroviruses 18 (18), 1407-1413 (2002) 1e-87 20
20PR
20RT
21
21PR
21RT
95 HIVDB
Kantor (2004) EVOLUTION of resistance to drugs in HIV-1-infected patients failing antiretroviral therapy AIDS 18 (11), 1503-1511 (2004) 1e-180 204
96PR
108RT
427
209PR
218RT
47 HIVDB
Kantor (2005) IMPACT of HIV-1 Subtype and Antiretroviral Therapy on Protease and Reverse Transcriptase Genotype: Results of a Global Collaboration PLoS Med 2 (4), E112 (2005) 0 884
292PR
592RT
1018
394PR
624RT
86 HIVDB
Kao (2011) Surveillance of HIV Type 1 Recent Infection and Molecular Epidemiology Among Different Risk Behaviors Between 2007 and 2009 After the HIV Type 1 CRF07_BC Outbreak in Taiwan AIDS Res. Hum. Retroviruses 27 (7), 745-749 (2011) 0 381
381PR
378RT
381
316PR
378RT
100 HIVDB
Karchava (2006) PREVALENCE of drug-resistance mutations and non-subtype B strains among HIV-infected infants from New York State J. Acquir. Immune Defic. Syndr. 42 (5), 614-619 (2006) 0  
14
9PR
13RT
0 Case report(s) / study subset
Karlsson (2001) RECENT origin of HIV-1 variants in resting CD4+ T-lymphocytes in untreated and suboptimally treated subjects Unpublished 1e-126  
134
134PR
133RT
0 Evolution/quasispecies study
Karlsson (2007) SEQUENTIAL Broadening of CTL Responses in Early HIV-1 Infection Is Associated with Viral Escape PLoS ONE 2, E225 (2007) 1e-141  
83
81PR
83RT
0 Evolution/quasispecies study
Karlsson (2007) ANTIRETROVIRAL drug therapy alters the profile of human immunodeficiency virus type 1-specific T-cell responses and shifts the immunodominant cytotoxic T-lymphocyte response from gag to pol J. Virol. 81 (20), 11543-11548 (2007) 1e-142  
10
4PR
8RT
0 Case report(s) / study subset
Kasang (2010) High prevalence of transmitted drug resistance mutations in therapy naive HIV-1 infected patients in Mwanza, Lake Victoria zone, Tanzania Unpublished 0 89
89PR
89RT
89
15PR
89RT
100 HIVDB
Kassaye (2008) Envelope co-receptor tropism, drug resistance, and viral evolution among subtype C HIV-1 infected individuals receiving non-suppressive antiretroviral therapy Unpublished 1e-165 16
16PR
16RT
16
11PR
9RT
100 HIVDB
Kassu (2006) MOLECULAR epidemiology of HIV type 1 in treatment-naive patients in north Ethiopia AIDS Res. Hum. Retroviruses 23 (4), 564-568 (2007) 1e-153 92
92PR
92RT
92
71PR
92RT
100 HIVDB
Kato (2004) COMPARISON of genotypic assay and peripheral blood mononuclear cell-based phenotypic assay in HIV-1 antiretroviral drug resistance Unpublished 1e-159  
112
56PR
56RT
0 ARV Rx and/or other data are N/A
Katzenstein (2007) SEVENTEEN-YEAR-OLD mother-to-child HIV type 1 transmission identified by phylogeny and signature patterns AIDS Res. Hum. Retroviruses 24 (8), 1117-1120 (2008) 0  
3
3RT
0 Case report(s) / study subset
Kaufmann (2001) IMPACT of HIV type 1 protease, reverse transcriptase, cleavage site, and p6 mutations on the virological response to quadruple therapy with saquinavir, ritonavir, and two nucleoside analogs AIDS Res. Hum. Retroviruses 17 (6), 487-497 (2001) 1e-130  
42
42PR
42RT
0 ARV Rx and/or other data are N/A
Kawashima (2009) Adaptation of HIV-1 to human leukocyte antigen class I Nature 458 (7238), 641-645 (2009) 4e-26  
290
290IN
0 Gene fragment(s)
Kaye (2001) OBSERVATIONS of HIV-1 genotypic drug resistance in a trial of four reverse transcriptase inhibitors (Quattro Trial) Antivir. Ther. (Lond.) (2001) In press 9e-94 58
58RT
58
58RT
100 HIVDB
Kazennova (2011) Direct Submission Submitted (10-AUG-2010) T-Lymphotropic Viruses Lab 0  
82
31PR
82RT
0 Unpublished
Kearney (2009) Human immunodeficiency virus type 1 population genetics and adaptation in newly infected individuals J. Virol. 83 (6), 2715-2727 (2009) 1e-163  
1946
1843PR
576RT
0 Evolution/quasispecies study
Kebe (2011) Distribution of HIV-1 subtypes and antiretroviral drug resistance mutations in Senegalese children experiencing virological failure under WHO recommended highly active antiretroviral therapy Unpublished 0  
49
7PR
48RT
0 Unpublished
Kebira (2011) Genetic Diversity of HIV-1 in Patients on Antiretroviral Therapy in Nairobi Unpublished 2e-47  
40
40IN
0 Gene fragment(s)
Keele (2006) CHIMPANZEE reservoirs of pandemic and nonpandemic HIV-1 Science 313 (5786), 523-526 (2006) 0 30
4PR
4RT
30IN
30
4RT
30IN
100 HIVDB
Keele (2008) CHARACTERIZATION of the follicular dendritic cell reservoir of human immunodeficiency virus type 1 J. Virol. 82 (11), 5548-5561 (2008) 1e-142  
431
332PR
428RT
0 Evolution/quasispecies study
Keele (2009) Increased mortality and AIDS-like immunopathology in wild chimpanzees infected with SIVcpz Nature 460 (7254), 515-519 (2009) 2e-86 14
14IN
14
14IN
100 HIVDB
Keele (2010) Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection Proc. Natl. Acad. Sci. U.S.A. 105 (21), 7552-7557 0  
1
1PR
1RT
1IN
0 Evolution/quasispecies study
Kemal (2006) MULTIDRUG-RESISTANT HIV-1 resulting from intrapatient viral recombination Unpublished 0  
96
93PR
96RT
0 Pending
Kemal (2007) HIV-1 Drug Resistance in Variants from the Female Genital Tract and Plasma J. Infect. Dis. 195 (4), 535-545 (2007) 0  
309
301PR
309RT
0 Evolution/quasispecies study
Kemal (2007) TRANSITION from Long-Term Nonprogression to HIV-1 Disease Associated with Escape from Cellular Immune Control Unpublished 0  
13
13PR
13RT
4IN
0 Evolution/quasispecies study
Kemal (2010) Multidrug-resistant HIV-1 and Recombination between Variants from the Genital Tract and Plasma: A Longitudinal Analysis Unpublished 0  
70
70RT
0 Evolution/quasispecies study
Kestler (2000) INDUCTION of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus Unpublished 5e-99  
1
1PR
1RT
1IN
0 Laboratory/experimental isolate
Khamadi (2005) GENOMIC Diversity of HIV-1 subtypes in Northern Kenya Unpublished 4e-52  
137
137IN
0 Gene fragment(s)
Khurana (2002) SEQUENCE of HIV-1 isolate 01IN565.14 from India Unpublished 1e-165  
4
4PR
4RT
4IN
0 Unpublished
Kieffer (2004) GENOTYPIC Analysis of HIV-1 Drug Resistance at the Limit of Detection: Virus Production without Evolution in Treated Adults with Undetectable HIV Loads J. Infect. Dis. 189 (8), 1452-1465 (2004) 1e-124  
342
174PR
168RT
0 Evolution/quasispecies study
Kiepiela (2005) DOMINANT influence of HLA-B in mediating the potential co-evolution of HIV and HLA Nature 432 (7018), 769-775 (2004) 0  
220
166PR
197RT
191IN
0 Sequence quality
Kijak (2001) RESISTANCE profiles to antiretroviral drugs in HIV-1 Drug-Naive Patients in Argentina Antivir. Ther. (Lond.) (2001) In press 1e-161 115
58PR
57RT
115
58PR
57RT
100 HIVDB
Kijak (2001) HIV type 1 genetic diversity is a major obstacle for antiretroviral drug resistance hybridization-based assays AIDS Res. Hum. Retroviruses 17 (15), 1415-1421 (2001) 2e-97  
93
93RT
0 ARV Rx and/or other data are N/A
Kijak (2002) ORIGIN of human immunodeficiency virus type 1 quasispecies emerging after antiretroviral treatment interruption in patients with therapeutic failure J. Virol. 76 (14), 7000-7009 (2002) 1e-109  
122
122PR
122RT
0 Evolution/quasispecies study
Kijak (2003) DEVELOPMENT and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa AIDS Res. Hum. Retroviruses 20 (5), 521-530 (2004) 0 51
51PR
51RT
51IN
51
11PR
51RT
51IN
100 HIVDB
Kijak (2007) DISTINGUISHING molecular forms of HIV-1 in Asia with a high-throughput, fluorescent genotyping assay, MHAbce v.2 Virology 358 (1), 178-191 (2007) 0  
12
12PR
12RT
12IN
0 Case report(s) / study subset
Kijak (2007) VARIABLE contexts and levels of hypermutation in HIV-1 proviral genomes recovered from primary peripheral blood mononuclear cells Virology 376 (1), 101-111 (2008) 0  
8
7RT
8IN
0 Case report(s) / study subset
Kim (2009) Human APOBEC3G drives HIV-1 evolution and the development of drug resistance Unpublished 1e-149  
250
250RT
0 Evolution/quasispecies study
Kim (2010) Genetic Variation of the HIV-1 Integrase Region in Newly Diagnosed Antiretroviral Drug-Naive Patients with HIV/AIDS in Korea Unpublished 1e-168  
75
75IN
0 Unpublished
Kim (2009) Comparison of Genotypic Resistance Mutations in Treatment Naive HIV-1 Infected Patients in Korea and China Unpublished 0 64
64PR
64RT
64
46PR
54RT
100 HIVDB
Kimata (1998) A lymph node-derived cytopathic simian immunodeficiency virus Mne variant replicates in nonstimulated peripheral blood mononuclear cells J. Virol. 72 (1), 245-256 (1998) 0.068  
1
1PR
1RT
0 Laboratory/experimental isolate
King (1998) RESISTANCE to the anti-human immunodeficiency virus type 1 compound L-chicoric acid results from a single mutation at amino acid 140 of integrase J. Virol. 72 (10), 8420-8424 (1998) 1e-164  
1
1IN
0 Case report(s) / study subset
Kinomoto (2004) HIV-1 proteases from drug-naive West African patients are differentially less susceptible to protease inhibitors Clin. Infect. Dis. 41 (2), 243-251 (2005) 3e-50 38
38PR
39
39PR
97 HIVDB
Kiptoo (2008) PREVALENCE of Nevirapine-Associated Resistance Mutations after Single Dose Prophylactic Treatment among Antenatal Clinic Attendees in North Rift Kenya AIDS Res. Hum. Retroviruses 24 (12), 1555-1559 (2008) 1e-151  
1
1RT
0 Case report(s) / study subset
Kirchhoff (1989) A novel proviral clone of HIV-2: biological and phylogenetic relationship to other primate immunodeficiency viruses Virology 177 (1), 305-311 (1990) 4e-97 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Kirmaier (2010) TRIM5 and interspecies transmission of primate immunodeficiency viruses PLoS Biol. 2010 Aug 24;8(8). pii: e1000462. 0  
1
1RT
1IN
0 Pending
Kita (2005) GENETIC diversity of HIV type 1 in Likasi, southeast of the Democratic Republic of Congo AIDS Res. Hum. Retroviruses 20 (12), 1352-1357 (2004) 2e-49  
27
27IN
0 Gene fragment(s)
Kitrinos (2009) Virologic failure in therapy-naive subjects on aplaviroc plus lopinavir-ritonavir: detection of aplaviroc resistance requires clonal analysis of envelope Antimicrob. Agents Chemother. 53 (3), 1124-1131 (2 1e-172  
18
5PR
17RT
0 Pending
Knops (2010) The evolution of protease mutation 76V is associated with protease mutation 46I and gag mutation 431V AIDS 24 (5), 779-781 (2010) 0 26
26PR
26RT
26
1PR
26RT
100 HIVDB
Knops (2010) Evolution of protease inhibitor resistance in the gag and pol genes of HIV subtype G isolates J. Antimicrob. Chemother. 65 (7), 1472-1476 (2010) 0 21
21PR
21RT
21
21RT
100 HIVDB
Koch (2001) GENETIC analysis of hiv type 1 strains in bujumbura (burundi): predominance of subtype c variant AIDS Res. Hum. Retroviruses 17 (3), 269-273 (2001) 2e-89 36
18PR
18RT
36
18PR
18RT
100 HIVDB
Koelsch (2003) CLADE B HIV-1 superinfection with wild-type virus after primary infection with drug-resistant clade B virus AIDS 17 (7), F11-F16 (2003) 1e-117  
9
9PR
9RT
0 Evolution/quasispecies study
Koizumi (2006) EMERGENCE of ART resistance associated primary mutations among drug naive HIV-1 individuals in rural western Cameroon Unpublished 1e-125 27
20PR
7RT
75
20PR
7RT
48IN
36 HIVDB
Komiyama (1989) NUCLEOTIDE sequences of gag and env genes of a Japanese isolate of HIV-1 and their expression in bacteria AIDS Res. Hum. Retroviruses 5 (4), 411-419 (1989) 2e-40  
1
1PR
0 Laboratory/experimental isolate
Konings (2003) PROTEASE mutations in HIV-1 non-B strains infecting drug-naive villagers in Cameroon AIDS Res. Hum. Retroviruses 20 (1), 105-109 (2004) 1e-51 128
128PR
128
128PR
100 HIVDB
Konings (2003) POL gene of drug-naive Cameroonian individual Unpublished 0 13
1PR
12RT
13
1PR
12RT
100 HIVDB
Konings (2006) HIV-1 Genetic Diversity in the East Province of Cameroon Unpublished 7e-50  
4
4PR
0 Pending
Konings (2006) HUMAN immunodeficiency virus type 1 (HIV-1) circulating recombinant form 02_AG (CRF02_AG) has a higher in vitro replicative capacity than its parental subtypes A and G J. Med. Virol. 78 (5), 523-534 (2006) 0  
5
5RT
0 Case report(s) / study subset
Korovina (2011) Direct Submission Submitted (18-JAN-2011) Pediatric HIV/AIDS Clinica 0  
8
8RT
0 Unpublished
Koulinska (2001) A new human immunodeficiency virus type 1 circulating recombinant form from Tanzania AIDS Res. Hum. Retroviruses 17 (5), 423-431 (2001) 1e-164 3
3PR
3RT
3IN
3
3PR
3RT
3IN
100 HIVDB
Koulinska (2002) COMMON genetic arrangements among human immunodeficiency virus type 1 subtype A and D recombinant genomes vertically transmitted in Tanzania AIDS Res. Hum. Retroviruses 18 (13), 947-956 (2002) 1e-165 6
5PR
4RT
6IN
7
6PR
7RT
6IN
85 HIVDB
Koulinska (2003) HYPERMUTATION of HIV type 1 genomes isolated from infants soon after vertical infection AIDS Res. Hum. Retroviruses 19 (12), 1115-1123 (2003) 0  
45
3PR
45RT
3IN
0 Case report(s) / study subset
Kousiappa (2008) GENETIC analysis of HIV type 1 strains from newly infected untreated patients in cyprus: high genetic diversity and low prevalence of drug resistance AIDS Res. Hum. Retroviruses 25 (1), 23-35 (2009) 0 37
37PR
37RT
37
5PR
37RT
100 HIVDB
Kousiappa (2009) Near Full-Length Genetic Analysis of HIV Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection AIDS Res Hum Retroviruses. 2009 Aug;25(8):727-40. 0 77
77PR
77RT
77IN
77
26PR
77RT
77IN
100 HIVDB
Kousiappa (2011) Molecular Characterization of HIV-1 Strains from Newly Diagnosed Patients in Cyprus (2007 - 2009) Recovers Multiple Clades Including Unique Recombinant Strains and Lack of Transmitted Drug Resistance AIDS Res. Hum. Retroviruses (2011) In press 0  
74
40PR
74RT
74IN
0 Pending
Kouyos (2010) Molecular epidemiology reveals long-term changes in HIV-1 subtype B transmission in Switzerland J Infect Dis. 2010 May 15;201(10):1488-97. 0  
549
428PR
305RT
0 Pending
Koyalta (2009) High Frequency of Antiretroviral Drug Resistance among HIV-Infected Adults Receiving First-Line Highly Active Antiretroviral Therapy in N Djamena, Chad Clin. Infect. Dis. DOI: 10.1086/599611 (2009) In p 1e-50 5
5PR
5RT
5
5PR
100 HIVDB
Koyanagi (1996) DUAL infection of the central nervous system by AIDS viruses with distinct cellular tropisms Science 236 (4803), 819-822 (1987) 1e-163 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Kraiselburd (2002) PROPERTIES of virus-like particles produced by SIV-chronically infected human cell clones Cell. Mol. Biol. (Noisy-le-grand) 41 Suppl 1, S41-S52 (1995) 2e-09  
1
1RT
1IN
0 Laboratory/experimental isolate
Kraus (1995) CHARACTERIZATION of a Novel Molecular Clone of HIV-2 Infectious for Macaca nemestrina Unpublished 1e-100 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Kreutz (1996) ANALYSIS of the envelope region of the highly divergent HIV-2ALT isolate extends the known range of variability within the primate immunodeficiency viruses AIDS Res. Hum. Retroviruses 8 (9), 1619-1629 (1992) 1e-165 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Kristiansen (2005) GENETIC evolution of HIV in patients remaining on a stable HAART regimen despite insufficient viral suppression Unpublished 0  
47
46PR
47RT
0 ARV Rx and/or other data are N/A
Krogstad (2002) MOTHER-TO-CHILD transmission in the United States of subtypes D and A/G human immunodeficiency virus type 1 AIDS Res. Hum. Retroviruses 18 (6), 413-417 (2002) 5e-96  
2
2PR
2RT
0 Case report(s) / study subset
Kuehnel (2000) MOLECULAR cloning of two west African human immunodeficiency virus type 2 isolates that replicate well in macrophages: a Gambian isolate, from a patient with neurologic acquired immunodeficiency syndrome, and a highly divergent Ghanian isolate Unpublished 4.2 1
1PR
1RT
1IN
1
1RT
100 HIVDB
Kuhn (1999) HIV-1 vif gene sequences found in Cologne, Germany in patients who had traveled to or originated from foreign countries Unpublished 0.02  
2
2IN
0 Gene fragment(s)
Kuhnel (1995) NUCLEOTIDE sequence of HIV-2D194, an isolate from a Gambian case of 'neuro-AIDS', which showed excellent growth in macrophages Nucleic Acids Res. 18 (20), 6142 (1990) 4e-98  
1
1RT
1IN
0 Laboratory/experimental isolate
Kuritzkes (2000) EFFECT of zidovudine resistance mutations on virologic response to treatment with zidovudine-lamivudine-ritonavir: genotypic analysis of human immunodeficiency virus type 1 isolates from AIDS clinical trials group protocol 315.ACTG Protocol 315 Team J. Infect. Dis. 181 (2), 491-497 (2000) 1e-133  
40
40PR
40RT
0 Sequence quality
Kuritzkes (2000) EMERGENCE of dual resistance to zidovudine and lamivudine in HIV-1-infected patients treated with zidovudine plus lamivudine as initial therapy J. Acquir. Immune Defic. Syndr. 23 (1), 26-34 (2000) 9e-94  
6
6RT
0 Pending
Kuritzkes (2004) RATE of thymidine analogue resistance mutation accumulation with zidovudine- or stavudine-based regimens J. Acquir. Immune Defic. Syndr. 36 (1), 600-603 (2004) 1e-123 405
403PR
405RT
405
403PR
405RT
100 HIVDB
Kurle (2007) EMERGENCE of NNRTI Drug Resistance Mutations after Single-Dose Nevirapine Exposure in HIV Type 1 Subtype C-Infected Infants in India AIDS Res. Hum. Retroviruses 23 (5), 682-685 (2007) 0 32
32RT
32
32RT
100 HIVDB
Kusagawa (2001) ISOLATION and characterization of a full-length molecular DNA clone of Ghanaian HIV type 1 intersubtype A/G recombinant CRF02_AG, which is replication competent in a restricted host range AIDS Res. Hum. Retroviruses 17 (7), 649-655 (2001) 4e-68 1
1PR
1RT
1IN
1
1PR
1RT
100 Laboratory/experimental isolate
Kusagawa (2002) ISOLATION and characterization of replication-competent molecular DNA clones of HIV type 1 CRF01_AE with different coreceptor usages AIDS Res. Hum. Retroviruses 18 (2), 115-122 (2002) 7e-86  
2
2PR
2RT
0 Case report(s) / study subset
Kusagawa (2003) IDENTIFICATION of HIN type 2 subtype B transmission in East Africa AIDS Res. Hum. Retroviruses 19 (11), 1045-1049 (2003) 0 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Kuwata (2005) INFECTIOUS Molecular Clones from a Simian Immunodeficiency Virus-Infected Rapid-Progressor (RP) Macaque: Evidence of Differential Selection of RP-Specific Envelope Mutations In Vitro and In Vivo J. Virol. 80 (3), 1463-1475 (2006) 0  
3
3RT
3IN
0 Laboratory/experimental isolate
La Seta Catamancio (2001) IN vitro evolution of the human immunodeficiency virus type 1 gag-protease region and maintenance of reverse transcriptase resistance following prolonged drug exposure J. Clin. Microbiol. 39 (3), 1124-1129 (2001) 1e-116  
32
16PR
16RT
0 Evolution/quasispecies study
Laeyendecker (2005) MOLECULAR Epidemiology of HIV-1 Subtypes in Southern China J. Acquir. Immune Defic. Syndr. 38 (3), 356-362 (2005) 5e-51 68
68PR
68
68PR
100 HIVDB
Lahuerta (2007) RAPID Spread and Genetic Diversification of HIV Type 1 Subtype C in a Rural Area of Southern Mozambique AIDS Res. Hum. Retroviruses 24 (2), 327-335 (2008) 1e-50 18
18PR
18
18PR
100 HIVDB
Lakhashe (2008) CHARACTERIZATION of B/C Recombinants of Near Full-Length HIV Type 1 from Northeastern India with Mosaics Identical to ARE195FL But with a Different Ancestral Origin AIDS Res. Hum. Retroviruses 24 (1), 92-99 (2008) 0 15
15PR
15RT
15IN
15
2PR
15RT
15IN
100 Case report(s) / study subset
Lakhashe (2008) EVIDENCE of a Novel B/C Recombinant Exhibiting Unique Breakpoints of Near Full-Length HIV Type 1 Genome from Northeastern India AIDS Res. Hum. Retroviruses 24 (2), 229-234 (2008) 0  
2
1PR
2RT
2IN
0 Case report(s) / study subset
Lakshmi (2009) Antiretroviral Drug Resistant Mutations at Baseline and at time of failure of antiretroviral therapy in HIV-1 co-infected TB patients AIDS Res. Hum. Retroviruses (2009) In press 9e-53 4
4PR
4
4PR
100 HIVDB
Lall (2008) PROFILE of Primary Resistance in HIV-1-Infected Treatment-Naive Individuals from Western India AIDS Res. Hum. Retroviruses 24 (7), 987-990 (2008) 0 40
40PR
40RT
40
3PR
40RT
100 HIVDB
Lan (2003) HIV Type 1 Isolates from 200 Untreated Individuals in Ho Chi Minh City (Vietnam): ANRS 1257 Study. Large Predominance of CRF01_AE and Presence of Major Resistance Mutations to Antiretroviral Drugs AIDS Res. Hum. Retroviruses 19 (10), 925-928 (2003) 1e-145 347
172PR
175RT
347
172PR
175RT
100 HIVDB
Land (2007) FULL-LENGTH HIV type 1 proviral sequencing of 10 highly exposed women from Nairobi, Kenya reveals a high proportion of intersubtype recombinants AIDS Res. Hum. Retroviruses 24 (6), 865-872 (2008) 0 13
13PR
13RT
13IN
13
6PR
13RT
13IN
100 HIVDB
Land (2008) HUMAN Immunodeficiency Virus (HIV) Type 1 Proviral Hypermutation Correlates with CD4 Count in HIV-Infected Women from Kenya J. Virol. 82 (16), 8172-8182 (2008) 0.032  
1
1IN
0 Case report(s) / study subset
Lapovok (2010) Direct Submission Submitted (03-JUN-2010) T-lymphotropic Viruses Lab 1e-167  
36
36IN
0 Pending
Lataillade (2007) NATURAL Polymorphism of the HIV-1 Integrase Gene and Mutations Associated with Integrase Inhibitor Resistance Antivir. Ther. (Lond.) 12, 563-570 (2007) 1e-168 66
66IN
66
66IN
100 HIVDB
Lau (2007) NEAR Full-Length Sequence Analysis of a Unique CRF01_AE/B Recombinant from Kuala Lumpur, Malaysia AIDS Res. Hum. Retroviruses 23 (9), 1139-1145 (2007) 0  
1
1PR
1RT
1IN
0 Case report(s) / study subset
Lau (2007) NEAR-FULL Length Sequence Analysis of Unique Recombinant Form of HIV-1 from Malaysia: Evidence of Rapid and Continuous HIV-1 Evolution in the Region Unpublished 0  
3
3PR
3RT
3IN
0 Case report(s) / study subset
Laukkanen (1999) VIRTUALLY full-length sequences of HIV type 1 subtype J reference strains AIDS Res. Hum. Retroviruses 15 (3), 293-297 (1999) 1e-164 2
2PR
2RT
2IN
2
2PR
2RT
2IN
100 HIVDB
Laukkanen (1999) DIRECT Submission Submitted (18-NOV-1998) Department of Infectious Disease Epi 1e-164  
2
2PR
2RT
2IN
0 Case report(s) / study subset
Laukkanen (2000) VIRTUALLY full-length subtype F and F/D recombinant HIV-1 from Africa and South America Virology 269 (1), 95-104 (2000) 1e-167 4
4PR
4RT
4IN
4
4PR
4RT
4IN
100 HIVDB
Laurent (2006) ANTIRETROVIRAL drug resistance and routine therapy, Cameroon Emerging Infect. Dis. 12 (6), 1001-1004 (2006) 0 21
21PR
21RT
21
13PR
21RT
100 HIVDB
Lazaro (2011) Molecular characterization of HIV-1 CRF01_AE in Mekong delta, Vietnam, and impact of T-cell epitope mutations on HLA recognition (ANRS 12159) Unpublished 1e-145  
35
34PR
1RT
0 Unpublished
Lee (2009) Onward Transmission and Primary Drug Resistance of HIV-1 in Drug-naive Seroconverters in Singapore Unpublished 0 60
60PR
60RT
60
24PR
60RT
100 HIVDB
Lee (2005) BREAST-MILK Shedding of Drug-Resistant HIV-1 Subtype C in Women Exposed to Single-Dose Nevirapine J. Infect. Dis. 192 (7), 1260-1264 (2005) 1e-120  
35
35RT
0 Pending
Leelamanit (2005) IN vivo sequence variability of viral protease of HIV-1 subtype E from therapy-naive Thai patients Unpublished 1e-50  
64
64PR
0 Unpublished
Leelamanit (2005) IN vivo variability of viral protease from HIV-1 subtype E infected Thai patients treated with reverse transcriptase inhibitors Unpublished 5e-51  
60
60PR
0 Pending
Leendertz (2010) High prevalence, coinfection rate, and genetic diversity of retroviruses in wild red colobus monkeys (Piliocolobus badius badius) in Tai National Park, Cote d'Ivoire J. Virol. 84 (15), 7427-7436 (2010) 3e-39  
21
21IN
0 Gene fragment(s)
Leigh Brown (2000) REDUCED susceptibility of human immunodeficiency virus type 1 (HIV-1) from patients with primary HIV infection to nonnucleoside reverse transcriptase inhibitors is associated with variation at novel amino acid sites J. Virol. 74 (22), 10269-10273 (2000) 1e-98 110
110RT
110
110RT
100 HIVDB
Leigh Brown (2005) GENETIC basis of hypersusceptibility to protease inhibitors and low replicative capacity of human immunodeficiency virus type 1 strains in primary infection J. Virol. 78 (5), 2242-2246 (2004) 5e-53  
174
174PR
0 Pending
Leitner (1995) BIOLOGICAL and molecular characterization of subtype D, G, and A/D recombinant HIV-1 transmissions in Sweden Virology 209 (1), 136-146 (1995) 1e-68  
3
3RT
0 Case report(s) / study subset
Lemey (2002) MAXIMUM Likelihood Analysis of Clock-Like Behavior in HIV: Implications on Dating Strategies in HIV Molecular Phylogenies Unpublished 1e-130  
6
6PR
6RT
0 Case report(s) / study subset
Lemey (2005) MOLECULAR footprint of drug-selective pressure in a human immunodeficiency virus transmission chain J. Virol. 79 (18), 11981-11989 (2005) 1e-146  
27
24PR
26RT
0 Case report(s) / study subset
Leoz (2008) INTEGRASE VIH-1 group O Unpublished 1e-100  
96
96IN
0 Pending
Lerma (2000) QUANTITATION of human immunodeficiency virus type 1 group O load in plasma by measuring reverse transcriptase activity J. Clin. Microbiol. 38 (1), 402-405 (2000) 7e-08  
2
2RT
0 Case report(s) / study subset
Lewis (2008) EPISODIC sexual transmission of HIV revealed by molecular phylodynamics PLoS Med. 5 (3), E50 (2008) 0  
100
93PR
100RT
0 Pending
Li (2006) RAPID Reversion of Sequence Polymorphisms Dominates Early Human Immunodeficiency Virus Type 1 Evolution J. Virol. 81 (1), 193-201 (2007) 0 18
18PR
18RT
18IN
18
13PR
18RT
18IN
100 HIVDB
Li (2010) Reduced replication capacity of NL4-3 chimeric viruses encoding RT-Integrase sequences from HIV-1 elite controllers Unpublished 0  
74
74RT
74IN
0 Unpublished
Li (2010) Polymorphisms for HIV-1 B pol and its potential influence on drug resistance in China Unpublished 0  
695
497PR
436RT
0 Unpublished
Li (2011) Factors associated with viral rebound in HIV-positive subjects receiving a therapeutic HIV-1 gag vaccine Unpublished 0  
204
204RT
0 Evolution/quasispecies study
Li (2005) THE sequence characterization and variation analysis of Human immunodeficiency virus type-1 vif gene in China Unpublished 0.02  
23
23IN
0 Gene fragment(s)
Li (2010) Near full-length genomic characterization of a novel HIV type 1 subtype B/C recombinant strain from Yunnan, China AIDS Res. Hum. Retroviruses 26 (6), 711-716 (2010) 0 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Li (2010) Near Full-Length Sequence Analysis of a Novel HIV-1 C/CRF01_AE Recombinant Variant from Yunnan, China AIDS Res. Hum. Retroviruses (2010) In press 0  
1
1RT
1IN
0 Pending
Li (2009) Genetic characterization of 13 subtype CRF01_AE near full-length genomes in Guangxi, China AIDS Res. Hum. Retroviruses 26 (6), 699-704 (2010) 0 13
13PR
13RT
13IN
13
3PR
13RT
13IN
100 HIVDB
Li (2011) High genetic diversity and low drug-resistance of HIV-1 was found in men who have sex with men in Shijiazhuang, China Unpublished 0  
15
11PR
15RT
15IN
0 Unpublished
Li (2007) DUAL infections with multiple lineages of HIV-1 strains in unique geographical recombination 'hotspots' in Asia Unpublished 1e-168  
76
37PR
39RT
0 Unpublished
Li (2005) MOLECULAR epidemiology of the heterosexual HIV-1 transmission in Kunming, Yunnan Province of China suggests origin from the local IDU epidemic AIDS Res. Hum. Retroviruses 21 (11), 977-980 (2005) 1e-174  
52
48PR
51RT
0 Pending
LI (1989)   UNPUBLISHED (1989) 5e-83  
1
1RT
1IN
0 ARV Rx and/or other data are N/A
Li (1991) MOLECULAR characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: identification of replication-competent and -defective viral genomes J. Virol. 65 (8), 3973-3985 (1991) 1e-128 1
1PR
1RT
1IN
2
2PR
2RT
50 HIVDB
Li (1989) EXTENSIVE genetic variability of simian immunodeficiency virus from African green monkeys J. Virol. 63 (4), 1800-1802 (1989) 9e-30  
1
1RT
0 Gene fragment(s)
Li (2011) High prevalence of HIV-1 subtype B' among heterosexuals in western Hubei, Central China: Bridging the epidemic into general population AIDS Res. Hum. Retroviruses (2010) In press 0  
59
38PR
33RT
0 Pending
Li (2011) Identification of a novel second-generation circulating recombinant form (CRF48_01B) in Malaysia: a descendant of the previously identified CRF33_01B J. Acquir. Immune Defic. Syndr. 54 (2), 129-136 (2 0 17
17PR
17RT
3IN
23
23PR
23RT
3IN
73 HIVDB
Liang (2009) Characterization of Genetic Diversity and Insight into the Functions and Evolution of the HIV-1 Gag gene: A Comparison of Parallel Pyrosequencing and Sanger Dideoxy Clone-based Sequencing Unpublished 2e-49  
44
44PR
0 Evolution/quasispecies study
Liao (2009) Phylodynamic analysis of the dissemination of HIV-1 CRF01_AE in Vietnam Virology 391 (1), 51-56 (2009) 0 33
33PR
33RT
33IN
33
19PR
33RT
33IN
100 HIVDB
Liao (2007) GENOTYPIC Analysis of the Protease and Reverse Transcriptase of HIV Type 1 Isolates from Recently Infected Injecting Drug Users in Western China AIDS Res. Hum. Retroviruses 23 (8), 1062-1065 (2007) 1e-148 49
24PR
25RT
49
24PR
25RT
100 HIVDB
Lidstrom (2011) Initiation of antiretroviral treatment in women after delivery can induce multi-class drug resistance in breastfeeding HIV-infected infants Unpublished 0  
186
40PR
186RT
0 Unpublished
Liegeois (2006) MOLECULAR characterization of a novel simian immunodeficiency virus lineage (SIVtal) from northern talapoins (Miopithecus ogouensis) Virology 349 (1), 55-65 (2006) 0 6
2PR
2RT
6IN
6
3RT
6IN
100 HIVDB
Liegeois (2008) Full-length genome characterization of a novel simian immunodeficiency virus lineage (SIVolc) from olive Colobus (Procolobus verus) and new SIVwrcPbb strains from Western Red Colobus (Piliocolobus badius badius) from the Tai Forest in Ivory Coast J. Virol. 83 (1), 428-439 (2009) 0 2
2PR
2RT
2IN
2
2RT
2IN
100 HIVDB
Liegeois (2011) Full-length genome sequence of a simian immunodeficiency virus (SIVsunK08) from a wild captured sun-tailed monkey (Cercopithecus solatus) in Gabon provides evidence for a species specific monophyletic SIVsun lineage AIDS Res. Hum. Retroviruses (2011) In press 0 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Liegeois (2011) Evidence of circulating monophyletic Simian Immunodeficiency Virus strain in sun-tailed monkeys (Cercopithecus solatus) Unpublished 8e-65  
2
2IN
0 Pending
Lihana (2006) HIV Type 1 Subtypes among STI Patients in Nairobi: A Genotypic Study Based on Partial pol Gene Sequencing AIDS Res. Hum. Retroviruses 22 (11), 1172-1177 (2006) 1e-50  
140
140IN
0 Gene fragment(s)
Lihana (2004) HIV Recombinants and Subtypes Among Patients Attending a Sexually Transmitted Disease Clinic in Nairobi, Kenya Unpublished 2e-49  
79
79IN
0 Pending
Liitsola (2000) AN AB recombinant and its parental HIV type 1 strains in the area of the former Soviet Union: low requirements for sequence identity in recombination. UNAIDS Virus Isolation Network AIDS Res. Hum. Retroviruses 16 (11), 1047-1053 (2000) 1e-163 3
3PR
3RT
3IN
3
3PR
3RT
3IN
100 HIVDB
Lillemark (2011) Characterization of HIV-1 from patients with virological failure to a boosted protease inhibitor regimen J. Med. Virol. 83 (3), 377-383 (2011) 1e-159  
1
1RT
0 Pending
Lin (2011) Biological characterization and drug susceptibilities of CRF07_BC strains from treatment-naive patients in Taiwan Unpublished 1e-172  
6
5PR
6RT
0 Unpublished
Lin (2007) MOLECULAR Epidemiology of HIV-1 Infection and Full-Length Genomic Analysis of Circulating Recombinant Form 07_BC Strains from Injection Drug Users in Taiwan J. Infect. Dis. 195 (9), 1283-1293 (2007) 0 58
58PR
4RT
4IN
58
57PR
4RT
4IN
100 HIVDB
Ling (2003) NON-INVASIVE Detection of New Simian Immunodeficiency Virus Lineages in Captive Sooty Mangabeys: Ability to Amplify Virion RNA from Fecal Samples Correlates with Plasma Viral Load J. Virol. (2003) In press 5e-30  
10
10IN
0 Pending
Linka (2004) Direct Submission Submitted (24-SEP-2009) National Reference Laborat 0  
1084
711PR
1084RT
0 Unpublished
Little (2008) PERSISTENCE of Transmitted Drug Resistance among Subjects with Primary Human Immunodeficiency Virus Infection J. Virol. 82 (11), 5510-5518 (2008) 0  
142
83PR
142RT
0 Case report(s) / study subset
Little (2008) ANTIRETROVIRAL-DRUG resistance among patients recently infected with HIV N. Engl. J. Med. 347 (6), 385-394 (2002) 0 316
316PR
316RT
316
267PR
310RT
100 HIVDB
Liu (1997) HIV-1 reverse transcriptase encoding region of brain derived viral RNA. Unpublished 9e-94  
10
10RT
0 Case report(s) / study subset
Liu (2010) Drug resistance and HCV co-infection in former blood donors infected with HIV-1 in China AIDS Res. Hum. Retroviruses (2010) In press 3e-51  
60
60PR
0 Pending
Liu (2007) POLYMORPHISMS and drug resistance analysis of HIV-1 CRF01_AE strains circulating in Fujian Province, China Arch. Virol. 152 (10), 1799-1805 (2007) 1e-50 44
44PR
44RT
44
44PR
100 HIVDB
Liu (2007) POLYMORPHISM and antiretroviral drug resistance patterns in the protease gene of HIV-1 subtypes infecting PI naive Chinese patients Unpublished 1e-51 70
70PR
72
72PR
97 HIVDB
Liu (2005) GENETIC Characterization of Full-length Human Immunodeficiency Virus Type 1 Genomes from Three Infected Paid Blood Donors in China Unpublished 0 3
3PR
3RT
3IN
3
3PR
3RT
3IN
100 HIVDB
Liu (2008) MOLECULAR epidemiology of human immunodeficiency virus type 1 and hepatitis C virus in former blood donors in central china AIDS Res. Hum. Retroviruses 24 (1), 1-6 (2008) 0  
55
50PR
55RT
2IN
0 Pending
Liu (2010) Identification and characterization of two new HIV type 1 unique (B/C) recombinant forms in China Unpublished 0  
2
2RT
2IN
0 Pending
Liu (2006) SELECTION on the human immunodeficiency virus type 1 proteome following primary infection J. Virol. 80 (19), 9519-9529 (2006) 0  
40
40PR
40RT
40IN
0 Evolution/quasispecies study
Liu (2009) Preinfection human immunodeficiency virus (HIV)-specific cytotoxic T lymphocytes failed to prevent HIV type 1 infection from strains genetically unrelated to viruses in long-term exposed partners J. Virol. 83 (20), 10821-10829 (2009) 0  
65
2PR
34RT
31IN
0 Case report(s) / study subset
Lloyd (2007) PREVALENCE of Resistance Mutations in HIV-1-Infected Hondurans at the Beginning of the National Antiretroviral Therapy Program AIDS Res. Hum. Retroviruses 24 (4), 529-535 (2008) 0 336
336PR
336RT
336
303PR
336RT
100 HIVDB
Loemba (2002) GENETIC divergence of human immunodeficiency virus type 1 Ethiopian clade C reverse transcriptase (RT) and rapid development of resistance against nonnucleoside inhibitors of RT Antimicrob. Agents Chemother. 46 (7), 2087-2094 (2002) 7e-86 14
14PR
28
14PR
14RT
50 Gene fragment(s)
Loffredo (2008) PATTERNS of CD8+ immunodominance may influence the ability of Mamu-B*08-positive macaques to naturally control simian immunodeficiency virus SIVmac239 replication J. Virol. 82 (4), 1723-1738 (2008) 0  
4
4RT
4IN
0 Case report(s) / study subset
Lole (1999) FULL-LENGTH human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination J. Virol. 73 (1), 152-160 (1999) 1e-165 6
6PR
6RT
6IN
6
6PR
6RT
6IN
100 HIVDB
Longo (2008) HIV-1 diversity among inmates of Italian prisons J. Med. Virol. 80 (10), 1689-1694 (2008) 0  
3
3RT
0 Case report(s) / study subset
Lopez-Galindez (2010) Initial fitness recovery of HIV-1 is driven by quasispecies heterogeneity and can occur without mutations in the consensus sequence PLoS One. 2010 Apr 26;5(4):e10319. 0  
22
22PR
22RT
22IN
0 Pending
Lorenzo-Redondo (2011) Dynamics of in vitro fitness recovery of HIV-1 J. Virol. 85 (4), 1861-1870 (2011) 0  
12
12PR
12RT
12IN
0 Evolution/quasispecies study
Low (2009) Natural Genotypic Polymorphisms of the HIV-1 Integrase Gene and Associated Drug Susceptibilities to a Panel of Diverse Integrase Strand Transfer Inhibitors Antimicrob Agents Chemother. 2009 1e-168 133
133IN
133
133IN
100 HIVDB
Loxton (2004) SEQUENCE Analysis of Near Full-Length HIV Type 1 Subtype D Primary Strains Isolated in Cape Town, South Africa, from 1984 to 1986 AIDS Res. Hum. Retroviruses 21 (5), 410-413 (2005) 0 4
4PR
4RT
4IN
4
4PR
4RT
4IN
100 HIVDB
Luk (2008) NEAR Full-Length Genome Characterization of an HIV Type 1 CRF25_cpx Strain from Cameroon AIDS Res. Hum. Retroviruses 24 (10), 1309-1314 (2008) 0 1
1PR
1RT
1IN
1
1RT
1IN
100 Case report(s) / study subset
Luk (2001) NATURALLY Occurring Sequence Polymorphisms within HIV Type 1 Group O Protease AIDS Res. Hum. Retroviruses 17 (16), 1555-1561 (2001) 5e-10 28
28PR
28
28PR
100 HIVDB
Luk (2007) NEAR Full-Length Genome Characterization of Three Additional HIV Type 1 CRF13_cpx Strains from Cameroon AIDS Res. Hum. Retroviruses 23 (2), 297-302 (2007) 0 3
3PR
3RT
3IN
3
3RT
3IN
100 HIVDB
Lukashov (2001) SELECTION by AZT and rapid replacement in the absence of drugs of HIV type 1 resistant to multiple nucleoside analogs AIDS Res. Hum. Retroviruses 17 (9), 807-818 (2001) 4e-96  
231
231RT
0 Evolution/quasispecies study
Luo (2009) Prevalence of drug-resistant HIV-1 in rural areas of Hubei province in the People's Republic of China J. Acquir. Immune Defic. Syndr. 50 (1), 1-8 (2009) 0 152
152PR
152RT
152
152RT
100 HIVDB
Lutz (2005) ANALYSIS of polymorphism in the protease and reverse transcriptase genes of HIV type 1 CRF02_AG subtypes from drug-naive patients from Saint-Etienne, France Unpublished 1e-120 10
6PR
4RT
10
6PR
4RT
100 HIVDB
Lwembe (2011) Defining new unique recombinant forms of HIV-1 from Rural Cameroon Villagers Unpublished 0  
4
1RT
4IN
0 Pending
Ly (2007) REVERSE transcriptase mutations in Cambodian CRF01_AE isolates after antiretroviral prophylaxis against HIV type 1 perinatal transmission AIDS Res. Hum. Retroviruses 23 (12), 1563-1567 (2007) 1e-133 27
27RT
27
27RT
100 HIVDB
Ly (2005) CHARACTERIZATION of mutations in HIV type 1 isolates from 144 Cambodian recently infected patients and pregnant women naive to antiretroviral drugs AIDS Res. Hum. Retroviruses 21 (11), 971-976 (2005) 1e-142 280
136PR
144RT
280
136PR
144RT
100 HIVDB
Machado Zaldivar (2011) Genetic diversity of HIV-1 in newly diagnosed Cuban patients Unpublished 0  
43
43PR
1RT
0 Unpublished
Machado (2002) USE of the sensitive/less-sensitive (detuned) EIA strategy for targeting genetic analysis of HIV-1 to recently infected blood donors AIDS 16 (1), 113-119 (2002) 1e-135 31
30PR
31RT
31
30PR
31RT
100 HIVDB
Machado (2003) GENOTYPIC resistance and HIV-1 subtype in Brazilian children on dual and triple combination therapy J. Clin. Virol. 30 (1), 24-31 (2004) 1e-110 149
74PR
75RT
149
74PR
75RT
100 HIVDB
Machado (2004) ALTERNATIVE, age- and viral load-related routes of nelfinavir resistance in human immunodeficiency virus type 1-infected children receiving highly active antiretroviral therapy Pediatr. Infect. Dis. J. 23 (11), 1057-1059 (2004) 1e-108 11
8PR
3RT
11
8PR
3RT
100 HIVDB
Machado (2004) OVERVIEW of genotypic and clinical profiles of human immunodeficiency virus type 1-infected children in Rio de Janeiro, Brazil An. Acad. Bras. Cienc. 76 (4), 727-741 (2004) 1e-116 141
73PR
68RT
141
73PR
68RT
100 HIVDB
Machado (2009) Molecular epidemiology of HIV-1 in Northern Brazil: identification of subtypes C and D and the introduction of CRF02_AG in the Amazon Region of Brazil Aids Research and Human Retrovirology 1 (1) (2009) 1e-50 1
1PR
1
1PR
100 HIVDB
Machuca (2004) UNKNOWN co-receptor usage in HIV isolates from patients undergoing long-term antiretroviral therapy Unpublished 1e-114  
40
19PR
21RT
0 Case report(s) / study subset
Madsen (2006) INTRODUCTION of HIV Type 1 into an Isolated Population: Molecular Epidemiologic Study from Greenland AIDS Res. Hum. Retroviruses 23 (5), 675-681 (2007) 0 75
75PR
75RT
75
70PR
75RT
100 HIVDB
Madsen (2007) REAPPEARANCE of an 11-year-old sequence in an HIV-1 infected patient during treatment interruption Scand. J. Infect. Dis. 40 (2), 174-182 (2008) 0  
18
6PR
18RT
0 Evolution/quasispecies study
Madsen (2008) PREVALENCE of protease and gag gene mutations in human immunodeficiency virus type 1 patients failing on a boosted protease inhibitor regimen Unpublished 0  
20
13PR
20RT
0 Unpublished
Madsen (2008) SHORT communication: high prevalence of drug-resistant human immunodeficiency virus type 1 in treatment-naive patients in Greenland AIDS Res. Hum. Retroviruses 24 (8), 1073-1077 (2008) 0  
14
12PR
14RT
0 Pending
Mahalanabis (2001) IMPROVED detection of HIV-1 drug resistance mutations by an oligoligase assay compared to consensus sequencing Unpublished 1e-128  
149
149PR
149RT
0 ARV Rx and/or other data are N/A
Maier (1998) MIXED reconstitution of mutated subunits of HIV-1 RT co-expressed in E. coli- two tags tie it up Unpublished 9e-94  
1
1PR
1RT
0 Laboratory/experimental isolate
Malet (2009) Quasispecies variant dynamics during emergence of resistance to raltegravir in HIV-1-infected patients J. Antimicrob. Chemother. 63 (4), 795-804 (2009) 1e-166 22
22IN
22
22IN
100 HIVDB
Maljkovic (2003) LIMITED Transmission of Drug-Resistant HIV Type 1 in 100 Swedish Newly Detected and Drug-Naive Patients Infected with Subtypes A, B, C, D, G, U, and CRF01_AE AIDS Res. Hum. Retroviruses 19 (11), 989-997 (2003) 0 100
100PR
100RT
100
100PR
100RT
100 HIVDB
Mamadou (2003) EMERGENCE of complex and diverse CRF02-AG/CRF06-cpx recombinant HIV type 1 strains in Niger, West Africa AIDS Res. Hum. Retroviruses 19 (1), 77-82 (2003) 0 3
3PR
3RT
3IN
3
3PR
3RT
3IN
100 HIVDB
Manenti (2009) Young pregnant women living with HIV/AIDS are infected almost exclusive with HIV-1 clade C in Criciuma, South Brazil AIDS Res Hum Retroviruses. 2010 Mar;26(3):351-7. 0 11
11PR
11RT
11
1PR
10RT
100 HIVDB
Marechal (2006) INCREASING HIV Type 1 Polymorphic Diversity But No Resistance to Antiretroviral Drugs in Untreated Patients from Central African Republic: A 2005 Study AIDS Res. Hum. Retroviruses 22 (10), 1036-1044 (2006) 1e-147 99
30PR
69RT
99
30PR
69RT
100 HIVDB
Margot (2010) Phenotypic Susceptibility to Bevirimat in Isolates from HIV-1-Infected Patients without Prior Exposure to Bevirimat Antimicrob. Agents Chemother. 54 (6), 2345-2353 (2 2e-51  
13
13PR
0 Pending
Markham (2007) RELATIONSHIP of Injection Drug Use, Antiretroviral Therapy Resistance, and Genetic Diversity in the HIV-1 Pol Gene Unpublished 5e-53  
907
907PR
0 Evolution/quasispecies study
Marthas (1991) RHESUS macaques inoculated with molecularly cloned simian immunodeficiency virus J. Med. Primatol. 18, 311-319 (1991) 8e-99  
1
1PR
1RT
1IN
0 Laboratory/experimental isolate
Martinez (1999) HUMAN immunodeficiency virus type 1 genetic evolution in patients with prolonged suppression of plasma viremia Virology 256 (2), 180-187 (1999) 9e-94  
60
60RT
0 Evolution/quasispecies study
Martinez-Picado (2000) ANTIRETROVIRAL resistance during successful therapy of HIV type 1 infection Proc. Natl. Acad. Sci. U.S.A. 97 (20), 10948-10953 (2000) 0  
137
120PR
123RT
0 Evolution/quasispecies study
Martinson (2008) HIV-1 transmission and drug resistance in women with and without prior exposure to single-dose nevirapine in Soweto, South Africa Unpublished 0 64
64PR
64RT
64
8PR
64RT
100 HIVDB
Marx (1991) ISOLATION of a simian immunodeficiency virus related to human immunodeficiency virus type 2 from a west African pet sooty mangabey J. Virol. 65 (8), 4480-4485 (1991) 3e-84 1
1IN
1
1RT
1IN
100 HIVDB
Mas (1999) HIV-1 Group O in Spain Unpublished 5e-12  
5
5RT
0 Pending
Mas (2000) ROLE of a dipeptide insertion between codons 69 and 70 of HIV-1 reverse transcriptase in the mechanism of AZT resistance EMBO J. 19 (21), 5752-5761 (2000) 3e-69  
1
1RT
0 Laboratory/experimental isolate
Masciotra (2000) EVIDENCE of a high frequency of HIV-1 subtype F infections in a heterosexual population in Buenos Aires, Argentina AIDS Res. Hum. Retroviruses 16 (10), 1007-1014 (2000) 1e-128 42
42PR
42
42PR
100 HIVDB
Masciotra (2002) DETECTION of Simian Immunodeficiency Virus in Diverse Species and of Human Immunodeficiency Virus Type 2 by Using Consensus Primers within the pol Region J. Clin. Microbiol. 40 (9), 3167-3171 (2002) 8e-80  
26
26IN
0 Gene fragment(s)
Masciotra (2007) HIGH Concordance between HIV-1 Drug Resistance Genotypes Generated from Plasma and Dried Blood Spots in Treated Persons Unpublished 0  
66
43PR
66RT
0 Pending
Masharsky (2002) MOLECULAR cloning and analysis of full-length genome of HIV type 1 strains prevalent in countries of the former Soviet Union AIDS Res. Hum. Retroviruses 19 (10), 933-939 (2003) 1e-163 2
2PR
2RT
2IN
15
8PR
15RT
9IN
13 HIVDB
Maslin (2005) ANTIRETROVIRAL Drug Resistance Among Drug-Naive HIV-1 Infected Patients in Djibouti (Horn of Africa) AIDS (2005) In press 3e-51  
11
11PR
0 Case report(s) / study subset
Masquelier (1999) ZIDOVUDINE resensitization and dual HIV-1 resistance to zidovudine and lamivudine in the delta lamivudine roll-over study Antivir. Ther. (Lond.) 4 (2), 69-77 (1999) 2e-91 48
48RT
50
50RT
96 HIVDB
Masquelier (2001) GENOTYPIC and phenotypic resistance patterns of human immunodeficiency virus type 1 variants with insertions or deletions in the reverse transcriptase (RT): multicenter study of patients treated with RT inhibitors Antimicrob. Agents Chemother. 45 (6), 1836-1842 (2001) 5e-83 42
42RT
43
43RT
97 HIVDB
Masquelier (2001) ZIDOVUDINE genotypic resistance in HIV-1-infected newborns in the French perinatal cohort J. Acquir. Immune Defic. Syndr. 27 (2), 99-104 (2001) 9e-94  
34
34RT
0 ARV Rx and/or other data are N/A
Masquelier (2002) MECHANISMS of Early Virologic Failure in Antiretroviral-Naive Patients Starting Protease Inhibitor-Containing Regimens: The APROVIR Study J. Infect. Dis. 186 (10), 1503-1507 (2002) 1e-122 47
24PR
23RT
47
24PR
23RT
100 HIVDB
Matsuoka-Aizawa (2003) ISOLATION and molecular characterization of a nelfinavir (NFV)-resistant human immunodeficiency virus type 1 that exhibits NFV-dependent enhancement of replication J. Virol. 77 (1), 318-327 (2003) 1e-108  
4
4PR
0 Case report(s) / study subset
Matteoli (2009) Direct Submission Submitted (27-MAY-2009) Department of Experimental 0  
15
13PR
3RT
0 Unpublished
Matthews (2008) CENTRAL role of reverting mutations in HLA associations with human immunodeficiency virus set point J. Virol. 82 (17), 8548-8559 (2008) 0  
449
28PR
423RT
276IN
0 Pending
Matthews (2009) Adaptation of HIV-1 to HLA I Unpublished 2e-50  
60
60PR
0 Pending
Mayers (1993) CHARACTERIZATION of HIV isolates arising after prolonged zidovudine therapy J. Acquir. Immune Defic. Syndr. 5 (8), 749-759 (1992) 2e-60  
9
9RT
0 Case report(s) / study subset
Mazzotta (2003) SEQUENCE analysis of plasma-derived HIV-1 from patients living in Florence Unpublished 0  
20
19PR
20RT
0 ARV Rx and/or other data are N/A
Mbisa (2011) Identification of mutations in all domains of non-B subtype HIV-1 reverse transcriptase linked to the development of Q151M multi-drug resistance: implications for drug susceptibility and replicative fitness Unpublished 0  
145
145RT
0 Evolution/quasispecies study
Mboudjeka (1999) THE pol and env-based phylogenetic analysis of HIV-1 among the Muslim in the northern part of Cameroon Unpublished 6e-43  
1
1IN
0 Gene fragment(s)
Mboudjeka (2000) GENETIC diversity of HIV-1 group M from Cameroon and Republic of Congo Arch. Virol. 144 (12), 2291-2311 (1999) 1e-48  
35
35IN
0 Gene fragment(s)
McClutchan (2003) PRECISE mapping of recombination breakpoints suggests a common parent of two BC recombinant HIV type 1 strains circulating in China AIDS Res. Hum. Retroviruses 18 (15), 1135-1140 (2002) 0 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
McConnell (2007) MOLECULAR epidemiology of HIV type 1 in newly diagnosed patients in southern Spain AIDS Res. Hum. Retroviruses 24 (6), 881-887 (2008) 6e-51 33
33PR
33RT
33
33PR
100 HIVDB
McCutchan (2003) HIV Type 1 Circulating Recombinant Form CRF09_cpx from West Africa Combines Subtypes A, F, G, and May Share Ancestors with CRF02_AG and Z321 AIDS Res. Hum. Retroviruses 20 (8), 819-826 (2004) 1e-165 4
4PR
4RT
4IN
4
4PR
4RT
4IN
100 HIVDB
McCutchan (2005) IN-DEPTH analysis of a heterosexually acquired human immunodeficiency virus type 1 superinfection: evolution, temporal fluctuation, and intercompartment dynamics from the seronegative window period through 30 months postinfection J. Virol. 79 (18), 11693-11704 (2005) 0 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
McIntosh (2000) NUCLEOTIDE sequence of a Cambridge isolate of human immunodeficiency virus type 1 Unpublished 1e-163 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
McLaughlin (2004) SEQUENCE Diversity of HIV-1 Genomes from the HIV Vaccine Trials Network Unpublished 0 4
4PR
4RT
4IN
4
4PR
4RT
4IN
100 HIVDB
McNulty (2006) EVALUATION of Dried Blood Spots for Human Immunodeficiency Virus Type 1 Drug Resistance Testing J. Clin. Microbiol. 45 (2), 517-521 (2007) 1e-141 43
43PR
43RT
43
43RT
100 HIVDB
Medrano (1999) SEQUENCE analysis of the polymerase domain of HIV-1 reverse transcriptase in naive and zidovudine-treated individuals reveals a higher polymorphism in alpha-helices as compared with beta-strands Virus Genes 18 (3), 203-210 (1999) 1e-161  
69
69RT
0 Evolution/quasispecies study
Meersseman (2006) FATAL brain necrosis in primary HIV infection Lancet 366 (9488), 866 (2005) 0  
3
3PR
3RT
0 Case report(s) / study subset
Meloni (2004) DISTINCT Human Immunodeficiency Virus Type 1 Subtype A Virus Circulating in West Africa: Sub-Subtype A3 J. Virol. 78 (22), 12438-12445 (2004) 0 5
5PR
5RT
5IN
5
5PR
5RT
5IN
100 HIVDB
Mendez Ortega (2011) An RNAi in silico approach to find an optimal shRNA cocktail against HIV-1 Virol. J. 7 (1), 369 (2010) 3e-50  
9
9PR
0 Evolution/quasispecies study
Meng (2008) CONSTRUCTION and Characterization of an Infectious Molecular Clone of HIV Type 1 CRF07_BC AIDS Res. Hum. Retroviruses 24 (2), 259-264 (2008) 0  
2
2PR
2RT
2IN
0 Laboratory/experimental isolate
Meng (2007) GENETIC Characterization of Three Newly Isolated CRF07_BC Near Full-Length Genomes in China AIDS Res. Hum. Retroviruses 23 (8), 1049-1054 (2007) 0  
3
3PR
3RT
3IN
0 Case report(s) / study subset
Mens (2011) HIV-1 Continues to Replicate and Evolve in Patients with Natural Control of HIV infection J. Virol. (2010) In press 1e-52  
158
158PR
0 Pending
Metzker (2002) MOLECULAR Evidence of HIV-1 Transmission in a Criminal Case Proc. Natl. Acad. Sci. U.S.A. 99, 14292-14297 (2002) 9e-94  
42
8PR
42RT
0 Evolution/quasispecies study
Mezei (2011) Molecular epidemiological analysis of env and pol sequences in newly diagnosed HIV-1 infected, untreated patients in Hungary AIDS Res. Hum. Retroviruses (2011) In press 2e-51 28
28PR
28
28PR
100 HIVDB
Miao (2010) Sequence and characterization of full-length genome of two HIV-1 strains isolated from two infected patients in China Unpublished 0  
2
2RT
2IN
0 Unpublished
Michael (1995) DEFECTIVE accessory genes in a human immunodeficiency virus type 1-infected long-term survivor lacking recoverable virus J. Virol. 69 (7), 4228-4236 (1995) 1e-16  
22
22IN
0 Gene fragment(s)
Middleton (2002) EVIDENCE for transmission of two different circular recombinant form-AE strains in HIV intravenous users in Australia Unpublished 1e-123  
12
12PR
12RT
0 Evolution/quasispecies study
Mikhail (2006) FULL length genome analysis of HIV-1 viral evolution, and date of origin in an American cohort Unpublished 0  
34
34PR
34RT
34IN
0 Unpublished
Milazzo (2000) EVIDENCE of stavudine-related phenotypic resistance among zidovudine-pretreated HIV-1-infected subjects receiving a therapeutic regimen of stavudine plus lamivudine J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 22 (1), 101 4e-96 40
40RT
40
40RT
100 HIVDB
Mintsa (2008) MOLECULAR epidemiological of HIV in North West of Gabon: Dominance of recombinant CRF02 Unpublished 2e-50 2
2PR
2RT
2
2PR
100 Case report(s) / study subset
Mintsa-Ndong (2009) High HIV Type 1 prevalence and wide genetic diversity with dominance of recombinant strains but low level of antiretroviral drug-resistance mutations in untreated patients in northeast Gabon, Central Africa AIDS Res. Hum. Retroviruses 25 (4), 411-418 (2009) 1e-145 9
8PR
8RT
9
5PR
4RT
100 HIVDB
Mitsuya (2006) N88D Facilitates the Co-occurrence of D30N and L90M and the Development of Multidrug Resistance in HIV Type 1 Protease following Nelfinavir Treatment Failure AIDS Res. Hum. Retroviruses 22 (12), 1300-1305 (2006) 5e-51 16
16PR
18
18PR
88 HIVDB
Miura (2004) SIMIAN and human immunodeficiency chimeric virus, NM3rN clone Published Only in Database (2004) 0  
1
1RT
1IN
0 Laboratory/experimental isolate
Miura (2010) Impaired fitness of acute/early viruses in persons who become HIV controllers J Virol. 2010 Aug;84(15):7581-91. Epub 2010 May 26. 0  
23
11PR
23RT
23IN
0 Unpublished
Miura (2010) Long-term successful control of super-multi-drug resistant HIV-1 by a combination therapy of Lamivdine, Raltegravir, boosted-Darunavir and Etravirin Unpublished 1e-152  
3
3RT
0 Pending
Miura (2008) GENETIC characterization of human immunodeficiency virus type 1 in elite controllers: lack of gross genetic defects or common amino acid changes J. Virol. 82 (17), 8422-8430 (2008) 0  
147
37PR
41RT
69IN
0 Pending
Miura (2008) HLA-ASSOCIATED Alterations in Replication Capacity of Chimeric NL4-3 Viruses Carrying gag-protease from Elite Controllers of Human Immunodeficiency Virus Type 1 J. Virol. 83 (1), 140-149 (2009) 1e-52  
31
31PR
0 Case report(s) / study subset
Mochizuki (1999) AN infectious DNA clone of HIV type 1 subtype C AIDS Res. Hum. Retroviruses 15 (14), 1321-1324 (1999) 1e-165 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Mokili (2002) IDENTIFICATION of a novel clade of human immunodeficiency virus type 1 in democratic republic of congo AIDS Res. Hum. Retroviruses 18 (11), 817-823 (2002) 1e-90 1
1PR
1RT
1IN
1
1PR
1RT
100 HIVDB
Monie (2005) A Novel Assay Allows Genotyping of the Latent Reservoir for Human Immunodeficiency Virus Type 1 in the Resting CD4+ T Cells of Viremic Patients Unpublished 1e-134  
400
326PR
334RT
0 Evolution/quasispecies study
Monno (2003) MUTATIONAL patterns of paired blood and rectal biopsies in HIV-infected patients on HAART J. Med. Virol. 70 (1), 1-9 (2003) 1e-178 17
17PR
17RT
32
30PR
32RT
53 HIVDB
Monno (2003) HIV-1 subtypes and circulating recombinant forms (CRFs) from HIV-infected patients residing in two regions of central and southern Italy J. Med. Virol. 75 (4), 483-490 (2005) 0  
6
6PR
6RT
0 Case report(s) / study subset
Monno (2003) SEQUENCE analysis of plasma-derived HIV-1 from patients living in Apulia Unpublished 1e-179  
34
31PR
34RT
0 ARV Rx and/or other data are N/A
Monno (2007) A multidrug-resistant (MDR) HIV-1 infection in a homosexual man and identified source patient Unpublished 1e-177  
4
4RT
0 Case report(s) / study subset
Montavon (2000) MOST env and gag subtype A HIV-1 viruses circulating in West and West Central Africa are similar to the prototype AG recombinant virus IBNG J. Acquir. Immune Defic. Syndr. 23 (5), 363-374 (2000) 1e-164 13
13PR
13RT
2IN
13
13PR
13RT
1IN
100 HIVDB
Montavon (2001) THE identification of a complex A/G/I/J recombinant HIV type 1 virus in various West African countries AIDS Res. Hum. Retroviruses 15 (18), 1707-1712 (1999) 7e-82 1
1PR
1RT
1IN
2
2PR
2RT
50 HIVDB
Montavon (2001) CRF06-CPX: a new Circulating Recombinant Form of HIV-1 in West Africa,involving subtypes A, G, K and J Unpublished 1e-165 2
2PR
2RT
2IN
9
9PR
9RT
2IN
22 HIVDB
Montavon (2002) IDENTIFICATION of a new circulating recombinant form of HIV type 1, CRF11-cpx, involving subtypes A, G, J, and CRF01-AE, in Central Africa AIDS Res. Hum. Retroviruses 18 (3), 231-236 (2002) 1e-75 3
3PR
3RT
3IN
3
3PR
3RT
100 HIVDB
Montes (2003) COMPARISON of drug resistance mutations and their interpretation in patients infected with non-B HIV-1 variants and matched patients infected with HIV-1 subtype B J. Acquir. Immune Defic. Syndr. 35 (4), 329-336 (2004) 1e-149 184
153PR
184RT
186
155PR
186RT
98 HIVDB
Moore (2006) EVIDENCE of HIV-1 adaptation to HLA-restricted immune responses at a population level Science 296 (5572), 1439-1443 (2002) 1e-124  
3
3RT
0 Case report(s) / study subset
Moriyama (1998) HIV-1 in Ghana Unpublished 1e-129  
1
1IN
0 Unpublished
Moriyama (1998) HIV-1 in Congo Unpublished 1e-128  
1
1IN
0 Pending
Morris (1999) MOSAIC structure of the human immunodeficiency virus type 1 genome infecting lymphoid cells and the brain: evidence for frequent in vivo recombination events in the evolution of regional populations J. Virol. 73 (10), 8720-8731 (1999) 9e-94  
11
11RT
0 Evolution/quasispecies study
Mouroux (2001) LOW rate of emergence of TAMs Unpublished 1e-98  
5
5RT
0 Case report(s) / study subset
Moussa (2010) First Data on HIV-1 Resistance Mutations to Antiretroviral Drugs in Central African Republic AIDS Res. Hum. Retroviruses 26 (11), 1247-1248 (20 4e-50  
7
7PR
0 Pending
Mueller (2007) DUAL Selection Pressure by Drugs and HLA Class I-Restricted Immune Responses on Human Immunodeficiency Virus Type 1 Protease J. Virol. 81 (6), 2887-2898 (2007) 2e-52  
71
71PR
0 Pending
Munoz-Nieto (2008) HIV Type 1 Intersubtype Recombinants during the Evolution of a Dual Infection with Subtypes B and G AIDS Res. Hum. Retroviruses 24 (2), 337-343 (2008) 0  
12
4PR
11RT
12IN
0 Case report(s) / study subset
Murillo (2009) Prevalence of drug resistance and importance of virus load measurements in Honduran HIV patients failing antiretroviral treatment HIV Med. 2010 Feb;11(2):95-103. Epub 2009 Aug 3. 1e-149  
124
98PR
51RT
0 Pending
Mwaengo (1998) MOLECULAR cloning and characterization of viruses isolated from chimpanzees with pathogenic human immunodeficiency virus type 1 infections J. Virol. 72 (11), 8976-8987 (1998) 1e-165 2
2PR
2RT
2IN
2
2PR
2RT
2IN
100 HIVDB
Mwangi (2006) VIREMIC sero-negative donations and genetic diversity of viral infections among blood donors in Kenya: implications on blood safety Unpublished 5e-48  
17
17IN
0 Gene fragment(s)
Nabatov (2001) STUDY of distribution of AZT-resistant subtype B HIV-1 during the second stage of HIV epidemic in former Soviet Union countries Unpublished 9e-94  
3
3RT
0 Case report(s) / study subset
Nadai (2009) HIV-1 epidemic in the Caribbean is dominated by subtype B PLoS ONE 4 (3), E4814 (2009) 5e-49  
2
2PR
0 Pending
Nagai (2011) Construction and characterization of infectious molecular clones derived from japanese blood donors Unpublished 0  
2
2PR
2RT
2IN
0 Laboratory/experimental isolate
Najera (1995) POL gene quasispecies of human immunodeficiency virus: mutations associated with drug resistance in virus from patients undergoing no drug therapy J. Virol. 69 (1), 23-31 (1995) 9e-97  
118
118RT
0 Evolution/quasispecies study
Nakano (1997) CLONAL selection of HIV type 1 variants associated with resistance to foscarnet in vitro: confirmation by molecular evolutionary analysis AIDS Res. Hum. Retroviruses 13 (7), 563-573 (1997) 1e-98  
51
51RT
0 Evolution/quasispecies study
Nasioulas (1999) MOLECULAR analysis of the full-length genome of HIV type 1 subtype I: evidence of A/G/I recombination AIDS Res. Hum. Retroviruses 15 (8), 745-758 (1999) 1e-163 2
2PR
2RT
2IN
2
2PR
2RT
2IN
100 HIVDB
Naugler (2002) T69D/N pol Mutation, HIV-1 RNA Levels and Syncytium-Inducing (SI) Phenotype Were Associated With CD4 Cell Depletion During Didanosine Therapy Unpublished 4e-96 50
50RT
50
50RT
100 HIVDB
Ndembi (2003) HIV type 1 infection in Pygmy hunter gatherers is from contact with Bantu rather than from nonhuman primates AIDS Res. Hum. Retroviruses 19 (5), 435-439 (2003) 1e-48  
10
10IN
0 Gene fragment(s)
Ndembi (2004) GENETIC Diversity of HIV Type 1 in Rural Eastern Cameroon J. Acquir. Immune Defic. Syndr. 37 (5), 1641-1650 (2004) 1e-48  
20
20IN
0 Gene fragment(s)
Ndembi (2008) TRANSMITTED Antiretroviral Drug Resistance Surveillance among Newly HIV Type 1-Diagnosed Women Attending an Antenatal Clinic in Entebbe, Uganda AIDS Res. Hum. Retroviruses 24 (6), 889-895 (2008) 2e-51 32
32PR
32RT
32
32PR
100 HIVDB
Ndembi (2009) Viral rebound and emergence of drug resistance in the absence of viral load testing: a randomized comparison between Combivir/nevirapine and Combivir/abacavir J Infect Dis. 2010 Jan 1;201(1):106-13. 2e-52 49
49PR
49RT
49
49PR
100 HIVDB
Ndembi (2011) Transmitted antiretroviral drug resistance among newly HIV-1 diagnosed young individuals in Kampala, Uganda AIDS (2011) In press 6e-52 36
36PR
36RT
36
36PR
100 HIVDB
Ndembi (2011) High Frequency of HIV-1 Dual Infections in Cameroon, West Central Africa J. Acquir. Immune Defic. Syndr. 57 (2), E25-E27 (2 2e-49  
54
54IN
0 Pending
Ndongmo (2006) HIV Genetic Diversity in Cameroon: Possible Public Health Importance AIDS Res. Hum. Retroviruses 22 (8), 812-816 (2006) 3e-50 37
37PR
37
37PR
100 HIVDB
Ndung'u (2000) MOLECULAR cloning and biological characterization of full-length HIV-1 subtype C from Botswana Virology 278 (2), 390-399 (2000) 1e-162  
4
4PR
4RT
4IN
0 Case report(s) / study subset
Ndung'u (2001) CONSTRUCTION and analysis of an infectious human Immunodeficiency virus type 1 subtype C molecular clone J. Virol. 75 (11), 4964-4972 (2001) 1e-162  
1
1PR
1RT
1IN
0 Case report(s) / study subset
Neel (2010) Molecular epidemiology of simian immunodeficiency virus infection in wild-living gorillas J. Virol. 84 (3), 1464-1476 (2010) 1e-53  
24
24IN
0 Gene Fragments
Negedu-momoh (2011) Evaluation of antiretroviral drug resistant variants among HIV art experienced and naive patients in nigeria Unpublished 2e-49  
3
3PR
0 Unpublished
Neilson (1999) SUBTYPES of human immunodeficiency virus type 1 and disease stage among women in Nairobi, Kenya J. Virol. 73 (5), 4393-4403 (1999) 1e-165 2
2PR
2RT
2IN
2
2PR
2RT
2IN
100 HIVDB
Nerrienet (2003) A new chimpanzee lentivirus (SIVcpzCAM13) in a wild-born Pan troglodytes troglodytes in Cameroon Unpublished 1e-128  
1
1RT
0 Pending
Nerrienet (2003) SIMIAN Immunodeficiency Virus Infection in Wild-Caught Chimpanzees from Cameroon J. Virol. 79 (2), 1312-1319 (2005) 0 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Neumann (1995) RESTRICTION of human immunodeficiency virus type 1 production in a human astrocytoma cell line is associated with a cellular block in Rev function J. Virol. 69 (4), 2159-2167 (1995) 1e-165  
1
1PR
1RT
1IN
0 Laboratory/experimental isolate
Ng (2011) Molecular Epidemiology of HIV-1 in Singapore and Identification of New CRF01_AE/B Recombinant Forms Unpublished 1e-51 151
151PR
151
151PR
100 HIVDB
Nguyen (2011) Cloning and expression of protease-encoding gene of HIV type 1 isolated from Vietnam Tap Chi Cong Nghe Sinh Hoc (2011) In press 4e-49  
1
1PR
0 Laboratory/experimental isolate
Niama (2009) CRF45_AKU, a Circulating Recombinant from Central Africa, Is Probably the Common Ancestor of HIV Type 1 MAL and HIV Type 1 NOGIL AIDS Res. Hum. Retroviruses 25 (12), 1345-1353 (20 0 4
4PR
4RT
4IN
6
4RT
6IN
66 HIVDB
Nielsen (2003) THE CATCH study - Combined Analysis of Resistance Transmission over time of Chronically and acute infected HIV patients Unpublished 1e-174  
33
33PR
30RT
0 HIVDB
Njai (2007) THE predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness Retrovirology 3, 40 (2006) 0 27
27PR
27RT
27IN
27
10PR
27RT
27IN
100 HIVDB
Njouom (2003) ASSESSMENT of HIV-1 subtyping for Cameroon strains using phylogenetic analysis of pol gene sequences J. Virol. Methods 110 (1), 1-8 (2003) 9e-95 40
23PR
30RT
40
23PR
30RT
100 HIVDB
Nkengasong (2001) DISTRIBUTION of HIV-1 subtypes among HIV-seropositive patients in the interior of Cote d'Ivoire J. Acquir. Immune Defic. Syndr. 23 (5), 430-436 (2000) 1e-108 12
12PR
12
12PR
100 HIVDB
Noel (2003) PHYLOGENETIC relationships between Puerto Rico and Continental USA HIV-1 pol sequences: a shared HIV-1 infection in USA and PR. Unpublished 1e-122  
584
287PR
297RT
0 Pending
Nouhin (2010) Natural polymorphisms of HIV-1 CRF01_AE integrase gene in ARV-naive individuals in Cambodia, Vietnam and Thailand: an ANRS AC12 resistance working group study Unpublished 1e-164 50
50IN
50
50IN
100 HIVDB
Nouhin (2010) Natural polymorphisms of HIV-1 CRF01_AE integrase coding region in ARV-naive individuals in Cambodia, Thailand and Vietnam: An ANRS AC12 working group study Infect. Genet. Evol. 11 (1), 38-43 (2011) 1e-163  
37
37IN
0 Pending
Novelli (2002) CONSTRUCTION and characterization of a full-length HIV-1(92UG001) subtype D infectious molecular clone AIDS Res. Hum. Retroviruses 18 (1), 85-88 (2002) 1e-162 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 Laboratory/experimental isolate
Novembre (1992) SIV from stump-tailed macaques: molecular characterization of a highly transmissible primate lentivirus Virology 186 (2), 783-787 (1992) 1e-100 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Novembre (1993) MULTIPLE viral determinants contribute to pathogenicity of the acutely lethal simian immunodeficiency virus SIVsmmPBj variant J. Virol. 67 (5), 2466-2474 (1993) 1e-100  
3
3RT
3IN
0 Laboratory/experimental isolate
Novembre (1998) ISOLATION and characterization of a neuropathogenic simian immunodeficiency virus derived from a sooty mangabey J. Virol. 72 (11), 8841-8851 (1998) 1e-100 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Novembre (2010) Neuropathogenic SIVsmmFGb Genetic Diversity and Selection-Induced Tissue-Specific Compartmentalization During Asymptomatic Infection and Temporal Evolution of Viral Genes in Lymphoid and Central Nervous System Tissues Unpublished 1e-101  
857
857IN
0 Evolution/quasispecies study
Novitsky (1999) MOLECULAR cloning and phylogenetic analysis of human immunodeficiency virus type 1 subtype C: a set of 23 full-length clones from Botswana J. Virol. 73 (5), 4427-4432 (1999) 1e-165 23
23PR
23RT
23IN
23
23PR
23RT
23IN
100 HIVDB
Novitsky (2000) HIV type 1 A/J recombinant with a pronounced pol gene mosaicism AIDS Res. Hum. Retroviruses 16 (10), 1015-1020 (2000) 1e-164 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Novitsky (2002) HUMAN immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design? J. Virol. 76 (11), 5435-5451 (2002) 1e-165 42
42PR
42RT
42IN
42
42PR
42RT
42IN
100 HIVDB
Novitsky (2002) HIV-1 subtype C/Denv/C recombinant from Botswana Unpublished 1e-102  
1
1PR
1RT
1IN
0 Unpublished
Novitsky (2007) THE Reverse Transcriptase 67N 70R 215Y Genotype Is the Predominant TAM Pathway Associated with Virologic Failure among HIV Type 1C-Infected Adults Treated with ZDV/ddI-Containing HAART in Southern Africa AIDS Res. Hum. Retroviruses 23 (7), 868-878 (2007) 0 63
63PR
63RT
63
20PR
63RT
100 HIVDB
Ntemgwa (2007) VARIATIONS in Reverse Transcriptase and RNase H Domain Mutations in Human Immunodeficiency Virus Type 1 Clinical Isolates Are Associated with Divergent Phenotypic Resistance to Zidovudine Antimicrob. Agents Chemother. 51 (11), 3861-3869 (2007) 0  
19
6PR
16RT
0 Pending
Ntemgwa (2007) NEAR Full-Length Genomic Analysis of a Novel Subtype A1/C Recombinant HIV Type 1 Isolate from Canada AIDS Res. Hum. Retroviruses 24 (4), 655-659 (2008) 0 1
1PR
1RT
1IN
1
1RT
1IN
100 Case report(s) / study subset
Ntemgwa (2008) DISCREPANCIES in Assignment of Subtype/Recombinant Forms by Genotyping Programs for HIV Type 1 Drug Resistance Testing May Falsely Predict Superinfection AIDS Res. Hum. Retroviruses 24 (7), 995-1002 (2008) 0  
1
1RT
0 Case report(s) / study subset
Nukoolkarn (2005) SEQUENCE variability of the HIV type 1 protease gene in thai patients experienced with antiretroviral therapy AIDS Res. Hum. Retroviruses 20 (12), 1368-1372 (2004) 4e-51 44
44PR
44
44PR
100 HIVDB
Nunberg (1991) VIRAL resistance to human immunodeficiency virus type 1-specific pyridinone reverse transcriptase inhibitors J. Virol. 65 (9), 4887-4892 (1991) 1e-98  
2
2RT
0 Laboratory/experimental isolate
Nwobegahay (2009) Prevalence of drug resistance mutations among drug-naive HIV-1 infected individuals in a treatment site in the Waterberg District of South Africa Unpublished 0 53
7PR
46RT
53
7PR
46RT
100 HIVDB
Nwobegahay (2009) Baseline Genetic Resistance of HIV Infected Patients Entering Antiretroviral Treatment Program at Two Treatment Sites in Limpopo Province, South Africa Unpublished 0 85
18PR
67RT
85
18PR
67RT
100 HIVDB
Nwobegahay (2010) Prevalence of antiretroviral drug resistance mutations among drug-naive HIV-1-infected persons attending Mankweng Hospital, South Africa Unpublished 0  
47
11PR
36RT
0 Unpublished
Nyambi (2009) HIV-1 Reverse Transcriptase Drug Resistance Mutations in Chronically Infected HAART-Experienced and Naive Individuals in Cameroon Unpublished 0 28
28RT
28
28RT
100 HIVDB
Nyombi (2007) DIVERSITY of human immunodeficiency virus type 1 subtypes in Kagera and Kilimanjaro regions, Tanzania AIDS Res. Hum. Retroviruses 24 (6), 761-769 (2008) 0 166
165PR
166RT
166
59PR
166RT
100 HIVDB
O'Brien (1996) HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain Nature 348 (6296), 69-73 (1990) 1e-163 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
O'Connell (2010) Prolonged control of an HIV-1 escape variant following treatment interruption in an HLA-B*27 positive patient Unpublished 0  
2
2PR
1RT
1IN
0 Case report(s) / study subset
O'Connell (2011) Sustained Elite Suppression of Replication Competent HIV-1 in a Patient Treated with Rituximab Based Chemotherapy Unpublished 0  
2
2PR
2RT
2IN
0 Case report(s) / study subset
O'Connor (2004) A Dominant Role for CD8+-T-Lymphocyte Selection in Simian Immunodeficiency Virus Sequence Variation J. Virol. 78 (24), 14012-14022 (2004) 0  
26
26RT
26IN
0 Laboratory/experimental isolate
Ochoa (2005) GENOTYPIC and phenotypic patterns at virological failure in a simplification trial comparing nevirapine, efavirenz or abacavir as substitutes of a protease inhibitor (the NEFA resistance substudy) Unpublished 0 25
25PR
25RT
26
25PR
25RT
96 HIVDB
Oelrichs (1999) FULL-LENGTH genomic sequence of an HIV type 1 subtype G from Kinshasa AIDS Res. Hum. Retroviruses 15 (6), 585-589 (1999) 1e-165 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Oelrichs (1999) GENOMIC sequence of HIV-1 from four members of the Sydney Blood Bank cohort of long term non-progressors Unpublished 1e-163 3
3PR
3RT
3IN
5
5PR
5RT
5IN
60 HIVDB
Oelrichs (1999) SEQUENCE of HIV-1 subtype A/E polymerase gene Unpublished 1e-164  
1
1PR
1RT
1IN
0 Case report(s) / study subset
Oelrichs (1999) SEQUENCE of HIV-1 subtype B gag gene poorly detected by both RT-PCR and P24 monoclonal during symptomatic seroconversion Unpublished 1e-114  
1
1PR
0 Case report(s) / study subset
Oelrichs (2000) RAPID full-length genomic sequencing of two cytopathically heterogeneous Australian primary HIV-1 isolates J. Biomed. Sci. 7 (2), 128-135 (2000) 1e-164 2
2PR
2RT
2IN
2
2PR
2RT
2IN
100 HIVDB
Oelrichs (2000) NEAR full-length proviral sequence of HIV-1 from an individual homozygous for the delta-32 CCR5 allele Unpublished 1e-155  
1
1PR
1RT
1IN
0 Case report(s) / study subset
Oelrichs (2001) A novel subtype A/G/J recombinant full-length HIV type 1 genome from Burkina Faso AIDS Res. Hum. Retroviruses 14 (16), 1495-1500 (1998) 1e-164 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Ojesina (2006) SUBTYPE-SPECIFIC Patterns in HIV Type 1 Reverse Transcriptase and Protease in Oyo State, Nigeria: Implications for Drug Resistance and Host Response AIDS Res. Hum. Retroviruses 22 (8), 770-779 (2006) 0 43
8PR
35RT
43
8PR
35RT
100 HIVDB
Ojesina (2008) CHARACTERIZATION of HIV Type 1 Reverse Transcriptase Mutations in Infants Infected by Mothers Who Received Peripartum Nevirapine Prophylaxis in Jos, Nigeria AIDS Res. Hum. Retroviruses 23 (12), 1587-1592 (2007) 0 14
14RT
14
14RT
100 HIVDB
Olivares (1998) COMPLETE sequence of an infectious molecular clone derived from a Spanish HIV type I isolate AIDS Res. Hum. Retroviruses 14 (18), 1649-1651 (1998) 1e-164  
1
1PR
1RT
1IN
0 Case report(s) / study subset
Oliveira (2011) Genetic diversity and drug resistance profiles in HIV-1 infected patients from Cape Verde Islands Unpublished 1e-174  
26
26RT
0 Unpublished
Onanga (2006) SIVSUN natural history in Cercopithecus solatus and Macaca fascicularis: Evidence of a common ''Evolution Profile'' in african monkeys related to the lack of pathogeny of SIVs in natural host Unpublished 3e-87 1
1IN
1
1IN
100 HIVDB
Op de Coul (2000) INDEPENDENT introduction of transmissible F/D recombinant HIV-1 from Africa into Belgium and The Netherlands Virology 270 (2), 267-277 (2000) 1e-114 6
6PR
6RT
6
6PR
6RT
100 HIVDB
Op De Coul (2000) GENETIC evidence of multiple transmissions of HIV type 1 subtype F within Romania from adult blood donors to children AIDS Res. Hum. Retroviruses 16 (4), 327-336 (2000) 7e-86 14
14PR
14RT
14
14PR
14RT
100 HIVDB
Oram (1990) NUCLEOTIDE sequence of a Ugandan HIV-1 provirus reveals genetic diversity from other HIV-1 isolates AIDS Res. Hum. Retroviruses 6 (9), 1073-1078 (1990) 1e-164 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Orlandi (1999) ANALYSIS of HIV-1 reverse transcriptase gene mutations in infected children treated with zidovudine J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 19 (3), 230 3e-93 51
51RT
52
52RT
98 HIVDB
Osterhaus (1999) ISOLATION and partial characterization of a lentivirus from talapoin monkeys (Myopithecus talapoin) Virology 260 (1), 116-124 (1999) 0.3  
1
1RT
0 Gene fragment(s)
Pace (2007) POPULATION level analysis of human immunodeficiency virus type 1 hypermutation and its relationship with APOBEC3G and vif genetic variation J. Virol. 80 (18), 9259-9269 (2006) 0  
130
100PR
122RT
125IN
0 Sequence quality
Palmer (2002) REVERSE transcriptase and protease sequence evolution in two HIV-1-infected couples J. Acquir. Immune Defic. Syndr. 31 (3), 285-290 (2002) 1e-121 18
18PR
18RT
18
18PR
18RT
100 HIVDB
Palumbo (2001) ANTIRETROVIRAL resistance mutations among pregnant human immunodeficiency virus type 1-infected women and their newborns in the United States: vertical transmission and clades J. Infect. Dis. 184 (9), 1120-1126 (2001) 2e-85  
6
6RT
0 Case report(s) / study subset
Pando (2007) HIGH Genetic Variability in Female Sex Workers (FSWs) from Argentina Unpublished 1e-145  
8
8PR
8RT
0 Case report(s) / study subset
Pandrea (2001) HIV type 1 genetic diversity and genotypic drug susceptibility in the Republic of Moldova AIDS Res. Hum. Retroviruses 17 (13), 1297-1304 (2001) 7e-86 6
6PR
6RT
6
6PR
6RT
100 HIVDB
Pandrea (2002) ANALYSIS of partial pol and env sequences indicates a high prevalence of HIV type 1 recombinant strains circulating in Gabon AIDS Res. Hum. Retroviruses 18 (15), 1103-1116 (2002) 1e-102 37
30PR
36RT
37
36PR
36RT
100 HIVDB
Papa (2002) HIV-1 subtypes and circulating recombinant forms (CRFs) in Northern Greece Virus Res. 85 (1), 85-93 (2002) 5e-92 50
50RT
50
50RT
100 HIVDB
Papa (2002) GENETIC Variation of the Protease and Reverse Transcriptase Genes in HIV-1 CRF04_cpx Strains AIDS Res. Hum. Retroviruses 18 (9), 677-680 (2002) 7e-80 10
7PR
3RT
10
7PR
3RT
100 HIVDB
Papathanasopoulos (2002) FULL-LENGTH Genome Analysis of HIV-1 Subtype C Utilizing CXCR4 and Intersubtype Recombinants Isolated in South Africa AIDS Res. Hum. Retroviruses 18 (12), 879-886 (2002) 1e-165 4
4PR
4RT
4IN
4
4PR
4RT
4IN
100 HIVDB
Papathanasopoulos (2003) FULL-LENGTH Genome Characterization of HIV Type 1 Subtype C Isolates from Two Slow-Progressing Perinatally Infected Siblings in South Africa AIDS Res. Hum. Retroviruses 19 (11), 1033-1037 (2003) 0 2
2PR
2RT
2IN
2
2PR
2RT
2IN
100 HIVDB
Papathanasopoulos (2010) Characterization of HIV type 1 genetic diversity among South African participants enrolled in the AIDS Vaccine Integrated Project (AVIP) study AIDS Res. Hum. Retroviruses 26 (6), 705-709 (2010) 1e-168 67
35PR
35RT
32IN
67
5PR
35RT
32IN
100 HIVDB
Papuashvili (2005) CHARACTERISTICS of HIV-1 env V3 loop sequences for subtype A1 variant spread in Eastern Europe Infect. Genet. Evol. 5 (1), 45-53 (2005) 0 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Paraschiv (2007) GENOTYPIC analysis of subtype F HIV-1 reverse transcriptase gene carrying both K65R mutation and TAMs Int J Infect Dis. 2009 Jan;13(1):81-9. Epub 2008 Jul 15. 1e-169  
14
14RT
0 Pending
Paraschiv (2008) NRTI resistance mutations in subtype F1 strains isolated from heavily treated adolescents in Romania Unpublished (2007) 0  
327
327RT
0 Pending
Paraschiv (2009) Nucleoside reverse transcriptase inhibitor resistance mutations in subtype F1 strains isolated from heavily treated adolescents in Romania Int. J. Infect. Dis. 13 (1), 81-89 (2009) 1e-164  
8
8RT
0 Pending
Paraschiv (2010) Diversity of HIV-1 subtype C strains isolated in Romania Infect. Genet. Evol. (2010) In press 1e-179  
57
3PR
57RT
0 Pending
Paraskevis (2000) MOLECULAR characterization of a recombinant HIV type 1 isolate (A/G/E/?): unidentified regions may be derived from parental subtype E sequences AIDS Res. Hum. Retroviruses 16 (9), 845-855 (2000) 1e-160 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Paraskevis (2001) MOLECULAR characterization of a complex, recombinant human immunodeficiency virus type 1 (HIV-1) isolate (A/G/J/K/?): evidence to support the existence of a novel HIV-1 subtype J. Gen. Virol. 82 (Pt 10), 2509-2514 (2001) 1e-158 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Paraskevis (2005) PREVALENCE of resistance-associated mutations in newly diagnosed HIV-1 patients in Greece Virus Res. 112 (1-2), 115-122 (2005) 1e-123 58
58RT
59
1PR
58RT
98 HIVDB
Paraskevis (2007) INCREASING Prevalence of HIV-1 Subtype A in Greece: Estimating Epidemic History and Origin J. Infect. Dis. 196 (8), 1167-1176 (2007) 0  
151
74PR
77RT
0 Pending
Paraskevis (2007) Increasing prevalence of HIV-1 subtype A in Greece: estimating epidemic history and origin J. Infect. Dis. 196 (8), 1167-1176 (2007) 4e-49  
26
26PR
0 Pending
Parboosing (2011) Resistance to antiretroviral drugs in newly diagnosed, young treatment-naive HIV-positive pregnant women in the province of KwaZulu-Natal, South Africa J. Med. Virol. 83 (9), 1508-1513 (2011) 0 56
56PR
56RT
56
11PR
56RT
100 HIVDB
Parczewski (2010) Characteristics of HIV-1 non-B subtype infections in Northwest Poland J. Med. Virol. 82 (8), 1306-1313 (2010) 0  
20
3PR
20RT
0 Pending
Paredes (2011) A376S in the connection subdomain of HIV-1 reverse transcriptase confers increased risk of virological failure to nevirapine therapy J. Infect. Dis. (2011) In press 0  
204
46PR
193RT
0 Pending
Parera (2003) LACK of Evidence for Protease Evolution in HIV-1-Infected Patients after 2 Years of Successful Highly Active Antiretroviral Therapy J. Infect. Dis. 189 (8), 1444-1451 (2004) 3e-53  
288
288PR
0 Evolution/quasispecies study
Parham (2011) High Prevalence of Drug Resistance in HIV-1 Infected Children Born in Honduras and Belize 2001 to 2004 AIDS Res. Hum. Retroviruses (2011) In press 1e-150  
61
53PR
54RT
0 Pending
Pariente (2004) LONG-TERM suppression of plasma viremia with highly active antiretroviral therapy despite virus evolution and very limited selection of drug-resistant genotypes J. Med. Virol. 73 (3), 350-361 (2004) 0  
175
175PR
175RT
0 Pending
Parikh (2006) ANTAGONISM between the HIV-1 Reverse-Transcriptase Mutation K65R and Thymidine-Analogue Mutations at the Genomic Level J. Infect. Dis. 194 (5), 651-660 (2006) 1e-174  
320
320RT
0 Evolution/quasispecies study
Park (1998) MUTATIONS in both gp120 and gp41 are responsible for the broad neutralization resistance of variant human immunodeficiency virus type 1 MN to antibodies directed at V3 and non-V3 epitopes J. Virol. 72 (9), 7099-7107 (1998) 1e-163  
1
1PR
1RT
1IN
0 Laboratory/experimental isolate
Park (2003) GENOTYPIC Resistance of Antiretroviral Drugs among Drug-Naive HIV Type 1 Patients with the Background of Long-Term Access-Easy Zidovudine Therapy AIDS Res. Hum. Retroviruses 19 (11), 1039-1043 (2003) 1e-126 86
39PR
47RT
86
39PR
47RT
100 HIVDB
Parker (2002) RESITANCE prevelance in HIV naive patients Unpublished 0 121
120PR
108RT
2IN
121
120PR
108RT
2IN
100 HIVDB
Parker (2003) DETECTION of resistance mutations in HIV-infected individuals who have discontinued antiretroviral therapy Unpublished 1e-123  
78
39PR
39RT
0 Evolution/quasispecies study
Parker (2004) PREVALENCE of drug resistant and non-clade B HIV-1 in antiretroviral-naive individuals in New York State Unpublished 1e-123 21
1PR
20RT
22
2PR
20RT
95 Case report(s) / study subset
Parkin (2000) LOSS of antiretroviral drug susceptibility at low viral load during early virological failure in treatment-experienced patients Unpublished 1e-126 50
50PR
50RT
51
51PR
51RT
98 HIVDB
Parkin (2006) THE K101P and K103R/V179D Mutations in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Confer Resistance to Nonnucleoside Reverse Transcriptase Inhibitors Antimicrob. Agents Chemother. 50 (1), 351-354 (2006) 1e-172 76
76RT
76
76RT
100 HIVDB
Parreira (2006) GENETIC characterization of human immunodeficiency virus type 1 from Beira, Mozambique Microbes Infect. 8 (9-10), 2442-2451 (2006) 1e-141  
42
18PR
42RT
0 Pending
Parry (2009) Gag determinants of fitness and drug susceptibility in protease inhibitor-resistant human immunodeficiency virus type 1 J. Virol. 83 (18), 9094-9101 (2009) 0  
1
1RT
1IN
0 Laboratory/experimental isolate
Pasquier (2001) HIV-1 subtyping using phylogenetic analysis of pol gene sequences J. Virol. Methods 94 (1-2), 45-54 (2001) 1e-127 84
33PR
51RT
84
33PR
51RT
100 HIVDB
Passaes (2009) Near full-length genome characterization of HIV type 1 unique BC recombinant forms from Southern Brazil AIDS Res. Hum. Retroviruses 25 (12), 1339-1344 (20 0 4
4PR
4RT
4IN
4
4RT
4IN
100 HIVDB
Passaes (2010) Lack of primary mutations associated with integrase inhibitors among HIV-1 subtypes B, C, and F circulating in Brazil J. Acquir. Immune Defic. Syndr. 51 (1), 7-12 (2009 1e-167 105
105IN
105
105IN
100 HIVDB
Patil (2011) Emergence of drug resistance amongst human immunodeficiency virus type 1 infected individuals at the end of 12 months of first line ART initiation in India Unpublished 0  
13
2PR
12RT
0 Unpublished
Peeters (1999) CHARACTERIZATION of a highly replicative intergroup M/O human immunodeficiency virus type 1 recombinant isolated from a Cameroonian patient J. Virol. 73 (9), 7368-7375 (1999) 4e-81 1
1PR
1RT
1IN
1
1PR
1RT
100 HIVDB
Peeters (2002) RISK to human health from a plethora of simian immunodeficiency viruses in primate bushmeat Emerging Infect. Dis. 8 (5), 451-457 (2002) 1e-75  
21
21IN
0 Pending
Pereira-Vaz (2008) HIGH prevalence of the protease codon 35 amino acid insertion in treatment-naive HIV-1 subtype C infected individuals in the central region of Portugal Unpublished 0  
7
7RT
0 Case report(s) / study subset
Pereira-Vaz (2010) Molecular epidemiology of HIV-1 in the central region of Portugal Unpublished 0  
146
34PR
146RT
0 Unpublished
Perez Bercoff (2010) Polymorphisms of HIV-2 integrase and selection of resistance to raltegravir Retrovirology 7 (1), 98 (2010) 0  
62
8RT
54IN
0 Pending
Perez (2001) HUMAN immunodeficiency virus type 1 protease genotype predicts immune and viral responses to combination therapy with protease inhibitors (PIs) in PI-naive patients J. Infect. Dis. 183 (4), 579-588 (2001) 1e-130 45
26PR
19RT
45
26PR
19RT
100 HIVDB
Perez (2006) HIV Type 1 Molecular Epidemiology in Cuba: High Genetic Diversity, Frequent Mosaicism, and Recent Expansion of BG Intersubtype Recombinant Forms AIDS Res. Hum. Retroviruses 22 (8), 724-733 (2006) 0 424
424PR
424RT
424
332PR
423RT
100 HIVDB
Perez (2011) Drug resistance in HIV Cuban children Unpublished 0  
22
3PR
22RT
0 Unpublished
Perez-Romero (2010) Assay design for genotyping HIV-patients with viral loads below 1,000 copies/mL Unpublished 1e-143  
5
5PR
1RT
0 Unpublished
Perno (2001) IMPACT of mutations conferring reduced susceptibility to lamivudine (3TC) on the response to antiretroviral therapy Unpublished 1e-130 203
203PR
203RT
203
203PR
203RT
100 HIVDB
Persaud (2000) A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children J. Clin. Invest. 105 (7), 995-1003 (2000) 1e-130  
26
21PR
23RT
0 Evolution/quasispecies study
Persaud (2004) CONTINUED Production of Drug-Sensitive Human Immunodeficiency Virus Type 1 in Children on Combination Antiretroviral Therapy Who Have Undetectable Viral Loads J. Virol. 78 (2), 968-979 (2004) 3e-53  
116
116PR
0 Evolution/quasispecies study
Persaud (2007) SLOW human immunodeficiency virus type 1 evolution in viral reservoirs in infants treated with effective antiretroviral therapy AIDS Res. Hum. Retroviruses 23 (3), 381-390 (2007) 6e-53  
101
101PR
0 Evolution/quasispecies study
Petch (2005) GENOTYPIC Analysis of the Protease and Reverse Transcriptase of HIV Type 1 Subtype C Isolates from Antiretroviral Drug-Naive Adults in Malawi AIDS Res. Hum. Retroviruses 21 (9), 799-805 (2005) 1e-119 39
18PR
21RT
39
18PR
21RT
100 HIVDB
Petroni (2003) B/F intersubtype recombinants of HIV-1 in Argentina: impact on genotypic patterns associated with antiretroviral drug resistance Unpublished 0  
316
316PR
316RT
0 ARV Rx and/or other data are N/A
Petroni (2006) UPDATE on Primary HIV-1 Resistance in Argentina: Emergence of Mutations Conferring High-Level Resistance to Nonnucleoside Reverse Transcriptase Inhibitors in Drug-Naive Patients J. Acquir. Immune Defic. Syndr. 42 (4), 506-510 (2006) 0 52
52PR
52RT
52
42PR
52RT
100 HIVDB
Petropoulos (2002) APPENDIX 2: Retroviral taxonomy, protein structure, sequences, and genetic maps (in) Coffin,J.M. (Ed.); RETROVIRUSES: 757; Cold Spring Harbo 1e-163  
1
1PR
1RT
1IN
0 Laboratory/experimental isolate
Pfafferott (2009) Adaptation of HIV-1 to HLA I Unpublished 0  
125
101RT
85IN
0 Unpublished
Phan (2007) SEQUENCE variation in pol gene of HIV-1 isolated from Bach Mai hospital in Hanoi Unpublished 0  
1
1RT
0 Case report(s) / study subset
Phan (2011) Sequence analysis of protease encoding gene of HIV type isolated in Vietnam Unpublished 6e-50  
4
4PR
0 Unpublished
Phan (2010) Characterization of HIV Type 1 Genotypes and Drug Resistance Mutations Among Drug-Naive HIV Type 1-Infected Patients in Northern Vietnam AIDS Res. Hum. Retroviruses 26 (2), 233-235 (2010) 2e-50 105
105PR
86RT
105
105PR
100 HIVDB
Philpott (2004) HUMAN immunodeficiency virus type 1 genomic RNA sequences in the female genital tract and blood: compartmentalization and intrapatient recombination J. Virol. 79 (1), 353-363 (2005) 0  
20
20PR
20RT
20IN
0 Evolution/quasispecies study
Picchio (2001) ALTERED viral fitness of HIV-1 following failure of protease inhibitor-based therapy J. Acquir. Immune Defic. Syndr. 25 (4), 289-295 (2000) 1e-121  
5
5PR
5RT
0 Case report(s) / study subset
Pieniazek (1991) PHYLOGENETIC relationships among Human Immunodeficiency Virus (HIV) isolates from single and mixed HIV-1/HIV-2 infections Unpublished (1993) 1e-126 4
4PR
16
16PR
25 HIVDB
Pieniazek (1998) INTRODUCTION of HIV-2 and multiple HIV-1 subtypes to Lebanon Emerging Infect. Dis. 4 (4), 649-656 (1998) 1e-126 26
26PR
26
26PR
100 HIVDB
Pieniazek (1999) PRESENCE of human immunodeficiency virus type 2 subtypes A and B in Abidjan, Cote d' Ivoire Unpublished 2e-24  
31
31PR
0 Pending
Pieniazek (2003) HIV-2 protease sequences of subtypes A and B harbor multiple mutations associated with protease inhibitor resistance in HIV-1 AIDS 18 (3), 495-502 (2004) 6e-25 27
27PR
27
27PR
100 HIVDB
Pilcher (1999) GENOTYPIC resistance and the treatment of HIV-1 infection in Espirito Santo, Brazil J. Infect. Dis. 179 (5), 1259-1263 (1999) 1e-128  
72
72PR
72RT
0 Sequence quality
Pillay (2002) HIV-1 subtype C reverse transcriptase sequences from drug-naive pregnant women in South Africa AIDS Res. Hum. Retroviruses 18 (8), 605-610 (2002) 2e-67 37
37RT
37
37RT
100 HIVDB
Pillay (2004) EMERGENCE of resistance mutations in children treated with ddI plus d4T after treatment to prevent mother-to-child transmission Unpublished 1e-174 40
40RT
46
46RT
86 HIVDB
Pillay (2004) POLYMORPHISMS in HIV Subtype C protease encode secondary drug resistance mutations Unpublished 1e-50  
31
31PR
0 Pending
Pillay (2005) HIV Type 1 Subtype C Drug Resistance among Pediatric and Adult South African Patients Failing Antiretroviral Therapy AIDS Res. Hum. Retroviruses 24 (11), 1449-1454 (2008) 0 68
68PR
68RT
68
61PR
68RT
100 HIVDB
Pilon (2011) Transmission Patterns of HIV and Hepatitis C Virus among Networks of People Who Inject Drugs Recruited through Respondent-Driven Sampling Unpublished 1e-168  
27
27RT
0 Unpublished
Pires (2004) PREVALENCE of Human Immunodeficiency Virus Drug Resistance Mutations and Subtypes in Drug-Naive, Infected Individuals in the Army Health Service of Rio de Janeiro, Brazil J. Clin. Microbiol. 42 (1), 426-430 (2004) 1e-114 98
49PR
49RT
99
49PR
50RT
98 HIVDB
Piyasirisilp (2000) A recent outbreak of human immunodeficiency virus type 1 infection in southern China was initiated by two highly homogeneous, geographically separated strains, circulating recombinant form AE and a novel BC recombinant J. Virol. 74 (23), 11286-11295 (2000) 1e-165 5
5PR
5RT
5IN
5
5PR
5RT
5IN
100 HIVDB
Plantier (2009) A new immunodeficiency virus derived from gorillas Nat. Med. (2009) In press 0 1
1PR
1RT
1IN
2
2RT
2IN
50 HIVDB
Poddubskaya (2009) The sequence of fragment of HIV-1 pol gene from Russia patient Unpublished 0  
46
46RT
0 Unpublished
Pollakis (2003) RECOMBINATION of HIV Type 1C (C'/C') in Ethiopia: Possible Link of EthHIV-1C' to Subtype C Sequences from the High-Prevalence Epidemics in India and Southern Africa AIDS Res. Hum. Retroviruses 19 (11), 999-1008 (2003) 1e-90 19
16PR
18RT
19
16PR
18RT
100 HIVDB
Powell (2007) CIRCULATING Recombinant Form (CRF) 37_cpx: An Old Strain in Cameroon Composed of Diverse, Genetically Distant Lineages of Subtypes A and G AIDS Res. Hum. Retroviruses 23 (7), 923-933 (2007) 0 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Powell (2007) QUASISPECIES analysis of novel HIV-1 recombinants of subtypes A and G reveals no similarity to the mosaic structure of CRF02_AG J. Med. Virol. 79 (9), 1270-1285 (2007) 0 3
3RT
3
3RT
100 Case report(s) / study subset
Powell (2007) IDENTIFICATION of a Novel Circulating Recombinant Form (CRF) 36_cpx in Cameroon That Combines Two CRFs (01_AE and 02_AG) with Ancestral Lineages of Subtypes A and G AIDS Res. Hum. Retroviruses 23 (8), 1008-1019 (2007) 0 2
2PR
2RT
2IN
2
2RT
2IN
100 HIVDB
Powell (2009) Longitudinal quasispecies analysis of viral variants in HIV type 1 dually infected individuals highlights the importance of sequence identity in viral recombination AIDS Res. Hum. Retroviruses 26 (3), 253-264 (2010) 0  
560
185RT
375IN
0 Evolution/quasispecies study
Praparattanapan (2011) Current Molecular Epidemiology and Recombination of HIV Type 1 Subtypes in Northern Thailand AIDS Res. Hum. Retroviruses (2011) In press 1e-148  
232
231PR
10RT
0 Pending
Prasetyo (2011) Direct Submission Submitted (20-AUG-2010) Department of Microbiology 8e-56  
13
13IN
0 Unpublished
Prejdova (2003) RESISTANCE development in HIV positive patients treated by protease inhibitors: correlation of the genotype and disease progression Unpublished 6e-52  
23
23PR
0 ARV Rx and/or other data are N/A
Punzi (2004) HIV infection and protease genetic diversity in a rural area of the Southern Central African Republic J. Med. Virol. 77 (4), 457-459 (2005) 1e-147 12
12PR
2RT
12
12PR
2RT
100 HIVDB
Pushkarsky (2003) DIRECT Submission Submitted (28-FEB-2003) Microbiology and Tropical Medicine, 0  
2
1RT
1IN
0 Case report(s) / study subset
Qari (2002) A rapid phenotypic assay for detecting multiple nucleoside analog reverse transcriptase inhibitor-resistant human immunodeficiency virus type 1 in plasma Antivir. Ther. (Lond.) (2002) In press 1e-116  
5
5PR
5RT
0 Case report(s) / study subset
Qiu (2005) CHARACTERIZATION of Five Nearly Full-Length Genomes of Early HIV Type 1 Strains in Ruili City: Implications for the Genesis of CRF07_BC and CRF08_BC Circulating in China AIDS Res. Hum. Retroviruses 21 (12), 1051-1056 (2005) 0 5
5PR
5RT
5IN
5
2PR
5RT
5IN
100 HIVDB
Quan (2003) DRUG resistance profiles of recombinant reverse transcriptases from human immunodeficiency virus type 1 subtypes A/E, B, and C AIDS Res. Hum. Retroviruses 19 (9), 743-753 (2003) 2e-61  
3
3RT
0 Laboratory/experimental isolate
Quarleri (2004) DIRECT Submission Submitted (01-DEC-2003) National Reference Center for AIDS-M 0  
16
16PR
16RT
0 ARV Rx and/or other data are N/A
Quesnel-Vallieres (2011) Novel HIV-1 Recombinant Forms in Antenatal Cohort, Montreal, Quebec, Canada Emerging Infect. Dis. 17 (2), 271-274 (2011) 0  
4
4RT
4IN
0 Pending
Quinones-Mateu (1995) MOLECULAR characterization of human immunodeficiency virus type 1 isolates from Venezuela AIDS Res. Hum. Retroviruses 11 (5), 605-616 (1995) 5e-92 8
8RT
8
8RT
100 HIVDB
Quinones-Mateu (1997) CHARACTERIZATION of the reverse transcriptase of a human immunodeficiency virus type 1 group O isolate Virology 236 (2), 364-373 (1997) 7e-08 1
1RT
1
1RT
100 HIVDB
Quinones-Mateu (1998) ANALYSIS of pol gene heterogeneity, viral quasispecies, and drug resistance in individuals infected with group O strains of human immunodeficiency virus type 1 J. Virol. 72 (11), 9002-9015 (1998) 1e-21 66
66RT
88
88RT
75 HIVDB
Ragonnet-Cronin (2010) Longitudinal Phylogenetic Surveillance Identifies Distinct Patterns of Cluster Dynamics J. Acquir. Immune Defic. Syndr. (2010) In press 1e-179 358
358PR
358RT
876
517PR
849RT
40 HIVDB
Rainwater (2005) NO Evidence for Rapid Subtype C Spread within an Epidemic in Which Multiple Subtypes and Intersubtype Recombinants Circulate AIDS Res. Hum. Retroviruses 21 (12), 1060-1065 (2005) 1e-166 22
22IN
23
23IN
95 HIVDB
Rajesh (2009) Antiretroviral drug-resistant mutations at baseline and at time of failure of antiretroviral therapy in HIV type 1-coinfected TB patients AIDS Res. Hum. Retroviruses 25 (11), 1179-1185 (20 1e-149 57
10PR
47RT
57
10PR
47RT
100 HIVDB
Ramirez de Arellano (2004) GENETIC Analysis of Regulatory, Promoter, and TAR Regions of LTR Sequences Belonging to HIV Type 1 Non-B Subtypes AIDS Res. Hum. Retroviruses 21 (11), 949-954 (2005) 1e-131  
15
15PR
11RT
0 Case report(s) / study subset
Ramos (1999) DUAL and recombinant infections: an integral part of the HIV-1 epidemic in Brazil Emerging Infect. Dis. 5 (1), 65-74 (1999) 1e-124 24
24PR
25
25PR
96 HIVDB
Ramos (2002) NEW HIV Type 1 CRF01_AE/B Recombinants Displaying Unique Distribution of Breakpoints from Incident Infections among Injecting Drug Users in Thailand AIDS Res. Hum. Retroviruses 19 (8), 667-674 (2003) 1e-164 4
4PR
4RT
4IN
4
4PR
4RT
4IN
100 HIVDB
Rangel (2009) Deletion, insertion and stop codon mutations in Vif genes of HIV-1 infecting long term progressor patients Unpublished 2e-21  
29
29IN
0 Gene fragment(s)
Rangel (2009) HIV diversity in Venezuela: predominance of HIV type 1 subtype B and genomic characterization of non-B variants AIDS Res. Hum. Retroviruses 25 (3), 347-350 (2009) 0  
163
72PR
157RT
0 Pending
Rangel (2009) Deletion, insertion and stop codon mutations in vif genes of HIV-1 infecting slow progressor patients J Infect Dev Ctries 3 (7), 531-538 (2009) 2e-21  
7
7IN
0 Pending
Rangel (2010) Absence of primary integrase resistance mutations in HIV type 1-infected patients in Venezuela AIDS Res. Hum. Retroviruses 26 (8), 923-926 (2010) 0 103
36PR
36RT
67IN
103
19PR
36RT
67IN
100 HIVDB
Rangel (2011) HIV diversity in Venezuela: predominance of HIV-1 subtype B and genomic characterization of non B viruses Unpublished 0  
168
74PR
164RT
0 Unpublished
Ravuri (2006) PRIMARY Drug Resistance Studies by Genotypic Analysis in HIV-1 Indian Subtype C-Infected Individuals Unpublished 0 50
50RT
50
50RT
100 HIVDB
Razafindratsimandresy (2006) HIGH HIV Type 1 Subtype Diversity and Few Drug Resistance Mutations among Seropositive People Detected during the 2005 Second Generation HIV Surveillance in Madagascar AIDS Res. Hum. Retroviruses 22 (6), 595-597 (2006) 1e-145 46
18PR
28RT
46
18PR
28RT
100 HIVDB
Razafindratsimandresy (2007) HIV Type 1 Diversity in the Seychelles AIDS Res. Hum. Retroviruses 23 (6), 761-763 (2007) 1e-144 61
22PR
39RT
61
22PR
39RT
100 HIVDB
Recordon-Pinson (2010) Evaluation of the genotypic prediction of HIV-1 coreceptor use versus a phenotypic assay and correlation with the virological response to maraviroc: the ANRS GenoTropism study Antimicrob. Agents Chemother. 54 (8), 3335-3340 (2 0  
31
16PR
18RT
0 Pending
Reed (2005) HIGH prevalence of a new SIV in cercopithecus erythrotis from the island of Bioko, Equatorial Guinea : molecular characterization of SIVery from tissue samples Unpublished 1e-76 11
11IN
11
11IN
100 HIVDB
Reeve (2009) Reduced genetic diversity in lymphoid and central nervous system tissues and selection-induced tissue-specific compartmentalization of neuropathogenic SIVsmmFGb during acute infection AIDS Res. Hum. Retroviruses 25 (6), 583-601 (2009) 1e-102  
1238
1238IN
0 Evolution/quasispecies study
Reid (2005) NATURAL resistance of human immunodeficiency virus type 2 to zidovudine Virology 336 (2), 251-264 (2005) 0  
10
10RT
0 Pending
Reinis (2002) HUMAN immunodeficiency virus 1 strains resistant to nucleoside inhibitors of reverse transcriptase in isolates from the Czech Republic as monitored by line probe assay and nucleotide sequencing Acta Virol. 45 (5-6), 279-286 (2001) 4e-96  
32
32RT
0 Pending
Reinis (2006) GENOMIC Analysis of HIV Type 1 Strains Derived from a Mother and Child Pair of Long-Term Nonprogressors AIDS Res. Hum. Retroviruses 23 (2), 309-315 (2007) 0  
4
4PR
4RT
4IN
0 Case report(s) / study subset
Reinke (2002) NATURAL selection results in conservation of HIV-1 integrase activity despite sequence variability AIDS 15 (7), 823-830 (2001) 1e-164 4
4IN
4
4IN
100 HIVDB
Reinke (2002) INHIBITION of human immunodeficiency virus type 1 isolates by the integrase inhibitor L-731,988, a diketo Acid Antimicrob. Agents Chemother. 46 (10), 3301-3303 (2002) 1e-166  
6
6IN
0 Pending
Reitz (1995) VIRAL variability and serum antibody response in a laboratory worker infected with HIV type 1 (HTLV type IIIB) AIDS Res. Hum. Retroviruses 10 (9), 1143-1155 (1994) 1e-164  
1
1PR
1RT
1IN
0 Case report(s) / study subset
Resch (2004) EVOLUTION of human immunodeficiency virus type 1 protease genotypes and phenotypes in vivo under selective pressure of the protease inhibitor ritonavir J. Virol. 79 (16), 10638-10649 (2005) 3e-53  
458
458PR
15RT
0 Evolution/quasispecies study
Reuman (2009) Panel of prototypical raltegravir-resistant infectious molecular clones in a novel integrase-deleted cloning vector Antimicrob. Agents Chemother. 54 (2), 934-936 (201 1e-166 16
16IN
16
16IN
100 HIVDB
Rey-Cuille (1994) HIV-2 EHO isolate has a divergent envelope gene and induces single cell killing by apoptosis Virology 202 (1), 471-476 (1994) 1e-101 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Rhee (2005) HIV-1 Protease and Reverse-Transcriptase Mutations: Correlations with Antiretroviral Therapy in Subtype B Isolates and Implications for Drug-Resistance Surveillance J. Infect. Dis. 192 (3), 456-465 (2005) 0 3193
1247PR
1946RT
3194
1248PR
1946RT
99 HIVDB
Rhee (2005) HIV-1 Protease and reverse-transcriptase mutations: correlations with antiretroviral therapy in subtype B isolates and implications for drug-resistance surveillance J. Infect. Dis. 192 (3), 456-465 (2005) 2e-48 5
5PR
5
5PR
100 HIVDB
Rhee (2007) PREDICTORS of Human Immunodeficiency Virus Type 1 Drug Resistance Unpublished 0 6
2PR
4RT
143
49PR
94RT
4 HIVDB
Rhee (2009) Predictive Value of HIV-1 Genotypic Resistance Test Interpretation Algorithms J. Infect. Dis. 200 (3), 453-463 (2009) 0 369
157PR
212RT
369
157PR
212RT
100 HIVDB
Rhodes (2001) CHARACTERIZATION of three nef-defective HIV-1 strains associated with long term nonprogression Unpublished 0.02  
37
37IN
0 Gene fragment(s)
Richard (2004) HIGH prevalence of antiretroviral resistance in treated Ugandans infected with non-subtype B human immunodeficiency virus type 1 AIDS Res. Hum. Retroviruses 20 (4), 355-364 (2004) 1e-116 90
90RT
90
90RT
100 HIVDB
Rios (2007) ANTIRETROVIRAL drug resistance and phylogenetic diversity of HIV-1 in Chile J. Med. Virol. 79 (6), 647-656 (2007) 1e-163 157
157PR
157RT
157
120PR
157RT
100 HIVDB
Riva (2002) EVALUATION of two commercial kits for testing genotypic drug-resistance on a panel of human immunodeficiency virus type 1 subtypes A-J Unpublished 1e-118  
22
22PR
22RT
0 ARV Rx and/or other data are N/A
Riva (2008) IDENTIFICATION of a Possible Ancestor of the Subtype A1 HIV Type 1 Variant Circulating in the Former Soviet Union AIDS Res. Hum. Retroviruses 24 (10), 1319-1325 (2008) 0  
1
1PR
1RT
1IN
0 Case report(s) / study subset
Rivera-Morales (2010) Genotype analysis of protease and reverse transcriptase genes on children with HIV-1 under structured treatment interruptions Unpublished 0  
4
2PR
2RT
0 Unpublished
Rivera-Morales (2011) Drug Resistance Mutations During Structured Interruptions of HAART in HIV-1 Infected Children Unpublished 0  
7
4PR
3RT
0 Case report(s) / study subset
Rodenburg (2001) NEAR full-length clones and reference sequences for subtype C isolates of HIV type 1 from three different continents AIDS Res. Hum. Retroviruses 17 (2), 161-168 (2001) 1e-165 13
13PR
13RT
13IN
13
13PR
13RT
13IN
100 HIVDB
Rodes (2000) EMERGENCE of drug resistance mutations in human immunodeficiency virus type 2-infected subjects undergoing antiretroviral therapy J. Clin. Microbiol. 38 (4), 1370-1374 (2000) 4e-19 13
4PR
12RT
13
1PR
12RT
100 HIVDB
Rodes (2002) RAPID Assessment of Phenotypic Resistance to Protease Inhibitors in Human Immunodeficiency Virus Type 1 Group O J. Clin. Microbiol. 40 (11), 4313-4316 (2002) 1.6 5
5PR
5
5PR
100 HIVDB
Rodes (2004) TREATMENT Response and Drug Resistance in Patients Infected with HIV Type 1 Group O Viruses AIDS Res. Hum. Retroviruses 21 (7), 602-607 (2005) 0 20
10PR
10RT
22
10PR
12RT
90 HIVDB
Rodrigues (2003) ARV Resistance Mutations in Non-B clades HIV-1 Unpublished 0 175
89PR
86RT
301
153PR
149RT
58 HIVDB
Rodrigues (2005) LOW prevalence of primary antiretroviral resistance mutations and predominance of HIV-1 clade C at polymerase gene in newly diagnosed individuals from south Brazil Virus Res. 116 (1-2), 201-207 (2006) 1e-118 45
44PR
1RT
45
44PR
1RT
100 HIVDB
Rodrigues (2008) MOLECULAR characterization and predictors of HIV infection among VCT users of Curitiba, Brazil Unpublished 0 37
37PR
37RT
37
31PR
12RT
100 HIVDB
Rodrigues (2010) Young pregnant women living with HIV/AIDS in Criciuma, Southern Brazil, are infected almost exclusively with HIV type 1 clade C AIDS Res. Hum. Retroviruses 26 (3), 351-357 (2010) 4e-50 9
9PR
9RT
9
9PR
100 HIVDB
Rodrigues (2010) Direct Submission Submitted (23-MAR-2010) Servico de Virologia, Inst 0  
776
169PR
754RT
0 Pending
Rodrigues (2010) Brazilian HIV-1 Surveillance Unpublished 3e-49  
1
1PR
0 Unpublished
Rodrigues (2010) Sao Paulo HIV Salvage Workgroup Unpublished 1e-150  
2
1PR
1RT
0 Unpublished
Rodriguez (2005) CONSTRUCTION and characterization of an infectious molecular clone of HIV-1 subtype A of Indian origin Virology 345 (2), 328-336 (2006) 0 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Roege (2003) K65R with and without S68: a new resistance profile in vivo detected in most patients failing abacavir, didanosine and stavudine Antivir. Ther. (Lond.) 8 (2), 173-182 (2003) 3e-97 20
20RT
20
20RT
100 HIVDB
Roge (2003) DRUG resistance mutations and outcome of second-line treatment in patients with first-line protease inhibitor failure on nelfinavir-containing HAART HIV Med. 4 (1), 38-47 (2003) 1e-131  
95
48PR
47RT
0 ARV Rx and/or other data are N/A
Rolland (2011) Direct Submission Submitted (08-FEB-2011) Microbiology, University o 0  
632
391PR
441RT
632IN
0 Pending
Romano (2000) DETECTION of genotypically drug-resistant HIV-1 variants and non-B subtypes in recently infected antiretroviral-naive adults in Italy AIDS 14 (14), 2204-2206 (2000) 1e-132 232
116PR
116RT
232
116PR
116RT
100 HIVDB
Romano (2002) PROLONGED low capability to reinfect peripheral blood lymphocytes by circulating protease inhibitor-resistant HIV-1 in a patient under antiretroviral therapy Unpublished 1e-123  
80
40PR
40RT
0 ARV Rx and/or other data are N/A
Romano (2002) TREATMENT with lopinavir/ritonavir in heavily pretreated subjects failing multiple antiretroviral regimens in clinical practice J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 30, 533-535 1e-124 80
80PR
80RT
80
80PR
80RT
100 HIVDB
Roques (2000) PHYLOGENETIC characteristics of three new HIV-1 N strains and implications for the origin of group N AIDS 18 (10), 1371-1381 (2004) 0 3
3PR
3RT
3IN
8
3PR
3RT
6IN
37 HIVDB
Ross (2001) THYMIDINE analog and multinucleoside resistance mutations are associated with decreased phenotypic susceptibility to stavudine in HIV type 1 isolated from zidovudine-naive patients experiencing viremia on stavudine-containing regimens AIDS Res. Hum. Retroviruses 17 (12), 1107-1115 (2001) 1e-130  
86
70PR
86RT
0 ARV Rx and/or other data are N/A
Rousseau (2003) LARGE-SCALE amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes J. Virol. Methods 136 (1-2), 118-125 (2006) 0 272
256PR
257RT
270IN
273
232PR
272RT
270IN
99 HIVDB
Rousseau (2008) HLA Class-I Driven Evolution of Human Immunodeficiency Virus Type 1 Subtype C Proteome: Immune Escape and Viral Load Unpublished 0  
148
148RT
0 Pending
Rousseau (2000) PATTERNS of resistance mutations to antiretroviral drugs in extensively pretreated HIV-1-infected patients with failure of highly active antiretroviral therapy J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 26, 36-43 ( 1e-112 22
22PR
22RT
22
22PR
22RT
100 HIVDB
Roye (2010) Genotypic Characterization of HIV-1 in Jamaica Unpublished 0  
7
4PR
7RT
7IN
0 Unpublished
Ruchansky (2008) IDENTIFICATION of a new HIV Type 1 Circulating Recombinant Form (CRF38_BF1) in Uruguay AIDS Res. Hum. Retroviruses 25 (3), 351-356 (2009) 0 4
4PR
4RT
4IN
4
4RT
4IN
100 Case report(s) / study subset
Rud (1992) INFECTIOUS molecular clones of SIVmac32H: Nef deletion controls ability to reisolate virus from rhesus macaques (in) Brown,F., Chanock,R.M. and Ginsberg,H.S. (Eds.); VACCIN 1e-99  
1
1PR
1RT
1IN
0 Laboratory/experimental isolate
Rudicell (2010) Impact of simian immunodeficiency virus infection on chimpanzee population dynamics PLoS Pathog. 6 (9), e1001116 (2010) 3e-86  
2
2IN
0 Pending
Rudicell (2011) High Prevalence of Simian Immunodeficiency Virus Infection in a Community of Savanna Chimpanzees J. Virol. (2011) In press 0  
6
3RT
6IN
0 Pending
Ruelle (2007) MODERATE antiretroviral efficacy and selection of resistance mutations in HIV-2: Analysis of the HIV-2 Belgium and Luxembourg database Unpublished 1e-149  
12
12RT
0 Pending
Ruff (2002) PERSISTENCE of wild-type virus and lack of temporal structure in the latent reservoir for human immunodeficiency virus type 1 in pediatric patients with extensive antiretroviral exposure J. Virol. 76 (18), 9481-9492 (2002) 1e-130  
81
81PR
81RT
0 Evolution/quasispecies study
Rumyantseva (2009) Molecular epidemiology of HIV-1 in Krasnoyarsk region, Russia AIDS Res Hum Retroviruses. 2009 Sep;25(9):931-6. 0  
80
4PR
80RT
0 Pending
Rusconi (2000) SUSCEPTIBILITY to PNU-140690 (Tipranavir) of human immunodeficiency virus type 1 isolates derived from patients with multidrug resistance to other protease inhibitors Antimicrob. Agents Chemother. 44 (5), 1328-1332 (2000) 1e-113  
10
10PR
0 ARV Rx and/or other data are N/A
Rusconi (2002) ACCUMULATION of drug-related mutations in HIV-1 genome and virus replicative capacity in multi-drug failure subjects J. Antimicrob. Chemother. 49 (2), 427-429 (2002) 1e-116  
17
8PR
9RT
0 ARV Rx and/or other data are N/A
Rusconi (2007) DISCOVERY of a novel non-conventional (folding) protease inhibitor with in vitro activity against Human Immunodeficiency Virus type 1 Unpublished 1e-142  
1
1RT
0 Laboratory/experimental isolate
Rychert (2006) HIV-1 Sequence Variation Occurs in CD4 Epitopes During Acute Infection Unpublished 1e-166  
14
14IN
0 Case report(s) / study subset
Sa Filho (2002) MUTATIONS associated with drug resistance in a population of drug naive HIV-1 infected individuals Unpublished 1e-98 89
89RT
90
90RT
98 HIVDB
Sa Filho (2004) ANALYSIS of full-length human immunodeficiency virus type 1 genome reveals a variable spectrum of subtypes B and f recombinants in Sao Paulo, Brazil AIDS Res. Hum. Retroviruses 21 (2), 145-151 (2005) 0 6
6PR
6RT
6IN
221
221PR
221RT
6IN
2 HIVDB
Sa Filho (2006) IDENTIFICATION of Two HIV Type 1 Circulating Recombinant Forms in Brazil AIDS Res. Hum. Retroviruses 22 (1), 1-13 (2006) 0 10
10PR
10RT
10IN
10
3PR
10RT
10IN
100 HIVDB
Sa-Filho (2003) ANALYSIS of the protease sequences of HIV-1 infected individuals after Indinavir monotherapy J. Clin. Virol. 28 (2), 186-202 (2003) 1e-123 50
50PR
50
50PR
100 HIVDB
Sa-Filho (2007) CHARACTERIZATION of the full-length human immunodeficiency virus-1 genome from recently infected subjects in Brazil AIDS Res. Hum. Retroviruses 23 (9), 1087-1094 (2007) 0 12
12PR
12RT
12IN
12
8PR
12RT
12IN
100 HIVDB
Sa-Filho (2009) HIV-1 diversity from newly diagnosed patients in Santos Metropolitan Area/Brazil AIDS Res Hum Retroviruses. 2009 Sep;25(9):925-9. 1e-150 31
31PR
30RT
31
20PR
20RT
100 HIVDB
Saad (2004) HIV Type 1 Strains Common in Europe, Africa, and Asia Cocirculate in Yemen AIDS Res. Hum. Retroviruses 21 (7), 644-648 (2005) 0 19
19PR
19RT
6IN
25
25PR
25RT
6IN
76 HIVDB
Saad (2005) MOLECULAR Epidemiology of HIV Type 1 in Ukraine: Birthplace of an Epidemic AIDS Res. Hum. Retroviruses 22 (8), 709-714 (2006) 0 175
163PR
163RT
12IN
175
172PR
175RT
12IN
100 HIVDB
Saad (2006) GENETIC Forms of HIV Type 1 in the Former Soviet Union Dominate the Epidemic in Azerbaijan AIDS Res. Hum. Retroviruses 22 (8), 796-800 (2006) 1e-138 41
41PR
41RT
41
41PR
41RT
100 HIVDB
Saah (2003) TREATMENT with indinavir, efavirenz, and adefovir after failure of nelfinavir therapy J. Infect. Dis. 187 (7), 1157-1162 (2003) 1e-130 354
354PR
354RT
354
354PR
354RT
100 HIVDB
Sagar (2005) DIVERSITY in HIV-1 Envelope V1-V3 Sequences Early in Infection Reflects Sequence Diversity Throughout the HIV-1 Genome But Does Not Predict the Extent of Sequence Diversity During Chronic Infection AIDS Res. Hum. Retroviruses 22 (5), 430-437 (2006) 1e-155  
160
132PR
134RT
0 Evolution/quasispecies study
Sagoe (2007) VARIABILITY of the human immunodeficiency virus type 1 polymerase gene from treatment naive patients in Accra, Ghana J. Clin. Virol. 40 (2), 163-167 (2007) 0 25
25PR
25RT
25
1PR
25RT
100 HIVDB
SahBandar (2009) Molecular epidemiology profile and emerging recombinant forms among HIV-1 infected subjects in Jakarta, Indonesia Unpublished 8e-51 1
1PR
1RT
3
3PR
33 Case report(s) / study subset
Sahbandar (2009) Current HIV type 1 molecular epidemiology profile and identification of unique recombinant forms in Jakarta, Indonesia AIDS Res. Hum. Retroviruses 25 (7), 637-646 (2009) 9e-50 1
1PR
1RT
3
3PR
33 HIVDB
SahBandar (2010) The Indonesian Variant of CRF33_01B: Near-Full Length Sequence Analysis Unpublished 0  
2
2RT
2IN
0 Pending
Sahu (2010) Recovery of replication-competent residual HIV-1 from plasma of a patient receiving prolonged, suppressive highly active antiretroviral therapy J. Virol. 84 (16), 8348-8352 (2010) 0  
5
5RT
5IN
0 Pending
Saini (2009) Drug-resistance associated mutations in HIV-1 among patients failing fixed dose combinations of antiretroviral drugs Unpublished 1e-49  
11
11PR
0 Unpublished
Saini (2009) High rate of drug resistance associated mutations in HIV-1 among patients failing fixed dose combinations of first line antiretroviral therapy Unpublished 1e-49  
5
5PR
0 Pending
Sakamoto (2006) INFECTIOUS DNA clones of CRF01_AE HIV-1 derived from Thainian isolates Unpublished 0  
5
5PR
5RT
5IN
0 Unpublished
Sakamoto (2006) INFECTIOUS molecular clones of subtype B HIV-1 derived from Japanese patients Unpublished 0  
2
2PR
2RT
2IN
0 Unpublished
Sakamoto (2006) CONSTRUCTION and characterization of naive HIV-1 subtype A infectious molecular clones derived from Rwanda patients for reference Unpublished 0  
132
25PR
132RT
132IN
0 Unpublished
Sakamoto (2006) CONSTRUCTION and characterization of an unique mosaic HIV-1 subtype C infectious molecular clones derived from a japanese patients Unpublished 0  
2
2RT
2IN
0 Laboratory/experimental isolate
Sakamoto (2009) Molecular characterization of subtype F infectious molecular clones possibly derived from Brazil Unpublished 0  
4
4RT
4IN
0 Unpublished
Saladini (2010) Near full-length sequence analysis of HIV-1 BF recombinants from Italy Unpublished 0  
14
1PR
14RT
14IN
0 Unpublished
Salazar-Gonzalez (2009) HIV-1 sequences in acute and early infection reveal the genetic identity, biological phenotype, and precise evolutionary pathways of transmitted/founder viruses and their progeny Unpublished 0  
333
166PR
204RT
333IN
0 Pending
Salazar-Gonzalez (2009) Full-length Genomes of Transmitted/Founder Viruses Reveal Biological Properties and Precise Evolutionary Pathways of HIV-1 in Acute and Early Infection Unpublished 0  
13
8PR
8RT
13IN
0 Pending
Salgado (2009) Mutation N155H in HIV-2 integrase confers high phenotypic resistance to raltegravir and impairs replication capacity J Clin Virol. 2009 Oct;46(2):173-5. Epub 2009 Jul 22. 1e-100  
5
5IN
0 Pending
Salminen (1995) RECOVERY of virtually full-length HIV-1 provirus of diverse subtypes from primary virus cultures using the polymerase chain reaction Virology 213 (1), 80-86 (1995) 1e-165 1
1PR
1RT
1IN
3
3PR
3RT
3IN
33 Laboratory/experimental isolate
Salminen (1996) FULL-LENGTH sequence of an ethiopian human immunodeficiency virus type 1 (HIV-1) isolate of genetic subtype C AIDS Res. Hum. Retroviruses 12 (14), 1329-1339 (1996) 1e-160 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Salminen (1997) EVOLUTION and probable transmission of intersubtype recombinant human immunodeficiency virus type 1 in a Zambian couple J. Virol. 71 (4), 2647-2655 (1997) 2e-71  
2
2PR
0 Case report(s) / study subset
Salminen (1998) RAPID and simple characterization of in vivo HIV-1 sequences using solid-phase direct sequencing AIDS Res. Hum. Retroviruses 8 (9), 1733-1742 (1992) 1e-162 2
2PR
2RT
2IN
2
2PR
2RT
2IN
100 HIVDB
Salminen (2000) CONSTRUCTION and biological characterization of infectious molecular clones of HIV-1 subtypes B and E (CRF01_AE) generated by the polymerase chain reaction Virology 278 (1), 103-110 (2000) 1e-164 1
1PR
1RT
1IN
4
4PR
4RT
4IN
25 Laboratory/experimental isolate
Samiei (2009) HIV-1 isolated from Lorestan province protease (pol) gene Unpublished 2e-49  
5
5PR
0 Pending
Sanabani (2004) FULL-LENGTH genome analysis of human immunodeficiency virus type 1 subtype C in Brazil AIDS Res. Hum. Retroviruses 22 (2), 171-176 (2006) 0 6
6PR
6RT
6IN
6
6PR
6RT
6IN
100 HIVDB
Sanabani (2006) ANALYSIS of the near full length genomes of HIV-1 subtypes B, F and BF recombinant from a cohort of 14 patients in Sao Paulo, Brazil Infect. Genet. Evol. 6 (5), 368-377 (2006) 0 14
14PR
14RT
14IN
14
13PR
14RT
14IN
100 HIVDB
Sanabani (2009) Near full-length genome analysis of low prevalent human immunodeficiency virus type 1 subclade F1 in Sao Paulo, Brazil Virol. J. 6, 78 (2009) 0 5
5PR
5RT
5IN
5
5RT
5IN
100 HIVDB
Sanabani (2010) Characterization and frequency of a newly identified HIV-1 BF1 intersubtype circulating recombinant form in Sao Paulo, Brazil Virol. J. 7, 74 (2010) 0 6
6PR
6RT
6IN
6
6RT
6IN
100 HIVDB
Sanchez (2004) MOLECULAR and epidemiological characterization of HIV-1 infected individuals from Medellin, Colombia Unpublished 0 37
37PR
37RT
8IN
45
45PR
45RT
8IN
82 HIVDB
Sanchez-Merino (2007) GENETIC Changes Associated with Distinct Patterns of HIV Type 1 Persistence in Chronically Infected Cell Lines AIDS Res. Hum. Retroviruses 23 (2), 251-260 (2007) 0  
3
3PR
3RT
3IN
0 Laboratory/experimental isolate
Sanders-Buell (2007) A Nascent HIV Type 1 Epidemic among Injecting Drug Users in Kabul, Afghanistan Is Dominated by Complex AD Recombinant Strain, CRF35_AD AIDS Res. Hum. Retroviruses 23 (6), 834-839 (2007) 0 4
4PR
4RT
4IN
4
1PR
4RT
4IN
100 HIVDB
Sanders-Buell (2010) Distinct circulating recombinant HIV-1 strains among injecting drug users and sex workers in Afghanistan AIDS Res. Hum. Retroviruses 26 (5), 605-608 (2010) 0 11
11PR
11RT
11IN
11
11RT
11IN
100 HIVDB
Santhosh (2005) FULL-LENGTH Genome Characterization of an HIV Type 2 Isolate from India AIDS Res. Hum. Retroviruses 24 (10), 1315-1317 (2008) 0 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Santiago (2002) SIVCPZ in wild chimpanzees Science 295 (5554), 465 (2002) 1e-136 1
1RT
1IN
1
1RT
1IN
100 HIVDB
Santiago (2003) AMPLIFICATION of a complete Simian immunodeficiency virus genome from fecal RNA of a wild chimpanzee J. Virol. 77 (3), 2233-2242 (2003) 8e-05 1
1PR
1RT
1IN
1
1PR
1RT
100 HIVDB
Santiago (2003) FOCI of Endemic Simian Immunodeficiency Virus Infection in Wild-Living Eastern Chimpanzees (Pan troglodytes schweinfurthii) J. Virol. 77 (13), 7545-7562 (2003) 2e-51  
3
3IN
0 Pending
Santiago (2003) NONINVASIVE Detection of Simian Immunodeficiency Virus Infection in a Wild-Living L'Hoest's Monkey (Cercopithecus lhoesti) AIDS Res. Hum. Retroviruses 19 (12), 1163-1166 (2003) 5e-61  
1
1IN
0 Pending
Santos (2005) CHARACTERIZATION of a new circulating recombinant form comprising HIV-1 subtypes C and B in southern Brazil AIDS 20 (16), 2011-2019 (2006) 0 102
95PR
68RT
1IN
102
81PR
62RT
1IN
100 HIVDB
Saracino (2005) IMPACT of unreported HIV-1 reverse transcriptase mutations on phenotypic resistance to nucleoside and non-nucleoside inhibitors J. Med. Virol. 78 (1), 9-17 (2006) 0  
37
36PR
37RT
0 Pending
Saracino (2007) GENOTYPIC resistance to tipranavir/ritonavir (TPV/r) in PI-experienced HIV patients enrolled in the Italian Expanded Access Program for Tipranavir Unpublished 0  
106
21PR
101RT
0 Unpublished
Saracino (2008) ANTIRETROVIRAL genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART J. Med. Virol. 80 (10), 1695-1706 (2008) 0  
121
72PR
77RT
0 Pending
Sarkar (2011) HIV-1 recombinants among Manipur IDUs, India Unpublished 1e-178  
1
1RT
1IN
0 Unpublished
Sarker (2010) Detection of a rare HIV-1 strain CRF16_A2D in Bangladesh Unpublished 1e-145  
2
2IN
0 Pending
Sato (2000) CONVERGENT evolution of reverse transcriptase (RT) genes of human immunodeficiency virus type 1 subtypes E and B following nucleoside analogue RT inhibitor therapies J. Virol. 74 (11), 5357-5362 (2000) 3e-59  
7
7RT
0 Case report(s) / study subset
Sato (2001) AUGMENTATION of human immunodeficiency virus type 1 subtype E (CRF01_AE) multiple-drug resistance by insertion of a foreign 11-amino-acid fragment into the reverse transcriptase J. Virol. 75 (12), 5604-5613 (2001) 1e-165  
93
11PR
93RT
1IN
0 Evolution/quasispecies study
Sato (2007) CONSTRUCTION and characterization of multidrug-resistant HIV-1 subtype B infectious molecular clones derived from Japanese patients for reference Unpublished 0  
4
2PR
4RT
4IN
0 Laboratory/experimental isolate
Sauermann (1990) MOLECULAR cloning and characterization of a German HIV-1 isolate AIDS Res. Hum. Retroviruses 6 (6), 813-823 (1990) 1e-161 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Saurya (2002) MOLECULAR characterization of HIV-1 from HAART treated AIDS patients with discordance between viral load and Cd4+ T cells Thesis (2002) Department of Haemtological Medicine, Universi 1e-124  
31
16PR
15RT
15IN
0 ARV Rx and/or other data are N/A
Schaefer (2005) GENETIC analysis of HIV-seropositive, Western Blot indeterminate individuals in Kinshasa, Zaire in the mid 1980s: no evidence for unusual HIV variants Unpublished 2e-50  
1
1PR
0 Case report(s) / study subset
Schaefer (2005) HIV-1 complex recombinant CRF06-cpx was the predominant strain in Burkina Faso by the mid 1980s Unpublished 8e-52 57
57PR
59
58PR
1IN
96 HIVDB
Schapiro (1997) THE effect of high-dose saquinavir on viral load and CD4+ T-cell counts in HIV-infected patients Unpublished 1e-128 67
67PR
68
68PR
98 HIVDB
Schmit (1997) MULTIPLE dideoxynucleoside analogue resistant (MddNR) HIV-1 strains isolated from patients from different european countries Unpublished 1e-121 23
23RT
38
5PR
33RT
60 Case report(s) / study subset
Schmit (1997) RESISTANCE-RELATED mutations in the HIV-1 protease gene of patients treated for 1 year with the protease inhibitor ritonavir (ABT-538) AIDS 10 (9), 995-999 (1996) 1e-130 14
14PR
15
15PR
93 HIVDB
Schmit (1998) EVOLUTION of HIV drug resistance in zidovudine (ZDV)/zalcitabine (ddC) and ZDV/diddanosine (ddI) - experienced patients receiving lamivudine (3TC) - containing combination therapy Unpublished 1e-98 41
41RT
41
41RT
100 HIVDB
Schmitz (2004) LV2, a Novel Postentry Restriction, Is Mediated by both Capsid and Envelope J. Virol. 78 (4), 2006-2016 (2004) 0  
2
2PR
2RT
2IN
0 Laboratory/experimental isolate
Schroeder (2005) CHARACTERIZATION of Intersubtype Recombinant HIV Type 1 Genomes Using a Nonradioactive Heteroduplex Tracking Assay AIDS Res. Hum. Retroviruses 21 (4), 314-318 (2005) 1e-121  
3
1PR
2RT
0 Case report(s) / study subset
Schuurman (2001) DIRECT Submission Submitted (31-OCT-2001) Virology, UMCU, Heidelberglaan 100, 1e-135  
2
2PR
2RT
0 Laboratory/experimental isolate
Scriba (2001) CHARACTERIZATION and phylogenetic analysis of South African HIV-1 subtype C accessory genes AIDS Res. Hum. Retroviruses 17 (8), 775-781 (2001) 4e-19  
22
22IN
0 Gene fragment(s)
Seclen (2010) High prevalence of natural polymorphisms in gag (CA-SP1) associated with reduced response to Bevirimat, an HIV-1 maturation inhibitor AIDS 24, 467 (2010) 0  
388
173PR
388RT
0 ARV Rx and/or other data are N/A.
Seki (1995) ISOLATION and characterization of human immunodeficiency virus type-1 mutants resistant to the non-nucleotide reverse transcriptase inhibitor MKC-442 Antivir. Chem. Chemother. 6, 73-79 (1995) 3e-69  
5
5RT
0 HIVDB
Sen (2007) HUMAN immunodeficiency virus type 1 drug resistance mutations in peripheral blood mononuclear cell proviral DNA among antiretroviral treatment-naive and treatment-experienced patients from Pune, India AIDS Res. Hum. Retroviruses 23 (4), 489-497 (2007) 0 23
23PR
23RT
75
33PR
75RT
30 HIVDB
Sen (2007) HIGH Prevalence of Human Immunodeficiency Virus Type 1 Drug Resistance Mutations in Antiretroviral Treatment-Experienced Patients from Pune, India AIDS Res. Hum. Retroviruses 23 (10), 1303-1308 (2007) 0 63
63PR
63RT
63
2PR
63RT
1IN
100 HIVDB
Sengupta (2010) Characterization of the transframe region and full protease gene of HIV-1 from India Unpublished 3e-51  
5
5PR
0 Unpublished
Seoighe (2007) A Model of Directional Selection Applied to the Evolution of Drug Resistance in HIV-1 Mol. Biol. Evol. (2007) In press 1e-169 600
600RT
600
600RT
100 HIVDB
Servais (2000) DIRECT Submission Thesis (2001) Department of Departement de Microbiologie, Im 1e-133 86
43PR
43RT
148
74PR
74RT
58 HIVDB
Servais (2001) COMPARISON of DNA sequencing and a line probe assay for detection of human immunodeficiency virus type 1 drug resistance mutations in patients failing highly active antiretroviral therapy J. Clin. Microbiol. 39 (2), 454-459 (2001) 1e-133 247
152PR
95RT
380
268PR
112RT
65 HIVDB
Sevin (2000) METHODS for investigation of the relationship between drug-susceptibility phenotype and human immunodeficiency virus type 1 genotype with applications to AIDS clinical trials group 333 J. Infect. Dis. 182 (1), 59-67 (2000) 1e-128 71
71PR
72
72PR
98 HIVDB
Shafer (2001) ONLINE comparison of HIV-1 drug resistance algorithms identifies rates and causes of discordant interpretations Antiviral Therapy 6 (Suppl. 1), 101 (2001) 1e-133 2174
2159PR
2160RT
2206
2192PR
2192RT
98 HIVDB
Shafer (1995) DRUG resistance and heterogeneous long-term virologic responses of human immunodeficiency virus type 1-infected subjects to zidovudine and didanosine combination therapy. The AIDS Clinical Trials Group 143 Virology Team J. Infect. Dis. 172 (1), 70-78 (1995) 1e-98 53
53RT
53
53RT
100 HIVDB
Shafer (1997) SEQUENCE and drug susceptibility of subtype C reverse transcriptase from human immunodeficiency virus type 1 seroconverters in Zimbabwe J. Virol. 71 (7), 5441-5448 (1997) 4e-65 12
12RT
12
12RT
100 HIVDB
Shafer (1998) MULTIPLE concurrent reverse transcriptase and protease mutations and multidrug resistance of HIV-1 isolates from heavily treated patients Ann. Intern. Med. 128 (11), 906-911 (1998) 1e-126 41
21PR
20RT
42
22PR
20RT
97 HIVDB
Shafer (1998) HIV-1 protease from patients in the United States who have not received protease inhibitors Unpublished 1e-135 51
51PR
51
51PR
100 HIVDB
Shafer (1999) SEQUENCE and drug susceptibility of subtype C protease from human immunodeficiency virus type 1 seroconverters in Zimbabwe AIDS Res. Hum. Retroviruses 15 (1), 65-69 (1999) 8e-92 12
12PR
12
12PR
100 HIVDB
Shafer (2000) REPRODUCIBILITY of human immunodeficiency virus type 1 (HIV-1) protease and reverse transcriptase sequencing of plasma samples from heavily treated HIV-1-infected individuals J. Virol. Methods 86 (2), 143-153 (2000) 1e-116 37
37PR
51
44PR
7RT
72 HIVDB
Shahid (2011) HIV-1 Circulating Recombinant Form (CRF) in Nepal J. Virol. (2011) In press 1e-166 6
6PR
6RT
6
6RT
100 HIVDB
Shahriar (2009) Nonpolymorphic HIV-1 Protease and RT Treatment-Selected Mutations Unpublished 0 5563
2593PR
2970RT
5563
2593PR
2970RT
100 HIVDB
Shahriar (2009) Nonpolymorphic HIV-1 Protease and RT Treatment-Selected Mutations Unpublished 1e-48 14
14PR
14
14PR
100 HIVDB
Shahriar (2009) Nonpolymorphic HIV-1 Protease and RT Treatment-Selected Mutations Unpublished 9e-49 9
9PR
9
9PR
100 HIVDB
Shang (2004) GENOTYPIC Resistance Mutation to Antiretroviral Drugs in Treatment-Naive HIV/AIDS Patients in the Northeast of China Unpublished 1e-114 54
54PR
54RT
54
54PR
54RT
100 HIVDB
Shanmugasundaram (2008) DISTINCT patterns of evolution in reverse transcriptase gene of HIV-1 subtype C in anti-retroviral naive and treated patients AIDS Res Hum Retroviruses. 2010 Sep 19. [Epub ahead of print 1e-180  
1
1RT
0 Pending
Shanmugasundaram (2008) Limited evolution of HIV-1 reverse transcriptase and protease in heterosexual transmission pairs Unpublished 4e-49  
7
7PR
0 Unpublished
Shanmugasundaram (2009) Pattern of nucleotide substitutions in reverse transcriptase region of HIV-1 subtype C among individuals untreated and treated with antiretroviral drugs Unpublished 4e-49  
3
3PR
0 Pending
Sheehy (1996) CONCURRENT evolution of regions of the envelope and polymerase genes of human immunodeficiency virus type 1 during zidovudine (AZT) therapy J. Gen. Virol. 77 (Pt 5), 1071-1081 (1996) 3e-50  
46
46RT
0 Evolution/quasispecies study
Sherefa (1998) FULL-LENGTH sequence of human immunodeficiency virus type 1 subtype A, recombined with subtype C in the env V3 domain AIDS Res. Hum. Retroviruses 14 (3), 289-292 (1998) 1e-162 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Shi (2010) Evolution and recombination of genes encoding HIV-1 drug resistance and tropism during antiretroviral therapy Virology 404 (1), 5-20 (2010) 0  
137
68PR
137RT
15IN
0 Pending
Shi (2004) CONSTRUCTION of an infectious HIV type 1 molecular clone from an African patient with a subtype D/C Recombinant Virus AIDS Res. Hum. Retroviruses 20 (9), 1015-1018 (2004) 0 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Shibata (1995) ISOLATION and characterization of a syncytium-inducing, macrophage/T-cell line-tropic human immunodeficiency virus type 1 isolate that readily infects chimpanzee cells in vitro and in vivo J. Virol. 69 (7), 4453-4462 (1995) 1e-160  
1
1PR
1RT
1IN
0 Laboratory/experimental isolate
Shibata (2006) CONSTRUCTION and characterization of an infectious DNA clone and of mutants of simian immunodeficiency virus isolated from the African green monkey J. Virol. 64 (1), 307-312 (1990) 0  
1
1RT
1IN
0 Laboratory/experimental isolate
Shiino (2002) EVOLUTIONARY analysis of ultra-frequent defective G to A mutations observed in the provirus of HIV-1 infected patients under long-term anti-retroviral drug therapy Unpublished 4e-29  
30
30PR
0 Gene fragment(s)
Shriner (2004) PERVASIVE Genomic Recombination of HIV-1 in Vivo Genetics 167 (4), 1573-1583 (2004) 0.02  
19
19IN
0 Gene fragment(s)
Si-Mohamed (2000) SELECTION of drug-resistant variants in the female genital tract of human immunodeficiency virus type 1-infected women receiving antiretroviral therapy J. Infect. Dis. 182 (1), 112-122 (2000) 1e-128 85
42PR
43RT
85
42PR
43RT
100 HIVDB
Sichtig (2008) LONGITUDINAL analysis of HIV-1 integrase mutation profiles in response to Raltegravir Unpublished 1e-165 223
223IN
224
224IN
99 HIVDB
Sierra (2004) THE analysis of near full-length genome sequences of human immunodeficiency virus type 1 BF intersubtype recombinant viruses from Chile, Venezuela and Spain reveals their relationship to diverse lineages of recombinant viruses related to CRF12_BF Infect. Genet. Evol. (2004) In press 0 6
6PR
6RT
6IN
6
6PR
6RT
6IN
100 HIVDB
Sierra (2006) IDENTIFICATION of 3 phylogenetically related HIV-1 BG intersubtype circulating recombinant forms in Cuba J. Acquir. Immune Defic. Syndr. 45 (2), 151-160 (2007) 0 14
14PR
14RT
14IN
20
5PR
20RT
20IN
70 HIVDB
Sierra (2007) ANALYSIS of near full-length genome sequences of HIV-1 isolates of Romanian origin Unpublished 0  
3
3RT
3IN
0 Case report(s) / study subset
Sierra (2006) IDENTIFICATION of HIV-1 determinants of cytopathogenicity and coreceptor usage Unpublished 0.023  
39
39IN
0 Gene fragment(s)
Sierra (2009) Selection of Thymidine Analog Resistance Mutational Patterns in Children Infected from a Common HIV-1 Subtype G Source Unpublished 0  
37
37RT
0 Evolution/quasispecies study
Simon (2002) IDENTIFICATION of a new human immunodeficiency virus type 1 distinct from group M and group O Nat. Med. 4 (9), 1032-1037 (1998) 2e-32 1
1PR
1RT
1IN
1
1PR
1RT
100 HIVDB
Simon (2008) COMPLEMENTATION of vif-defective human immunodeficiency virus type 1 by primate, but not nonprimate, lentivirus vif genes J. Virol. 69 (7), 4166-4172 (1995) 0  
1
1PR
1RT
1IN
0 Case report(s) / study subset
Simon (2002) EVOLVING patterns of HIV-1 resistance to antiretroviral agents in newly infected individuals AIDS 16 (11), 1511-1519 (2002) 1e-135 184
152PR
152RT
184
152PR
152RT
100 HIVDB
Simon (2003) INFECTIVITY and Replication Capacity of Drug-Resistant Human Immunodeficiency Virus Type 1 Variants Isolated during Primary Infection J. Virol. 77 (14), 7736-7745 (2003) 1e-144  
36
36PR
18RT
0 Case report(s) / study subset
Simon (2005) NATURAL Variation in Vif: Differential Impact on APOBEC3G/3F and a Potential Role in HIV-1 Diversification PLoS Pathog. 1 (1), e6 (2005) 0  
26
8PR
13RT
13IN
0 Case report(s) / study subset
Sirivichayakul (2001) SURVEY of reverse transcriptase from the heterosexual epidemic of human immunodeficiency virus type 1 CRF01_AE in Thailand from 1990 to 2000 AIDS Res. Hum. Retroviruses 17 (11), 1077-1081 (2001) 1e-81 43
3PR
43RT
43
3PR
43RT
100 HIVDB
Sirivichayakul (2005) RT and protease sequences from HIV-1 non-B infected persons from Thailand Unpublished 1e-138 106
12PR
94RT
106
12PR
94RT
100 HIVDB
Skaria (2011) Genetic compartmentalization of antiretroviral resistance mutations, HLA-associated polymorphisms and envelope V3 genotype in plasma viruses during advanced HIV infection Unpublished 0  
70
69PR
70RT
0 Pending
Skinner (1998) ANALYSIS of a large collection of natural HIV-1 integrase sequences, including those from long-term nonprogressors J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 19 (2), 99- 1e-165 102
102IN
102
102IN
100 HIVDB
Smith (2005) HIV Drug Resistance Acquired Through Superinfection (DRATS) Unpublished 0  
5
5PR
5RT
0 Case report(s) / study subset
Smith (2000) DIRECT Submission Submitted (30-DEC-1996) Medical Microbiology and Immunology, 2e-08 1
1RT
1
1RT
1IN
100 HIVDB
Smolen (2010) HIV type 1 genetic diversity in Silesia, Poland: a retrospective analysis AIDS Res. Hum. Retroviruses 26 (7), 767-776 (2010) 1e-146  
4
4RT
0 Pending
Snoeck (2002) PREVALENCE and origin of HIV-1 group M subtypes among patients attending a Belgian hospital in 1999 Virus Res. 85 (1), 95-107 (2002) 1e-120 18
15PR
16RT
45
39PR
42RT
40 HIVDB
Soares (2004) EPIDEMIOLOGIC and molecular characterization of human immunodeficiency virus type 1 in Southern Brazil Unpublished 1e-138 86
69PR
71RT
91
70PR
77RT
4IN
94 HIVDB
Soares (2007) Differential kinetics of drug resistance mutation acquisition in HIV-1 of subtypes B and C Unpublished 1e-142 5
5PR
16
13PR
3RT
31 HIVDB
Soares (2010) Molecular diversity and polymerase gene genotypes of HIV-1 among treatment-naive Cameroonian subjects with advanced disease J. Clin. Virol. 48 (3), 173-179 (2010) 1e-149 29
26PR
27RT
29
10PR
24RT
100 HIVDB
Soares (1997) A full-length and replication-competent proviral clone of SIVAGM from tantalus monkeys Virology 228 (2), 394-399 (1997) 0.1 1
1PR
1RT
1IN
1
1PR
1RT
100 HIVDB
Soares (2003) A specific subtype C of human immunodeficiency virus type 1 circulates in Brazil AIDS 17 (1), 11-21 (2003) 1e-133 190
97PR
93RT
190
97PR
93RT
100 HIVDB
Sodroski (1993) A second post-transcriptional trans-activator gene required for HTLV-III replication Nature 321 (6068), 412-417 (1986) 2e-10  
1
1IN
0 Laboratory/experimental isolate
Sofie (2006) LONG-TERM Foscarnet Therapy Remodels Thymidine Analog Mutations and Alters Resistance to Zidovudine and Lamivudine in Human Immunodeficiency Virus-1 Unpublished 0  
27
13PR
27RT
0 ARV Rx and/or other data are N/A
Soheilli (2009) Presence of HIV-1 CRF35_AD in Iran AIDS Res. Hum. Retroviruses 25 (1), 123-124 (2009) 1e-143 3
1PR
2RT
3
1PR
2RT
100 HIVDB
Solomon (2006) HIGH prevalence of treatment failure among treatment-experienced HIV-infected individuals in Chennai, India Unpublished 1e-177  
12
12RT
0 Pending
Songok (2003) ACTIVE generation and selection for A/D recombinant forms of HIV-1 in Kenya Unpublished 1e-122  
24
24RT
0 Pending
Soto-Ramirez (1997) HIV-1 pol sequences from India fit distinct subtype pattern J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 13 (4), 299 5e-58 5
5RT
5
5RT
100 HIVDB
Soulie (2009) Presence of HIV-1 R5 viruses in CSF even in patients harboring R5X4/X4 viruses in plasma Unpublished 1e-147  
20
19PR
1RT
0 Case report(s) / study subset
Soundararajan (2007) CHARACTERIZATION of HIV-1 Isolates from Antiretroviral Drug-Naive Children in Southern India AIDS Res. Hum. Retroviruses 23 (9), 1119-1126 (2007) 1e-144 33
1PR
32RT
33
1PR
32RT
100 HIVDB
Souquiere (2001) WILD Mandrillus sphinx are carriers of two types of lentivirus J. Virol. 75 (15), 7086-7096 (2001) 1e-123 19
1PR
1RT
19IN
19
1PR
2RT
19IN
100 HIVDB
Souquiere (2006) THE two distinct SIVs infecting Mandrillus sphinx were subjected to differential selection in env region Unpublished 3e-88 14
14IN
14
14IN
100 HIVDB
Souza (2008) MOLECULAR Characterization of HIV Type 1 BF Pol Recombinants from Sao Paulo, Brazil AIDS Res. Hum. Retroviruses 24 (12), 1521-1525 (2008) 0  
36
6PR
36RT
0 ARV Rx and/or other data are N/A
Sova (1995) CONSERVATION of an intact human immunodeficiency virus type 1 vif gene in vitro and in vivo J. Virol. 69 (4), 2557-2564 (1995) 0.02  
42
42IN
0 Gene fragment(s)
Spire (1989) NUCLEOTIDE sequence of HIV1-NDK: a highly cytopathic strain of the human immunodeficiency virus Gene 81 (2), 275-284 (1989) 1e-164 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Spivak (2009) A Case of Seronegative HIV-1 Infection J Infect Dis. 2010 Feb 1;201(3):341-5. 1e-171  
1
1PR
1RT
0 Case report(s) / study subset
Srinivasan (1993) MOLECULAR characterization of human immunodeficiency virus from Zaire: nucleotide sequence analysis identifies conserved and variable domains in the envelope gene Gene 52 (1), 71-82 (1987) 3e-79  
1
1IN
0 Gene fragment(s)
Ssemwanga (2010) Multiple HIV-1 Infections in Sexual Partnerships in a Rural Clinical Cohort in Uganda Unpublished 5e-57  
107
107IN
0 Evolution/quasispecies study
Ssemwanga (2011) HIV-1 subtype distribution, multiple infections, sexual networks and life histories in a cohort of women engaged in risky sexual behavior in Kampala, Uganda Unpublished 4e-41  
792
792IN
0 Unpublished
Ssemwanga (2011) Transmitted antiretroviral drug resistance among drug-naive commercial sex workers with recent infection in Kampala, Uganda Unpublished 2e-51  
19
19PR
0 Unpublished
Stanojevic (2002) HIV-1 subtypes in Yugoslavia AIDS Res. Hum. Retroviruses 18 (7), 519-522 (2002) 2e-97 33
33RT
33
33RT
100 HIVDB
Stanojevic (2003) GENOTYPIC resistance of HIV-1 among patients in Serbia and Montenegro Unpublished 1e-49  
10
10PR
0 Gene fragment(s)
Starcich (1986) IDENTIFICATION and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS Cell 45 (5), 637-648 (1986) 1e-120 1
1PR
1RT
1IN
1
1PR
1RT
100 HIVDB
Stoeckli (2002) PHENOTYPIC and genotypic analysis of biologically cloned human immunodeficiency virus type 1 isolates from patients treated with Zidovudine and Lamivudine Antimicrob. Agents Chemother. 46 (12), 4000-4003 (2002) 4e-96  
41
41RT
0 Pending
Stone (2004) HIV-1 reverse transcriptase (RT) mutation selection during in vitro exposure to Tenofovir +/- Abacavir and Tenofovir +/- Lamivudine Unpublished 0  
21
21RT
0 Pending
Strain (2005) GENETIC Composition of Human Immunodeficiency Virus Type 1 in Cerebrospinal Fluid and Blood without Treatment and during Failing Antiretroviral Therapy J. Virol. 79 (3), 1772-1788 (2005) 0  
36
36PR
36RT
0 Evolution/quasispecies study
Streeck (2008) IMMUNE-DRIVEN recombination and loss of control after HIV superinfection J. Exp. Med. 205 (8), 1789-1796 (2008) 0  
9
3PR
9RT
9IN
0 Case report(s) / study subset
Struck (2007) A new HIV-1 B/F1 unique recombinant form (URF) outbreak in Luxembourg: near full-length genome characterization and phylogenetic analysis Unpublished 0 20
20PR
20RT
20IN
21
21RT
21IN
95 Case report(s) / study subset
Strunnikova (1998) EVOLUTION of human immunodeficiency virus type 1 in relation to disease progression in children J. Hum. Virol. 1 (3), 224-239 (1998) 1e-135  
61
61RT
0 Evolution/quasispecies study
Sturmer (2005) PHYLOGENETIC analysis of HIV-1 transmission: pol gene sequences are insufficient to clarify true relationships between patient isolates AIDS 18 (16), 2109-2113 (2004) 1e-172  
23
23PR
23RT
0 Pending
Stuyver (2001) LINE probe assay for rapid detection of drug-selected mutations in the human immunodeficiency virus type 1 reverse transcriptase gene Antimicrob. Agents Chemother. 41 (2), 284-291 (1997) 0  
25
25RT
0 ARV Rx and/or other data are N/A
Su (2003) HIV-1 subtype B' dictates the AIDS epidemic among paid blood donors in the Henan and Hubei provinces of China AIDS 17 (17), 2515-2520 (2003) 0 3
3PR
3RT
3IN
3
3PR
3RT
3IN
100 HIVDB
Su (2011) HIV-1 Subtypes Based on the pol Gene and Primary Drug Resistance in Isolates from Guangxi, Southern China Unpublished 1e-166  
124
90PR
124RT
0 Unpublished
Subbarao (2002) FULL-LENGTH HIV-1 CRF01_AE sequence Unpublished 1e-164  
1
1PR
1RT
1IN
0 HIVDB
Sugimoto (2010) Protection of macaques with diverse MHC genotypes against a heterologous SIV by vaccination with a deglycosylated live-attenuated SIV PLoS ONE 5 (7), E11678 (2010) 2e-92  
15
15IN
0 Laboratory/experimental isolate
Sukasem (2005) SURVEILLANCE of genotypic resistance mutations in chronic HIV-1 treated individuals after completion of the National Access to Antiretroviral Program in Thailand Infection 35 (2), 81-88 (2007) 1e-122  
350
168PR
182RT
0 Pending
Sundaravaradan (2005) GENETIC Characterization of HIV Type 1 Reverse Transcriptase Gene From Mothers and Infants Following Perinatal Transmission Unpublished 0  
131
131RT
0 Evolution/quasispecies study
Sung (2000) NATURAL polymorphisms of protease in protease inhibitor-naive HIV-1 infected patients in Korea: a novel L63M in subtype B AIDS Res. Hum. Retroviruses 19 (6), 525-530 (2003) 1e-161 69
68PR
15RT
1IN
160
93PR
102RT
1IN
43 HIVDB
Sung (2001) PHYLOGENETIC analysis of reverse transcriptase in antiretroviral drug-naive Korean HIV type 1 patients AIDS Res. Hum. Retroviruses 17 (16), 1549-1554 (2001) 4e-96 23
23RT
24
24RT
95 HIVDB
Sung (2006) HIGH frequency of drug resistance mutations in human immunodeficiency virus type 1-infected korean patients treated with HAART AIDS Res. Hum. Retroviruses 23 (10), 1223-1229 (2007) 1e-136  
26
23PR
14RT
0 Pending
Sutthent (2001) EFFECT of perinatal short-course zidovudine on the clinical and virological manifestations of HIV-1 subtype E infection in infants J. Clin. Virol. 25 (1), 47-56 (2002) 6e-64 30
30RT
30
30RT
100 HIVDB
Sutthent (2004) SURVEILLANCE of HIV-1 drug resistance in Thailand Unpublished 1e-150  
104
36PR
68RT
0 Pending
Sutthent (2004) MOLECULAR Epidemiology of HIV-1 in Thailand Unpublished 6e-44  
67
67RT
0 Gene fragment(s)
Sutthent (2005) STUDY of HIV-1 drug resistant mutation in GPO-VIR treated HIV-1 infected Thais Unpublished 0  
46
37PR
9RT
0 Pending
Suzuki (2001) NOVEL deletion of HIV type 1 reverse transcriptase residue 69 conferring selective high-level resistance to nevirapine AIDS Res. Hum. Retroviruses 17 (13), 1293-1296 (2001) 2e-91  
6
6RT
0 Pending
Suzuki (2002) AMINO acid insertions in p6gag of the human immunodeficiency virus type 1 alter incorporation of vpr into virions Unpublished 1e-126  
5
5PR
5RT
0 Case report(s) / study subset
Svicher (2005) NOVEL human immunodeficiency virus type 1 protease mutations potentially involved in resistance to protease inhibitors Antimicrob. Agents Chemother. 49 (5), 2015-2025 (2005) 0  
148
116PR
148RT
0 ARV Rx and/or other data are N/A
Svicher (2006) INVOLVEMENT of novel human immunodeficiency virus type 1 reverse transcriptase mutations in the regulation of resistance to nucleoside inhibitors J. Virol. 80 (14), 7186-7198 (2006) 0  
424
346PR
423RT
0 Pending
Swanson (2003) MOLECULAR Characterization of 39 HIV-1 Isolates Representing Group M (Subtypes A-G) and Group O: Sequence Analysis of gag p24, pol integrase, and env gp41 AIDS Res. Hum. Retroviruses 19 (7), 625-629 (2003) 1e-165 39
39IN
39
39IN
100 HIVDB
Swanson (2003) FULL-LENGTH Sequence Analysis of HIV-1 Isolate CM237: A CRF01_AE/B Intersubtype Recombinant from Thailand AIDS Res. Hum. Retroviruses 19 (8), 707-712 (2003) 0 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Tachedjian (1995) CHARACTERISATION of foscarnet-resistant strains of human immunodeficiency virus type 1 Virology 212 (1), 58-68 (1995) 9e-97  
9
9RT
0 Laboratory/experimental isolate
Tachedjian (1996) ZIDOVUDINE resistance is suppressed by mutations conferring resistance of human immunodeficiency virus type 1 to foscarnet J. Virol. 70 (10), 7171-7181 (1996) 5e-89  
2
2RT
1IN
0 Pending
Tachedjian (1998) CORESISTANCE to zidovudine and foscarnet is associated with multiple mutations in the human immunodeficiency virus type 1 reverse transcriptase Antimicrob. Agents Chemother. 42 (11), 3038-3043 (1998) 2e-79  
2
2RT
0 ARV Rx and/or other data are N/A
Takahoko (2001) INFECTIOUS DNA clone of HIV type 1 A/G recombinant (CRF02_AG) replicable in peripheral blood mononuclear cells AIDS Res. Hum. Retroviruses 17 (11), 1083-1087 (2001) 1e-161 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Takebe (2003) HIGH prevalence of diverse forms of HIV-1 intersubtype recombinants in Central Myanmar: geographical hot spot of extensive recombination Unpublished 0 9
9PR
9RT
9IN
9
9PR
9RT
9IN
100 HIVDB
Takehisa (1998) VARIOUS types of HIV mixed infections in Cameroon Virology 245 (1), 1-10 (1998) 8e-49  
48
48IN
0 Gene fragment(s)
Takehisa (1999) HUMAN immunodeficiency virus type 1 intergroup (M/O) recombination in cameroon J. Virol. 73 (8), 6810-6820 (1999) 4e-95  
9
9IN
0 Gene fragment(s)
Takehisa (2001) PHYLOGENETIC analysis of HIV type 2 in Ghana and intrasubtype recombination in HIV type 2 AIDS Res. Hum. Retroviruses 13 (7), 621-623 (1997) 2e-48  
11
11IN
0 Gene fragment(s)
Takehisa (2001) NATURAL infection of wild-born mandrills (Mandrillus sphinx) with two different types of simian immunodeficiency virus AIDS Res. Hum. Retroviruses 17 (12), 1143-1154 (2001) 2e-98 6
1PR
1RT
6IN
6
1PR
1RT
5IN
100 HIVDB
Takehisa (2001) TRIPLE HIV-1 infection with group O and Group M of different clades in a single Cameroonian AIDS patient J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 14 (1), 81- 6e-44  
3
3IN
0 Case report(s) / study subset
Takehisa (2007) GENERATION of infectious molecular clones of simian immunodeficiency virus from fecal consensus sequences of wild chimpanzees J. Virol. 81 (14), 7463-7475 (2007) 0 5
5PR
5RT
5IN
5
5RT
5IN
100 HIVDB
Takehisa (2009) Origin and biology of simian immunodeficiency virus in wild-living western gorillas J. Virol. 83 (4), 1635-1648 (2009) 0  
7
5RT
7IN
0 Pending
Takekawa (2006) CONSTRUCTION and characterization of HIV-1 subtype G infectious molecular clones derived from a Ghananian patient Unpublished 0 2
2PR
2RT
2IN
2
2PR
2RT
2IN
100 Laboratory/experimental isolate
Takekawa (2009) A new generation of recombinants between CRF02_AG and subtype A detected in Ghana : analysis by infectious molecular clones Unpublished 0  
5
5RT
5IN
0 Unpublished
Takekawa (2009) Molecular characterization of infectious molecular clones derived from multidrug-resistant HIV-1 subtype B in Japan Unpublished 0  
5
5RT
5IN
0 Unpublished
Takekawa (2009) Molecular characterization of infectious molecular clones derived from naive subtype B HIV-1 in Japan Unpublished 0  
2
2PR
2RT
2IN
0 Unpublished
Takekawa (2009) A comprehensive panel of infectious molecular clones derived from HIV isolates of BBI subtype infectivity panel Unpublished 0  
40
10PR
40RT
40IN
0 Unpublished
Takemura (2005) A novel simian immunodeficiency virus from black mangabey (Lophocebus aterrimus) in the Democratic Republic of Congo J. Gen. Virol. 86 (PT 7), 1967-1971 (2005) 1e-152 1
1RT
1
1RT
1IN
100 HIVDB
Takeuchi (2002) ISOLATION and characterization of an infectious HIV type 1 molecular clone from a patient with primary infection AIDS Res. Hum. Retroviruses 18 (15), 1127-1133 (2002) 1e-163 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Tamalet (2000) MULTIDRUG resistance genotypes (insertions in the beta3-beta4 finger subdomain) of HIV-1 RT in clinical isolates Unpublished 1e-123 7
7RT
154
79PR
75RT
4 HIVDB
Tan (2007) CONSTRUCTION and characterization of an infectious molecular clone of HIV-1 subtype B' isolated from Hubei Province, China Unpublished 0  
1
1PR
1RT
1IN
0 Case report(s) / study subset
Tang (2007) DRUG-RESISTANT associated mutations in RT of AIDS patients with ART in Hubei, China Unpublished 1e-169  
173
160PR
169RT
0 Pending
Tang (2009) Viral attenuation due to HLA-B57 escape mutations enables control of HIV following vertical transmission despite depletion of CD8 T cell targets Unpublished 3e-50  
1
1PR
0 Case report(s) / study subset
Tanuma (2011) Impact of CRF01_AE-specific polymorphic mutations G335D and A371V in the connection subdomain of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) on susceptibility to nucleoside RT inhibitors Microbes Infect. 12 (14-15), 1170-1177 (2010) 1e-162  
38
38RT
0 Pending
Tanuri (1999) GENETIC variation and susceptibilities to protease inhibitors among subtype B and F isolates in Brazil Antimicrob. Agents Chemother. 43 (2), 253-258 (1999) 1e-126 8
8PR
8
8PR
100 HIVDB
Tanuri (1999) PRIMARY infections with HIV-1 of women and their offspring in Rio de Janeiro, Brazil: Finding of recombinant of HIV-1 subtypes B and F Unpublished 1e-109  
1
1PR
0 Case report(s) / study subset
Tatsumi (2003) INFECTIOUS DNA clones of HIV-1 subtype A Unpublished 0 4
4PR
4RT
4IN
4
4PR
4RT
4IN
100 HIVDB
Tatsumi (2006) INFECTIOUS DNA clones of subtype B HIV-1 Unpublished 0  
1
1PR
1RT
1IN
0 Laboratory/experimental isolate
Tatsumi (2006) INFECTIOUS DNA clones of subtype G and CRF02_AG HIV-1 derived from Ghananian isolates Unpublished 0 6
6PR
6RT
6IN
6
2PR
6RT
6IN
100 HIVDB
Tatsumi (2006) CONSTRUCTION and characterization of HIV-1 laboratory strain Ba-L infectious molecular clones Unpublished 0  
1
1PR
1RT
1IN
0 Laboratory/experimental isolate
Tatsumi (2006) CONSTRUCTION and characterization of HIV-1 subtype C infectious molecular clones derived from Zambian isolates Unpublished 0 16
16PR
16RT
16IN
16
11PR
16RT
16IN
100 HIVDB
Taylor (2003) HIV-1 Costa Rican novel sequences Unpublished 1e-122  
31
31PR
31RT
0 Gene fragment(s)
Taylor (2003) IDENTIFICATION of a transmission chain of HIV typd 1 containing drug resistance-associated mutations AIDS Res. Hum. Retroviruses 19 (5), 353-361 (2003) 1e-130  
31
31PR
31RT
0 Evolution/quasispecies study
Tebit (2002) GENOTYPIC and phenotypic analysis of HIV type 1 primary isolates from western Cameroon AIDS Res. Hum. Retroviruses 18 (1), 39-48 (2002) 1e-163 19
19PR
1RT
1IN
20
20PR
20RT
1IN
95 HIVDB
Tebit (2003) CONSTRUCTION and characterisation of a full-length infectious molecular clone from a fast replicating, X4-tropic HIV-1 CRF02.AG primary isolate Virology 313 (2), 645-652 (2003) 0  
1
1RT
1IN
0 Laboratory/experimental isolate
Tebit (2004) CONSTRUCTION and characterization of an HIV-1 group O infectious molecular clone and analysis of vpr- and nef-negative derivatives Virology 326 (2), 329-339 (2004) 0  
2
2PR
2RT
2IN
0 Laboratory/experimental isolate
Tebit (2009) Analysis of the diversity of the HIV-1 pol gene and drug resistance associated changes among drug-naive patients in Burkina Faso J. Med. Virol. 81 (10), 1691-1701 (2009) 1e-178 104
104PR
104RT
104
1PR
104RT
100 HIVDB
Tee (2005) THE Evolving Molecular Epidemiology of HIV Type 1 among Injecting Drug Users (IDUs) in Malaysia AIDS Res. Hum. Retroviruses 21 (12), 1046-1050 (2005) 1e-147 53
24PR
53RT
53
24PR
53RT
100 HIVDB
Tee (2005) EMERGENCE of HIV-1 CRF01_AE/B unique recombinant forms in Kuala Lumpur, Malaysia AIDS 19 (2), 119-126 (2005) 1e-138 138
38PR
100RT
138
38PR
100RT
100 HIVDB
Tee (2005) PREVALENCE and pattern of drug resistance mutations among antiretroviral-treated HIV-1 patients with suboptimal virological response in Malaysia Med. Microbiol. Immunol. (Berl.) 195 (2), 107-112 (2006) 1e-132 63
14PR
49RT
63
14PR
49RT
100 HIVDB
Tee (2006) IDENTIFICATION of a Novel Circulating Recombinant Form (CRF33_01B) Disseminating Widely Among Various Risk Populations in Kuala Lumpur, Malaysia J. Acquir. Immune Defic. Syndr. 43 (5), 523-529 (2006) 0 8
8PR
8RT
8IN
8
7PR
8RT
8IN
100 HIVDB
Tee (2009) Estimating the date of origin of an HIV-1 circulating recombinant form Virology 387 (1), 229-234 (2009) 1e-165 9
9PR
9RT
9
8PR
3RT
100 Case report(s) / study subset
Tee (2009) Isolation and characterization of a replication-competent molecular clone of an HIV-1 circulating recombinant form (CRF33_01B) PLoS ONE 4 (8), E6666 (2009) 0 1
1PR
1RT
1IN
1
1RT
1IN
100 Laboratory/experimental isolate
Teixeira (2010) The Detection of in Vivo and in Vitro HIV Type 1 B/F Profiles in Brazil Using a Real-Time PCR Assay for Five HIV Type 1 Genomic Regions AIDS Res. Hum. Retroviruses 26 (9), 981-990 (2010) 0  
261
58PR
153RT
50IN
0 Pending
Teixeira (2006) HIV-1 polymorphism and resistance mutation profile to antiretroviral drugs in drug-naive injection drug users of Rio de Janeiro, Brazil, in pre- and post-HAART eras Unpublished 1e-134 65
65PR
65RT
65
60PR
58RT
100 HIVDB
Telan (2010) An Early Phase of HIV Epidemic in a Population Previously Exposed to HCV in the Philippines Unpublished 1e-160  
22
22PR
4RT
0 Unpublished
Tendeiro (2006) HIV-1 sequences variation in Portugal Unpublished 0  
93
60PR
93RT
0 Unpublished
THEODORE (1993)   Unpublished (1988) 1e-166 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Theodore (1996) CONSTRUCTION and characterization of a stable full-length macrophage-tropic HIV type 1 molecular clone that directs the production of high titers of progeny virions AIDS Res. Hum. Retroviruses 12 (3), 191-194 (1996) 1e-163 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Thitithanyanont (2006) PERSISTENT seronegativity in an asymptomatic 27-month-old child with vertical HIV-1-infection Unpublished 0  
2
1PR
2RT
2IN
0 Case report(s) / study subset
Thomson (2000) WIDESPREAD circulation of a B/F intersubtype recombinant form among HIV-1-infected individuals in Buenos Aires, Argentina AIDS 14 (7), 897-899 (2000) 9e-98 38
38RT
52
3PR
52RT
73 HIVDB
Thomson (2001) HIV-1 genetic diversity in Galicia Spain: BG intersubtype recombinant viruses circulating among injecting drug users AIDS 15 (4), 509-516 (2001) 1e-106 21
21PR
21RT
21
21PR
21RT
100 HIVDB
Thomson (2002) DIVERSITY of mosaic structures and common ancestry of human immunodeficiency virus type 1 BF intersubtype recombinant viruses from Argentina revealed by analysis of near full-length genome sequences J. Gen. Virol. 83 (Pt 1), 107-119 (2002) 1e-164 8
8PR
8RT
8IN
8
8PR
8RT
8IN
100 HIVDB
Thomson (2004) ANALYSIS of near full-length genome sequences of HIV type 1 BF intersubtype recombinant viruses from Brazil reveals their independent origins and their lack of relationship to CRF12_BF AIDS Res. Hum. Retroviruses 20 (10), 1126-1133 (2004) 0 8
8PR
8RT
8IN
8
8PR
8RT
8IN
100 HIVDB
Thomson (2005) IDENTIFICATION of a novel HIV-1 complex circulating recombinant form (CRF18_cpx) of Central African origin in Cuba AIDS (2005) In press 0 2
2PR
2RT
2IN
2
2RT
2IN
100 HIVDB
Thomson (2005) DIRECT Submission Submitted (18-JAN-2005) Patogenia Viral, Instituto de Salud 0 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Thomson (2007) NEW Insights into the Origin of the HIV Type 1 Subtype A Epidemic in Former Soviet Union's Countries Derived from Sequence Analyses of Preepidemically Transmitted Viruses AIDS Res. Hum. Retroviruses 23 (12), 1599-1604 (2007) 0 106
106PR
106RT
1IN
108
69PR
104RT
1IN
98 HIVDB
Thomson (2009) Molecular Epidemiology of HIV-1 in St Petersburg, Russia: Predominance of Subtype A, Former Soviet Union Variant, and Identification of Intrasubtype Subclusters J. Acquir. Immune Defic. Syndr. (2009) In press 1e-173 102
102PR
102RT
102
81PR
91RT
100 HIVDB
Thorat (2011) Surveillance of Transmitted HIV-1 Drug Resistance Among HIV-1 Positive Women Attending Antenatal Clinic in Kakinada, India AIDS Res. Hum. Retroviruses (2011) In press 0 47
47PR
47RT
47
4PR
47RT
100 HIVDB
Tirado (2003) COMPARTMENTALIZATION of Drug Resistance-Associated Mutations in a Treatment-Naive HIV-Infected Female AIDS Res. Hum. Retroviruses 20 (6), 684-686 (2004) 1e-128  
4
2PR
2RT
0 Evolution/quasispecies study
Tirado (2004) DIFFERENTIAL Evolution of Cell-Associated Virus in Blood and Genital Tract of HIV-infected Females during HAART Unpublished 1e-124  
40
20PR
20RT
0 Evolution/quasispecies study
Tobin (2004) GENETICS Studies Reveal Two Causes of Low-level Viremias During HAART: Proliferation of HIV-1 Infected Cells and Viral Replication Unpublished 2e-52  
309
309PR
0 Evolution/quasispecies study
Tominaga (2007) A high frequency of defective vif genes in peripheral blood mononuclear cells from HIV type 1-infected individuals AIDS Res. Hum. Retroviruses 12 (16), 1543-1549 (1996) 0.02  
36
36IN
0 Gene fragment(s)
Tong (2008) DRUG-RESISTANT associated mutations in RT of AIDS patients with ART in Hubei, China Unpublished 0  
2
2RT
0 Pending
Toni (2005) PRESENCE of CRF09_cpx and complex CRF02_AG/CRF09_cpx recombinant HIV type 1 strains in Cote d'Ivoire, West Africa AIDS Res. Hum. Retroviruses 21 (7), 667-672 (2005) 0 6
6PR
6RT
6IN
6
3PR
6RT
6IN
100 HIVDB
Toni (2007) HIV-1 antiretroviral drug resistance in recently infected patients in Abidjan, Cote d Ivoire: a four year survey, 2002-2006 AIDS Res. Hum. Retroviruses 23 (9), 1155-1160 (2007) 1e-146 102
23PR
79RT
102
23PR
79RT
100 HIVDB
Toni (2006) PRIMARY HIV-1 drug resistance in Abidjan (Cote d'Ivoire): a genotypic and phenotypic study AIDS 16 (3), 488-491 (2002) 1e-147 159
62PR
97RT
159
62PR
97RT
100 HIVDB
Toni (2008) DETECTION of human immunodeficiency virus (HIV) type 1 M184V and K103N minority variants in patients with primary HIV infection Antimicrob. Agents Chemother. 53 (4), 1670-1672 (2009) 0  
23
16PR
21RT
0 Pending
Toni (2003) PRESENCE of key drug resistance mutations in isolates from untreated patients of Abidjan, Cote d'Ivoire : ANRS 1257 Study AIDS Res. Hum. Retroviruses 19 (8), 713-717 (2003) 1e-90 196
100PR
96RT
198
101PR
97RT
98 HIVDB
Toni (2005) CHARACTERIZATION of Nevirapine (NVP) Resistance Mutations and HIV Type 1 Subtype in Women from Abidjan (Cote d'Ivoire) After NVP Single-Dose Prophylaxis of HIV Type 1 Mother-to-Child Transmission AIDS Res. Hum. Retroviruses 21 (12), 1031-1034 (2005) 1e-145 28
28RT
28
28RT
100 HIVDB
Toro (2005) MOLECULAR and epidemiological characteristics of blood-borne virus infections among recent immigrants in Spain J. Med. Virol. 78 (12), 1599-1608 (2006) 1e-137  
37
36PR
15RT
0 Pending
Torti (2009) Heterogeneity and penetration of HIV-1 non-subtype B viruses in Brescia Province (northern Italy): public health implications Unpublished 1e-48  
1
1PR
0 Unpublished
Toure-Kane (2001) FULL-LENGTH genome sequencing of HIV type 1 group O viruses isolated from a heterosexual transmission cluster in Senegal AIDS Res. Hum. Retroviruses 17 (12), 1211-1216 (2001) 1e-143 3
3PR
3RT
3IN
3
3PR
3RT
3IN
100 HIVDB
Tovanabutra (2001) FIRST CRF01_AE/B recombinant of HIV-1 is found in Thailand AIDS 15 (8), 1063-1065 (2001) 1e-161 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Tovanabutra (2003) A New Circulating Recombinant Form, CRF15_01B, Reinforces the Linkage between IDU and Heterosexual Epidemics in Thailand AIDS Res. Hum. Retroviruses 19 (7), 561-567 (2003) 0 3
3PR
3RT
3IN
3
3PR
3RT
3IN
100 HIVDB
Tovanabutra (2004) THE Changing Molecular Epidemiology of HIV Type 1 among Northern Thai Drug Users, 1999 to 2002 AIDS Res. Hum. Retroviruses 20 (5), 465-475 (2004) 0 38
38PR
38RT
38IN
38
38PR
38RT
38IN
100 HIVDB
Tovanabutra (2005) CHARACTERIZATION of Complete HIV Type 1 Genomes from Non-B Subtype Infections in U.S. Military Personnel AIDS Res. Hum. Retroviruses 21 (5), 424-429 (2005) 0 13
13PR
12RT
13IN
13
10PR
13RT
13IN
100 HIVDB
Tovanabutra (2007) IDENTIFICATION of CRF34_01B, a Second Circulating Recombinant Form Unrelated to and More Complex Than CRF15_01B, among Injecting Drug Users in Northern Thailand AIDS Res. Hum. Retroviruses 23 (6), 829-833 (2007) 0 3
3PR
3RT
3IN
3
3PR
3RT
3IN
100 HIVDB
Tovanabutra (2010) Evaluation of HIV-1 strains in men having sex with men and in female sex workers in Mombasa, Kenya AIDS Res. Hum. Retroviruses 26 (2), 123-131 (2010) 0 22
22PR
22RT
22IN
22
22RT
22IN
100 HIVDB
Towler (2008) ANALYSIS of Nevirapine Resistance Mutations in Cloned HIV Type 1 Variants from HIV-Infected Ugandan Infants Using a Single-Step Amplification-Sequencing Method (AmpliSeq) AIDS Res. Hum. Retroviruses 24 (9), 1209-1213 (2008) 0  
6
3PR
6RT
0 Case report(s) / study subset
Towler (2010) Analysis of drug resistance in children receiving antiretroviral therapy for treatment of HIV-1 infection in Uganda AIDS Res. Hum. Retroviruses 26 (5), 563-568 (2010) 0 94
94PR
94RT
94
18PR
94RT
100 HIVDB
Tramuto (2003) DETECTION of HIV type 1 non-B subtypes in Sicily, Italy AIDS Res. Hum. Retroviruses 20 (2), 251-254 (2004) 0  
8
8PR
8RT
0 ARV Rx and/or other data are N/A
Tramuto (2004) DETECTION of a New 3-Base Pair Insertion Mutation in the Protease Gene of Human Immunodeficiency Virus Type 1 during Highly Active Antiretroviral Therapy (HAART) AIDS Res. Hum. Retroviruses 21 (5), 420-423 (2005) 0  
27
27PR
27RT
0 Pending
Tramuto (2007) GENETIC Diversity of HIV-1 Non-B Strains in Sicily: Evidence of Intersubtype Recombinants by Sequence Analysis of gag, pol, and env Genes AIDS Res. Hum. Retroviruses 23 (9), 1131-1138 (2007) 0  
6
6RT
0 Case report(s) / study subset
Tramuto (2011) How is changing HIV-1 molecular epidemiology in Sicily? The role of immigrant flows and viral dynamic evolution Unpublished 0  
44
24PR
44RT
0 Unpublished
Treurnicht (2010) Adaptive changes in HIV-1 subtype C proteins during early infection are driven by changes in HLA-associated immune pressure Virology 396 (2), 213-225 (2010) 0  
20
20RT
20IN
0 Evolution/quasispecies study
Trinh (2009) Drug resistant mutations of HIV-1 protease and reverse transcriptase genes among antiviral naive treated children in Southern Vietnam Unpublished 3e-50  
26
26PR
0 Pending
Trinh (2011) HIV vaccine development based on Vietnamese HIV-1 strains Unpublished 0  
2
1PR
2RT
2IN
0 Unpublished
Triques (2000) NEAR-FULL-LENGTH genome sequencing of divergent African HIV type 1 subtype F viruses leads to the identification of a new HIV type 1 subtype designated K AIDS Res. Hum. Retroviruses 16 (2), 139-151 (2000) 3e-88 5
5PR
5RT
5IN
5
5PR
5RT
100 HIVDB
Tristem (1991) NUCLEOTIDE sequence of a Guinea-Bissau-derived human immunodeficiency virus type 2 proviral clone (HIV-2CAM2) J. Gen. Virol. 72 (PT 3), 721-724 (1991) 3e-97 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Troyer (2005) CHANGES in Human Immunodeficiency Virus Type 1 Fitness and Genetic Diversity during Disease Progression J. Virol. 79 (14), 9006-9018 (2005) 1e-127  
18
18RT
0 Pending
Troyer (2007) A radiolabeled oligonucleotide ligation assay demonstrates the high frequency of nevirapine resistance mutations in HIV-1 quasispecies of NVP-treated and untreated mother-infant pairs from Uganda Unpublished 1e-138  
8
8RT
0 Case report(s) / study subset
Truong (2006) ROUTINE surveillance for the detection of acute and recent HIV infections and transmission of antiretroviral resistance AIDS 20 (17), 2193-2197 (2006) 3e-51 93
93PR
93RT
93
93PR
100 HIVDB
Tscherning-Casper (2001) EVIDENCE of the existence of a new circulating recombinant form of HIV type 1 subtype A/J in Cameroon. The European Network on the Study of In Utero Transmission of HIV-1 AIDS Res. Hum. Retroviruses 16 (13), 1313-1318 (2000) 3e-82 15
15PR
15
15PR
100 HIVDB
Tsui (2005) DIRECT Submission Submitted (10-OCT-2005) Department of Medicine, The Chinese 0  
5
1PR
5RT
5IN
0 Case report(s) / study subset
Tsuiji (2006) V118 mutations in the transcriptase gene of HIV-1 from drug-naive hemophiliac patients in Japan Unpublished 1e-153 41
21PR
20RT
41
21PR
20RT
100 HIVDB
Tsujimoto (2002) SEQUENCE of a novel simian immunodeficiency virus from a wild-caught African mandrill Nature 341 (6242), 539-541 (1989) 3e-99 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Tu (2009) Surveillance for human immunodeficiency virus-1 subtypes and drug resistance among volunteer blood donors in Yunnan, China Unpublished 3e-51 45
45PR
45RT
45
45PR
100 HIVDB
Tuaillon (2005) PHENOTYPIC Susceptibility to Nonnucleoside Inhibitors of Virion-Associated Reverse Transcriptase From Different HIV Types and Groups J. Acquir. Immune Defic. Syndr. 37 (5), 1543-1549 (2004) 1e-138  
7
7RT
0 Case report(s) / study subset
Turnbull (2010) Kinetics of expansion of epitope-specific T cell responses during primary HIV-1 infection J. Immunol. 182 (11), 7131-7145 (2009) 0  
142
16PR
17RT
142IN
0 Evolution/quasispecies study
Turner (2003) NUCLEOTIDE and Amino Acid Polymorphisms at Drug Resistance Sites in Non-B Subtype HIV-1 Variants Unpublished 0  
4
2PR
2RT
0 Case report(s) / study subset
Tymchuk (2010) Baseline HIV Resistance in Malawi Unpublished 0 20
20PR
20RT
20
1PR
20RT
100 HIVDB
Tzitzivacos (2008) VIRAL genetic determinants of nonprogressive HIV-1 subtype C infection in antiretroviral drug naive children Unpublished 0  
7
7RT
7IN
0 Case report(s) / study subset
Umeki-Sakamoto (2010) Characterization of drug-resistance mutation profile kinetics in HIV-1 with infectious molecular clones Unpublished 0  
15
4PR
15RT
15IN
0 Laboratory/experimental isolate
Unger (1993) SIMIAN immunodeficiency virus (SIVmac) exhibits complex splicing for tat, rev, and env mRNA Virology 182 (1), 177-185 (1991) 0.001  
1
1IN
0 Gene fragment(s)
Vachot (2004) SHORT communication: retrospective study to time the introduction of HIV type 1 non-B subtypes in Lyon, France, using env genes obtained from primary infection samples AIDS Res. Hum. Retroviruses 20 (7), 687-691 (2004) 0  
4
4RT
0 Case report(s) / study subset
Vahey (1999) PERFORMANCE of the Affymetrix GeneChip HIV PRT 440 platform for antiretroviral drug resistance genotyping of human immunodeficiency virus type 1 clades and viral isolates with length polymorphisms J. Clin. Microbiol. 37 (8), 2533-2537 (1999) 1e-111 35
35PR
35RT
35
35PR
35RT
100 HIVDB
Vaillancourt (1999) THE HIV type 1 protease inhibitor saquinavir can select for multiple mutations that confer increasing resistance AIDS Res. Hum. Retroviruses 15 (4), 355-363 (1999) 1e-128 108
108PR
135
135PR
80 HIVDB
Vallari (2010) Four new HIV-1 group N isolates from Cameroon: Prevalence continues to be low AIDS Res. Hum. Retroviruses 26 (1), 109-115 (2010) 0 4
3PR
3RT
4IN
4
3RT
4IN
100 HIVDB
Vallari (2011) Confirmation of Putative HIV-1 Group P in Cameroon J. Virol. 85 (3), 1403-1407 (2011) 0 1
1PR
1RT
1IN
2
1RT
2IN
50 HIVDB
Valle-Bahena (2004) FREQUENCY of Protease and Reverse Transcriptase Drug Resistance Mutations in Naive HIV-Infected Patients Arch. Med. Res. 37 (8), 1022-1027 (2006) 0 39
33PR
36RT
39
33PR
36RT
100 HIVDB
Vallejo (2001) TROPISM, coreceptor use, and phylogenetic analysis of both the V3 loop and the protease gene of three novel HIV-1 group O isolates J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 18 (5), 417 5e-10 3
3PR
3
3PR
100 HIVDB
van Beveren (1995) APPENDIX B: ARV-2 genome (in) Weiss,R.L., Teich,N., Varmus,H. and Coffin,J. (Eds.); R 1e-163 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
van Beveren (1999) APPENDIX B: HTLV-3/LAV genome (in) Weiss,R.L., Teich,N., Varmus,H. and Coffin,J. (Eds.); R 1e-164  
1
1PR
1RT
1IN
0 Laboratory/experimental isolate
van der Ende (2000) ANTIVIRAL resistance of biological HIV-2 from Netherlands clones obtained from individuals on nucleoside reverse transcriptase inhibitor therapy Unpublished 0.001 6
6RT
6
6RT
100 HIVDB
van der Hoek (2005) INCREASED multinucleoside drug resistance and decreased replicative capacity of a human immunodeficiency virus type 1 variant with an 8-amino-Acid insert in the reverse transcriptase J. Virol. 79 (6), 3536-3543 (2005) 1e-169  
13
13PR
13RT
0 Pending
van der Hoek (2006) CHARACTERIZATION of An HIV-1 Group M Variant That Is Distinct from The Known Subtypes AIDS Res. Hum. Retroviruses 23 (3), 466-470 (2007) 0 4
4PR
4RT
4IN
4
1PR
4RT
4IN
100 HIVDB
van Hal (2009) HIV-1 integrase polymorphisms are associated with prior antiretroviral drug exposure Retrovirology 6, 12 (2009) 1e-168 133
133IN
133
133IN
100 HIVDB
van Harmelen (2002) CHARACTERIZATION of full-length HIV type 1 subtype C sequences from South Africa AIDS Res. Hum. Retroviruses 17 (16), 1527-1531 (2001) 1e-163 4
4PR
4RT
4IN
4
4PR
4RT
4IN
100 HIVDB
Van Heuverswyn (2006) HUMAN immunodeficiency viruses: SIV infection in wild gorillas Nature 444 (7116), 164 (2006) 1e-147  
4
1RT
4IN
0 Pending
Van Heuverswyn (2008) GENETIC diversity and phylogeographic clustering of SIVcpzPtt in wild chimpanzees in Cameroon Virology 368 (1), 155-171 (2007) 0  
2
2RT
2IN
0 Pending
Van Laethem (2000) PATIENT HIV-1 strains carrying the multiple nucleoside resistance mutations are cross-resistant to abacavir AIDS 14 (4), 469-471 (2000) 1e-86 5
5RT
5
5RT
100 HIVDB
Van Laethem (2001) MUTATIONS in the non-nucleoside binding-pocket interfere with the multi-nucleoside resistance phenotype AIDS 15 (5), 553-561 (2001) 3e-90  
10
10RT
0 Evolution/quasispecies study
Van Laethem (2002) MULTINUCLEOSIDE resistant HIV-1 strains Unpublished 1e-74  
6
6RT
0 Pending
Van Laethem (2005) A genotypic resistance assay for the detection of drug resistance in the human immunodeficiency virus type 1 envelope gene J. Virol. Methods 123 (1), 25-34 (2005) 0  
8
5PR
8RT
0 Case report(s) / study subset
Van Laethem (2008) A genotypic assay for the amplification and sequencing of integrase from diverse HIV-1 group M subtypes J. Virol. Methods 153 (2), 176-181 (2008) 1e-167  
70
70IN
0 Pending
van Vaerenbergh (2002) INITIATION of HAART in drug-naive HIV-1 infected patients prevents viral breakthrough for a median period of 35.5 months in 60% of the patients Unpublished 1e-135  
69
34PR
35RT
0 Pending
Van Zyl (2008) ANTIRETROVIRAL resistance mutations in patients with prolonged failure on antiretroviral therapy in Tygerberg Family Clinic, Western Cape, South Africa: An observational study using statistical models Unpublished 1e-152  
75
25PR
68RT
0 Pending
Vandamme (1994) CHARACTERIZATION of HIV-1 strains isolated from patients treated with TIBO R82913 AIDS Res. Hum. Retroviruses 10 (1), 39-46 (1994) 2e-57 6
6RT
7
7RT
85 HIVDB
Vanden Haesevelde (1994) GENOMIC cloning and complete sequence analysis of a highly divergent African human immunodeficiency virus isolate J. Virol. 68 (3), 1586-1596 (1994) 1e-142 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Vanden Haesevelde (1996) SEQUENCE analysis of a highly divergent HIV-1-related lentivirus isolated from a wild captured chimpanzee Virology 221 (2), 346-350 (1996) 1e-138 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
VanRompay (1996) ZIDOVUDINE-RESISTANT simian immunodeficiency virus Unpublished 1.1 1
1PR
1RT
1
1RT
100 HIVDB
Varghese (2010) HIV-1 Integrase Sequence Variability in Antiretroviral Naive Patients and in Triple-Class Experienced Patients Subsequently Treated with Raltegravir AIDS Res. Hum. Retroviruses (2010) In press 1e-167  
150
150IN
0 Pending
Vartanian (2001) SUSTAINED G-->A hypermutation during reverse transcription of an entire human immunodeficiency virus type 1 strain Vau group O genome J. Gen. Virol. 83 (Pt 4), 801-805 (2002) 1e-145  
2
2PR
2RT
2IN
0 Laboratory/experimental isolate
Vatteroni (2008) HIV-1 subtypes Unpublished 0  
3
3RT
0 Case report(s) / study subset
Vaughan (2003) CHARACTERIZATION of HIV-1 clades in the Caribbean using pol gene sequences Unpublished 1e-139 71
71PR
71RT
71
71PR
71RT
100 HIVDB
Vazquez de Parga (2008) ANALYSIS of drug resistance-associated mutations in treatment-naive individuals infected with different genetic forms of HIV-1 circulating in countries of the former Soviet Union J. Med. Virol. 77 (3), 337-344 (2005) 0 230
230PR
230RT
230
129PR
213RT
100 HIVDB
Vazquez-Valls (2010) Molecular epidemiology of HIV type 1 in Mexico: emergence of BG and BF intersubtype recombinants AIDS Res. Hum. Retroviruses 26 (7), 777-781 (2010) 1e-50  
18
18PR
0 Pending
Venturi (1999) GENOTYPIC resistance to zidovudine as a predictor of failure of subsequent therapy with human immunodeficiency virus type-1 nucleoside reverse-transcriptase inhibitors Eur. J. Clin. Microbiol. Infect. Dis. 18 (4), 274-282 (1999) 1e-98 78
78RT
78
78RT
100 HIVDB
Venturi (2000) ANTIRETROVIRAL resistance mutations in human immunodeficiency virus type 1 reverse transcriptase and protease from paired cerebrospinal fluid and plasma samples J. Infect. Dis. 181 (2), 740-745 (2000) 1e-130 68
26PR
42RT
68
26PR
42RT
100 HIVDB
Venturi (2002) DIVERGENT distribution of HIV-1 drug-resistant variants on and off antiretroviral therapy Unpublished 1e-129 67
66PR
66RT
270
270PR
270RT
24 HIVDB
Veras (2006) HIV Type 1 Genetic Variability in Central Brazil AIDS Res. Hum. Retroviruses 23 (12), 1481-1489 (2007) 2e-52  
14
14PR
0 Pending
Vercauteren (2008) PREVALENCE and Epidemiology of HIV Type 1 Drug Resistance among Newly Diagnosed Therapy-Naive Patients in Belgium from 2003 to 2006 AIDS Res. Hum. Retroviruses (2008) In press 0 298
298PR
298RT
298
174PR
298RT
7IN
100 HIVDB
Vercauteren (2009) Transmission of drug-resistant HIV-1 is stabilizing in Europe J. Infect. Dis. 200 (10), 1503-1508 (2009) 0 1741
1741PR
1740RT
1741
876PR
1459RT
100 HIVDB
Vercauteren (2009) Transmission of drug-resistant HIV-1 is stabilizing in Europe J. Infect. Dis. 200 (10), 1503-1508 (2009) 2e-46 1
1PR
1RT
1
1PR
100 HIVDB
Vergani (2007) EVOLUTION of the HIV-1 protease region in heavily pretreated HIV-1 infected patients receiving Atazanavir J. Clin. Virol. 41 (2), 154-159 (2008) 1e-141  
24
5PR
24RT
0 Pending
Vergne (2000) GENETIC diversity of protease and reverse transcriptase sequences in non-subtype-B human immunodeficiency virus type 1 strains: evidence of many minor drug resistance mutations in treatment-naive patients J. Clin. Microbiol. 38 (11), 3919-3925 (2000) 1e-135 125
125PR
125RT
125
125PR
125RT
100 HIVDB
Vergne (2002) RESISTANCE to antiretroviral treatment in Gabon: need for implementation of guidelines on antiretroviral therapy use and HIV-1 drug resistance monitoring in developing countries J. Acquir. Immune Defic. Syndr. 29 (2), 165-168 (2002) 1e-121 32
32PR
31RT
32
32PR
32RT
100 HIVDB
Vergne (2003) LOW rate of genotypic HIV-1 drug-resistant strains in the Senegalese government initiative of access to antiretroviral therapy AIDS 17 SUPPL 3, S31-S38 (2003) 0 45
45PR
45RT
45
45PR
45RT
100 HIVDB
Vergne (2006) NATURAL polymorphism in protease and reverse transcriptase genes and in vitro antiretroviral drug susceptibilities of non-B HIV-1 strains from treatment-naive patients J. Clin. Virol. 36 (1), 43-49 (2006) 0 19
19PR
19RT
19
10PR
19RT
100 HIVDB
Vergne (2009) HIV-1 drug-resistance mutations among newly diagnosed patients before scaling-up programmes in Burkina Faso and Cameroon Antivir. Ther. (Lond.) 11 (5), 575-579 (2006) 0 195
195PR
195RT
195
1PR
195RT
100 HIVDB
Verhofstede (2003) DRUG-RESISTANT Variants That Evolve During Nonsuppressive Therapy Persist in HIV-1-Infected Peripheral Blood Mononuclear Cells After Long-Term Highly Active Antiretroviral Therapy J. Acquir. Immune Defic. Syndr. 35 (5), 473-483 (2004) 1e-126  
319
156PR
182RT
0 Evolution/quasispecies study
Verhofstede (2008) Effectiveness of antiretroviral therapy and development of drug resistance in HIV-1 infected patients in Mombasa, Kenya Unpublished 2e-49 4
4PR
4
4PR
100 HIVDB
Verschoor (2003) A novel simian immunodeficiency virus isolated from a Schmidt's guenon (Cercopithecus ascanius schmidti) J. Gen. Virol. 85 (PT 1), 21-24 (2004) 1e-144 1
1RT
1IN
1
1RT
1IN
100 HIVDB
Vessiere (2006) HIV-1 pol gene polymorphism and antiretroviral resistance mutations in drug naive pregnant women, in Yaounde, Cameroon Unpublished 1e-147 140
57PR
83RT
140
57PR
83RT
100 HIVDB
Vessiere (2009) First evidence of a HIV-1 M/O recombinant form circulating outside Cameroon AIDS. 2010 Apr 24;24(7):1079-82. 0 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Viani (2006) PREVALENCE of Primary HIV-1 Drug Resistance among Recently Infected Adolescents: A Multicenter Adolescent Medicine Trials Network for HIV/AIDS Interventions Study J. Infect. Dis. 194 (11), 1505-1509 (2006) 1e-174 55
55PR
55RT
55
55PR
55RT
100 HIVDB
Vicente (2001) GENETIC variability of HIV-1 protease from Nigeria and correlation with protease inhibitors drug resistance Virus Genes 22 (2), 181-186 (2001) 4e-81 10
10PR
10
10PR
100 HIVDB
Vicente (2001) THE HIV epidemic in the Amazon Basin is driven by prototypic and recombinant HIV-1 subtypes B and F J. Acquir. Immune Defic. Syndr. 23 (4), 327-331 (2000) 1e-112 10
10PR
10
10PR
100 HIVDB
Vicenti (2007) USE of peripheral blood DNA for genotype antiretroviral resistance testing in drug-naive HIV-infected subjects Clin. Infect. Dis. 44 (12), 1657-1661 (2007) 1e-142 526
256PR
270RT
526
256PR
270RT
100 HIVDB
Vicenti (2007) Use of peripheral blood DNA for genotype antiretroviral resistance testing in drug-naive HIV-infected subjects Clin. Infect. Dis. 44 (12), 1657-1661 (2007) 8e-48 1
1PR
1
1PR
100 HIVDB
Vidal (2002) GENOTYPIC and phenotypic resistance patterns in early stage HIV patients failing initial therapy with stavudine, didanosine and nevirapine Unpublished 1e-133 51
25PR
26RT
51
25PR
26RT
100 HIVDB
Vidal (2003) DIRECT Submission Submitted (03-JUN-2002) Vidal N., UR 36, I.R.D, BP 64501, 34 0 4
4PR
4RT
4IN
4
4PR
4RT
3IN
100 HIVDB
Vidal (1998) GENETIC follow-up of SIVagm in its natural host Cercopithecus aethiops sabaeus, and experimental infection of Erythrocebus patas Unpublished 3e-41  
8
8IN
0 Gene fragment(s)
Vidal (2001) IDENTIFICATION of a complex env subtype E HIV type 1 virus from the democratic republic of congo, recombinant with A, G, H, J, K, and unknown subtypes AIDS Res. Hum. Retroviruses 16 (18), 2059-2064 (2000) 1e-117 1
1PR
1RT
1IN
3
1PR
2RT
1IN
33 HIVDB
Vidal (2006) IDENTIFICATION and molecular characterization of subsubtype A4 in central Africa AIDS Res. Hum. Retroviruses 22 (2), 182-187 (2006) 0 3
3PR
3RT
3IN
3
2PR
3RT
3IN
100 HIVDB
Vidal (2006) HIV type 1 pol gene diversity and antiretroviral drug resistance mutations in the Democratic Republic of Congo (DRC) AIDS Res. Hum. Retroviruses 22 (2), 202-206 (2006) 0 70
70PR
70RT
70
35PR
70RT
100 HIVDB
Vidal (2007) HIV Type 1 Diversity and Antiretroviral Drug Resistance Mutations in Burundi AIDS Res. Hum. Retroviruses 23 (1), 175-180 (2007) 0 105
105PR
105RT
105
42PR
105RT
100 HIVDB
Vidal (2007) CHARACTERIZATION of an Old Complex Circulating Recombinant Form, CRF27_cpx, Originating from the Democratic Republic of Congo (DRC) and Circulating in France AIDS Res. Hum. Retroviruses 24 (2), 315-321 (2008) 0 2
2PR
2RT
2IN
3
2RT
3IN
66 HIVDB
Vignoles (2006) HIGH frequency of primary mutations associated with antiretroviral drug resistance in recently diagnosed HIV-infected children Antivir. Ther. (Lond.) 12 (7), 1133-1137 (2007) 0  
67
47PR
67RT
0 Pending
Villena (2007) RELATIVE Fitness and Replication Capacity of a Multinucleoside Analogue-Resistant Clinical Human Immunodeficiency Virus Type 1 Isolate with a Deletion of Codon 69 in the Reverse Transcriptase Coding Region J. Virol. 81 (9), 4713-4721 (2007) 0  
4
4RT
0 Case report(s) / study subset
Vinner (2010) Sequence analysis of near full-length Human immunodeficiency virus type 1 sequences from Guinea-Bissau; selection of vaccine epitopes relevant in both West African and European countries Unpublished 0  
3
3RT
3IN
0 Unpublished
Vinogradova (2010) Short communication: Molecular epidemiology of HIV type 1 in the Republic of Dagestan, Russian Federation: virtually uniform circulation of subtype A, former Soviet Union variant, with predominance of the V77I(PR) subvariant AIDS Res. Hum. Retroviruses 26 (4), 395-400 (2010) 0 39
39PR
39RT
39
16PR
33RT
100 HIVDB
Vinoles (2005) SEROINCIDENCE AND PHYLOGENY OF HUMAN IMMUNODEFICIENCY VIRUS INFECTIONS IN A COHORT OF COMMERCIAL SEX WORKERS IN MONTEVIDEO, URUGUAY Am. J. Trop. Med. Hyg. 72 (4), 495-500 (2005) 0 5
5PR
5RT
4IN
5
4PR
5RT
4IN
100 HIVDB
Viputtijul (2002) HETEROSEXUALLY Acquired CRF01_AE/B Recombinant HIV Type 1 Found in Thailand AIDS Res. Hum. Retroviruses 18 (16), 1235-1237 (2002) 1e-157 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Visawapoka (2006) CIRCULATING and Unique Recombinant Forms of HIV Type 1 Containing Subsubtype A2 AIDS Res. Hum. Retroviruses 22 (7), 695-702 (2006) 0 4
4PR
4RT
4IN
4
1PR
4RT
4IN
100 HIVDB
von Truchsess (2006) THE first B/G intersubtype recombinant form of human immunodeficiency virus type 1 (HIV-1) identified in Germany was undetected or underquantitated by some commercial viral load assays J. Med. Virol. 78 (3), 311-317 (2006) 1e-163  
1
1IN
0 Case report(s) / study subset
von Wyl (2007) EMERGENCE of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types Arch. Intern. Med. 167 (16), 1782-1790 (2007) 6e-53 184
184PR
184RT
184
184PR
100 HIVDB
von Wyl (2010) Epidemiological and biological evidence for a compensatory effect of connection domain mutation N348I on M184V in HIV-1 reverse transcriptase J. Infect. Dis. 201 (7), 1054-1062 (2010) 0  
57
33PR
57RT
0 Pending
von Wyl (2010) HIV-1 reverse transcriptase connection domain mutations: dynamics of emergence and implications for success of combination antiretroviral therapy Clin. Infect. Dis. 51 (5), 620-628 (2010) 0  
11
11RT
0 Pending
Wain-Hobson (1985) NUCLEOTIDE sequence of the AIDS virus, LAV Cell 40 (1), 9-17 (1985) 1e-164 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Wallis (2010) Case report of the rare deletion at codon 69 of reverse transcriptase in a South African HIV-1 subtype C infected patient Virus Genes 41 (3), 358-360 (2010) 1e-158 2
2PR
2RT
3
3PR
3RT
66 HIVDB
Walter (2000) PHENOTYPIC HIV-1 resistance correlates with treatment outcome of nelfinavir salvage therapy Antivir. Ther. (Lond.) 5 (4), 249-256 (2000) 1e-123 19
19PR
19
19PR
100 HIVDB
Wang (2004) FIRST demonstration of a lack of viral sequence evolution in a nonprogressor, defining replication-incompetent HIV-1 infection Virology 312 (1), 135-150 (2003) 0  
4
4PR
4RT
4IN
0 Case report(s) / study subset
Wang (2005) HIV-1 genotypic drug resistance variants in antiretroviral treatment naive patients in southern China Cell Res. 2005 Nov-Dec;15(11-12):843-9. 1e-149  
38
32PR
31RT
0 Pending
Wang (2001) GENOTYPING analysis of HIV-1 isolate protease from VGH Taipei Unpublished 1e-121  
15
15PR
0 Unpublished
Wang (2008) IDENTIFICATION of Subtype B, Multiple Circulating Recombinant Forms and Unique Recombinants of HIV Type 1 in an MSM Cohort in China AIDS Res. Hum. Retroviruses 24 (10), 1245-1254 (2008) 1e-171  
36
29PR
28RT
0 Pending
Wang (2011) Near Full-Length Sequence Analysis of Two New HIV Type 1 Unique (CRF01_AE/B) Recombinant Forms among MSM in China Unpublished 0  
2
1PR
2RT
2IN
0 Unpublished
Wang (2011) The Dynamic Face of HIV-1 Subtypes Among Men who Have Sex with Men in Beijing, China Curr. HIV Res. (2011) In press 0  
1
1PR
1RT
1IN
0 Case report(s) / study subset
Wang (2009) Protective HLA class I alleles that restrict acute-phase CD8+ T-cell responses are associated with viral escape mutations located in highly conserved regions of human immunodeficiency virus type 1 J. Virol. 83 (4), 1845-1855 (2009) 0  
91
61PR
91RT
91IN
0 Pending
Wang (2000) MOLECULAR evidence for drug-induced compartmentalizaion of HIV-1 quasispecies in a patient with periodic changes to the HAART regimens AIDS (2001) In press 1e-118  
30
16PR
14RT
0 Evolution/quasispecies study
Wang (2008) CONSTRUCTION and Characterization of a Full-Length Infectious Molecular Clone from the HIV Type 1 Subtype Thai-B Isolated in Henan Province, China AIDS Res. Hum. Retroviruses 24 (2), 251-257 (2008) 0  
1
1PR
1RT
1IN
0 Laboratory/experimental isolate
Warachit (2007) ABERRANT life cycle of human immunodeficiency virus type 1 CRF15_01B-like clinical isolates from Thailand in human CD4+ T-cell lines Microbes Infect. 9 (4), 449-459 (2007) 0 1
1PR
1RT
1IN
2
2PR
2RT
2IN
50 Case report(s) / study subset
Warachit (2007) DIRECT Submission Submitted (22-DEC-2006) Virology, Research Institute of Micr 1e-163  
4
4IN
0 Pending
Warren (1992) COMPARATIVE purification of recombinant HIV-1 and HIV-2 reverse transcriptase: preparation of heterodimeric enzyme devoid of unprocessed gene product Protein Expr. Purif. 3 (6), 479-487 (1992) 4.2  
1
1RT
0 HIVDB
Watanaveeradej (2003) DIRECT Submission Submitted (26-MAR-2003) Threat Assessment, U.S. Military HIV 0 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Watanaveeradej (2006) MOLECULAR Epidemiology of HIV-1 in Preparation for a Phase III Prime-boost Vaccine Trial in Thailand and a New Approach to HIV-1 Genotyping Unpublished 0 27
27PR
26RT
27IN
27
20PR
27RT
27IN
100 HIVDB
Watkins (2003) SELECTION of high-level resistance to human immunodeficiency virus type 1 protease inhibitors Antimicrob. Agents Chemother. 47 (2), 759-769 (2003) 2e-53  
116
116PR
0 Laboratory/experimental isolate
Weber (2002) HUMAN immunodeficiency virus type 1 fitness evolution under a protease inhibitor-based therapy depends on the basal genotypic context of the virus and correlates with a diverse virologic and immunologic response Unpublished 1e-133 25
25PR
25RT
25
25PR
25RT
100 HIVDB
Weber (2005) DIMINISHED Replicative Fitness of Primary Human Immunodeficiency Virus Type 1 Isolates Harboring the K65R Mutation J. Clin. Microbiol. 43 (3), 1395-1400 (2005) 1e-171 10
10PR
10RT
10
10PR
10RT
100 HIVDB
Wei (2004) BIASED G-to-A hypermutation in HIV-1 proviral DNA from a long-term non-progressor AIDS 18 (13), 1863-1865 (2004) 0  
1
1PR
1RT
1IN
0 Case report(s) / study subset
Weidle (2000) PRESENCE of human immunodeficiency virus (HIV) type 1, group M, non-B subtypes, Bronx, New York: a sentinel site for monitoring HIV genetic diversity in the United States J. Infect. Dis. 181 (2), 470-475 (2000) 1e-118 6
6PR
6
6PR
100 HIVDB
Weidle (2002) RESISTANCE to antiretroviral therapy among patients in Uganda J. Acquir. Immune Defic. Syndr. 26 (5), 495-500 (2001) 1e-106 15
15PR
15
15PR
100 HIVDB
Weidt (1992) CHARACTERIZATION of a new German HIV-1 isolate: HIV-1NH5 Unpublished (1992) 5e-89  
2
1RT
1IN
0 Case report(s) / study subset
Weinstock (2004) THE Epidemiology of Antiretroviral Drug Resistance among Drug-Naive HIV-1-Infected Persons in 10 US Cities J. Infect. Dis. 189 (12), 2174-2180 (2004) 1e-146  
149
148PR
149RT
0 Case report(s) / study subset
Whitcomb (2006) DIRECT Submission Submitted (09-SEP-2006) Monogram Biosciences, 345 Oyster Poi 1e-167  
3
2PR
3RT
0 Laboratory/experimental isolate
Wichukchinda (2005) HETEROSEXUAL Transmission of Novel CRF01_AE and Subtype B Recombinant Forms of HIV Type 1 in Northern Thailand AIDS Res. Hum. Retroviruses 21 (8), 734-738 (2005) 0  
4
4PR
3RT
0 Case report(s) / study subset
Wieland (1994) IN vivo genetic variability of the HIV-1 vif gene Virology 203 (1), 43-51 (1994) 0.02  
52
52IN
0 Gene fragment(s)
Wieland (1997) DIVERSITY of the vif gene of human immunodeficiency virus type 1 in Uganda J. Gen. Virol. 78 (PT 2), 393-400 (1997) 0.02  
15
15IN
0 Gene fragment(s)
Wilbe (2002) IDENTIFICATION of Two CRF11-cpx Genomes and Two Preliminary Representatives of a New Circulating Recombinant Form (CRF13-cpx) of HIV Type 1 in Cameroon AIDS Res. Hum. Retroviruses 18 (12), 849-856 (2002) 1e-72 4
4PR
4RT
4IN
4
4PR
4RT
100 HIVDB
Wilbe (2003) CHARACTERIZATION of novel recombinant HIV-1 genomes using the branching index Virology 316 (1), 116-125 (2003) 0 4
4PR
4RT
4IN
4
4PR
4RT
4IN
100 HIVDB
Wildemann (1993) IN vivo occurance of drug resistance mutations under prolonged zidovudine treatment in HIV-1 infected patients with asymptomatic and advanced disease Unpublished 9e-94 54
54RT
80
80RT
67 Case report(s) / study subset
Wilkinson (2009) Molecular characterization of non-subtype C and recombinant HIV-1 viruses from Cape Town, South Africa Infect Genet Evol. 2009 Sep;9(5):840-6. Epub 2009 May 14. 0  
11
2PR
4RT
11IN
0 Pending
Willey (1996) IDENTIFICATION of conserved and divergent domains within the envelope gene of the acquired immunodeficiency syndrome retrovirus Proc. Natl. Acad. Sci. U.S.A. 83 (14), 5038-5042 (1986) 1e-128  
1
1PR
1RT
0 HIVDB
Williamson (2003) CHARACTERIZATION and Selection of HIV-1 Subtype C Isolates For Use in Vaccine Development AIDS Res. Hum. Retroviruses 19 (2), 133-144 (2003) 1e-163 28
1PR
28RT
1IN
28
1PR
28RT
1IN
100 HIVDB
Wilson (1999) FREQUENT detection of escape from cytotoxic T-lymphocyte recognition in perinatal human immunodeficiency virus (HIV) type 1 transmission: the ariel project for the prevention of transmission of HIV from mother to infant J. Virol. 73 (5), 3975-3985 (1999) 1e-127  
112
112RT
0 Evolution/quasispecies study
Winslow (1995) LIMITED sequence diversity of the HIV type 1 protease gene from clinical isolates and in vitro susceptibility to HIV protease inhibitors AIDS Res. Hum. Retroviruses 11 (1), 107-113 (1995) 1e-127 13
13PR
21
21PR
61 HIVDB
Winters (1997) HUMAN immunodeficiency virus type 1 reverse transcriptase genotype and drug susceptibility changes in infected individuals receiving dideoxyinosine monotherapy for 1 to 2 years Antimicrob. Agents Chemother. 41 (4), 757-762 (1997) 1e-98 44
44RT
44
44RT
100 HIVDB
Winters (1998) A 6-basepair insert in the reverse transcriptase gene of human immunodeficiency virus type 1 confers resistance to multiple nucleoside inhibitors J. Clin. Invest. 102 (10), 1769-1775 (1998) 1e-124 10
9PR
10RT
14
12PR
14RT
71 HIVDB
Winters (2004) GENOTYPIC, phenotypic, and modeling studies of a deletion in the beta3-beta4 region of the human immunodeficiency virus type 1 reverse transcriptase gene that is associated with resistance to nucleoside reverse transcriptase inhibitors J. Virol. 74 (22), 10707-10713 (2000) 1e-166 7
7RT
7
7RT
100 HIVDB
Winters (2005) NEW Two-Amino Acid Insertion Near Codon 70 of the HIV Type 1 Protease Gene AIDS Res. Hum. Retroviruses 21 (4), 311-313 (2005) 0  
1
1RT
0 Pending
Wittkop (2010) Virological and immunological response in HIV-1-infected patients with multiple treatment failures receiving raltegravir and optimized background therapy, ANRS CO3 Aquitaine Cohort J. Antimicrob. Chemother. 63 (6), 1251-1255 (2009) 1e-167 34
34IN
34
34IN
100 HIVDB
Wolinsky (2007) COMPLEX Pathways of HIV Immune Escape Unpublished 1e-175  
26
26PR
26RT
0 Case report(s) / study subset
Womack (2001) IDENTIFICATION of non-B human immunodeficiency virus type 1 subtypes in rural Georgia J. Infect. Dis. 183 (1), 138-142 (2001) 9e-57  
2
2RT
0 Case report(s) / study subset
Wong (1997) DIRECT Submission Submitted (02-SEP-1996) Department of Medicine, University o 1e-101  
314
314RT
0 Gene fragment(s)
Wong (1997) RECOVERY of replication-competent HIV despite prolonged suppression of plasma viremia Science 278 (5341), 1291-1295 (1997) 1e-126  
14
14PR
14RT
0 Evolution/quasispecies study
Wong-Staal (1993) COMPLETE nucleotide sequence of the AIDS virus, HTLV-III Nature 313 (6000), 277-284 (1985) 1e-163 1
1PR
1RT
1IN
4
4PR
4RT
1IN
25 Laboratory/experimental isolate
Worobey (2010) Island biogeography reveals the deep history of SIV Science 329 (5998), 1487 (2010) 2e-68 22
22IN
22
22IN
100 HIVDB
Wright (2010) Gag-protease-mediated replication capacity in HIV-1 subtype C chronic infection: associations with HLA type and clinical parameters J. Virol. 84 (20), 10820-10831 (2010) 3e-50 179
179PR
179
179PR
100 HIVDB
Wright (2010) Gag-protease-mediated replication capacity in HIV-1 subtype C chronic infection: associations with HLA type and clinical parameters J. Virol. 84 (20), 10820-10831 (2010) 5e-49 4
4PR
4
4PR
100 HIVDB
Wright (2011) Influence of Gag-Protease-Mediated Replication Capacity on Disease Progression in Individuals Recently Infected with HIV-1 Subtype C J. Virol. 85 (8), 3996-4006 (2011) 2e-50 14
14PR
14
14PR
100 HIVDB
Wright (2011) Influence of Gag-Protease-Mediated Replication Capacity on Disease Progression in Individuals Recently Infected with HIV-1 Subtype C J. Virol. 85 (8), 3996-4006 (2011) 3e-48 2
2PR
2
2PR
100 HIVDB
Wu (2009) Construction and application of an infectious molecular clone of T-tropic and subtype B-Thai HIV-1 virus Unpublished 0  
1
1PR
1RT
1IN
0 Unpublished
Wu (2010) Construction and characterization of a full-length infectious clone from a fast replicating, X4-tropic HIV-1 subtype Thai- B isolate Unpublished 0  
3
3PR
3RT
3IN
0 Unpublished
Wu (2002) MUTATION Patterns and Structural Correlates in Human Immunodeficiency Virus Type 1 Protease Following Different Protease Inhibitor Treatments J. Virol. 77 (8), 4836-4847 (2003) 1e-133 216
216PR
216
216PR
100 HIVDB
Xiang (2005) HIV type 2 pathogenicity is not related to subtype in rural Guinea Bissau AIDS Res. Hum. Retroviruses 13 (6), 501-505 (1997) 6e-43  
128
128IN
0 Pending
Xu (2007) GENETIC Diversity of Integrase (IN) Sequences in Antiretroviral Treatment-Naive and Treatment-Experienced HIV Type 2 Patients AIDS Res. Hum. Retroviruses 24 (7), 1003-1007 (2008) 1e-101  
11
11IN
0 Pending
Xu (2009) Dynamics of raltegravir resistance profile in an HIV-2 infected patient Unpublished 1e-100  
216
216IN
0 Evolution/quasispecies study
Xu (2010) Development and evaluation of national reference panel for HIV-1 genotypic resistance assay on HIV-1 protease and reverse transcriptase in China Mol Diagn Ther. 14(1):31-41 (2010) 1e-166  
7
4PR
4RT
0 Pending
Yahi (2001) USE of drug resistance sequence data for the systematic detection of non-B human immunodeficiency virus type 1 (HIV-1) subtypes: how to create a sentinel site for monitoring the genetic diversity of HIV-1 at a country scale J. Infect. Dis. 183 (9), 1311-1317 (2001) 1e-101 135
68PR
67RT
135
68PR
67RT
100 HIVDB
Yamada (2000) COMPARISON of proviral accessory genes between long-term nonprogressors and progressors of human immunodeficiency virus type 1 infection Arch. Virol. 145 (5), 1021-1027 (2000) 0.011  
49
49IN
0 Gene fragment(s)
Yamaguchi (1995) CLINICAL isolates of HIV-1 contain few pre-existing proteinase inhibitor resistance-conferring mutations Biochim. Biophys. Acta 1253 (2), 136-140 (1995) 1e-135 22
22PR
28
28PR
78 HIVDB
Yamaguchi (2002) EVALUATION of HIV type 1 group O isolates: identification of five phylogenetic clusters AIDS Res. Hum. Retroviruses 18 (4), 269-282 (2002) 1e-147 22
22IN
37
37IN
59 HIVDB
Yamaguchi (2003) NEAR full-length genomes of 15 HIV type 1 group O isolates AIDS Res. Hum. Retroviruses 19 (11), 979-988 (2003) 0 15
15PR
15RT
15IN
15
15PR
15RT
15IN
100 HIVDB
Yamaguchi (2005) HIV infections in northwestern Cameroon: identification of HIV type 1 group O and dual HIV type 1 group M and group O infections AIDS Res. Hum. Retroviruses 20 (9), 944-957 (2004) 1e-164 15
15IN
15
15IN
100 HIVDB
Yamaguchi (2006) IDENTIFICATION of HIV Type 1 Group N Infections in a Husband and Wife in Cameroon: Viral Genome Sequences Provide Evidence for Horizontal Transmission AIDS Res. Hum. Retroviruses 22 (1), 83-92 (2006) 0 2
2PR
2RT
2IN
2
2RT
2IN
100 HIVDB
Yamaguchi (2006) HIV-1 Group N: Evidence of Ongoing Transmission in Cameroon AIDS Res. Hum. Retroviruses 22 (5), 453-457 (2006) 1e-155 1
1IN
1
1IN
100 HIVDB
Yamaguchi (2008) HIV Type 2 Intergroup Recombinant Identified in Cameroon AIDS Res. Hum. Retroviruses 24 (1), 86-91 (2008) 0  
2
1RT
2IN
0 Pending
Yamaguchi (2009) HIV type 1 group M subtype G in Cameroon: five genome sequences AIDS Res. Hum. Retroviruses 25 (4), 469-473 (2009) 0 5
5PR
5RT
5IN
5
5RT
5IN
100 HIVDB
Yamaguchi (2010) Near full-length sequence of HIV type 1 subtype J strain 04CMU11421 from Cameroon AIDS Res. Hum. Retroviruses 26 (6), 693-697 (2010) 0 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Yang Hsu (2005) CHARACTERIZATION of mutations in CRF01_AE virus isolates from antiretroviral treatment naive and experienced patients in Singapore J. Acquir. Immune Defic. Syndr. (2005) In press 0 104
104PR
104RT
104
102PR
104RT
100 HIVDB
Yang (2000) PHYLOGENETIC analysis of protease and transmembrane region of HIV type 1 group O AIDS Res. Hum. Retroviruses 16 (11), 1075-1081 (2000) 8e-15 20
20PR
20
20PR
100 HIVDB
Yang (2004) GENETIC diversity and high proportion of intersubtype recombinants among HIV type 1-infected pregnant women in Kisumu, western Kenya AIDS Res. Hum. Retroviruses 20 (5), 565-574 (2004) 1e-157 38
38PR
38RT
38
38PR
38RT
100 HIVDB
Yang (2010) Development and Application of a Broadly Sensitive Dried-Blood-Spot-Based Genotyping Assay for Global Surveillance of HIV-1 Drug Resistance J. Clin. Microbiol. 48 (9), 3158-3164 (2010) 1e-147  
32
32RT
0 Pending
Yang (2010) First case of HIV-1 CRF06_cpx in Taiwan Unpublished 0  
1
1RT
0 Unpublished
Yang (2010) An uncommon case of HIV-1 transmission due to a knife fight Unpublished 0  
47
47RT
0 Pending
Yang (2008) GENETIC and stochastic influences on the interaction of human immunodeficiency virus type 1 and cytotoxic T lymphocytes in identical twins Unpublished 0  
23
23RT
23IN
0 Evolution/quasispecies study
Yang (2003) IDENTIFICATION and characterization of a new class of human immunodeficiency virus type 1 recombinants comprised of two circulating recombinant forms, CRF07_BC and CRF08_BC, in China J. Virol. 77 (1), 685-695 (2003) 5e-90 5
5PR
5RT
2IN
5
5PR
5RT
100 HIVDB
Yang (2007) DRUG-RESISTANT associated mutations in RT of AIDS patients with ART in Hubei, China Unpublished 0  
3
2PR
1RT
0 Case report(s) / study subset
Yang (2002) ON-GOING generation of multiple forms of HIV-1 intersubtype recombinants in the Yunnan Province of China AIDS 16 (10), 1401-1407 (2002) 1e-121 39
39PR
39RT
39
39PR
39RT
100 HIVDB
Ye (2011) Sequence analysis of gag-pol gene of Human Immunodeficiency Virus Type 1 of Inersubtype (B'/C) Recombinant Strain in Beijing of China Unpublished 1e-146  
39
33PR
29RT
0 Pending
Yebra (2008) CLINICAL differences and viral diversity between newly HIV type 1-diagnosed African and non-African patients in Spain (2005-2007) AIDS Res. Hum. Retroviruses 25 (1), 37-44 (2009) 0  
13
2PR
12RT
0 Pending
Yebra (2010) HIV-1 non-B subtypes: High transmitted NNRTI-resistance in Spain and impaired genotypic resistance interpretation due to variability Antiviral Res. 85 (2), 409-417 (2010) 0 187
187PR
184RT
187
94PR
171RT
100 HIVDB
Yedavalli (1998) CONSERVATION of an intact vif gene of human immunodeficiency virus type 1 during maternal-fetal transmission J. Virol. 72 (2), 1092-1102 (1998) 0.02  
90
90IN
0 Gene fragment(s)
Yedavalli (2001) LOW conservation of functional domains of HIV type 1 vif and vpr genes in infected mothers correlates with lack of vertical transmission AIDS Res. Hum. Retroviruses 17 (10), 911-923 (2001) 0.02  
58
58IN
0 Gene fragment(s)
Yerly (2001) DRUG resistance mutations in HIV-1-infected subjects during protease inhibitor-containing HAART with nelfinavir or indinavir Antivir. Ther. (Lond.) (2001) In press 1e-130  
188
94PR
94RT
0 ARV Rx and/or other data are N/A
Yerly (2004) HIV-1 co/super-infection in intravenous drug users AIDS 18 (10), 1413-1421 (2004) 1e-109  
57
57RT
0 Pending
Yerly (2005) NOSOCOMIAL outbreak of multiple bloodborne viral infections J. Infect. Dis. 184 (3), 369-372 (2001) 2e-48 1
1PR
1
1PR
100 HIVDB
York-Higgins (2003) HUMAN immunodeficiency virus type 1 cellular host range, replication, and cytopathicity are linked to the envelope region of the viral genome J. Virol. 64 (8), 4016-4020 (1990) 0  
1
1PR
1RT
1IN
0 Laboratory/experimental isolate
Young (1998) RESISTANCE mutations in protease and reverse transcriptase genes of human immunodeficiency virus type 1 isolates from patients with combination antiretroviral therapy failure J. Infect. Dis. 178 (5), 1497-1501 (1998) 1e-127 39
39PR
39RT
39
39PR
39RT
100 HIVDB
Youngpairoy (2006) ANTIRETROVIRAL resistance-associated mutations in protease and reverse transcriptase of Human Immunodeficiency virus type 1 from drug naive persons in Cameroon: a high prevalence of novel mutations Unpublished 0 43
43PR
43RT
57
28PR
57RT
75 HIVDB
Yu (2008) Genetic diversity and drug resistance of HIV type 1 circulating recombinant Form_BC among drug users in Guangdong Province AIDS Res. Hum. Retroviruses 25 (9), 869-875 (2009) 1e-170 100
99PR
100RT
100
57PR
79RT
100 HIVDB
Yuste (2000) UNUSUAL distribution of mutations associated with serial bottleneck passages of human immunodeficiency virus type 1 J. Virol. 74 (20), 9546-9552 (2000) 1e-165  
8
8PR
8RT
8IN
0 Evolution/quasispecies study
Zagury (1996) GENETIC variability between isolates of human immunodeficiency virus (HIV) type 2 is comparable to the variability among HIV type 1 Proc. Natl. Acad. Sci. U.S.A. 85 (16), 5941-5945 (1988) 9e-98 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Zarandia (2005) HIV-1 Genetic Diversity and Genotypic Drug Susceptibility in the Republic of Georgia AIDS Res. Hum. Retroviruses 22 (5), 470-476 (2006) 0 48
43PR
43RT
5IN
48
48PR
48RT
5IN
100 HIVDB
Zeh (2003) NIGERIAN HIV Type 2 Subtype A and B from Heterotypic HIV Type 1 and HIV Type 2 or Monotypic HIV Type 2 Infections AIDS Res. Hum. Retroviruses 21 (1), 17-27 (2005) 1e-50 106
106PR
106
106PR
100 HIVDB
Zeh (2010) Emergence of HIV-1 Drug Resistance among Breastfeeding Infants Born to HIV-infected Mothers taking Highly Active Antiretroviral Therapy for Prevention of Mother-to-Child Transmission Unpublished 0  
20
20RT
0 Unpublished
Zhang (2010) Surveillance of transmitted HIV type 1 drug resistance in newly diagnosed hiv type 1-infected patients in Shandong Province, China AIDS Res. Hum. Retroviruses 26 (1), 99-103 (2010) 1e-145 18
18PR
18RT
18
18RT
100 HIVDB
Zhang (1999) QUANTIFYING residual HIV-1 replication in patients receiving combination antiretroviral therapy N. Engl. J. Med. 340 (21), 1605-1613 (1999) 1e-121  
50
50PR
0 Evolution/quasispecies study
Zhang (2004) CULTURED HIV-1, Group M, Subtype A Unpublished 6e-46  
1
1IN
0 Case report(s) / study subset
Zhang (1997) DRUG resistance during indinavir therapy is caused by mutations in the protease gene and in its Gag substrate cleavage sites J. Virol. 71 (9), 6662-6670 (1997) 1e-130 565
565PR
567
567PR
99 HIVDB
Zhao (2009) Identification of new recombinant of CRF22 with subtype A1 or CRF02_AG of HIV-1 in Cameroon AIDS Res Hum Retroviruses. 2010 Sep;26(9):1033-45. 0 3
3PR
3RT
3IN
4
4RT
4IN
75 HIVDB
Zhao (2009) Prevalence of drug resistance in treatment-naive HIV-1 patients in Shenzhen, China Unpublished 1e-163  
21
18PR
9RT
0 Case report(s) / study subset
Zheng (1996) SEQUENCE analyses of the reverse transcriptase region of HIV-1 isolates from Sydney, Australia Unpublished 1e-98  
91
91RT
0 ARV Rx and/or other data are N/A
Zhong (2003) GENETIC and Biological Properties of HIV Type 1 Isolates Prevalent in Villagers of the Cameroon Equatorial Rain Forests and Grass Fields: Further Evidence of Broad HIV Type 1 Genetic Diversity AIDS Res. Hum. Retroviruses 19 (12), 1167-1178 (2003) 1e-49 4
4PR
4
4PR
100 HIVDB
Zhong (2007) GENETIC Diversity and Drug Resistance of Human Immunodeficiency Virus Type 1 (HIV-1) Strains Circulating in Shanghai AIDS Res. Hum. Retroviruses 23 (7), 847-856 (2007) 1e-151 70
70PR
70RT
70
49PR
70RT
100 HIVDB
Zhou (2007) HIV-1 subtypes and recombinants in Heilongjiang province Chin Med J (Engl). 2007 Nov 20;120(22):2006-10. 1e-141  
25
25RT
0 Pending
Zhu (1995) WAS HIV present in 1959? Nature 374 (6522), 503-504 (1995) 1e-163  
1
1PR
1RT
1IN
0 Pending
Zhu (2001) AN African HIV-1 sequence from 1959 and implications for the origin of the epidemic Nature 391 (6667), 594-597 (1998) 2e-17  
15
15RT
0 Gene fragment(s)
Zolfo (2010) Genotypic impact of prolonged detectable HIV-1 RNA viral load after HAART failure in a CRF01_AE infected cohort AIDS Res. Hum. Retroviruses (2010) In press 6e-49 2
2PR
2
2PR
100 HIVDB
Zolopa (1999) HIV-1 genotypic resistance patterns predict response to saquinavir-ritonavir therapy in patients in whom previous protease inhibitor therapy had failed Ann. Intern. Med. 131 (11), 813-821 (1999) 1e-121 102
54PR
48RT
108
55PR
54RT
94 HIVDB
zur Megede (2002) NOVEL evolutionary analyses of full-length HIV type 1 subtype C molecular clones from Cape Town, South Africa AIDS Res. Hum. Retroviruses 18 (17), 1327-1332 (2002) 1e-164 3
3PR
3RT
3IN
3
3PR
3RT
3IN
100 HIVDB